data_1s24_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1s24 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.312 0.577 . . . . 0.68999999999999995 110.409 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.7 mp -92.41 168.86 11.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.864 . . . . 0.65000000000000002 110.213 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.445 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 4.6 mttt -130.46 155.0 47.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.28999999999999998 110.422 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.538 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 28.7 m95 -129.39 135.57 48.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.273 -0.892 . . . . 0.29999999999999999 110.584 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.438 HD12 ' N ' ' A' ' 12' ' ' HIS . 2.0 tp -108.06 128.24 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.021 -1.049 . . . . 0.46000000000000002 110.524 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.2 t -74.8 100.12 3.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.877 . . . . 0.37 109.906 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tt -56.11 -20.05 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.41999999999999998 110.464 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.7 m -65.79 -38.17 88.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.48999999999999999 110.803 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.4 p -129.23 -34.89 1.83 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.037 -1.04 . . . . 0.28000000000000003 111.029 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.24 38.45 1.65 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.765 -1.334 . . . . 0.17000000000000001 109.765 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.438 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.1 t-160 -104.1 128.06 51.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -1.165 . . . . 0.20999999999999999 110.067 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.9 mt -92.18 143.17 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.242 -0.911 . . . . 0.16 110.836 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 64.0 t80 -108.76 131.24 55.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.706 -0.621 . . . . 0.10000000000000001 109.485 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -106.29 107.94 19.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.537 -0.727 . . . . 0.11 109.815 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -50.39 -24.6 3.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 0.12 110.631 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.66 13.18 18.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.19 110.523 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 tp -176.68 62.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.154 -0.966 . . . . 0.27000000000000002 109.881 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.64 -134.35 0.06 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.025 -1.23 . . . . 0.20999999999999999 110.025 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -80.41 150.73 29.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.454 -1.027 . . . . 0.27000000000000002 110.664 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -105.23 -25.07 12.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.872 . . . . 0.38 110.046 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.33 -43.24 28.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.408 -0.808 . . . . 0.39000000000000001 110.333 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -70.53 -43.36 69.76 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.213 -0.929 . . . . 0.39000000000000001 110.11 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.66 30.06 1.0 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.162 -1.175 . . . . 0.28000000000000003 110.162 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CE1' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -73.03 81.39 1.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.85 -1.382 . . . . 0.31 109.944 179.151 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.5 t -49.33 150.89 2.9 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.40000000000000002 110.989 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.45 95.77 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.703 1.37 . . . . 0.25 110.255 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.1 41.37 0.12 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.509 -1.436 . . . . 0.089999999999999997 109.509 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -118.21 104.93 11.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -1.148 . . . . 0.14999999999999999 110.086 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -75.67 141.56 42.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.23999999999999999 110.649 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.482 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 0.4 OUTLIER -51.95 -29.62 21.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.359 -0.838 . . . . 0.28000000000000003 110.39 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -54.12 -50.69 66.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.31 110.386 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -74.96 -2.24 26.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.293 -0.879 . . . . 0.25 110.873 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.48 HD13 ' CE2' ' A' ' 25' ' ' PHE . 43.9 mt . . . . . 0 N--CA 1.489 1.509 0 O-C-N 120.934 -1.104 . . . . 0.26000000000000001 110.338 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.552 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 85.5 t90 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.223 0.535 . . . . 0.25 110.245 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 88.4 m -121.21 -170.75 2.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.11 110.394 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.3 t -88.11 135.74 32.9 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.31 110.156 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.96 -13.28 28.97 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.458 1.241 . . . . 0.58999999999999997 110.736 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.82 -25.31 10.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 0.56999999999999995 110.795 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 85.1 m -111.32 -75.15 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.046 -1.033 . . . . 0.39000000000000001 110.571 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.03 35.54 0.77 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.444 -1.462 . . . . 0.22 109.444 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.62 -170.45 1.67 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -1.171 . . . . 0.12 110.514 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 p -78.49 -167.45 1.08 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.17000000000000001 110.383 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -83.65 -16.02 46.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -0.88 . . . . 0.33000000000000002 110.574 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.79 -22.75 59.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.091 -1.005 . . . . 0.42999999999999999 110.6 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.46 -17.81 60.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.42999999999999999 110.572 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -96.42 134.63 39.35 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.223 -0.923 . . . . 0.46999999999999997 110.928 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.437 ' CG2' HG21 ' A' ' 6' ' ' ILE . 34.2 m -125.67 171.13 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.858 . . . . 0.48999999999999999 109.972 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.27 130.27 34.82 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.163 -0.961 . . . . 0.56999999999999995 110.784 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.4 t80 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 0.56999999999999995 110.383 179.754 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.363 0.602 . . . . 0.68999999999999995 110.508 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 mp -75.56 162.69 28.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -0.8 . . . . 0.65000000000000002 110.523 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -134.19 134.91 42.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -0.871 . . . . 0.28999999999999998 110.231 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.532 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 24.8 m95 -115.24 -178.13 3.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.29999999999999999 110.229 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.476 HG22 HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -161.37 124.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.399 -0.813 . . . . 0.46000000000000002 110.059 178.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.2 t -69.3 100.02 1.27 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.371 -0.831 . . . . 0.37 110.418 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tt -53.98 -22.06 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.178 -0.951 . . . . 0.41999999999999998 109.982 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.7 m -80.75 -28.88 36.33 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.25 -0.906 . . . . 0.48999999999999999 110.175 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -110.2 -53.39 2.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 0.28000000000000003 110.553 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.72 -11.02 12.25 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.133 -1.187 . . . . 0.17000000000000001 110.133 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -75.65 138.86 41.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.941 -1.329 . . . . 0.20999999999999999 110.482 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 51.3 mt -97.6 136.91 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.364 -0.835 . . . . 0.16 110.589 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.475 ' CE1' ' HA2' ' A' ' 19' ' ' GLY . 87.3 t80 -92.18 138.9 31.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.404 -0.81 . . . . 0.10000000000000001 110.305 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -112.41 108.87 18.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.49 -0.756 . . . . 0.11 109.988 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -50.98 -24.42 3.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.154 -0.966 . . . . 0.12 110.7 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.31 16.43 8.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.19 110.4 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -176.96 69.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.27000000000000002 109.855 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.475 ' HA2' ' CE1' ' A' ' 14' ' ' TYR . . . -68.37 -137.04 0.07 OUTLIER Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.143 -1.183 . . . . 0.20999999999999999 110.143 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 22' ' ' ALA . 15.8 t0 -87.07 149.77 24.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.406 -1.055 . . . . 0.27000000000000002 110.718 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.408 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 36.5 mt-10 -97.17 -30.59 12.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.854 . . . . 0.38 110.023 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.424 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . -75.16 -44.86 44.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.387 -0.821 . . . . 0.39000000000000001 110.316 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -63.61 -38.94 93.04 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.255 -0.903 . . . . 0.39000000000000001 110.312 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.13 23.21 4.28 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.677 -1.369 . . . . 0.28000000000000003 109.677 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.476 ' CE2' HG23 ' A' ' 29' ' ' THR . 0.7 OUTLIER -66.72 83.81 0.11 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.099 -1.236 . . . . 0.31 110.124 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.4 t -49.77 152.54 2.53 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.446 -0.784 . . . . 0.40000000000000002 110.918 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -58.04 106.99 0.28 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.703 1.37 . . . . 0.25 110.468 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.4 38.99 0.46 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.474 -1.45 . . . . 0.089999999999999997 109.474 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.476 HG23 ' CE2' ' A' ' 25' ' ' PHE . 26.2 m -108.97 134.4 51.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -1.115 . . . . 0.14999999999999999 110.353 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -117.96 141.02 48.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.23999999999999999 110.346 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.532 ' CZ ' ' CZ3' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -48.94 -36.59 17.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.198 -0.939 . . . . 0.28000000000000003 110.747 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -57.15 -34.79 68.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.237 -0.914 . . . . 0.31 109.989 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -87.37 -23.07 24.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.333 -0.854 . . . . 0.25 110.234 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 31' ' ' PHE . 20.8 mt . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.26000000000000001 109.913 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.532 ' CZ3' ' CZ ' ' A' ' 31' ' ' PHE . 79.7 t90 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.336 0.589 . . . . 0.25 110.363 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.473 ' N ' ' CD2' ' A' ' 38' ' ' TRP . 25.3 p -173.94 -160.89 0.11 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.389 -0.819 . . . . 0.11 110.148 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.55 143.4 72.06 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.307 -0.87 . . . . 0.31 110.091 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.56 -7.62 19.69 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.664 1.35 . . . . 0.58999999999999997 111.373 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.8 -32.21 2.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.952 -1.093 . . . . 0.56999999999999995 111.05 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 63.3 m -92.4 -70.34 0.7 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.07 -1.019 . . . . 0.39000000000000001 110.407 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.27 25.11 4.83 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.288 -1.525 . . . . 0.22 109.288 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.14 174.4 5.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -1.147 . . . . 0.12 110.569 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.0 p -67.42 -162.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.17000000000000001 110.345 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -78.65 -2.83 40.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.33000000000000002 110.769 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -45.03 64.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.957 -1.09 . . . . 0.42999999999999999 110.463 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -73.02 -20.25 61.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.42999999999999999 110.219 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -90.58 129.7 36.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.46999999999999997 110.495 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.4 m -128.21 159.97 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.48999999999999999 110.21 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.42 119.05 17.12 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.195 -0.94 . . . . 0.56999999999999995 110.383 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.1 t80 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.56999999999999995 110.628 -179.552 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.389 0.614 . . . . 0.68999999999999995 110.483 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mp -92.36 163.13 13.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.298 -0.876 . . . . 0.65000000000000002 110.284 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.73 146.56 50.89 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.244 -0.91 . . . . 0.28999999999999998 109.809 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.553 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 25.0 m95 -119.82 -176.55 3.2 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.319 -0.863 . . . . 0.29999999999999999 109.616 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.461 HG22 HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -152.96 129.42 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.407 -0.917 . . . . 0.46000000000000002 110.481 178.405 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 t -75.69 92.14 2.96 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.495 -0.753 . . . . 0.37 109.982 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.423 HG13 ' N ' ' A' ' 9' ' ' THR . 15.9 pt -51.67 -23.64 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.009 -1.057 . . . . 0.41999999999999998 109.928 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.423 ' N ' HG13 ' A' ' 8' ' ' ILE . 45.9 m -68.9 -26.96 65.37 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.495 -0.753 . . . . 0.48999999999999999 110.295 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.7 m -125.83 -49.99 1.6 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -0.953 . . . . 0.28000000000000003 111.284 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.402 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . 118.97 13.22 6.63 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.905 -1.278 . . . . 0.17000000000000001 109.905 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.02 125.51 37.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.994 -1.297 . . . . 0.20999999999999999 110.177 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.4 mt -88.79 141.17 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.16 110.696 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -102.44 148.1 25.91 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.657 0.741 . . . . 0.10000000000000001 110.35 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -124.15 106.75 10.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.579 -0.701 . . . . 0.11 109.923 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.427 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 98.8 mt-10 -50.26 -24.42 2.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.12 110.565 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.21 20.19 7.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.19 110.257 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tp -176.49 65.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.27000000000000002 109.966 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.8 -141.56 0.32 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.886 -1.286 . . . . 0.20999999999999999 109.886 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.02 171.63 7.24 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.38 -1.07 . . . . 0.27000000000000002 110.543 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -106.42 -35.63 7.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.35 -0.844 . . . . 0.38 110.159 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.36 -41.73 89.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.872 . . . . 0.39000000000000001 110.171 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -73.91 -3.33 28.26 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.253 -0.904 . . . . 0.39000000000000001 110.901 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.22 25.19 64.34 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.348 -1.501 . . . . 0.28000000000000003 109.348 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -82.66 79.99 8.91 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.277 -1.131 . . . . 0.31 109.985 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.0 t -49.46 151.29 2.84 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.389 -0.819 . . . . 0.40000000000000002 111.004 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -60.0 114.97 2.32 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.704 1.371 . . . . 0.25 110.42 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.65 16.58 5.89 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.868 -1.293 . . . . 0.089999999999999997 109.868 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.3 m -86.01 116.52 24.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.244 . . . . 0.14999999999999999 110.224 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.427 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 43.6 mtt85 -90.26 140.65 29.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.23999999999999999 110.576 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.489 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -59.18 -35.14 73.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.888 . . . . 0.28000000000000003 110.165 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -52.28 -30.64 28.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.31 110.35 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -100.86 19.04 17.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -0.844 . . . . 0.25 110.345 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.475 HD12 ' CZ ' ' A' ' 25' ' ' PHE . 92.9 mt . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.26000000000000001 109.989 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 85.8 t90 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.328 0.585 . . . . 0.25 110.372 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.7 m -128.96 -164.58 1.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.11 110.181 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.45 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -79.95 152.79 74.73 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.128 -0.983 . . . . 0.31 110.236 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -62.97 -12.88 31.74 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.583 1.307 . . . . 0.58999999999999997 111.325 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -157.49 40.69 0.3 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.91 -1.119 . . . . 0.56999999999999995 111.185 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.45 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 56.7 m -141.88 -59.51 0.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.034 -1.042 . . . . 0.39000000000000001 110.184 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.08 25.62 11.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.117 -1.593 . . . . 0.22 109.117 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.12 -170.37 2.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -1.112 . . . . 0.12 110.408 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.2 p -108.89 -173.19 2.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.17000000000000001 110.372 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -63.04 -16.65 60.58 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.268 -0.895 . . . . 0.33000000000000002 110.261 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -55.58 -38.77 69.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.42999999999999999 110.246 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 5.7 m-20 -77.05 -12.88 60.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.31 -0.869 . . . . 0.42999999999999999 110.473 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -100.72 136.82 39.98 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.049 -1.032 . . . . 0.46999999999999997 110.772 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 52' ' ' LEU . 99.5 t -133.15 149.05 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.47 -0.769 . . . . 0.48999999999999999 109.985 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.417 ' N ' HG11 ' A' ' 51' ' ' VAL . 1.1 tt -63.71 120.54 12.02 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.112 -0.992 . . . . 0.56999999999999995 110.279 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 30.0 t80 . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.335 -0.853 . . . . 0.56999999999999995 110.375 -179.326 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.329 0.585 . . . . 0.68999999999999995 110.403 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mp -98.85 170.05 9.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.507 -0.745 . . . . 0.65000000000000002 110.678 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -134.84 148.93 50.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.28999999999999998 110.186 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.45 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 48.9 m95 -129.91 178.87 6.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 0.29999999999999999 110.504 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 tp -156.32 120.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.65 -0.656 . . . . 0.46000000000000002 109.741 178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 11' ' ' GLY . 18.9 t -67.67 96.93 0.58 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.372 -0.83 . . . . 0.37 110.313 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 9' ' ' THR . 1.5 tt -54.99 -19.92 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.142 -0.974 . . . . 0.41999999999999998 110.289 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.418 ' N ' HG22 ' A' ' 8' ' ' ILE . 43.6 m -80.62 -28.35 37.01 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.261 -0.899 . . . . 0.48999999999999999 110.381 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.4 m -117.23 -46.43 2.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.163 -0.961 . . . . 0.28000000000000003 110.856 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . 109.0 19.8 8.35 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.678 -1.369 . . . . 0.17000000000000001 109.678 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -99.65 134.48 42.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -1.21 . . . . 0.20999999999999999 110.069 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 4.4 mt -96.24 141.04 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.16 110.656 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -108.21 144.56 35.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.512 -0.742 . . . . 0.10000000000000001 110.329 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -119.9 109.42 15.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.429 -0.794 . . . . 0.11 110.097 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.412 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 69.8 mt-10 -50.22 -27.85 6.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 0.12 110.474 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.85 12.83 24.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.921 . . . . 0.19 110.617 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.55 68.45 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.12 -0.987 . . . . 0.27000000000000002 110.42 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.25 -135.5 0.01 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.402 -1.479 . . . . 0.20999999999999999 109.402 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.25 164.75 12.71 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.225 -1.161 . . . . 0.27000000000000002 110.287 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -92.81 -22.14 19.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -0.913 . . . . 0.38 110.31 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.67 -36.46 17.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.39000000000000001 110.366 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -65.19 -26.92 68.35 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.255 -0.903 . . . . 0.39000000000000001 110.332 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.83 27.47 14.17 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.548 -1.421 . . . . 0.28000000000000003 109.548 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.491 ' CZ ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -73.51 84.0 1.51 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.108 -1.231 . . . . 0.31 110.208 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.4 t -50.06 143.94 11.58 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.192 -0.943 . . . . 0.40000000000000002 110.474 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.15 106.57 0.21 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.653 1.344 . . . . 0.25 110.645 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.02 44.42 0.17 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.582 -1.407 . . . . 0.089999999999999997 109.582 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 m -130.59 122.87 28.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.11 -1.229 . . . . 0.14999999999999999 110.511 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.412 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 1.7 ptm180 -103.58 150.91 23.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.23999999999999999 110.446 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.547 ' CZ ' ' CZ3' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -48.4 -44.62 35.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.232 -0.917 . . . . 0.28000000000000003 110.833 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -53.61 -48.73 69.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.31 110.234 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.93 -22.57 66.5 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.265 -0.897 . . . . 0.25 110.217 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.491 HD12 ' CZ ' ' A' ' 25' ' ' PHE . 46.8 mt . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.431 -0.793 . . . . 0.26000000000000001 110.047 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.547 ' CZ3' ' CZ ' ' A' ' 31' ' ' PHE . 79.8 t90 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.234 0.54 . . . . 0.25 110.096 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.6 p -162.36 -160.53 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.11 110.386 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.434 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -86.55 160.95 49.64 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.358 -0.839 . . . . 0.31 110.422 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -73.88 -23.05 16.81 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.607 1.319 . . . . 0.58999999999999997 110.953 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -139.49 30.46 2.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.993 -1.067 . . . . 0.56999999999999995 111.178 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.434 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 60.6 m -141.57 -46.15 0.37 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.974 -1.079 . . . . 0.39000000000000001 110.255 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.27 28.92 47.18 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.5 -1.44 . . . . 0.22 109.5 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.32 -171.81 2.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -1.174 . . . . 0.12 110.334 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.4 p -109.25 -159.85 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.17000000000000001 110.336 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -58.34 -18.5 27.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.394 -0.816 . . . . 0.33000000000000002 110.253 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -50.22 -48.29 54.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.064 -1.022 . . . . 0.42999999999999999 110.56 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.03 -20.42 61.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.42999999999999999 110.154 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -95.92 137.58 34.78 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.315 -0.866 . . . . 0.46999999999999997 110.764 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 80.7 t -125.11 158.73 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.388 -0.82 . . . . 0.48999999999999999 109.931 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.33 100.13 2.58 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.179 -0.951 . . . . 0.56999999999999995 110.083 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 28.6 t80 . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.446 -0.784 . . . . 0.56999999999999995 110.516 -179.361 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.338 0.59 . . . . 0.68999999999999995 110.537 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.64 179.16 7.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.435 -0.791 . . . . 0.65000000000000002 110.587 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -146.68 138.8 24.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.405 -0.809 . . . . 0.28999999999999998 110.451 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.54 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 29.2 m95 -118.23 -178.37 3.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -0.822 . . . . 0.29999999999999999 110.08 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -156.55 118.67 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.394 -0.816 . . . . 0.46000000000000002 110.374 177.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.6 t -63.93 92.2 0.07 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.243 -0.911 . . . . 0.37 109.919 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 9' ' ' THR . 8.6 pt -51.7 -23.71 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.182 -0.949 . . . . 0.41999999999999998 110.073 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.417 ' N ' HG13 ' A' ' 8' ' ' ILE . 36.3 m -72.48 -29.42 63.63 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.306 -0.871 . . . . 0.48999999999999999 110.039 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.2 m -114.29 -49.04 2.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.28000000000000003 110.667 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.22 8.64 16.81 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.032 -1.227 . . . . 0.17000000000000001 110.032 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.25 133.97 35.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.911 -1.347 . . . . 0.20999999999999999 110.091 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 90.4 mt -93.2 124.43 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.16 110.783 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -84.55 131.04 34.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.42 -0.8 . . . . 0.10000000000000001 109.978 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -108.44 111.78 23.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.11 109.815 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.426 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -51.9 -23.95 5.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.12 110.265 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.75 13.55 12.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.19 110.509 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.57 64.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.27000000000000002 109.756 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.43 -136.29 0.12 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.049 -1.221 . . . . 0.20999999999999999 110.049 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -84.91 144.53 28.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -1.04 . . . . 0.27000000000000002 110.598 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -91.07 -22.95 20.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.307 -0.871 . . . . 0.38 110.082 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.8 -39.93 15.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.39000000000000001 110.302 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -65.96 -32.35 73.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.39000000000000001 110.259 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.18 29.22 4.63 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.54 -1.424 . . . . 0.28000000000000003 109.54 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.567 ' CE1' ' CD1' ' A' ' 38' ' ' TRP . 1.5 m-85 -73.69 82.74 1.58 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.111 -1.229 . . . . 0.31 110.181 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.2 t -49.49 149.3 4.16 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.40000000000000002 110.785 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.17 110.83 0.62 Allowed 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.666 1.351 . . . . 0.25 110.397 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.09 19.82 4.63 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.741 -1.344 . . . . 0.089999999999999997 109.741 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.3 m -86.58 133.76 33.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.058 -1.26 . . . . 0.14999999999999999 110.262 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.426 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 2.3 mtp180 -116.12 144.56 43.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.87 . . . . 0.23999999999999999 110.431 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.462 ' HA ' ' CD1' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -49.57 -25.16 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.314 -0.866 . . . . 0.28000000000000003 110.525 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.41 -24.33 54.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.895 . . . . 0.31 110.479 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -114.17 11.28 17.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.25 110.836 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.494 HG23 ' CE3' ' A' ' 38' ' ' TRP . 8.6 mt . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.071 -1.018 . . . . 0.26000000000000001 110.928 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.567 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 82.2 t90 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.351 0.596 . . . . 0.25 110.67 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.433 ' N ' ' CG ' ' A' ' 38' ' ' TRP . 25.0 p -169.66 -161.34 0.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.329 -0.857 . . . . 0.11 110.31 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.438 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -91.82 169.25 11.48 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 0.31 110.227 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.28 -40.53 31.84 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.584 1.307 . . . . 0.58999999999999997 110.746 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.1 50.76 1.03 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.091 -1.005 . . . . 0.56999999999999995 110.689 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.438 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 61.7 m -136.58 -45.63 0.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.39000000000000001 110.086 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.34 32.45 51.69 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.354 -1.498 . . . . 0.22 109.354 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.23 166.72 10.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 0.12 110.443 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.4 p -91.59 -162.15 0.89 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.398 -0.814 . . . . 0.17000000000000001 110.161 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp -61.67 -15.47 40.3 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.239 -0.913 . . . . 0.33000000000000002 110.377 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 49' ' ' ASP . 23.2 pt-20 -51.79 -40.68 60.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.052 -1.03 . . . . 0.42999999999999999 110.354 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.426 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 14.9 m-20 -80.58 -18.37 48.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.231 -0.918 . . . . 0.42999999999999999 110.368 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -95.21 124.17 39.11 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.185 -0.947 . . . . 0.46999999999999997 110.455 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 52' ' ' LEU . 97.9 t -117.21 148.02 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.279 -0.888 . . . . 0.48999999999999999 110.088 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.422 ' N ' HG12 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -67.76 117.44 9.67 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.152 -0.968 . . . . 0.56999999999999995 110.096 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 31.7 t80 . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.56999999999999995 110.535 -178.943 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.304 0.573 . . . . 0.68999999999999995 110.351 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.5 mp -91.03 164.16 14.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.409 -0.807 . . . . 0.65000000000000002 110.725 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -122.56 144.76 48.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -0.835 . . . . 0.28999999999999998 110.07 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.506 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 39.2 m95 -121.5 179.07 4.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 0.29999999999999999 110.537 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.1 tp -153.88 128.18 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.717 -0.614 . . . . 0.46000000000000002 110.068 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 45.3 t -76.97 98.03 4.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.37 110.291 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -52.68 -23.3 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.097 -1.002 . . . . 0.41999999999999998 110.175 179.446 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.432 ' N ' HG22 ' A' ' 8' ' ' ILE . 52.4 m -79.82 -30.61 40.52 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.388 -0.82 . . . . 0.48999999999999999 110.351 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -108.99 -54.44 2.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 0.28000000000000003 110.569 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.38 13.48 10.63 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.896 -1.281 . . . . 0.17000000000000001 109.896 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -99.33 133.82 43.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.934 -1.333 . . . . 0.20999999999999999 110.047 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 3.9 mt -89.68 145.68 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.16 110.631 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.406 ' CE1' ' HA2' ' A' ' 19' ' ' GLY . 75.4 t80 -104.82 129.26 53.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.564 -0.71 . . . . 0.10000000000000001 110.352 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -102.8 104.39 14.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.301 -0.874 . . . . 0.11 110.006 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -51.89 -23.0 4.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -0.865 . . . . 0.12 110.758 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.31 -2.74 26.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.235 -0.915 . . . . 0.19 110.943 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.433 ' O ' ' CG ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -173.42 68.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.987 -1.071 . . . . 0.27000000000000002 110.062 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.406 ' HA2' ' CE1' ' A' ' 14' ' ' TYR . . . -62.97 -136.96 0.01 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.328 -1.109 . . . . 0.20999999999999999 110.328 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -92.71 166.09 12.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.294 -1.121 . . . . 0.27000000000000002 110.512 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -109.21 -27.1 9.74 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.326 -0.858 . . . . 0.38 110.129 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.74 -54.16 17.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.39000000000000001 110.172 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -63.56 -24.76 67.94 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.228 -0.92 . . . . 0.39000000000000001 110.137 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.5 28.99 5.52 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.542 -1.423 . . . . 0.28000000000000003 109.542 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.581 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.7 OUTLIER -81.49 79.88 7.99 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.153 -1.204 . . . . 0.31 110.442 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -53.26 152.82 7.63 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.254 -0.904 . . . . 0.40000000000000002 110.511 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -54.54 95.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.608 1.32 . . . . 0.25 110.307 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 144.81 -15.88 1.98 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.815 -1.314 . . . . 0.089999999999999997 109.815 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.6 m -50.45 121.94 6.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.017 -1.284 . . . . 0.14999999999999999 110.633 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -105.6 139.84 39.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.23999999999999999 110.266 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.483 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -47.32 -46.77 25.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.337 -0.852 . . . . 0.28000000000000003 110.835 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.67 -33.57 47.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.284 -0.885 . . . . 0.31 110.233 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.42 11.81 27.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.335 -0.853 . . . . 0.25 110.653 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.468 HD13 ' CZ ' ' A' ' 25' ' ' PHE . 91.3 mt . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.011 -1.056 . . . . 0.26000000000000001 109.971 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 81.0 t90 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.218 0.532 . . . . 0.25 109.993 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 95.3 m -143.38 -175.12 4.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.11 110.401 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -74.08 136.97 75.85 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.31 110.233 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -72.6 -13.05 27.25 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.463 1.244 . . . . 0.58999999999999997 110.846 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.51 -23.94 11.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.027 -1.046 . . . . 0.56999999999999995 110.756 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 95.8 m -111.86 -75.04 0.62 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.027 -1.046 . . . . 0.39000000000000001 110.418 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.38 36.83 0.67 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.402 -1.479 . . . . 0.22 109.402 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.66 -169.17 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -1.166 . . . . 0.12 110.499 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.7 p -88.8 -162.5 0.86 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 0.17000000000000001 110.4 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.25 -9.79 54.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.853 . . . . 0.33000000000000002 110.639 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -52.14 -44.76 64.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.984 -1.072 . . . . 0.42999999999999999 110.463 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.9 OUTLIER -71.31 -20.6 62.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.161 -0.962 . . . . 0.42999999999999999 110.033 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -96.06 134.08 39.54 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.248 -0.907 . . . . 0.46999999999999997 110.662 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.54 171.85 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.831 . . . . 0.48999999999999999 110.115 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.62 118.51 18.54 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.253 -0.904 . . . . 0.56999999999999995 110.311 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.0 t80 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.56999999999999995 110.579 -179.442 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.408 0.623 . . . . 0.68999999999999995 110.35 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 mp -104.1 179.79 4.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.65000000000000002 110.743 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -139.63 145.97 39.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.496 -0.752 . . . . 0.28999999999999998 110.009 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.524 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 34.1 m95 -127.82 134.72 49.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.082 -1.011 . . . . 0.29999999999999999 110.658 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.44 HD12 ' N ' ' A' ' 12' ' ' HIS . 2.6 tp -111.62 132.62 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.023 -1.048 . . . . 0.46000000000000002 110.297 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.9 t -79.13 100.05 7.24 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.345 -0.847 . . . . 0.37 110.037 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.428 HG21 ' N ' ' A' ' 9' ' ' THR . 1.6 tt -56.17 -18.74 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.917 . . . . 0.41999999999999998 110.619 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.428 ' N ' HG21 ' A' ' 8' ' ' ILE . 92.0 m -70.08 -39.56 75.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.885 . . . . 0.48999999999999999 110.824 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.9 p -126.8 -35.31 2.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.971 -1.081 . . . . 0.28000000000000003 111.116 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.97 44.7 1.08 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.852 -1.299 . . . . 0.17000000000000001 109.852 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.44 ' N ' HD12 ' A' ' 6' ' ' ILE . 9.5 t60 -108.74 127.7 54.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -1.211 . . . . 0.20999999999999999 110.142 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.8 mt -93.09 133.52 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.16 110.8 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -102.84 121.39 42.39 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.506 -0.746 . . . . 0.10000000000000001 109.295 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -98.98 106.26 18.5 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.415 -0.803 . . . . 0.11 110.19 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.433 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -48.74 -24.16 1.3 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.385 -0.822 . . . . 0.12 111.015 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.65 14.45 8.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.067 -1.021 . . . . 0.19 110.803 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 tt -176.61 69.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.1 -1.0 . . . . 0.27000000000000002 109.999 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.06 -136.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.842 -1.303 . . . . 0.20999999999999999 109.842 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -113.37 161.31 17.42 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.347 -1.09 . . . . 0.27000000000000002 110.179 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -97.27 -27.74 14.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.38 110.36 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.95 -29.03 58.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.92 . . . . 0.39000000000000001 110.345 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -88.9 16.59 6.7 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.298 -0.876 . . . . 0.39000000000000001 110.805 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.1 28.38 63.87 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.456 -1.458 . . . . 0.28000000000000003 109.456 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -86.85 82.71 7.72 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.232 -1.158 . . . . 0.31 110.046 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.8 t -47.86 151.4 1.63 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.469 -0.769 . . . . 0.40000000000000002 110.961 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -56.96 104.92 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.701 1.369 . . . . 0.25 110.467 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.1 35.51 0.76 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.622 -1.391 . . . . 0.089999999999999997 109.622 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.431 HG23 ' CG1' ' A' ' 34' ' ' ILE . 58.2 m -90.3 134.32 34.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.189 -1.183 . . . . 0.14999999999999999 110.32 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.433 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -105.72 135.51 47.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 0.23999999999999999 110.468 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.478 ' CB ' ' CE2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -51.0 -47.21 61.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.28000000000000003 110.473 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -54.91 -41.43 70.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.861 . . . . 0.31 110.442 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.98 -24.34 52.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.25 110.394 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.461 HD12 ' CE2' ' A' ' 25' ' ' PHE . 63.4 mt . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.26000000000000001 110.119 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 89.4 t90 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.27 0.557 . . . . 0.25 110.47 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.8 p -162.24 -160.89 0.7 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.11 110.343 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.56 120.85 70.37 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.401 -0.812 . . . . 0.31 110.173 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.35 -12.82 34.88 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.473 1.249 . . . . 0.58999999999999997 110.849 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.412 ' OD2' ' ND1' ' A' ' 12' ' ' HIS . 87.8 m-20 -102.55 -26.84 13.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.052 -1.03 . . . . 0.56999999999999995 110.674 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 96.6 m -114.32 -75.42 0.59 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.139 -0.976 . . . . 0.39000000000000001 110.327 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.3 40.83 0.35 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.396 -1.482 . . . . 0.22 109.396 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.43 -175.09 3.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -1.173 . . . . 0.12 110.667 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 p -82.55 -166.71 1.36 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.385 -0.822 . . . . 0.17000000000000001 110.511 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -69.02 -8.76 48.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.32 -0.863 . . . . 0.33000000000000002 110.551 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -50.95 -42.88 60.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.987 -1.07 . . . . 0.42999999999999999 110.299 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -76.02 -20.64 57.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.319 -0.863 . . . . 0.42999999999999999 110.377 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -92.86 131.41 37.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.46999999999999997 110.596 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.415 ' CG2' HG22 ' A' ' 6' ' ' ILE . 35.9 m -124.27 163.19 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.279 -0.888 . . . . 0.48999999999999999 110.161 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.86 120.35 25.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.56999999999999995 110.581 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.1 t80 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.362 -0.836 . . . . 0.56999999999999995 110.389 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' A' ' 17' ' ' ALA . 42.6 m-85 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.344 0.592 . . . . 0.68999999999999995 110.479 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 mp -75.04 164.44 26.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.65000000000000002 110.528 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -130.31 136.58 49.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.28999999999999998 110.093 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.517 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 29.6 m95 -115.84 170.61 8.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.966 . . . . 0.29999999999999999 110.283 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.431 HG23 ' CG2' ' A' ' 51' ' ' VAL . 2.1 tp -144.38 136.27 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.454 -0.779 . . . . 0.46000000000000002 109.775 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.402 ' O ' ' N ' ' A' ' 11' ' ' GLY . 8.4 t -84.44 95.12 8.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.366 -0.834 . . . . 0.37 110.342 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -52.81 -22.88 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.11 -0.993 . . . . 0.41999999999999998 110.043 179.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.423 ' N ' HG21 ' A' ' 8' ' ' ILE . 49.2 m -72.72 -28.02 62.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.372 -0.83 . . . . 0.48999999999999999 110.302 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 78.9 m -124.6 -51.38 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.28000000000000003 110.64 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . 117.3 19.34 5.11 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.833 -1.307 . . . . 0.17000000000000001 109.833 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -97.57 133.09 42.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.051 -1.264 . . . . 0.20999999999999999 110.102 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 3.9 mt -91.28 134.51 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.16 110.504 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -94.33 125.89 39.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.5 -0.75 . . . . 0.10000000000000001 109.892 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -95.83 102.55 14.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.459 -0.775 . . . . 0.11 110.289 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -49.35 -30.96 8.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.85 . . . . 0.12 110.702 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 2' ' ' TYR . . . -91.74 17.47 8.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.895 . . . . 0.19 110.457 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -177.0 70.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -0.956 . . . . 0.27000000000000002 110.076 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.87 -135.4 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.89 -1.284 . . . . 0.20999999999999999 109.89 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD2' ' N ' ' A' ' 22' ' ' ALA . 16.3 t70 -113.12 168.97 9.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.345 -1.091 . . . . 0.27000000000000002 110.571 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -87.81 -46.62 9.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.27 -0.894 . . . . 0.38 110.073 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . -53.83 -43.76 69.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.337 -0.852 . . . . 0.39000000000000001 110.205 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -70.88 -30.22 66.54 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.32 -0.862 . . . . 0.39000000000000001 110.083 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.27 28.85 18.89 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.686 -1.366 . . . . 0.28000000000000003 109.686 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CE2' ' NE1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -69.19 82.86 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.275 . . . . 0.31 110.064 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.5 t -49.49 145.75 7.57 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.196 -0.94 . . . . 0.40000000000000002 110.723 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -53.51 105.66 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.683 1.359 . . . . 0.25 110.712 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.48 41.98 0.26 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.879 -1.288 . . . . 0.089999999999999997 109.879 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.19 126.76 44.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -1.218 . . . . 0.14999999999999999 110.267 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.429 ' HG2' ' CB ' ' A' ' 33' ' ' ASP . 0.4 OUTLIER -118.38 148.68 42.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.23999999999999999 110.256 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.485 ' CE2' ' HG2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -47.78 -40.74 21.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.254 -0.904 . . . . 0.28000000000000003 110.673 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -59.31 -32.38 70.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.191 -0.943 . . . . 0.31 109.983 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.429 ' CB ' ' HG2' ' A' ' 30' ' ' ARG . 21.3 t0 -95.39 12.67 28.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 0.25 110.551 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 34' ' ' ILE . 92.3 mt . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.092 -1.005 . . . . 0.26000000000000001 110.119 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.424 ' NE1' ' CE2' ' A' ' 25' ' ' PHE . 85.6 t90 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.292 0.568 . . . . 0.25 110.553 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 8.4 m -135.07 172.31 13.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.342 -0.849 . . . . 0.11 110.173 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.438 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -55.92 151.6 23.76 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.31 110.334 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -74.22 -7.77 20.15 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.513 1.27 . . . . 0.58999999999999997 111.201 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -150.64 32.72 0.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.899 -1.126 . . . . 0.56999999999999995 111.053 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.438 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 59.0 m -142.11 -65.86 0.41 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.084 -1.01 . . . . 0.39000000000000001 110.045 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.54 29.4 3.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.496 -1.442 . . . . 0.22 109.496 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -105.71 171.01 7.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -1.106 . . . . 0.12 110.462 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.5 p -90.13 -162.39 0.89 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.17000000000000001 110.205 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.485 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 23.0 mttt -68.08 -14.33 62.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.341 -0.849 . . . . 0.33000000000000002 110.437 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -52.7 -45.87 67.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.098 -1.001 . . . . 0.42999999999999999 110.215 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 1.6 m-20 -70.49 -20.89 62.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.321 -0.862 . . . . 0.42999999999999999 109.992 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -97.76 134.75 40.51 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.378 -0.826 . . . . 0.46999999999999997 110.593 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.431 ' CG2' HG23 ' A' ' 6' ' ' ILE . 34.3 m -130.75 170.93 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.48999999999999999 110.274 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.25 119.44 22.33 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.165 -0.959 . . . . 0.56999999999999995 110.344 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.8 t80 . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.883 . . . . 0.56999999999999995 110.529 -179.559 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.366 0.603 . . . . 0.68999999999999995 110.512 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.93 157.42 15.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 0.65000000000000002 110.481 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.431 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 0.9 OUTLIER -121.2 160.36 23.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.28999999999999998 110.097 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.447 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 55.9 m95 -135.09 127.1 29.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.151 -0.968 . . . . 0.29999999999999999 110.651 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.462 HG23 HD12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -98.83 130.43 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.09 -1.006 . . . . 0.46000000000000002 110.028 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.422 ' N ' HD11 ' A' ' 6' ' ' ILE . 12.0 t -78.68 92.88 4.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.216 -0.928 . . . . 0.37 109.507 177.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.448 HG22 ' CG2' ' A' ' 51' ' ' VAL . 48.0 pt -51.49 -23.99 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.884 -1.135 . . . . 0.41999999999999998 110.031 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.9 m -77.13 -27.4 53.91 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.546 -0.721 . . . . 0.48999999999999999 110.195 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.7 m -117.03 -47.35 2.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.28000000000000003 111.503 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . 114.28 -22.14 14.15 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.126 -1.59 . . . . 0.17000000000000001 109.126 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 13' ' ' ILE . 8.8 t60 -69.67 145.3 52.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -1.177 . . . . 0.20999999999999999 110.213 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.454 ' O ' ' CD2' ' A' ' 12' ' ' HIS . 7.2 mt -108.14 151.84 10.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.391 -0.818 . . . . 0.16 111.041 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.401 ' OH ' ' CE2' ' A' ' 25' ' ' PHE . 75.6 t80 -103.82 128.47 51.26 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.701 -0.624 . . . . 0.10000000000000001 109.992 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -102.89 103.85 14.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.532 -0.73 . . . . 0.11 110.344 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -51.37 -23.45 3.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.389 -0.819 . . . . 0.12 110.717 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.79 11.77 10.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.19 110.897 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -176.47 69.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.27000000000000002 109.906 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.72 -146.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.011 -1.236 . . . . 0.20999999999999999 110.011 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.06 172.96 9.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.399 -1.059 . . . . 0.27000000000000002 110.697 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -110.58 -21.57 12.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.38 110.301 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.11 -59.92 2.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.39000000000000001 110.399 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -57.68 -21.23 39.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.39000000000000001 110.3 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.36 31.96 6.92 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.198 -1.561 . . . . 0.28000000000000003 109.198 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -78.71 76.98 5.2 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.345 -1.091 . . . . 0.31 110.122 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.9 t -51.38 148.45 8.89 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.431 -0.793 . . . . 0.40000000000000002 110.865 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -56.51 123.83 14.79 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.695 1.366 . . . . 0.25 110.493 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.6 22.87 5.28 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.572 -1.411 . . . . 0.089999999999999997 109.572 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.8 m -97.29 132.69 42.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -1.159 . . . . 0.14999999999999999 110.268 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.8 ttp85 -109.01 142.24 39.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.23999999999999999 110.394 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.549 ' CZ ' ' CZ3' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -48.01 -48.25 32.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.266 -0.897 . . . . 0.28000000000000003 110.821 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.54 -46.82 66.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.89 . . . . 0.31 110.179 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.59 -11.66 60.74 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.4 -0.813 . . . . 0.25 110.378 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 31' ' ' PHE . 77.8 mt . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.026 -1.046 . . . . 0.26000000000000001 109.973 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 69.2 t90 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.342 0.591 . . . . 0.25 110.241 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.2 p -156.49 -160.38 0.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.11 110.192 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 1.2 t -81.22 145.77 56.82 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 0.31 110.123 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.16 -12.98 21.22 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.397 1.209 . . . . 0.58999999999999997 111.194 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -121.23 -12.79 8.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.899 -1.126 . . . . 0.56999999999999995 111.387 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 99.1 m -116.17 -72.91 0.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.917 -1.114 . . . . 0.39000000000000001 110.597 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.29 29.65 1.9 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.675 -1.37 . . . . 0.22 109.675 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.87 -174.88 2.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -1.154 . . . . 0.12 110.285 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.7 p -89.82 -158.86 0.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.17000000000000001 110.315 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -64.22 -12.08 37.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.427 -0.796 . . . . 0.33000000000000002 110.568 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -48.33 -45.98 35.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.048 -1.032 . . . . 0.42999999999999999 110.846 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.406 ' OD1' ' CD2' ' A' ' 50' ' ' TYR . 2.7 p30 -79.53 -19.31 49.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.42999999999999999 110.334 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.406 ' CD2' ' OD1' ' A' ' 49' ' ' ASP . 2.7 m-85 -94.13 128.72 40.7 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.118 -0.989 . . . . 0.46999999999999997 110.573 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.448 ' CG2' HG22 ' A' ' 8' ' ' ILE . 95.4 t -123.15 161.86 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.48999999999999999 110.148 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.24 110.43 10.74 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.223 -0.923 . . . . 0.56999999999999995 110.371 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.0 t80 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.56999999999999995 110.539 -179.787 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.435 ' CE1' ' HA2' ' A' ' 28' ' ' GLY . 34.1 m-85 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.285 0.564 . . . . 0.68999999999999995 110.383 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mp -84.14 172.34 12.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.373 -0.829 . . . . 0.65000000000000002 110.689 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -138.08 130.21 28.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.322 -0.861 . . . . 0.28999999999999998 110.001 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.529 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 30.2 m95 -108.9 179.94 4.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.165 -0.959 . . . . 0.29999999999999999 110.374 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.428 HG21 ' CG2' ' A' ' 51' ' ' VAL . 2.7 tp -156.55 129.7 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.584 -0.697 . . . . 0.46000000000000002 110.209 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.1 t -79.29 98.35 6.63 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.375 -0.828 . . . . 0.37 110.301 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 tt -55.96 -20.32 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.961 . . . . 0.41999999999999998 110.18 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.1 m -75.73 -27.35 58.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.373 -0.83 . . . . 0.48999999999999999 110.125 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.2 m -120.45 -50.74 2.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.28000000000000003 110.743 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.06 19.95 6.56 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.17000000000000001 109.506 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -100.31 120.11 39.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -1.223 . . . . 0.20999999999999999 110.05 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.5 mt -81.95 134.88 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.93 . . . . 0.16 110.577 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.401 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 48.2 t80 -92.93 125.78 37.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.458 -0.776 . . . . 0.10000000000000001 110.067 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -99.35 103.55 15.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.499 -0.751 . . . . 0.11 109.975 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -49.57 -24.94 2.39 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.277 -0.89 . . . . 0.12 110.895 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.69 22.52 7.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.19 110.058 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -176.22 66.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.27000000000000002 110.041 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.89 -140.06 0.67 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.777 -1.329 . . . . 0.20999999999999999 109.777 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.42 173.24 6.39 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.357 -1.084 . . . . 0.27000000000000002 110.599 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.58 -23.38 12.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.365 -0.834 . . . . 0.38 110.159 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.18 -29.42 28.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.39000000000000001 110.329 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -87.39 14.03 8.81 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.303 -0.873 . . . . 0.39000000000000001 110.823 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.85 28.39 68.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.406 -1.478 . . . . 0.28000000000000003 109.406 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.562 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -86.85 79.1 8.91 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.24 -1.153 . . . . 0.31 110.316 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.3 t -60.77 154.51 57.46 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.403 -0.811 . . . . 0.40000000000000002 110.76 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -60.7 119.29 6.38 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.751 1.395 . . . . 0.25 110.484 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.435 ' HA2' ' CE1' ' A' ' 2' ' ' TYR . . . 113.2 38.33 1.25 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.474 -1.45 . . . . 0.089999999999999997 109.474 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.4 m -114.58 130.84 56.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -1.158 . . . . 0.14999999999999999 110.391 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -108.5 142.15 39.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.23999999999999999 110.282 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.24 -43.88 32.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.124 -0.985 . . . . 0.28000000000000003 110.668 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -54.76 -22.7 14.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.941 . . . . 0.31 109.774 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.56 22.07 16.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.343 -0.848 . . . . 0.25 110.161 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 34' ' ' ILE . 89.7 mt . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.26000000000000001 110.471 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.562 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 59.5 t90 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.148 0.499 . . . . 0.25 109.966 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 88.6 m -132.47 -169.26 2.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.137 -0.977 . . . . 0.11 110.768 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.445 ' HB3' ' CB ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -82.19 163.06 54.57 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.31 110.375 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -67.66 -33.91 26.63 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.609 1.32 . . . . 0.58999999999999997 110.222 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -150.25 57.63 0.95 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.56999999999999995 109.947 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.445 ' CB ' ' HB3' ' A' ' 40' ' ' CYS . 1.8 t -141.58 -56.0 0.47 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.347 -0.845 . . . . 0.39000000000000001 110.248 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.6 41.13 5.49 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.46 -1.456 . . . . 0.22 109.46 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.27 171.1 8.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.16 -1.2 . . . . 0.12 110.494 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.0 p -92.09 -172.51 3.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.17000000000000001 110.427 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -15.75 48.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.33000000000000002 110.261 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -54.41 -38.44 66.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.42999999999999999 110.223 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.45 -19.3 58.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.42999999999999999 110.449 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.41 ' CZ ' ' CH2' ' A' ' 38' ' ' TRP . 4.0 m-85 -95.3 129.86 42.27 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.162 -0.961 . . . . 0.46999999999999997 110.591 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.428 ' CG2' HG21 ' A' ' 6' ' ' ILE . 33.2 m -125.6 172.8 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.48999999999999999 110.246 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.84 116.57 19.26 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.299 -0.876 . . . . 0.56999999999999995 110.252 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.6 t80 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.56999999999999995 110.633 -179.145 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.413 0.625 . . . . 0.68999999999999995 110.505 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.411 ' O ' ' CG ' ' A' ' 16' ' ' GLU . 6.9 mp -108.96 159.55 16.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.44 -0.788 . . . . 0.65000000000000002 110.582 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.442 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 9.5 mttp -113.9 160.45 18.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.237 -0.915 . . . . 0.28999999999999998 109.832 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.527 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 29.1 m95 -128.2 133.07 48.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.093 -1.004 . . . . 0.29999999999999999 110.598 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.414 HD11 ' N ' ' A' ' 12' ' ' HIS . 3.5 tp -104.02 141.62 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.093 -1.004 . . . . 0.46000000000000002 111.016 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 t -92.35 102.35 14.84 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.385 -0.822 . . . . 0.37 109.978 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 tt -55.79 -20.09 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.952 . . . . 0.41999999999999998 110.595 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.3 m -67.55 -36.73 81.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.48999999999999999 110.936 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.3 p -131.33 -34.4 1.41 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.984 -1.073 . . . . 0.28000000000000003 111.157 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.81 41.65 1.55 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.489 -1.444 . . . . 0.17000000000000001 109.489 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.431 ' CE1' ' HG2' ' A' ' 41' ' ' PRO . 13.7 t-80 -105.06 126.68 52.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -1.113 . . . . 0.20999999999999999 110.113 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.401 HG13 HD13 ' A' ' 6' ' ' ILE . 6.0 mt -93.69 133.18 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.16 110.685 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -97.33 132.23 43.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.571 -0.705 . . . . 0.10000000000000001 109.538 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -102.69 103.62 13.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.529 -0.732 . . . . 0.11 110.165 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 3' ' ' LEU . 26.0 mt-10 -52.2 -22.91 4.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.901 . . . . 0.12 110.596 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.25 12.68 13.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.19 110.699 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tp -177.25 68.81 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.172 -0.955 . . . . 0.27000000000000002 109.655 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.99 -139.54 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.254 -1.139 . . . . 0.20999999999999999 110.254 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -89.37 164.35 14.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.44 -1.035 . . . . 0.27000000000000002 110.809 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -107.12 -31.98 8.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.444 -0.785 . . . . 0.38 109.93 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.29 -53.46 19.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.311 -0.868 . . . . 0.39000000000000001 110.264 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -60.86 -27.78 68.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.39000000000000001 110.072 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.12 28.41 6.87 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.601 -1.4 . . . . 0.28000000000000003 109.601 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.67 83.53 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.066 -1.255 . . . . 0.31 110.128 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.0 t -50.79 145.83 10.95 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.456 -0.777 . . . . 0.40000000000000002 110.74 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -55.56 116.84 3.44 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.631 1.332 . . . . 0.25 110.431 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 116.11 24.46 3.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.663 -1.375 . . . . 0.089999999999999997 109.663 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.8 m -98.13 116.2 29.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -1.198 . . . . 0.14999999999999999 110.149 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -94.99 142.66 27.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.244 -0.91 . . . . 0.23999999999999999 110.626 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.479 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 1.2 t80 -50.57 -27.19 6.29 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.282 -0.887 . . . . 0.28000000000000003 110.252 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.08 -33.8 58.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -0.971 . . . . 0.31 109.804 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -89.51 7.58 35.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.521 -0.737 . . . . 0.25 110.45 178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 31' ' ' PHE . 33.8 mt . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.09 -1.006 . . . . 0.26000000000000001 109.67 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 88.2 t90 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.239 0.542 . . . . 0.25 110.04 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 97.8 m -127.12 -175.1 3.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.11 110.266 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.41 ' SG ' ' CE2' ' A' ' 50' ' ' TYR . 0.5 OUTLIER -81.38 138.73 48.18 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.31 110.283 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HG2' ' CE1' ' A' ' 12' ' ' HIS . 36.9 Cg_endo -71.66 -16.3 30.15 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.488 1.257 . . . . 0.58999999999999997 110.816 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.2 -0.36 15.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.988 . . . . 0.56999999999999995 111.236 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 64.2 m -138.45 -68.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.953 -1.092 . . . . 0.39000000000000001 110.404 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.17 32.26 3.55 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.327 -1.509 . . . . 0.22 109.327 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.89 -168.74 1.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -1.106 . . . . 0.12 110.613 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 p -88.04 178.31 6.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.38 -0.825 . . . . 0.17000000000000001 110.526 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -65.05 -22.28 66.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 0.33000000000000002 110.172 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -58.04 -18.96 27.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.42999999999999999 110.406 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -83.65 -15.47 48.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.42999999999999999 110.661 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.41 ' CE2' ' SG ' ' A' ' 40' ' ' CYS . 1.9 m-85 -99.81 145.24 27.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.046 -1.034 . . . . 0.46999999999999997 111.199 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.402 ' CG2' HG22 ' A' ' 6' ' ' ILE . 32.3 m -145.75 164.56 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.538 -0.727 . . . . 0.48999999999999999 109.905 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.2 tp -69.77 127.76 34.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 0.56999999999999995 110.824 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.3 t80 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.56999999999999995 110.202 179.468 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.441 0.638 . . . . 0.68999999999999995 110.345 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.8 mp -87.46 -178.27 6.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.358 -0.839 . . . . 0.65000000000000002 110.455 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.41 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 25.0 mttt -142.98 146.6 34.06 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.483 -0.761 . . . . 0.28999999999999998 110.165 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.562 ' CE3' ' CD2' ' A' ' 31' ' ' PHE . 22.7 m95 -130.09 123.6 30.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.29999999999999999 110.078 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -106.63 134.47 48.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.037 -1.04 . . . . 0.46000000000000002 110.278 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.3 t -79.89 96.04 6.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.407 -0.808 . . . . 0.37 110.098 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.7 pt -53.23 -22.6 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.132 -0.98 . . . . 0.41999999999999998 110.146 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.6 m -75.57 -28.16 58.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.295 -0.878 . . . . 0.48999999999999999 110.203 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.4 m -115.24 -50.93 2.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.28000000000000003 110.869 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.4 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . 113.12 19.02 6.95 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.47 -1.452 . . . . 0.17000000000000001 109.47 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -102.0 131.54 48.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -1.22 . . . . 0.20999999999999999 110.002 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 73.0 mt -95.31 136.71 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.16 110.761 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.404 ' OH ' ' CD2' ' A' ' 25' ' ' PHE . 66.1 t80 -99.4 132.53 44.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.10000000000000001 109.959 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -109.7 111.56 23.1 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.511 -0.743 . . . . 0.11 109.703 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.445 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -51.15 -24.06 3.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.12 110.493 -179.233 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.55 17.53 11.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.172 -0.955 . . . . 0.19 110.245 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -177.31 68.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.27000000000000002 109.71 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.28 -137.1 1.73 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.224 -1.151 . . . . 0.20999999999999999 110.224 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 22' ' ' ALA . 11.3 t70 -78.97 158.42 27.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.432 -1.04 . . . . 0.27000000000000002 110.776 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -104.13 -33.29 8.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.38 110.094 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . -80.01 -45.62 18.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.39000000000000001 110.205 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.12 -35.22 71.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -0.928 . . . . 0.39000000000000001 109.976 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.2 20.37 7.53 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.568 -1.413 . . . . 0.28000000000000003 109.568 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.571 ' CE1' ' CD1' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -67.79 77.97 0.2 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.111 -1.229 . . . . 0.31 110.224 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.0 t -52.66 151.65 7.73 Favored Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.444 -0.785 . . . . 0.40000000000000002 110.702 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -58.89 116.77 3.49 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.703 1.37 . . . . 0.25 110.394 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.62 -23.95 5.59 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.346 -1.502 . . . . 0.089999999999999997 109.346 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.7 m -53.26 132.29 38.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -1.152 . . . . 0.14999999999999999 110.235 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.445 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 16.1 mtp180 -115.51 146.29 41.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.853 . . . . 0.23999999999999999 110.394 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.562 ' CD2' ' CE3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -50.93 -33.65 25.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.28000000000000003 110.273 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -53.21 -50.98 63.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.871 . . . . 0.31 110.02 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -70.06 -7.84 44.49 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.416 -0.803 . . . . 0.25 110.471 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.442 ' CG2' ' HB3' ' A' ' 38' ' ' TRP . 30.1 mt . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.156 -0.965 . . . . 0.26000000000000001 110.154 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.571 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 54.9 t90 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.286 0.565 . . . . 0.25 110.126 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -162.16 176.81 10.27 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.373 -0.83 . . . . 0.11 110.361 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.449 ' HB3' ' CB ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -51.55 149.77 7.6 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.85 . . . . 0.31 109.988 178.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.52 -27.85 70.19 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.527 1.278 . . . . 0.58999999999999997 110.74 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.2 57.36 0.89 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.935 . . . . 0.56999999999999995 110.217 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.449 ' CB ' ' HB3' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -152.46 -45.53 0.1 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.259 -0.901 . . . . 0.39000000000000001 110.045 -179.157 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.53 42.65 95.57 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.54 -1.424 . . . . 0.22 109.54 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.41 32.74 5.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -1.198 . . . . 0.12 110.823 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.1 p 44.02 -153.65 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.578 0.704 . . . . 0.17000000000000001 111.101 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -13.08 58.49 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.515 -0.741 . . . . 0.33000000000000002 110.447 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.08 -48.84 43.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.085 -1.009 . . . . 0.42999999999999999 110.794 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -76.64 -16.63 59.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.42999999999999999 110.43 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -93.56 135.92 34.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.042 -1.036 . . . . 0.46999999999999997 110.51 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -131.59 150.12 33.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.282 -0.886 . . . . 0.48999999999999999 110.232 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -63.63 125.12 23.24 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.352 -0.842 . . . . 0.56999999999999995 110.43 -179.546 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.436 ' N ' HD12 ' A' ' 52' ' ' LEU . 17.1 t80 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 0.56999999999999995 110.38 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.356 0.598 . . . . 0.68999999999999995 110.487 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.7 mp -90.53 171.31 9.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.65000000000000002 110.397 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.438 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 19.6 mttp -136.12 158.37 44.58 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.28999999999999998 109.959 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.531 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 31.2 m95 -127.8 136.44 51.47 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -0.944 . . . . 0.29999999999999999 110.579 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.444 HG21 ' CG2' ' A' ' 51' ' ' VAL . 3.4 tp -106.13 137.87 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.964 -1.085 . . . . 0.46000000000000002 110.568 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 11' ' ' GLY . 7.6 t -83.41 96.13 8.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.547 -0.721 . . . . 0.37 110.25 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.4 tt -56.11 -19.95 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.981 -1.074 . . . . 0.41999999999999998 110.027 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.9 m -77.64 -27.15 50.97 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.325 -0.86 . . . . 0.48999999999999999 110.105 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 64.4 m -123.64 -54.99 1.74 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.338 -0.851 . . . . 0.28000000000000003 110.632 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . 119.83 27.07 2.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.84 -1.304 . . . . 0.17000000000000001 109.84 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.406 ' N ' HD12 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -109.36 144.06 38.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -1.185 . . . . 0.20999999999999999 110.278 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.417 HG13 HD11 ' A' ' 6' ' ' ILE . 7.2 mt -98.41 145.53 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.847 . . . . 0.16 110.968 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -105.7 133.58 50.21 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.369 -0.604 . . . . 0.10000000000000001 109.369 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -101.6 106.76 17.87 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.552 -0.718 . . . . 0.11 110.198 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -50.28 -25.98 4.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.308 -0.87 . . . . 0.12 110.722 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.07 19.97 15.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.19 110.352 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.55 70.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.27000000000000002 110.338 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 25' ' ' PHE . . . -64.24 -135.69 0.01 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.572 -1.411 . . . . 0.20999999999999999 109.572 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -99.39 172.08 7.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -1.169 . . . . 0.27000000000000002 110.702 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.37 -24.18 20.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.38 110.003 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.25 -36.95 17.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.307 -0.87 . . . . 0.39000000000000001 110.106 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -66.91 -21.65 65.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.39000000000000001 110.074 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.16 31.06 53.8 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.258 -1.537 . . . . 0.28000000000000003 109.258 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.476 ' CE1' HD13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -71.72 82.43 0.87 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.15 -1.206 . . . . 0.31 110.141 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.3 t -49.29 142.27 10.87 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.40000000000000002 110.767 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -52.83 108.5 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.555 1.292 . . . . 0.25 110.69 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.01 44.04 0.26 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.602 -1.399 . . . . 0.089999999999999997 109.602 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.5 m -122.63 136.26 54.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -1.165 . . . . 0.14999999999999999 110.555 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -122.87 144.34 49.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.351 -0.843 . . . . 0.23999999999999999 110.224 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.491 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -48.18 -49.13 33.77 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.224 -0.922 . . . . 0.28000000000000003 110.494 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -53.37 -26.8 20.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.31 109.64 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.21 16.73 20.46 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.491 -0.755 . . . . 0.25 110.133 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.476 HD13 ' CE1' ' A' ' 25' ' ' PHE . 92.2 mt . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.26000000000000001 110.327 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.424 ' NE1' ' CE2' ' A' ' 25' ' ' PHE . 63.7 t90 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.371 0.605 . . . . 0.25 110.28 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 83.4 m -148.65 -167.31 2.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.325 -0.859 . . . . 0.11 110.133 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.24 169.98 18.1 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.232 -0.918 . . . . 0.31 109.981 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -57.94 -47.7 19.53 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.563 1.296 . . . . 0.58999999999999997 110.206 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -178.82 57.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.45 -0.781 . . . . 0.56999999999999995 109.981 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 21.1 p -162.14 -36.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.152 -0.968 . . . . 0.39000000000000001 111.113 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -95.67 -41.53 3.85 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.574 -1.411 . . . . 0.22 109.574 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 56.82 163.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -1.047 . . . . 0.12 110.945 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 44.61 -161.23 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.468 -0.77 . . . . 0.17000000000000001 111.053 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -122.31 -21.53 5.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.338 -0.851 . . . . 0.33000000000000002 110.72 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.49 -28.96 48.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.977 . . . . 0.42999999999999999 110.448 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.07 -17.69 60.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.42999999999999999 110.34 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -97.15 136.41 37.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.095 -1.003 . . . . 0.46999999999999997 110.725 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.444 ' CG2' HG21 ' A' ' 6' ' ' ILE . 26.8 m -136.27 162.83 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.48999999999999999 109.914 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.88 118.84 19.87 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.121 -0.987 . . . . 0.56999999999999995 110.5 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.1 t80 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.56999999999999995 110.518 -179.741 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.413 0.625 . . . . 0.68999999999999995 110.466 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.67 167.21 12.7 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.248 -0.907 . . . . 0.65000000000000002 110.272 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -127.4 125.57 40.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.28999999999999998 110.474 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.526 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 23.2 m95 -106.62 179.22 4.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.29999999999999999 110.032 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.51 HG23 HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -157.69 126.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 119.844 -0.742 . . . . 0.46000000000000002 110.193 178.025 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.5 t -73.47 91.1 1.76 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.353 -0.842 . . . . 0.37 109.488 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.5 pt -51.92 -22.95 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.195 -0.941 . . . . 0.41999999999999998 110.334 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 94.4 m -59.03 -27.86 65.87 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.379 -0.825 . . . . 0.48999999999999999 110.714 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -137.11 -36.7 0.66 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.145 -0.972 . . . . 0.28000000000000003 111.243 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.412 ' HA2' HD13 ' A' ' 6' ' ' ILE . . . 117.16 19.78 5.03 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.516 -1.326 . . . . 0.17000000000000001 110.077 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.37 115.1 26.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.047 -1.266 . . . . 0.20999999999999999 110.232 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 74.2 mt -84.2 128.62 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.925 . . . . 0.16 110.539 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.405 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 63.2 t80 -91.74 120.82 32.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.10000000000000001 109.814 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -99.18 103.98 15.91 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.217 -0.927 . . . . 0.11 109.879 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -47.58 -26.57 1.5 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.12 111.075 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.33 19.01 8.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.176 -0.953 . . . . 0.19 110.579 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -176.1 68.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.27000000000000002 110.165 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.16 -143.42 0.79 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.737 -1.345 . . . . 0.20999999999999999 109.737 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.56 165.25 12.43 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.34 -1.094 . . . . 0.27000000000000002 110.297 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.04 -41.79 6.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.237 -0.914 . . . . 0.38 110.346 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.72 -50.2 70.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.39000000000000001 110.26 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.09 -21.07 44.39 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.176 -0.953 . . . . 0.39000000000000001 110.397 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.38 23.25 17.1 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.221 -1.551 . . . . 0.28000000000000003 109.221 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -83.83 78.91 9.64 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.242 -1.151 . . . . 0.31 110.05 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 28' ' ' GLY . 13.4 t -49.24 151.67 2.42 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.357 -0.84 . . . . 0.40000000000000002 110.985 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.68 80.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.713 1.375 . . . . 0.25 110.387 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 26' ' ' THR . . . 153.82 42.11 0.02 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.148 -1.581 . . . . 0.089999999999999997 109.148 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.6 m -112.56 134.44 54.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.35 -1.088 . . . . 0.14999999999999999 110.341 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -111.43 145.96 38.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.829 . . . . 0.23999999999999999 110.163 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.441 ' CD2' ' HD3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -52.39 -41.21 62.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.919 . . . . 0.28000000000000003 110.251 179.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -53.64 -43.63 68.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.873 . . . . 0.31 110.204 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -79.17 2.03 22.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.25 110.772 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.7 mt . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.0 -1.063 . . . . 0.26000000000000001 110.075 179.878 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.573 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 87.9 t90 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.299 0.571 . . . . 0.25 110.479 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.4 m -133.88 -174.51 3.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.11 110.191 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.55 156.13 65.47 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.077 -1.015 . . . . 0.31 110.286 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.67 -5.14 14.6 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.487 1.256 . . . . 0.58999999999999997 111.201 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 50.1 p30 -146.09 20.6 1.41 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.875 -1.14 . . . . 0.56999999999999995 110.968 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 76.8 m -143.0 -49.03 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.165 -0.959 . . . . 0.39000000000000001 110.424 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.01 33.23 46.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.409 -1.476 . . . . 0.22 109.409 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.57 -172.05 2.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -1.169 . . . . 0.12 110.49 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.97 -171.91 2.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.855 . . . . 0.17000000000000001 110.332 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HD3' ' CD2' ' A' ' 31' ' ' PHE . 20.3 mttt -60.56 -18.8 54.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.35 -0.844 . . . . 0.33000000000000002 110.227 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.24 -41.07 65.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.42999999999999999 110.361 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.29 -24.23 63.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.42999999999999999 109.826 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -92.96 137.88 31.97 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.443 -0.786 . . . . 0.46999999999999997 110.512 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.6 p -129.69 163.68 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 0.48999999999999999 110.032 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.84 108.75 4.1 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.114 -0.991 . . . . 0.56999999999999995 110.084 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.56999999999999995 110.749 -178.926 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.324 0.583 . . . . 0.68999999999999995 110.358 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 mp -81.73 165.93 20.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.65000000000000002 110.759 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.44 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 23.6 mttm -134.38 151.39 51.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.28999999999999998 110.12 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.554 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 20.1 m95 -133.03 127.15 33.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.3 -0.875 . . . . 0.29999999999999999 109.927 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.432 HD11 ' HA2' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -102.64 134.43 43.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.112 -0.992 . . . . 0.46000000000000002 110.898 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 50' ' ' TYR . 16.3 t -79.9 95.71 6.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.579 -0.7 . . . . 0.37 109.588 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 tt -55.26 -20.12 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.41999999999999998 110.628 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.1 m -63.46 -27.98 69.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.28 -0.888 . . . . 0.48999999999999999 110.885 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.5 p -134.09 -35.89 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.967 -1.083 . . . . 0.28000000000000003 111.397 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.432 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 112.21 35.96 1.71 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.533 -1.318 . . . . 0.17000000000000001 109.854 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -112.14 129.26 56.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.128 -1.219 . . . . 0.20999999999999999 110.397 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 13.5 mt -91.58 146.66 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.16 111.096 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -108.68 129.14 55.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.565 -0.709 . . . . 0.10000000000000001 109.809 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -105.32 106.75 17.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.549 -0.719 . . . . 0.11 110.234 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -49.88 -24.54 2.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.12 110.664 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.0 14.25 9.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.19 110.71 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 tp -176.08 67.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.025 -1.047 . . . . 0.27000000000000002 109.955 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.43 -143.03 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.897 -1.281 . . . . 0.20999999999999999 109.897 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.88 165.38 11.59 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.37 -1.076 . . . . 0.27000000000000002 110.525 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -107.19 -20.02 13.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.38 110.545 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.59 -36.0 38.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.151 -0.968 . . . . 0.39000000000000001 110.392 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -81.42 -13.31 58.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.39000000000000001 110.729 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.81 27.7 16.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.073 -1.611 . . . . 0.28000000000000003 109.073 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -82.97 82.77 8.07 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.371 -1.076 . . . . 0.31 110.229 -179.654 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.3 t -49.69 142.34 12.36 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.173 -0.954 . . . . 0.40000000000000002 110.77 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -53.05 109.66 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.559 1.294 . . . . 0.25 110.612 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.92 -14.03 5.23 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.142 -1.183 . . . . 0.089999999999999997 110.142 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -51.53 129.68 26.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.95 -1.324 . . . . 0.14999999999999999 110.804 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -108.83 134.19 51.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.357 -0.84 . . . . 0.23999999999999999 110.003 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.522 ' CD2' ' CD2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -47.06 -51.88 16.48 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.242 -0.911 . . . . 0.28000000000000003 110.947 -179.372 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -51.5 -37.15 47.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 0.31 109.96 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -85.5 8.8 17.82 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.438 -0.789 . . . . 0.25 110.274 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.441 HD13 ' CZ ' ' A' ' 25' ' ' PHE . 78.5 mt . . . . . 0 N--CA 1.491 1.593 0 O-C-N 120.98 -1.075 . . . . 0.26000000000000001 110.226 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 83.2 t90 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.152 0.501 . . . . 0.25 110.251 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 91.6 m -130.96 -167.08 1.78 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.11 110.546 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.09 143.29 34.63 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.31 110.375 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -78.28 -17.07 13.42 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.567 1.298 . . . . 0.58999999999999997 111.009 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -28.55 9.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.05 -1.031 . . . . 0.56999999999999995 110.866 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 94.1 m -101.22 -71.99 0.69 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 0.39000000000000001 110.606 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.82 29.38 1.86 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.581 -1.408 . . . . 0.22 109.581 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.51 -173.84 2.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.103 -1.234 . . . . 0.12 110.337 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.1 p -97.12 -170.88 2.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.17000000000000001 110.393 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 5.8 tttt -61.44 -16.66 48.99 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.364 -0.835 . . . . 0.33000000000000002 110.388 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -58.29 -28.38 64.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -0.97 . . . . 0.42999999999999999 110.634 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -86.23 -16.98 35.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.42999999999999999 110.51 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 7' ' ' CYS . 1.9 m-85 -94.34 138.28 32.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -0.932 . . . . 0.46999999999999997 110.86 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.3 t -132.75 163.05 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.775 . . . . 0.48999999999999999 110.047 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.28 117.19 15.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.172 -0.955 . . . . 0.56999999999999995 110.334 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.7 t80 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.56999999999999995 110.531 -179.775 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.488 ' CD1' ' HB3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.898 0.856 . . . . 0.68999999999999995 111.283 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.84 169.39 6.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -0.865 . . . . 0.65000000000000002 110.517 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.71 128.13 15.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.39 -0.819 . . . . 0.28999999999999998 109.947 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.525 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 27.5 m95 -107.42 174.25 5.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.29999999999999999 110.019 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.446 ' CD1' HG13 ' A' ' 13' ' ' ILE . 2.4 tp -149.18 123.31 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.46000000000000002 110.438 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.1 t -69.33 95.12 0.76 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.376 -0.828 . . . . 0.37 109.933 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 9' ' ' THR . 11.0 pt -52.28 -22.76 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.16 -0.963 . . . . 0.41999999999999998 110.174 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.411 ' N ' HG13 ' A' ' 8' ' ' ILE . 34.2 m -61.37 -43.99 97.93 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.445 -0.784 . . . . 0.48999999999999999 110.915 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.9 p -123.59 -32.09 3.39 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.983 . . . . 0.28000000000000003 110.945 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.27 30.66 3.79 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.811 -1.316 . . . . 0.17000000000000001 109.811 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -95.17 112.97 24.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.244 -1.151 . . . . 0.20999999999999999 110.015 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.446 HG13 ' CD1' ' A' ' 6' ' ' ILE . 63.2 mt -80.72 128.73 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.16 110.533 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -92.6 132.25 37.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.519 -0.738 . . . . 0.10000000000000001 110.052 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -101.69 104.57 15.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.541 -0.724 . . . . 0.11 110.102 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.488 ' HB3' ' CD1' ' A' ' 2' ' ' TYR . 10.2 mt-10 -53.4 -27.12 22.54 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.159 -0.963 . . . . 0.12 110.651 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.01 18.73 7.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.143 -0.973 . . . . 0.19 110.452 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -176.39 66.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.883 . . . . 0.27000000000000002 109.843 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.83 -142.64 0.06 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.952 -1.259 . . . . 0.20999999999999999 109.952 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.42 173.76 7.36 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.409 -1.054 . . . . 0.27000000000000002 110.727 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -109.62 -33.43 6.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.324 -0.86 . . . . 0.38 110.167 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.52 -60.44 3.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.39000000000000001 110.363 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -61.3 -17.88 55.82 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.39000000000000001 110.57 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.15 33.34 7.76 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.279 -1.529 . . . . 0.28000000000000003 109.279 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -81.06 76.44 8.01 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.394 -1.062 . . . . 0.31 110.174 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -50.97 151.22 4.67 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.341 -0.849 . . . . 0.40000000000000002 110.912 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.03 123.88 14.68 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.631 1.332 . . . . 0.25 110.466 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.7 23.87 4.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.538 -1.425 . . . . 0.089999999999999997 109.538 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.9 m -94.63 135.83 35.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -1.232 . . . . 0.14999999999999999 110.325 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.66 138.4 47.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.349 -0.844 . . . . 0.23999999999999999 110.428 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.478 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -50.12 -30.97 12.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.219 -0.925 . . . . 0.28000000000000003 110.628 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -61.28 -55.04 36.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.153 -0.967 . . . . 0.31 110.204 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -28.76 69.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.25 110.243 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.471 HD11 ' CE2' ' A' ' 25' ' ' PHE . 82.4 mt . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.26000000000000001 110.288 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.533 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 88.2 t90 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.296 0.569 . . . . 0.25 110.532 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.44 ' N ' ' CG ' ' A' ' 38' ' ' TRP . 25.4 p -167.2 -160.65 0.38 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.333 -0.854 . . . . 0.11 110.283 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.7 OUTLIER -87.53 144.13 35.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.397 -0.814 . . . . 0.31 110.307 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.16 9.72 3.97 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.667 1.351 . . . . 0.58999999999999997 111.281 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 37.4 p-10 -152.02 17.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.84 -1.163 . . . . 0.56999999999999995 110.934 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 58.0 m -144.92 -72.3 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.068 . . . . 0.39000000000000001 110.284 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.22 36.76 0.73 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.485 -1.446 . . . . 0.22 109.485 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.35 176.0 5.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -1.156 . . . . 0.12 110.592 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -100.8 -162.68 0.96 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.341 -0.85 . . . . 0.17000000000000001 109.964 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -55.15 -21.79 14.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.125 -0.984 . . . . 0.33000000000000002 109.722 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.56 -27.59 27.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.42999999999999999 109.91 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.85 -21.69 20.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.431 -0.793 . . . . 0.42999999999999999 109.908 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -97.27 137.63 35.98 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.263 -0.898 . . . . 0.46999999999999997 110.655 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.428 ' CG1' HG22 ' A' ' 6' ' ' ILE . 7.2 p -127.23 148.1 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.48999999999999999 110.0 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.67 115.52 4.83 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.141 -0.974 . . . . 0.56999999999999995 110.348 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.7 t80 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.37 -0.831 . . . . 0.56999999999999995 110.397 -179.379 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.394 0.616 . . . . 0.68999999999999995 110.39 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.62 170.66 7.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.65000000000000002 110.524 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -127.32 124.01 37.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.28999999999999998 110.372 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.479 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 35.5 m95 -100.94 172.43 7.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.197 -0.939 . . . . 0.29999999999999999 110.025 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.411 HD11 HG13 ' A' ' 13' ' ' ILE . 2.2 tp -147.37 126.47 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.46000000000000002 110.254 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.4 ' O ' ' N ' ' A' ' 11' ' ' GLY . 10.1 t -73.18 89.13 1.5 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.296 -0.877 . . . . 0.37 109.973 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.9 pt -49.77 -25.83 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.066 -1.021 . . . . 0.41999999999999998 109.982 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -75.61 -28.71 58.96 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.606 -0.684 . . . . 0.48999999999999999 110.147 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -112.57 -54.45 2.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.28000000000000003 110.497 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . 115.11 19.65 5.86 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.585 -1.406 . . . . 0.17000000000000001 109.585 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -103.93 136.07 44.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -1.207 . . . . 0.20999999999999999 110.134 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 3.3 mt -93.93 130.05 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.321 -0.862 . . . . 0.16 110.477 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.494 ' CE1' ' HA2' ' A' ' 19' ' ' GLY . 81.0 t80 -97.68 133.14 42.61 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.10000000000000001 109.616 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -111.63 111.15 21.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.11 110.239 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.437 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 66.2 mt-10 -50.56 -23.35 2.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.383 -0.823 . . . . 0.12 110.989 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.65 8.05 15.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.976 -1.077 . . . . 0.19 110.968 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -176.6 68.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.022 -1.049 . . . . 0.27000000000000002 109.625 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.494 ' HA2' ' CE1' ' A' ' 14' ' ' TYR . . . -66.57 -138.39 0.04 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.011 -1.235 . . . . 0.20999999999999999 110.011 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -100.35 172.48 7.12 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.408 -1.054 . . . . 0.27000000000000002 110.812 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.88 -31.68 9.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.384 -0.823 . . . . 0.38 110.318 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.93 -50.37 35.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 0.39000000000000001 110.187 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -60.3 -18.35 48.83 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.304 -0.872 . . . . 0.39000000000000001 110.574 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.14 23.03 23.52 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.389 -1.484 . . . . 0.28000000000000003 109.389 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.584 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 1.8 m-30 -83.07 78.14 9.63 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.269 -1.136 . . . . 0.31 110.411 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.6 t -58.35 155.8 25.27 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.443 -0.785 . . . . 0.40000000000000002 110.678 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -53.75 113.35 1.28 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.619 1.326 . . . . 0.25 110.463 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.7 34.61 1.05 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.276 -1.53 . . . . 0.089999999999999997 109.276 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.4 m -117.2 121.55 41.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -1.163 . . . . 0.14999999999999999 110.351 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.437 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 0.5 OUTLIER -108.61 150.86 26.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.279 -0.888 . . . . 0.23999999999999999 110.353 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.496 ' CZ ' ' CZ3' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -47.58 -42.79 24.61 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.285 -0.885 . . . . 0.28000000000000003 111.015 -179.491 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -60.34 -42.73 96.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.31 110.808 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -78.28 -24.89 46.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.212 -0.93 . . . . 0.25 110.463 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.479 HD13 ' CE2' ' A' ' 25' ' ' PHE . 65.2 mt . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.26000000000000001 110.231 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.584 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 74.3 t90 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.323 0.582 . . . . 0.25 110.482 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.5 p -167.28 -161.7 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.887 . . . . 0.11 110.335 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 1.4 t -89.99 140.98 27.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.31 110.285 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 7.0 Cg_exo -70.91 -7.2 20.87 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.482 1.254 . . . . 0.58999999999999997 111.378 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -127.73 -9.11 5.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.911 -1.118 . . . . 0.56999999999999995 111.499 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 84.3 m -121.76 -75.62 0.59 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.897 -1.127 . . . . 0.39000000000000001 110.536 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.19 33.46 0.96 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.536 -1.426 . . . . 0.22 109.536 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.22 177.02 4.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -1.205 . . . . 0.12 110.447 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -72.28 -162.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.17000000000000001 110.365 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -75.19 -4.58 39.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.33000000000000002 110.734 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.05 -41.25 62.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.993 -1.067 . . . . 0.42999999999999999 110.453 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.35 -25.66 62.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.42999999999999999 110.008 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -89.06 132.29 34.84 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.296 -0.877 . . . . 0.46999999999999997 110.487 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.1 t -130.28 159.66 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.48999999999999999 110.129 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.7 tp -64.45 117.41 7.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.154 -0.966 . . . . 0.56999999999999995 110.529 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.414 ' CB ' ' O ' ' A' ' 4' ' ' LYS . 28.0 t80 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.56999999999999995 110.35 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.503 ' CE1' ' NH2' ' A' ' 30' ' ' ARG . 40.6 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.351 0.596 . . . . 0.68999999999999995 110.334 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.7 mp -81.32 167.68 19.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.389 -0.819 . . . . 0.65000000000000002 110.465 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.51 124.86 20.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.28999999999999998 110.08 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.501 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 34.4 m95 -100.89 142.14 32.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.29999999999999999 110.266 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.478 HD11 HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -107.52 129.04 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.958 -1.089 . . . . 0.46000000000000002 109.806 178.127 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.409 ' N ' HD13 ' A' ' 6' ' ' ILE . 9.6 t -77.19 87.08 3.64 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.374 -0.829 . . . . 0.37 109.172 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.0 tt -50.47 -22.63 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.15 -0.969 . . . . 0.41999999999999998 110.531 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 m -66.51 -30.23 70.5 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.284 -0.885 . . . . 0.48999999999999999 110.685 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 p -140.15 -15.86 0.98 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.907 -1.121 . . . . 0.28000000000000003 112.662 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.8 -28.3 15.39 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.29 -1.434 . . . . 0.17000000000000001 110.049 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -51.86 135.35 30.18 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.06 -1.259 . . . . 0.20999999999999999 110.415 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.433 ' CG1' HG12 ' A' ' 6' ' ' ILE . 6.7 mt -109.81 142.48 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.82 . . . . 0.16 110.768 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -98.22 123.14 42.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.596 -0.69 . . . . 0.10000000000000001 109.433 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -103.26 108.51 19.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.11 110.137 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -48.23 -25.64 1.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.12 110.764 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.32 21.07 5.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.19 110.234 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 tp -176.24 60.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.27000000000000002 109.988 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.51 -139.55 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.852 -1.299 . . . . 0.20999999999999999 109.852 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.69 172.15 7.01 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.392 -1.064 . . . . 0.27000000000000002 110.561 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.47 -45.07 4.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.353 -0.842 . . . . 0.38 110.356 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.51 -54.64 41.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.39000000000000001 110.354 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -60.57 -16.94 42.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.39000000000000001 110.595 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.33 29.99 23.39 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.935 -1.666 . . . . 0.28000000000000003 108.935 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.415 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -80.94 78.42 7.75 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.441 -1.035 . . . . 0.31 110.291 -179.56 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.4 t -52.06 149.17 9.81 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.327 -0.858 . . . . 0.40000000000000002 110.592 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.86 116.7 3.44 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.675 1.355 . . . . 0.25 110.514 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.47 ' HA2' ' CE1' ' A' ' 2' ' ' TYR . . . 131.97 -23.34 4.17 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.468 -1.453 . . . . 0.089999999999999997 109.468 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.3 m -55.95 129.77 41.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -1.092 . . . . 0.14999999999999999 110.458 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.503 ' NH2' ' CE1' ' A' ' 2' ' ' TYR . 47.5 mtt85 -107.94 148.51 29.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.23999999999999999 110.244 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.451 ' CB ' ' CZ2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -49.84 -39.38 38.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 0.28000000000000003 110.627 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.5 -44.9 62.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.31 110.435 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -82.29 5.13 21.08 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.309 -0.869 . . . . 0.25 110.384 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.425 ' CG2' ' HB3' ' A' ' 38' ' ' TRP . 96.1 mt . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.002 -1.061 . . . . 0.26000000000000001 110.231 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.425 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 86.2 t90 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.223 0.535 . . . . 0.25 110.173 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.421 ' O ' ' CE2' ' A' ' 38' ' ' TRP . 25.9 p -159.07 -160.4 0.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.11 110.607 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 2.4 t -95.66 140.98 22.57 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.497 -0.752 . . . . 0.31 110.376 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.36 -2.06 12.16 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.538 1.283 . . . . 0.58999999999999997 111.336 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -132.0 13.9 4.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.891 -1.131 . . . . 0.56999999999999995 111.075 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 64.6 m -147.61 -71.65 0.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.011 -1.055 . . . . 0.39000000000000001 110.377 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.63 33.5 1.0 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.744 -1.342 . . . . 0.22 109.744 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.55 -170.71 1.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -1.201 . . . . 0.12 110.466 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.7 p -107.27 -162.59 0.85 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.344 -0.848 . . . . 0.17000000000000001 110.059 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -57.99 -19.48 31.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.155 -0.966 . . . . 0.33000000000000002 109.847 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -51.92 -40.37 60.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.42999999999999999 110.299 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.02 -23.19 48.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.315 -0.866 . . . . 0.42999999999999999 109.974 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -94.84 138.04 33.14 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.321 -0.862 . . . . 0.46999999999999997 110.406 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.3 t -122.78 160.89 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.299 -0.876 . . . . 0.48999999999999999 110.167 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.04 101.58 2.76 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.262 -0.899 . . . . 0.56999999999999995 110.129 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.42 ' CD1' ' HB ' ' A' ' 6' ' ' ILE . 2.7 t80 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.805 . . . . 0.56999999999999995 110.35 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.356 0.598 . . . . 0.68999999999999995 110.462 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mp -91.85 170.99 9.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.65000000000000002 110.054 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.454 ' CG ' ' HB3' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -130.98 133.61 45.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.106 -0.996 . . . . 0.28999999999999998 110.919 -179.423 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.515 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 24.7 m95 -118.54 178.8 4.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.327 -0.858 . . . . 0.29999999999999999 109.445 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.5 HD11 HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -163.32 124.58 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.297 -0.877 . . . . 0.46000000000000002 110.488 178.207 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.5 t -69.17 93.43 0.61 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.459 -0.775 . . . . 0.37 109.591 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 9' ' ' THR . 2.6 tt -54.44 -19.67 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 0.41999999999999998 110.576 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.43 ' N ' HG22 ' A' ' 8' ' ' ILE . 76.3 m -65.14 -27.89 69.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.205 -0.935 . . . . 0.48999999999999999 110.95 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.1 p -134.35 -35.35 0.92 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.053 -1.029 . . . . 0.28000000000000003 111.375 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.406 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . 112.95 36.43 1.52 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.445 -1.359 . . . . 0.17000000000000001 109.794 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -106.46 108.96 20.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.104 -1.233 . . . . 0.20999999999999999 110.269 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.497 ' CD1' ' CE1' ' A' ' 53' ' ' TYR . 89.9 mt -81.29 131.58 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.366 -0.834 . . . . 0.16 110.762 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -97.88 128.25 44.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.338 -0.851 . . . . 0.10000000000000001 109.555 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -109.75 110.92 22.08 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.353 -0.842 . . . . 0.11 109.673 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.437 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -49.37 -24.33 1.88 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 0.12 110.824 -178.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.5 9.94 14.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.183 -0.948 . . . . 0.19 110.683 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.87 67.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.029 -1.045 . . . . 0.27000000000000002 109.806 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.08 -140.56 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.008 -1.237 . . . . 0.20999999999999999 110.008 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.05 164.38 23.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.416 -1.049 . . . . 0.27000000000000002 110.728 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -114.4 -25.73 8.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.38 110.158 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.38 -46.88 25.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.39000000000000001 110.185 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -69.56 -34.64 74.48 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.269 -0.894 . . . . 0.39000000000000001 110.358 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.73 32.62 2.63 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.766 -1.334 . . . . 0.28000000000000003 109.766 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.411 ' CE1' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -72.33 82.48 1.04 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.053 -1.263 . . . . 0.31 109.782 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.2 t -48.26 142.64 7.76 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.40000000000000002 111.083 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.28 111.4 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.681 1.358 . . . . 0.25 110.484 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.24 -25.22 3.03 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.422 -1.471 . . . . 0.089999999999999997 109.422 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.6 m -56.68 130.73 46.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -1.108 . . . . 0.14999999999999999 110.349 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.437 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 1.0 OUTLIER -107.13 142.04 37.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.23999999999999999 110.349 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.477 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 0.8 OUTLIER -53.08 -36.46 60.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.28000000000000003 110.168 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -54.74 -26.0 31.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.31 109.797 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -96.17 -21.11 18.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.374 -0.829 . . . . 0.25 110.058 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 31' ' ' PHE . 20.3 mt . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.26000000000000001 109.7 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.425 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 85.1 t90 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.282 0.563 . . . . 0.25 110.3 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 92.1 m -148.05 -174.53 4.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -0.871 . . . . 0.11 110.399 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.21 140.62 53.1 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.31 110.335 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -72.16 -19.74 25.73 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.52 1.274 . . . . 0.58999999999999997 110.822 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.31 -22.63 15.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.56999999999999995 110.507 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 75.1 m -116.46 -61.46 1.72 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.39000000000000001 110.381 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.45 36.1 3.65 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.37 -1.492 . . . . 0.22 109.37 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -114.05 159.29 20.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -1.109 . . . . 0.12 110.474 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.8 p -65.35 -160.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.17000000000000001 110.34 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -67.96 -9.62 46.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.33000000000000002 110.775 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -50.76 -40.68 55.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.025 -1.047 . . . . 0.42999999999999999 110.752 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 50' ' ' TYR . 49.0 p-10 -86.76 -15.76 38.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.42999999999999999 110.809 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.419 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 2.2 m-85 -91.95 140.72 29.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.46999999999999997 110.916 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.36 164.93 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.41 -0.806 . . . . 0.48999999999999999 110.203 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.67 122.22 16.33 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.245 -0.909 . . . . 0.56999999999999995 110.649 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.497 ' CE1' ' CD1' ' A' ' 13' ' ' ILE . 77.5 t80 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.56999999999999995 110.395 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . 0.432 ' CE1' ' HA2' ' A' ' 28' ' ' GLY . 18.1 m-85 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.406 0.622 . . . . 0.68999999999999995 110.365 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mp -81.9 165.31 20.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -0.852 . . . . 0.65000000000000002 110.527 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -135.61 129.74 33.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 0.28999999999999998 109.885 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.536 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 28.9 m95 -107.24 173.81 6.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.29999999999999999 110.22 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.417 HD13 HG13 ' A' ' 13' ' ' ILE . 1.7 tp -138.99 127.17 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.447 -0.783 . . . . 0.46000000000000002 109.969 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 11' ' ' GLY . 11.5 t -76.93 87.56 3.48 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.367 -0.833 . . . . 0.37 109.807 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.1 pt -49.14 -25.36 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.147 -0.971 . . . . 0.41999999999999998 110.087 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 m -69.27 -28.7 66.54 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.537 -0.727 . . . . 0.48999999999999999 110.131 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 83.6 m -123.36 -50.31 1.89 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.28000000000000003 110.803 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . 120.75 -5.99 11.41 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.253 -1.139 . . . . 0.17000000000000001 110.253 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -76.12 137.82 40.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.851 -1.382 . . . . 0.20999999999999999 110.391 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.417 HG13 HD13 ' A' ' 6' ' ' ILE . 3.7 mt -95.07 127.4 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.16 110.239 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.406 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 82.4 t80 -79.9 121.61 25.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.407 -0.808 . . . . 0.10000000000000001 109.91 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -99.03 104.93 17.0 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.351 -0.843 . . . . 0.11 109.989 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -49.2 -24.28 1.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.466 -0.771 . . . . 0.12 110.771 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.12 17.97 6.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.126 -0.984 . . . . 0.19 110.474 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.78 53.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.27000000000000002 109.797 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.65 -136.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.052 -1.219 . . . . 0.20999999999999999 110.052 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -89.33 165.68 14.23 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.365 -1.08 . . . . 0.27000000000000002 110.412 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.67 -25.47 11.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.38 110.22 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.71 -56.69 5.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.39000000000000001 110.11 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -60.42 -22.09 62.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.172 -0.955 . . . . 0.39000000000000001 110.156 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.16 28.66 8.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.378 -1.489 . . . . 0.28000000000000003 109.378 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.473 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.9 OUTLIER -74.09 75.74 1.74 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.215 -1.168 . . . . 0.31 110.448 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -60.31 151.35 68.64 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.432 -0.793 . . . . 0.40000000000000002 110.581 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -52.02 95.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.585 1.308 . . . . 0.25 110.569 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.432 ' HA2' ' CE1' ' A' ' 2' ' ' TYR . . . 152.68 -21.48 0.81 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.67 -1.372 . . . . 0.089999999999999997 109.67 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 m -64.92 128.99 38.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -1.202 . . . . 0.14999999999999999 110.553 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.31 145.22 43.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.23999999999999999 110.19 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.406 ' CB ' ' CZ2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -47.96 -47.31 32.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.241 -0.912 . . . . 0.28000000000000003 110.831 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -50.35 -33.72 21.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.876 . . . . 0.31 110.095 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -93.45 12.97 23.12 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.432 -0.792 . . . . 0.25 110.27 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 34' ' ' ILE . 92.8 mt . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.072 -1.017 . . . . 0.26000000000000001 110.358 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 78.6 t90 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.226 0.536 . . . . 0.25 110.066 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.3 m -136.7 -178.59 5.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.229 -0.919 . . . . 0.11 110.436 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.42 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -67.32 149.9 98.17 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.288 -0.883 . . . . 0.31 109.999 179.555 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -70.62 -5.14 16.07 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.668 1.351 . . . . 0.58999999999999997 111.513 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -156.18 32.11 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.817 -1.177 . . . . 0.56999999999999995 111.216 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.42 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 57.7 m -141.19 -57.86 0.49 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.015 -1.053 . . . . 0.39000000000000001 110.234 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.56 26.15 7.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.39 -1.484 . . . . 0.22 109.39 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.13 177.19 5.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.171 -1.193 . . . . 0.12 110.359 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.4 p -113.7 -165.15 0.98 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.326 -0.858 . . . . 0.17000000000000001 110.129 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -32.45 44.1 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.296 -0.877 . . . . 0.33000000000000002 110.436 177.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.94 -33.84 11.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.456 -0.778 . . . . 0.42999999999999999 110.294 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.49 -26.19 28.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.42999999999999999 109.785 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -92.59 128.11 38.32 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.374 -0.828 . . . . 0.46999999999999997 110.296 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.2 t -119.47 160.6 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.48999999999999999 110.252 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.68 103.33 6.6 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.167 -0.958 . . . . 0.56999999999999995 110.208 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.9 t80 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.56999999999999995 110.701 -179.269 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.287 0.565 . . . . 0.38 110.418 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -59.32 131.42 50.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.203 -0.935 . . . . 0.68999999999999995 110.409 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.7 mp -92.41 168.86 11.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.864 . . . . 0.65000000000000002 110.213 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.445 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 4.6 mttt -130.46 155.0 47.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.28999999999999998 110.422 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.538 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 28.7 m95 -129.39 135.57 48.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.273 -0.892 . . . . 0.29999999999999999 110.584 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.438 HD12 ' N ' ' A' ' 12' ' ' HIS . 2.0 tp -108.06 128.24 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.021 -1.049 . . . . 0.46000000000000002 110.524 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.2 t -74.8 100.12 3.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.877 . . . . 0.37 109.906 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 tt -56.11 -20.05 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.41999999999999998 110.464 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.7 m -65.79 -38.17 88.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.48999999999999999 110.803 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.4 p -129.23 -34.89 1.83 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.037 -1.04 . . . . 0.28000000000000003 111.029 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.24 38.45 1.65 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.765 -1.334 . . . . 0.17000000000000001 109.765 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.438 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.1 t-160 -104.1 128.06 51.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -1.165 . . . . 0.20999999999999999 110.067 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.9 mt -92.18 143.17 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.242 -0.911 . . . . 0.16 110.836 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 64.0 t80 -108.76 131.24 55.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.706 -0.621 . . . . 0.10000000000000001 109.485 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -106.29 107.94 19.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.537 -0.727 . . . . 0.11 109.815 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -50.39 -24.6 3.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 0.12 110.631 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.66 13.18 18.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.19 110.523 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 tp -176.68 62.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.154 -0.966 . . . . 0.27000000000000002 109.881 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.64 -134.35 0.06 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.025 -1.23 . . . . 0.20999999999999999 110.025 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -80.41 150.73 29.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.454 -1.027 . . . . 0.27000000000000002 110.664 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -105.23 -25.07 12.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.872 . . . . 0.38 110.046 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.33 -43.24 28.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.408 -0.808 . . . . 0.39000000000000001 110.333 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -70.53 -43.36 69.76 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.213 -0.929 . . . . 0.39000000000000001 110.11 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.66 30.06 1.0 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.162 -1.175 . . . . 0.28000000000000003 110.162 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CE1' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -73.03 81.39 1.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.85 -1.382 . . . . 0.31 109.944 179.151 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.5 t -49.33 150.89 2.9 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.40000000000000002 110.989 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.45 95.77 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.703 1.37 . . . . 0.25 110.255 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.1 41.37 0.12 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.509 -1.436 . . . . 0.089999999999999997 109.509 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -118.21 104.93 11.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -1.148 . . . . 0.14999999999999999 110.086 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -75.67 141.56 42.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.23999999999999999 110.649 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.482 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 0.4 OUTLIER -51.95 -29.62 21.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.359 -0.838 . . . . 0.28000000000000003 110.39 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -54.12 -50.69 66.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.31 110.386 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -74.96 -2.24 26.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.293 -0.879 . . . . 0.25 110.873 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.48 HD13 ' CE2' ' A' ' 25' ' ' PHE . 43.9 mt -103.79 90.51 2.91 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 120.934 -1.104 . . . . 0.26000000000000001 110.338 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -62.12 -163.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.648 1.341 . . . . 0.34000000000000002 110.543 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -69.4 -15.96 63.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.37 110.708 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -50.03 -29.28 8.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.004 . . . . 0.39000000000000001 110.649 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.552 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 85.5 t90 -89.84 140.75 29.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.25 110.245 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 88.4 m -121.21 -170.75 2.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.11 110.394 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.3 t -88.11 135.74 32.9 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.31 110.156 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.96 -13.28 28.97 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.458 1.241 . . . . 0.58999999999999997 110.736 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.82 -25.31 10.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 0.56999999999999995 110.795 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 85.1 m -111.32 -75.15 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.046 -1.033 . . . . 0.39000000000000001 110.571 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.03 35.54 0.77 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.444 -1.462 . . . . 0.22 109.444 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.62 -170.45 1.67 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -1.171 . . . . 0.12 110.514 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 p -78.49 -167.45 1.08 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.17000000000000001 110.383 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -83.65 -16.02 46.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -0.88 . . . . 0.33000000000000002 110.574 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.79 -22.75 59.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.091 -1.005 . . . . 0.42999999999999999 110.6 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.46 -17.81 60.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.42999999999999999 110.572 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -96.42 134.63 39.35 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.223 -0.923 . . . . 0.46999999999999997 110.928 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.437 ' CG2' HG21 ' A' ' 6' ' ' ILE . 34.2 m -125.67 171.13 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.858 . . . . 0.48999999999999999 109.972 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.27 130.27 34.82 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.163 -0.961 . . . . 0.56999999999999995 110.784 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -85.06 113.1 21.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 0.56999999999999995 110.383 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 54.23 172.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.28000000000000003 110.47 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 47.69 56.73 6.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.28000000000000003 111.002 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.965 -1.016 . . . . 0.46000000000000002 110.346 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.201 0.524 . . . . 0.38 110.377 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -146.93 136.9 23.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.68999999999999995 110.508 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 mp -75.56 162.69 28.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -0.8 . . . . 0.65000000000000002 110.523 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -134.19 134.91 42.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -0.871 . . . . 0.28999999999999998 110.231 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.532 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 24.8 m95 -115.24 -178.13 3.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.29999999999999999 110.229 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.476 HG22 HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -161.37 124.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.399 -0.813 . . . . 0.46000000000000002 110.059 178.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.2 t -69.3 100.02 1.27 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.371 -0.831 . . . . 0.37 110.418 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tt -53.98 -22.06 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.178 -0.951 . . . . 0.41999999999999998 109.982 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.7 m -80.75 -28.88 36.33 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.25 -0.906 . . . . 0.48999999999999999 110.175 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -110.2 -53.39 2.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 0.28000000000000003 110.553 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.72 -11.02 12.25 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.133 -1.187 . . . . 0.17000000000000001 110.133 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -75.65 138.86 41.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.941 -1.329 . . . . 0.20999999999999999 110.482 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 51.3 mt -97.6 136.91 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.364 -0.835 . . . . 0.16 110.589 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.475 ' CE1' ' HA2' ' A' ' 19' ' ' GLY . 87.3 t80 -92.18 138.9 31.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.404 -0.81 . . . . 0.10000000000000001 110.305 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -112.41 108.87 18.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.49 -0.756 . . . . 0.11 109.988 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -50.98 -24.42 3.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.154 -0.966 . . . . 0.12 110.7 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.31 16.43 8.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.19 110.4 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -176.96 69.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.27000000000000002 109.855 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.475 ' HA2' ' CE1' ' A' ' 14' ' ' TYR . . . -68.37 -137.04 0.07 OUTLIER Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.143 -1.183 . . . . 0.20999999999999999 110.143 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 22' ' ' ALA . 15.8 t0 -87.07 149.77 24.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.406 -1.055 . . . . 0.27000000000000002 110.718 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.408 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 36.5 mt-10 -97.17 -30.59 12.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.854 . . . . 0.38 110.023 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.424 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . -75.16 -44.86 44.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.387 -0.821 . . . . 0.39000000000000001 110.316 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -63.61 -38.94 93.04 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.255 -0.903 . . . . 0.39000000000000001 110.312 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.13 23.21 4.28 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.677 -1.369 . . . . 0.28000000000000003 109.677 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.476 ' CE2' HG23 ' A' ' 29' ' ' THR . 0.7 OUTLIER -66.72 83.81 0.11 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.099 -1.236 . . . . 0.31 110.124 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.4 t -49.77 152.54 2.53 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.446 -0.784 . . . . 0.40000000000000002 110.918 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -58.04 106.99 0.28 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.703 1.37 . . . . 0.25 110.468 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.4 38.99 0.46 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.474 -1.45 . . . . 0.089999999999999997 109.474 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.476 HG23 ' CE2' ' A' ' 25' ' ' PHE . 26.2 m -108.97 134.4 51.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -1.115 . . . . 0.14999999999999999 110.353 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -117.96 141.02 48.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.23999999999999999 110.346 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.532 ' CZ ' ' CZ3' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -48.94 -36.59 17.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.198 -0.939 . . . . 0.28000000000000003 110.747 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -57.15 -34.79 68.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.237 -0.914 . . . . 0.31 109.989 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -87.37 -23.07 24.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.333 -0.854 . . . . 0.25 110.234 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 31' ' ' PHE . 20.8 mt -58.68 109.82 2.15 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.26000000000000001 109.913 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -62.02 -161.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.458 1.241 . . . . 0.34000000000000002 110.492 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.47 -25.14 21.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.37 110.26 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -55.51 -30.61 60.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.39000000000000001 110.443 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.532 ' CZ3' ' CZ ' ' A' ' 31' ' ' PHE . 79.7 t90 -75.86 169.52 17.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.933 . . . . 0.25 110.363 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.473 ' N ' ' CD2' ' A' ' 38' ' ' TRP . 25.3 p -173.94 -160.89 0.11 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.389 -0.819 . . . . 0.11 110.148 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.55 143.4 72.06 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.307 -0.87 . . . . 0.31 110.091 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.56 -7.62 19.69 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.664 1.35 . . . . 0.58999999999999997 111.373 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.8 -32.21 2.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.952 -1.093 . . . . 0.56999999999999995 111.05 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 63.3 m -92.4 -70.34 0.7 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.07 -1.019 . . . . 0.39000000000000001 110.407 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.27 25.11 4.83 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.288 -1.525 . . . . 0.22 109.288 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.14 174.4 5.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -1.147 . . . . 0.12 110.569 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.0 p -67.42 -162.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.17000000000000001 110.345 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -78.65 -2.83 40.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.33000000000000002 110.769 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -45.03 64.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.957 -1.09 . . . . 0.42999999999999999 110.463 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -73.02 -20.25 61.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.42999999999999999 110.219 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -90.58 129.7 36.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.46999999999999997 110.495 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.4 m -128.21 159.97 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.48999999999999999 110.21 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.42 119.05 17.12 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.195 -0.94 . . . . 0.56999999999999995 110.383 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -69.93 129.53 39.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.56999999999999995 110.628 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -107.56 122.06 45.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.28000000000000003 110.219 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.79 118.86 12.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -0.873 . . . . 0.28000000000000003 110.503 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.941 -1.028 . . . . 0.46000000000000002 110.363 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.221 0.534 . . . . 0.38 110.476 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -104.2 134.99 46.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.68999999999999995 110.483 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mp -92.36 163.13 13.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.298 -0.876 . . . . 0.65000000000000002 110.284 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.73 146.56 50.89 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.244 -0.91 . . . . 0.28999999999999998 109.809 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.553 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 25.0 m95 -119.82 -176.55 3.2 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.319 -0.863 . . . . 0.29999999999999999 109.616 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.461 HG22 HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -152.96 129.42 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.407 -0.917 . . . . 0.46000000000000002 110.481 178.405 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 t -75.69 92.14 2.96 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.495 -0.753 . . . . 0.37 109.982 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.423 HG13 ' N ' ' A' ' 9' ' ' THR . 15.9 pt -51.67 -23.64 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.009 -1.057 . . . . 0.41999999999999998 109.928 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.423 ' N ' HG13 ' A' ' 8' ' ' ILE . 45.9 m -68.9 -26.96 65.37 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.495 -0.753 . . . . 0.48999999999999999 110.295 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.7 m -125.83 -49.99 1.6 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -0.953 . . . . 0.28000000000000003 111.284 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.402 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . 118.97 13.22 6.63 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.905 -1.278 . . . . 0.17000000000000001 109.905 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.02 125.51 37.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.994 -1.297 . . . . 0.20999999999999999 110.177 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.4 mt -88.79 141.17 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.16 110.696 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -102.44 148.1 25.91 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.657 0.741 . . . . 0.10000000000000001 110.35 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -124.15 106.75 10.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.579 -0.701 . . . . 0.11 109.923 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.427 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 98.8 mt-10 -50.26 -24.42 2.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.12 110.565 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.21 20.19 7.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.19 110.257 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tp -176.49 65.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.27000000000000002 109.966 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.8 -141.56 0.32 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.886 -1.286 . . . . 0.20999999999999999 109.886 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.02 171.63 7.24 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.38 -1.07 . . . . 0.27000000000000002 110.543 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -106.42 -35.63 7.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.35 -0.844 . . . . 0.38 110.159 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.36 -41.73 89.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.872 . . . . 0.39000000000000001 110.171 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -73.91 -3.33 28.26 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.253 -0.904 . . . . 0.39000000000000001 110.901 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.22 25.19 64.34 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.348 -1.501 . . . . 0.28000000000000003 109.348 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -82.66 79.99 8.91 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.277 -1.131 . . . . 0.31 109.985 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.0 t -49.46 151.29 2.84 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.389 -0.819 . . . . 0.40000000000000002 111.004 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -60.0 114.97 2.32 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.704 1.371 . . . . 0.25 110.42 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.65 16.58 5.89 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.868 -1.293 . . . . 0.089999999999999997 109.868 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.3 m -86.01 116.52 24.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.244 . . . . 0.14999999999999999 110.224 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.427 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 43.6 mtt85 -90.26 140.65 29.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.23999999999999999 110.576 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.489 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -59.18 -35.14 73.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.888 . . . . 0.28000000000000003 110.165 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -52.28 -30.64 28.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.31 110.35 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -100.86 19.04 17.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -0.844 . . . . 0.25 110.345 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.475 HD12 ' CZ ' ' A' ' 25' ' ' PHE . 92.9 mt -116.4 104.97 51.17 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.26000000000000001 109.989 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -58.83 -155.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.604 1.318 . . . . 0.34000000000000002 110.684 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -93.75 18.43 10.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.908 . . . . 0.37 110.54 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -81.32 -48.84 11.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.39000000000000001 110.289 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 85.8 t90 -62.78 144.92 56.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.366 -0.834 . . . . 0.25 110.372 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.7 m -128.96 -164.58 1.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.11 110.181 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.45 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -79.95 152.79 74.73 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.128 -0.983 . . . . 0.31 110.236 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -62.97 -12.88 31.74 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.583 1.307 . . . . 0.58999999999999997 111.325 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -157.49 40.69 0.3 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.91 -1.119 . . . . 0.56999999999999995 111.185 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.45 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 56.7 m -141.88 -59.51 0.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.034 -1.042 . . . . 0.39000000000000001 110.184 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.08 25.62 11.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.117 -1.593 . . . . 0.22 109.117 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.12 -170.37 2.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -1.112 . . . . 0.12 110.408 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.2 p -108.89 -173.19 2.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.17000000000000001 110.372 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -63.04 -16.65 60.58 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.268 -0.895 . . . . 0.33000000000000002 110.261 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -55.58 -38.77 69.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.42999999999999999 110.246 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 5.7 m-20 -77.05 -12.88 60.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.31 -0.869 . . . . 0.42999999999999999 110.473 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -100.72 136.82 39.98 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.049 -1.032 . . . . 0.46999999999999997 110.772 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 52' ' ' LEU . 99.5 t -133.15 149.05 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.47 -0.769 . . . . 0.48999999999999999 109.985 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.417 ' N ' HG11 ' A' ' 51' ' ' VAL . 1.1 tt -63.71 120.54 12.02 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.112 -0.992 . . . . 0.56999999999999995 110.279 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -76.63 118.46 19.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.335 -0.853 . . . . 0.56999999999999995 110.375 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.01 72.08 0.19 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.28000000000000003 110.361 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -68.01 108.87 3.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.28000000000000003 110.302 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.979 -1.01 . . . . 0.46000000000000002 110.335 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.24 0.543 . . . . 0.38 110.25 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -65.73 141.08 58.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.894 . . . . 0.68999999999999995 110.403 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mp -98.85 170.05 9.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.507 -0.745 . . . . 0.65000000000000002 110.678 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -134.84 148.93 50.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.28999999999999998 110.186 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.45 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 48.9 m95 -129.91 178.87 6.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 0.29999999999999999 110.504 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 tp -156.32 120.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.65 -0.656 . . . . 0.46000000000000002 109.741 178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 11' ' ' GLY . 18.9 t -67.67 96.93 0.58 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.372 -0.83 . . . . 0.37 110.313 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 9' ' ' THR . 1.5 tt -54.99 -19.92 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.142 -0.974 . . . . 0.41999999999999998 110.289 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.418 ' N ' HG22 ' A' ' 8' ' ' ILE . 43.6 m -80.62 -28.35 37.01 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.261 -0.899 . . . . 0.48999999999999999 110.381 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.4 m -117.23 -46.43 2.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.163 -0.961 . . . . 0.28000000000000003 110.856 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . 109.0 19.8 8.35 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.678 -1.369 . . . . 0.17000000000000001 109.678 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -99.65 134.48 42.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -1.21 . . . . 0.20999999999999999 110.069 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 4.4 mt -96.24 141.04 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.16 110.656 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -108.21 144.56 35.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.512 -0.742 . . . . 0.10000000000000001 110.329 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -119.9 109.42 15.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.429 -0.794 . . . . 0.11 110.097 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.412 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 69.8 mt-10 -50.22 -27.85 6.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 0.12 110.474 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.85 12.83 24.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.921 . . . . 0.19 110.617 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.55 68.45 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.12 -0.987 . . . . 0.27000000000000002 110.42 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.25 -135.5 0.01 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.402 -1.479 . . . . 0.20999999999999999 109.402 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.25 164.75 12.71 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.225 -1.161 . . . . 0.27000000000000002 110.287 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -92.81 -22.14 19.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -0.913 . . . . 0.38 110.31 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.67 -36.46 17.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.39000000000000001 110.366 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -65.19 -26.92 68.35 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.255 -0.903 . . . . 0.39000000000000001 110.332 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.83 27.47 14.17 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.548 -1.421 . . . . 0.28000000000000003 109.548 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.491 ' CZ ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -73.51 84.0 1.51 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.108 -1.231 . . . . 0.31 110.208 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.4 t -50.06 143.94 11.58 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.192 -0.943 . . . . 0.40000000000000002 110.474 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.15 106.57 0.21 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.653 1.344 . . . . 0.25 110.645 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.02 44.42 0.17 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.582 -1.407 . . . . 0.089999999999999997 109.582 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 m -130.59 122.87 28.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.11 -1.229 . . . . 0.14999999999999999 110.511 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.412 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 1.7 ptm180 -103.58 150.91 23.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.23999999999999999 110.446 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.547 ' CZ ' ' CZ3' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -48.4 -44.62 35.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.232 -0.917 . . . . 0.28000000000000003 110.833 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -53.61 -48.73 69.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.31 110.234 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.93 -22.57 66.5 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.265 -0.897 . . . . 0.25 110.217 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.491 HD12 ' CZ ' ' A' ' 25' ' ' PHE . 46.8 mt -80.53 111.03 19.4 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.431 -0.793 . . . . 0.26000000000000001 110.047 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -69.52 -169.72 0.33 Allowed 'Trans proline' 0 C--N 1.314 -1.278 0 O-C-N 123.493 1.259 . . . . 0.34000000000000002 110.853 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -72.04 -17.32 62.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 0.37 110.49 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -52.31 -31.49 33.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.094 -1.004 . . . . 0.39000000000000001 110.151 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.547 ' CZ3' ' CZ ' ' A' ' 31' ' ' PHE . 79.8 t90 -83.02 160.69 21.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.421 -0.799 . . . . 0.25 110.096 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.6 p -162.36 -160.53 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.11 110.386 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.434 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -86.55 160.95 49.64 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.358 -0.839 . . . . 0.31 110.422 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -73.88 -23.05 16.81 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.607 1.319 . . . . 0.58999999999999997 110.953 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -139.49 30.46 2.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.993 -1.067 . . . . 0.56999999999999995 111.178 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.434 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 60.6 m -141.57 -46.15 0.37 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.974 -1.079 . . . . 0.39000000000000001 110.255 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.27 28.92 47.18 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.5 -1.44 . . . . 0.22 109.5 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.32 -171.81 2.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -1.174 . . . . 0.12 110.334 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.4 p -109.25 -159.85 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.17000000000000001 110.336 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -58.34 -18.5 27.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.394 -0.816 . . . . 0.33000000000000002 110.253 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -50.22 -48.29 54.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.064 -1.022 . . . . 0.42999999999999999 110.56 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.03 -20.42 61.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.42999999999999999 110.154 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -95.92 137.58 34.78 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.315 -0.866 . . . . 0.46999999999999997 110.764 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 80.7 t -125.11 158.73 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.388 -0.82 . . . . 0.48999999999999999 109.931 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.33 100.13 2.58 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.179 -0.951 . . . . 0.56999999999999995 110.083 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -52.77 135.14 36.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.446 -0.784 . . . . 0.56999999999999995 110.516 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -98.1 107.59 20.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.28000000000000003 110.287 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -110.49 101.88 10.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.28000000000000003 110.386 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.8 tttm . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 118.024 -0.989 . . . . 0.46000000000000002 110.358 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.264 0.555 . . . . 0.38 110.409 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -103.21 138.82 39.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.68999999999999995 110.537 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.64 179.16 7.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.435 -0.791 . . . . 0.65000000000000002 110.587 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -146.68 138.8 24.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.405 -0.809 . . . . 0.28999999999999998 110.451 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.54 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 29.2 m95 -118.23 -178.37 3.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -0.822 . . . . 0.29999999999999999 110.08 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -156.55 118.67 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.394 -0.816 . . . . 0.46000000000000002 110.374 177.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.6 t -63.93 92.2 0.07 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.243 -0.911 . . . . 0.37 109.919 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 9' ' ' THR . 8.6 pt -51.7 -23.71 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.182 -0.949 . . . . 0.41999999999999998 110.073 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.417 ' N ' HG13 ' A' ' 8' ' ' ILE . 36.3 m -72.48 -29.42 63.63 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.306 -0.871 . . . . 0.48999999999999999 110.039 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.2 m -114.29 -49.04 2.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.28000000000000003 110.667 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.22 8.64 16.81 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.032 -1.227 . . . . 0.17000000000000001 110.032 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.25 133.97 35.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.911 -1.347 . . . . 0.20999999999999999 110.091 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 90.4 mt -93.2 124.43 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.16 110.783 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -84.55 131.04 34.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.42 -0.8 . . . . 0.10000000000000001 109.978 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -108.44 111.78 23.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.11 109.815 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -51.9 -23.95 5.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.12 110.265 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.75 13.55 12.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.19 110.509 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.57 64.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.27000000000000002 109.756 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.43 -136.29 0.12 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.049 -1.221 . . . . 0.20999999999999999 110.049 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -84.91 144.53 28.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -1.04 . . . . 0.27000000000000002 110.598 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -91.07 -22.95 20.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.307 -0.871 . . . . 0.38 110.082 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.8 -39.93 15.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.39000000000000001 110.302 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -65.96 -32.35 73.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.39000000000000001 110.259 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.18 29.22 4.63 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.54 -1.424 . . . . 0.28000000000000003 109.54 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.567 ' CE1' ' CD1' ' A' ' 38' ' ' TRP . 1.5 m-85 -73.69 82.74 1.58 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.111 -1.229 . . . . 0.31 110.181 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.2 t -49.49 149.3 4.16 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.40000000000000002 110.785 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.17 110.83 0.62 Allowed 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.666 1.351 . . . . 0.25 110.397 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.09 19.82 4.63 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.741 -1.344 . . . . 0.089999999999999997 109.741 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.3 m -86.58 133.76 33.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.058 -1.26 . . . . 0.14999999999999999 110.262 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.426 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 2.3 mtp180 -116.12 144.56 43.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.87 . . . . 0.23999999999999999 110.431 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.462 ' HA ' ' CD1' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -49.57 -25.16 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.314 -0.866 . . . . 0.28000000000000003 110.525 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.41 -24.33 54.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.895 . . . . 0.31 110.479 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -114.17 11.28 17.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.25 110.836 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.501 ' N ' ' CD ' ' A' ' 35' ' ' PRO . 8.6 mt -81.18 -44.19 1.17 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.071 -1.018 . . . . 0.26000000000000001 110.928 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 34' ' ' ILE . 78.1 Cg_exo -46.94 94.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.09 0 O-C-N 123.035 1.019 . . . . 0.34000000000000002 111.209 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 34' ' ' ILE . 25.8 t0 -175.48 -46.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.419 -0.801 . . . . 0.37 109.879 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.58 32.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.862 . . . . 0.39000000000000001 109.962 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.567 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 82.2 t90 -112.13 170.26 8.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.411 -0.806 . . . . 0.25 110.67 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.433 ' N ' ' CG ' ' A' ' 38' ' ' TRP . 25.0 p -169.66 -161.34 0.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.329 -0.857 . . . . 0.11 110.31 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.438 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -91.82 169.25 11.48 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 0.31 110.227 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.28 -40.53 31.84 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.584 1.307 . . . . 0.58999999999999997 110.746 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.1 50.76 1.03 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.091 -1.005 . . . . 0.56999999999999995 110.689 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.438 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 61.7 m -136.58 -45.63 0.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.39000000000000001 110.086 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.34 32.45 51.69 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.354 -1.498 . . . . 0.22 109.354 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.23 166.72 10.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 0.12 110.443 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.4 p -91.59 -162.15 0.89 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.398 -0.814 . . . . 0.17000000000000001 110.161 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp -61.67 -15.47 40.3 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.239 -0.913 . . . . 0.33000000000000002 110.377 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 49' ' ' ASP . 23.2 pt-20 -51.79 -40.68 60.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.052 -1.03 . . . . 0.42999999999999999 110.354 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.426 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 14.9 m-20 -80.58 -18.37 48.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.231 -0.918 . . . . 0.42999999999999999 110.368 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -95.21 124.17 39.11 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.185 -0.947 . . . . 0.46999999999999997 110.455 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 52' ' ' LEU . 97.9 t -117.21 148.02 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.279 -0.888 . . . . 0.48999999999999999 110.088 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.422 ' N ' HG12 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -67.76 117.44 9.67 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.152 -0.968 . . . . 0.56999999999999995 110.096 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -67.72 141.92 56.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.56999999999999995 110.535 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.84 126.7 0.47 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.324 -0.86 . . . . 0.28000000000000003 110.406 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.56 52.66 0.83 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.28000000000000003 110.457 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.2 pttt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.96 -1.019 . . . . 0.46000000000000002 110.39 179.951 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.277 0.56 . . . . 0.38 110.356 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -122.18 138.41 54.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -0.877 . . . . 0.68999999999999995 110.351 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.5 mp -91.03 164.16 14.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.409 -0.807 . . . . 0.65000000000000002 110.725 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -122.56 144.76 48.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -0.835 . . . . 0.28999999999999998 110.07 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.506 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 39.2 m95 -121.5 179.07 4.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 0.29999999999999999 110.537 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.1 tp -153.88 128.18 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.717 -0.614 . . . . 0.46000000000000002 110.068 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 45.3 t -76.97 98.03 4.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.37 110.291 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -52.68 -23.3 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.097 -1.002 . . . . 0.41999999999999998 110.175 179.446 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.432 ' N ' HG22 ' A' ' 8' ' ' ILE . 52.4 m -79.82 -30.61 40.52 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.388 -0.82 . . . . 0.48999999999999999 110.351 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -108.99 -54.44 2.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 0.28000000000000003 110.569 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.38 13.48 10.63 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.896 -1.281 . . . . 0.17000000000000001 109.896 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -99.33 133.82 43.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.934 -1.333 . . . . 0.20999999999999999 110.047 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 3.9 mt -89.68 145.68 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.16 110.631 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.406 ' CE1' ' HA2' ' A' ' 19' ' ' GLY . 75.4 t80 -104.82 129.26 53.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.564 -0.71 . . . . 0.10000000000000001 110.352 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -102.8 104.39 14.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.301 -0.874 . . . . 0.11 110.006 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -51.89 -23.0 4.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -0.865 . . . . 0.12 110.758 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.31 -2.74 26.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.235 -0.915 . . . . 0.19 110.943 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.433 ' O ' ' CG ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -173.42 68.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.987 -1.071 . . . . 0.27000000000000002 110.062 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.406 ' HA2' ' CE1' ' A' ' 14' ' ' TYR . . . -62.97 -136.96 0.01 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.328 -1.109 . . . . 0.20999999999999999 110.328 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -92.71 166.09 12.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.294 -1.121 . . . . 0.27000000000000002 110.512 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -109.21 -27.1 9.74 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.326 -0.858 . . . . 0.38 110.129 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.74 -54.16 17.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.39000000000000001 110.172 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -63.56 -24.76 67.94 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.228 -0.92 . . . . 0.39000000000000001 110.137 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.5 28.99 5.52 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.542 -1.423 . . . . 0.28000000000000003 109.542 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.581 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.7 OUTLIER -81.49 79.88 7.99 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.153 -1.204 . . . . 0.31 110.442 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -53.26 152.82 7.63 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.254 -0.904 . . . . 0.40000000000000002 110.511 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -54.54 95.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.608 1.32 . . . . 0.25 110.307 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 144.81 -15.88 1.98 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.815 -1.314 . . . . 0.089999999999999997 109.815 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.6 m -50.45 121.94 6.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.017 -1.284 . . . . 0.14999999999999999 110.633 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -105.6 139.84 39.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.23999999999999999 110.266 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.483 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -47.32 -46.77 25.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.337 -0.852 . . . . 0.28000000000000003 110.835 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.67 -33.57 47.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.284 -0.885 . . . . 0.31 110.233 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.42 11.81 27.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.335 -0.853 . . . . 0.25 110.653 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.468 HD13 ' CZ ' ' A' ' 25' ' ' PHE . 91.3 mt -109.44 108.17 59.83 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.011 -1.056 . . . . 0.26000000000000001 109.971 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -61.82 -164.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.482 1.254 . . . . 0.34000000000000002 110.785 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.16 -17.81 48.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.37 110.735 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.72 -43.58 62.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.13 -0.981 . . . . 0.39000000000000001 110.465 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 81.0 t90 -69.97 144.88 52.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.25 109.993 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 95.3 m -143.38 -175.12 4.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.11 110.401 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -74.08 136.97 75.85 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.31 110.233 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -72.6 -13.05 27.25 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.463 1.244 . . . . 0.58999999999999997 110.846 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.51 -23.94 11.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.027 -1.046 . . . . 0.56999999999999995 110.756 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 95.8 m -111.86 -75.04 0.62 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.027 -1.046 . . . . 0.39000000000000001 110.418 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.38 36.83 0.67 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.402 -1.479 . . . . 0.22 109.402 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.66 -169.17 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -1.166 . . . . 0.12 110.499 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.7 p -88.8 -162.5 0.86 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 0.17000000000000001 110.4 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.25 -9.79 54.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.853 . . . . 0.33000000000000002 110.639 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -52.14 -44.76 64.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.984 -1.072 . . . . 0.42999999999999999 110.463 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.9 OUTLIER -71.31 -20.6 62.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.161 -0.962 . . . . 0.42999999999999999 110.033 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -96.06 134.08 39.54 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.248 -0.907 . . . . 0.46999999999999997 110.662 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.54 171.85 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.831 . . . . 0.48999999999999999 110.115 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.62 118.51 18.54 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.253 -0.904 . . . . 0.56999999999999995 110.311 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -63.12 105.42 0.7 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.56999999999999995 110.579 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -144.72 103.89 3.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.845 . . . . 0.28000000000000003 110.176 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.14 137.73 26.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.28000000000000003 110.484 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.018 -0.991 . . . . 0.46000000000000002 110.266 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.198 0.523 . . . . 0.38 110.414 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -122.35 139.64 53.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.68999999999999995 110.35 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 mp -104.1 179.79 4.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.65000000000000002 110.743 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -139.63 145.97 39.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.496 -0.752 . . . . 0.28999999999999998 110.009 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.524 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 34.1 m95 -127.82 134.72 49.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.082 -1.011 . . . . 0.29999999999999999 110.658 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.44 HD12 ' N ' ' A' ' 12' ' ' HIS . 2.6 tp -111.62 132.62 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.023 -1.048 . . . . 0.46000000000000002 110.297 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.9 t -79.13 100.05 7.24 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.345 -0.847 . . . . 0.37 110.037 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.428 HG21 ' N ' ' A' ' 9' ' ' THR . 1.6 tt -56.17 -18.74 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.917 . . . . 0.41999999999999998 110.619 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.428 ' N ' HG21 ' A' ' 8' ' ' ILE . 92.0 m -70.08 -39.56 75.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.885 . . . . 0.48999999999999999 110.824 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.9 p -126.8 -35.31 2.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.971 -1.081 . . . . 0.28000000000000003 111.116 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.97 44.7 1.08 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.852 -1.299 . . . . 0.17000000000000001 109.852 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.44 ' N ' HD12 ' A' ' 6' ' ' ILE . 9.5 t60 -108.74 127.7 54.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -1.211 . . . . 0.20999999999999999 110.142 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.8 mt -93.09 133.52 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.16 110.8 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -102.84 121.39 42.39 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.506 -0.746 . . . . 0.10000000000000001 109.295 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -98.98 106.26 18.5 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.415 -0.803 . . . . 0.11 110.19 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.433 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -48.74 -24.16 1.3 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.385 -0.822 . . . . 0.12 111.015 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.65 14.45 8.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.067 -1.021 . . . . 0.19 110.803 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 tt -176.61 69.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.1 -1.0 . . . . 0.27000000000000002 109.999 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.06 -136.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.842 -1.303 . . . . 0.20999999999999999 109.842 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -113.37 161.31 17.42 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.347 -1.09 . . . . 0.27000000000000002 110.179 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -97.27 -27.74 14.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.38 110.36 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.95 -29.03 58.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.92 . . . . 0.39000000000000001 110.345 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -88.9 16.59 6.7 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.298 -0.876 . . . . 0.39000000000000001 110.805 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.1 28.38 63.87 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.456 -1.458 . . . . 0.28000000000000003 109.456 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -86.85 82.71 7.72 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.232 -1.158 . . . . 0.31 110.046 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.8 t -47.86 151.4 1.63 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.469 -0.769 . . . . 0.40000000000000002 110.961 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -56.96 104.92 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.701 1.369 . . . . 0.25 110.467 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.1 35.51 0.76 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.622 -1.391 . . . . 0.089999999999999997 109.622 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.431 HG23 ' CG1' ' A' ' 34' ' ' ILE . 58.2 m -90.3 134.32 34.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.189 -1.183 . . . . 0.14999999999999999 110.32 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.433 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -105.72 135.51 47.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 0.23999999999999999 110.468 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.478 ' CB ' ' CE2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -51.0 -47.21 61.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.28000000000000003 110.473 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -54.91 -41.43 70.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.861 . . . . 0.31 110.442 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.98 -24.34 52.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.25 110.394 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.461 HD12 ' CE2' ' A' ' 25' ' ' PHE . 63.4 mt -68.88 118.36 60.39 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.26000000000000001 110.119 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -62.91 -150.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 O-C-N 123.446 1.235 . . . . 0.34000000000000002 110.512 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -100.12 -19.86 16.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.37 110.525 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.52 -40.04 58.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.187 -0.946 . . . . 0.39000000000000001 110.591 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 89.4 t90 -67.65 164.11 19.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.278 -0.889 . . . . 0.25 110.47 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.8 p -162.24 -160.89 0.7 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.11 110.343 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.56 120.85 70.37 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.401 -0.812 . . . . 0.31 110.173 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.35 -12.82 34.88 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.473 1.249 . . . . 0.58999999999999997 110.849 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.412 ' OD2' ' ND1' ' A' ' 12' ' ' HIS . 87.8 m-20 -102.55 -26.84 13.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.052 -1.03 . . . . 0.56999999999999995 110.674 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 96.6 m -114.32 -75.42 0.59 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.139 -0.976 . . . . 0.39000000000000001 110.327 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.3 40.83 0.35 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.396 -1.482 . . . . 0.22 109.396 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.43 -175.09 3.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -1.173 . . . . 0.12 110.667 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 p -82.55 -166.71 1.36 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.385 -0.822 . . . . 0.17000000000000001 110.511 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -69.02 -8.76 48.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.32 -0.863 . . . . 0.33000000000000002 110.551 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -50.95 -42.88 60.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.987 -1.07 . . . . 0.42999999999999999 110.299 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -76.02 -20.64 57.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.319 -0.863 . . . . 0.42999999999999999 110.377 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -92.86 131.41 37.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.46999999999999997 110.596 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.415 ' CG2' HG22 ' A' ' 6' ' ' ILE . 35.9 m -124.27 163.19 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.279 -0.888 . . . . 0.48999999999999999 110.161 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.86 120.35 25.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.56999999999999995 110.581 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -75.38 113.68 13.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -0.836 . . . . 0.56999999999999995 110.389 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.34 148.32 25.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 0.28000000000000003 110.446 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -98.99 57.87 1.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.28000000000000003 110.3 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.963 -1.018 . . . . 0.46000000000000002 110.35 -179.898 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.273 0.559 . . . . 0.38 110.366 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' A' ' 17' ' ' ALA . 42.6 m-85 -95.02 133.68 38.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.925 . . . . 0.68999999999999995 110.479 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 mp -75.04 164.44 26.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.65000000000000002 110.528 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -130.31 136.58 49.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.28999999999999998 110.093 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.517 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 29.6 m95 -115.84 170.61 8.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.966 . . . . 0.29999999999999999 110.283 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.431 HG23 ' CG2' ' A' ' 51' ' ' VAL . 2.1 tp -144.38 136.27 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.454 -0.779 . . . . 0.46000000000000002 109.775 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.402 ' O ' ' N ' ' A' ' 11' ' ' GLY . 8.4 t -84.44 95.12 8.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.366 -0.834 . . . . 0.37 110.342 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -52.81 -22.88 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.11 -0.993 . . . . 0.41999999999999998 110.043 179.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.423 ' N ' HG21 ' A' ' 8' ' ' ILE . 49.2 m -72.72 -28.02 62.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.372 -0.83 . . . . 0.48999999999999999 110.302 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 78.9 m -124.6 -51.38 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.28000000000000003 110.64 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . 117.3 19.34 5.11 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.833 -1.307 . . . . 0.17000000000000001 109.833 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -97.57 133.09 42.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.051 -1.264 . . . . 0.20999999999999999 110.102 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 3.9 mt -91.28 134.51 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.16 110.504 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -94.33 125.89 39.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.5 -0.75 . . . . 0.10000000000000001 109.892 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -95.83 102.55 14.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.459 -0.775 . . . . 0.11 110.289 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -49.35 -30.96 8.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.85 . . . . 0.12 110.702 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.445 ' HB3' ' CD2' ' A' ' 2' ' ' TYR . . . -91.74 17.47 8.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.895 . . . . 0.19 110.457 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -177.0 70.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -0.956 . . . . 0.27000000000000002 110.076 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.87 -135.4 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.89 -1.284 . . . . 0.20999999999999999 109.89 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD2' ' N ' ' A' ' 22' ' ' ALA . 16.3 t70 -113.12 168.97 9.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.345 -1.091 . . . . 0.27000000000000002 110.571 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -87.81 -46.62 9.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.27 -0.894 . . . . 0.38 110.073 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . -53.83 -43.76 69.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.337 -0.852 . . . . 0.39000000000000001 110.205 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -70.88 -30.22 66.54 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.32 -0.862 . . . . 0.39000000000000001 110.083 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.27 28.85 18.89 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.686 -1.366 . . . . 0.28000000000000003 109.686 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CE2' ' NE1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -69.19 82.86 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.275 . . . . 0.31 110.064 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.5 t -49.49 145.75 7.57 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.196 -0.94 . . . . 0.40000000000000002 110.723 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -53.51 105.66 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.683 1.359 . . . . 0.25 110.712 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.48 41.98 0.26 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.879 -1.288 . . . . 0.089999999999999997 109.879 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.19 126.76 44.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -1.218 . . . . 0.14999999999999999 110.267 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.429 ' HG2' ' CB ' ' A' ' 33' ' ' ASP . 0.4 OUTLIER -118.38 148.68 42.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.23999999999999999 110.256 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.485 ' CE2' ' HG2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -47.78 -40.74 21.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.254 -0.904 . . . . 0.28000000000000003 110.673 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -59.31 -32.38 70.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.191 -0.943 . . . . 0.31 109.983 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.429 ' CB ' ' HG2' ' A' ' 30' ' ' ARG . 21.3 t0 -95.39 12.67 28.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 0.25 110.551 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 34' ' ' ILE . 92.3 mt -113.83 64.21 1.17 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.092 -1.005 . . . . 0.26000000000000001 110.119 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -66.05 -21.24 56.53 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.538 1.283 . . . . 0.34000000000000002 110.508 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.92 -175.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.37 110.45 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.26 42.16 1.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.297 -0.877 . . . . 0.39000000000000001 110.175 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.424 ' NE1' ' CE2' ' A' ' 25' ' ' PHE . 85.6 t90 -51.92 143.54 13.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.25 110.553 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 8.4 m -135.07 172.31 13.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.342 -0.849 . . . . 0.11 110.173 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.438 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -55.92 151.6 23.76 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.31 110.334 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -74.22 -7.77 20.15 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.513 1.27 . . . . 0.58999999999999997 111.201 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -150.64 32.72 0.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.899 -1.126 . . . . 0.56999999999999995 111.053 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.438 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 59.0 m -142.11 -65.86 0.41 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.084 -1.01 . . . . 0.39000000000000001 110.045 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.54 29.4 3.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.496 -1.442 . . . . 0.22 109.496 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -105.71 171.01 7.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -1.106 . . . . 0.12 110.462 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.5 p -90.13 -162.39 0.89 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.17000000000000001 110.205 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.485 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 23.0 mttt -68.08 -14.33 62.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.341 -0.849 . . . . 0.33000000000000002 110.437 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -52.7 -45.87 67.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.098 -1.001 . . . . 0.42999999999999999 110.215 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 1.6 m-20 -70.49 -20.89 62.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.321 -0.862 . . . . 0.42999999999999999 109.992 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -97.76 134.75 40.51 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.378 -0.826 . . . . 0.46999999999999997 110.593 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.431 ' CG2' HG23 ' A' ' 6' ' ' ILE . 34.3 m -130.75 170.93 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.48999999999999999 110.274 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.25 119.44 22.33 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.165 -0.959 . . . . 0.56999999999999995 110.344 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -76.28 162.33 28.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.883 . . . . 0.56999999999999995 110.529 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -126.03 106.92 9.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.28000000000000003 110.238 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -81.36 158.39 24.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.28000000000000003 110.48 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.933 -1.032 . . . . 0.46000000000000002 110.418 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.309 0.576 . . . . 0.38 110.441 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -65.76 137.11 57.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.68999999999999995 110.512 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.93 157.42 15.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 0.65000000000000002 110.481 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.431 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 0.9 OUTLIER -121.2 160.36 23.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.28999999999999998 110.097 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.447 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 55.9 m95 -135.09 127.1 29.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.151 -0.968 . . . . 0.29999999999999999 110.651 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.462 HG23 HD12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -98.83 130.43 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.09 -1.006 . . . . 0.46000000000000002 110.028 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.422 ' N ' HD11 ' A' ' 6' ' ' ILE . 12.0 t -78.68 92.88 4.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.216 -0.928 . . . . 0.37 109.507 177.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.448 HG22 ' CG2' ' A' ' 51' ' ' VAL . 48.0 pt -51.49 -23.99 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.884 -1.135 . . . . 0.41999999999999998 110.031 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.9 m -77.13 -27.4 53.91 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.546 -0.721 . . . . 0.48999999999999999 110.195 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.7 m -117.03 -47.35 2.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.28000000000000003 111.503 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . 114.28 -22.14 14.15 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.126 -1.59 . . . . 0.17000000000000001 109.126 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 13' ' ' ILE . 8.8 t60 -69.67 145.3 52.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -1.177 . . . . 0.20999999999999999 110.213 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.454 ' O ' ' CD2' ' A' ' 12' ' ' HIS . 7.2 mt -108.14 151.84 10.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.391 -0.818 . . . . 0.16 111.041 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.401 ' OH ' ' CE2' ' A' ' 25' ' ' PHE . 75.6 t80 -103.82 128.47 51.26 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.701 -0.624 . . . . 0.10000000000000001 109.992 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -102.89 103.85 14.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.532 -0.73 . . . . 0.11 110.344 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -51.37 -23.45 3.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.389 -0.819 . . . . 0.12 110.717 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.79 11.77 10.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.19 110.897 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -176.47 69.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.27000000000000002 109.906 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.72 -146.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.011 -1.236 . . . . 0.20999999999999999 110.011 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.06 172.96 9.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.399 -1.059 . . . . 0.27000000000000002 110.697 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -110.58 -21.57 12.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.38 110.301 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.11 -59.92 2.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.39000000000000001 110.399 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -57.68 -21.23 39.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.39000000000000001 110.3 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.36 31.96 6.92 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.198 -1.561 . . . . 0.28000000000000003 109.198 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -78.71 76.98 5.2 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.345 -1.091 . . . . 0.31 110.122 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.9 t -51.38 148.45 8.89 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.431 -0.793 . . . . 0.40000000000000002 110.865 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -56.51 123.83 14.79 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.695 1.366 . . . . 0.25 110.493 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.6 22.87 5.28 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.572 -1.411 . . . . 0.089999999999999997 109.572 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.8 m -97.29 132.69 42.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -1.159 . . . . 0.14999999999999999 110.268 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.8 ttp85 -109.01 142.24 39.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.23999999999999999 110.394 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.549 ' CZ ' ' CZ3' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -48.01 -48.25 32.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.266 -0.897 . . . . 0.28000000000000003 110.821 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.54 -46.82 66.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.89 . . . . 0.31 110.179 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.59 -11.66 60.74 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.4 -0.813 . . . . 0.25 110.378 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 31' ' ' PHE . 77.8 mt -87.46 121.53 71.11 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.026 -1.046 . . . . 0.26000000000000001 109.973 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.8 -174.9 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.402 1.212 . . . . 0.34000000000000002 110.505 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.37 -20.28 54.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 0.37 110.369 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -50.0 -37.32 32.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.39000000000000001 110.53 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 69.2 t90 -77.19 157.31 30.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.323 -0.861 . . . . 0.25 110.241 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.2 p -156.49 -160.38 0.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.11 110.192 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 1.2 t -81.22 145.77 56.82 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 0.31 110.123 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.16 -12.98 21.22 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.397 1.209 . . . . 0.58999999999999997 111.194 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -121.23 -12.79 8.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.899 -1.126 . . . . 0.56999999999999995 111.387 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 99.1 m -116.17 -72.91 0.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.917 -1.114 . . . . 0.39000000000000001 110.597 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.29 29.65 1.9 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.675 -1.37 . . . . 0.22 109.675 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.87 -174.88 2.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -1.154 . . . . 0.12 110.285 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.7 p -89.82 -158.86 0.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.17000000000000001 110.315 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -64.22 -12.08 37.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.427 -0.796 . . . . 0.33000000000000002 110.568 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -48.33 -45.98 35.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.048 -1.032 . . . . 0.42999999999999999 110.846 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.406 ' OD1' ' CD2' ' A' ' 50' ' ' TYR . 2.7 p30 -79.53 -19.31 49.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.42999999999999999 110.334 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.406 ' CD2' ' OD1' ' A' ' 49' ' ' ASP . 2.7 m-85 -94.13 128.72 40.7 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.118 -0.989 . . . . 0.46999999999999997 110.573 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.448 ' CG2' HG22 ' A' ' 8' ' ' ILE . 95.4 t -123.15 161.86 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.48999999999999999 110.148 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.24 110.43 10.74 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.223 -0.923 . . . . 0.56999999999999995 110.371 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -51.33 144.21 10.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.56999999999999995 110.539 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -153.71 135.05 14.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.28000000000000003 110.385 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -77.81 100.76 6.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.28000000000000003 110.459 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.1 mttt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.943 -1.027 . . . . 0.46000000000000002 110.414 179.852 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.268 0.556 . . . . 0.38 110.344 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.435 ' CE1' ' HA2' ' A' ' 28' ' ' GLY . 34.1 m-85 -121.22 134.38 55.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.68999999999999995 110.383 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mp -84.14 172.34 12.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.373 -0.829 . . . . 0.65000000000000002 110.689 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -138.08 130.21 28.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.322 -0.861 . . . . 0.28999999999999998 110.001 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.529 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 30.2 m95 -108.9 179.94 4.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.165 -0.959 . . . . 0.29999999999999999 110.374 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.428 HG21 ' CG2' ' A' ' 51' ' ' VAL . 2.7 tp -156.55 129.7 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.584 -0.697 . . . . 0.46000000000000002 110.209 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.1 t -79.29 98.35 6.63 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.375 -0.828 . . . . 0.37 110.301 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 tt -55.96 -20.32 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.961 . . . . 0.41999999999999998 110.18 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.1 m -75.73 -27.35 58.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.373 -0.83 . . . . 0.48999999999999999 110.125 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.2 m -120.45 -50.74 2.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.28000000000000003 110.743 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.06 19.95 6.56 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.17000000000000001 109.506 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -100.31 120.11 39.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -1.223 . . . . 0.20999999999999999 110.05 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.5 mt -81.95 134.88 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.93 . . . . 0.16 110.577 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.401 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 48.2 t80 -92.93 125.78 37.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.458 -0.776 . . . . 0.10000000000000001 110.067 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -99.35 103.55 15.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.499 -0.751 . . . . 0.11 109.975 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -49.57 -24.94 2.39 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.277 -0.89 . . . . 0.12 110.895 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.69 22.52 7.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.19 110.058 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -176.22 66.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.27000000000000002 110.041 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.89 -140.06 0.67 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.777 -1.329 . . . . 0.20999999999999999 109.777 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.42 173.24 6.39 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.357 -1.084 . . . . 0.27000000000000002 110.599 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.58 -23.38 12.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.365 -0.834 . . . . 0.38 110.159 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.18 -29.42 28.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.39000000000000001 110.329 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -87.39 14.03 8.81 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.303 -0.873 . . . . 0.39000000000000001 110.823 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.85 28.39 68.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.406 -1.478 . . . . 0.28000000000000003 109.406 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.562 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -86.85 79.1 8.91 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.24 -1.153 . . . . 0.31 110.316 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.3 t -60.77 154.51 57.46 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.403 -0.811 . . . . 0.40000000000000002 110.76 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -60.7 119.29 6.38 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.751 1.395 . . . . 0.25 110.484 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.435 ' HA2' ' CE1' ' A' ' 2' ' ' TYR . . . 113.2 38.33 1.25 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.474 -1.45 . . . . 0.089999999999999997 109.474 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.4 m -114.58 130.84 56.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -1.158 . . . . 0.14999999999999999 110.391 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -108.5 142.15 39.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.23999999999999999 110.282 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.24 -43.88 32.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.124 -0.985 . . . . 0.28000000000000003 110.668 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -54.76 -22.7 14.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.941 . . . . 0.31 109.774 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.56 22.07 16.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.343 -0.848 . . . . 0.25 110.161 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 34' ' ' ILE . 89.7 mt -120.11 70.64 15.49 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.26000000000000001 110.471 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -85.05 13.36 2.8 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.543 1.286 . . . . 0.34000000000000002 111.146 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.27 30.23 1.3 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.979 -1.076 . . . . 0.37 110.91 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 t70 51.49 44.72 28.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.11 -0.994 . . . . 0.39000000000000001 110.742 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.562 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 59.5 t90 -52.37 151.3 4.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.25 109.966 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 88.6 m -132.47 -169.26 2.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.137 -0.977 . . . . 0.11 110.768 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.445 ' HB3' ' CB ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -82.19 163.06 54.57 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.31 110.375 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -67.66 -33.91 26.63 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.609 1.32 . . . . 0.58999999999999997 110.222 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -150.25 57.63 0.95 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.56999999999999995 109.947 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.445 ' CB ' ' HB3' ' A' ' 40' ' ' CYS . 1.8 t -141.58 -56.0 0.47 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.347 -0.845 . . . . 0.39000000000000001 110.248 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.6 41.13 5.49 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.46 -1.456 . . . . 0.22 109.46 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.27 171.1 8.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.16 -1.2 . . . . 0.12 110.494 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.0 p -92.09 -172.51 3.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.17000000000000001 110.427 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -15.75 48.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.33000000000000002 110.261 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -54.41 -38.44 66.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.42999999999999999 110.223 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.45 -19.3 58.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.42999999999999999 110.449 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.41 ' CZ ' ' CH2' ' A' ' 38' ' ' TRP . 4.0 m-85 -95.3 129.86 42.27 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.162 -0.961 . . . . 0.46999999999999997 110.591 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.428 ' CG2' HG21 ' A' ' 6' ' ' ILE . 33.2 m -125.6 172.8 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.48999999999999999 110.246 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.84 116.57 19.26 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.299 -0.876 . . . . 0.56999999999999995 110.252 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -69.83 139.69 53.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.56999999999999995 110.633 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 49.63 91.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.383 -0.823 . . . . 0.28000000000000003 110.737 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -57.07 114.3 2.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.28000000000000003 110.135 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.109 -0.948 . . . . 0.46000000000000002 110.435 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.288 0.566 . . . . 0.38 110.427 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -120.22 142.26 49.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 0.68999999999999995 110.505 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.411 ' O ' ' CG ' ' A' ' 16' ' ' GLU . 6.9 mp -108.96 159.55 16.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.44 -0.788 . . . . 0.65000000000000002 110.582 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.442 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 9.5 mttp -113.9 160.45 18.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.237 -0.915 . . . . 0.28999999999999998 109.832 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.527 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 29.1 m95 -128.2 133.07 48.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.093 -1.004 . . . . 0.29999999999999999 110.598 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.414 HD11 ' N ' ' A' ' 12' ' ' HIS . 3.5 tp -104.02 141.62 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.093 -1.004 . . . . 0.46000000000000002 111.016 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 t -92.35 102.35 14.84 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.385 -0.822 . . . . 0.37 109.978 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 tt -55.79 -20.09 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.952 . . . . 0.41999999999999998 110.595 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.3 m -67.55 -36.73 81.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.48999999999999999 110.936 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.3 p -131.33 -34.4 1.41 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.984 -1.073 . . . . 0.28000000000000003 111.157 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.81 41.65 1.55 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.489 -1.444 . . . . 0.17000000000000001 109.489 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.431 ' CE1' ' HG2' ' A' ' 41' ' ' PRO . 13.7 t-80 -105.06 126.68 52.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -1.113 . . . . 0.20999999999999999 110.113 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.401 HG13 HD13 ' A' ' 6' ' ' ILE . 6.0 mt -93.69 133.18 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.16 110.685 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -97.33 132.23 43.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.571 -0.705 . . . . 0.10000000000000001 109.538 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -102.69 103.62 13.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.529 -0.732 . . . . 0.11 110.165 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 3' ' ' LEU . 26.0 mt-10 -52.2 -22.91 4.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.901 . . . . 0.12 110.596 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.25 12.68 13.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.19 110.699 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tp -177.25 68.81 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.172 -0.955 . . . . 0.27000000000000002 109.655 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.99 -139.54 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.254 -1.139 . . . . 0.20999999999999999 110.254 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -89.37 164.35 14.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.44 -1.035 . . . . 0.27000000000000002 110.809 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -107.12 -31.98 8.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.444 -0.785 . . . . 0.38 109.93 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.29 -53.46 19.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.311 -0.868 . . . . 0.39000000000000001 110.264 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -60.86 -27.78 68.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.39000000000000001 110.072 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.12 28.41 6.87 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.601 -1.4 . . . . 0.28000000000000003 109.601 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.67 83.53 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.066 -1.255 . . . . 0.31 110.128 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.0 t -50.79 145.83 10.95 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.456 -0.777 . . . . 0.40000000000000002 110.74 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -55.56 116.84 3.44 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.631 1.332 . . . . 0.25 110.431 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 116.11 24.46 3.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.663 -1.375 . . . . 0.089999999999999997 109.663 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.8 m -98.13 116.2 29.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -1.198 . . . . 0.14999999999999999 110.149 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -94.99 142.66 27.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.244 -0.91 . . . . 0.23999999999999999 110.626 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.479 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 1.2 t80 -50.57 -27.19 6.29 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.282 -0.887 . . . . 0.28000000000000003 110.252 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.08 -33.8 58.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -0.971 . . . . 0.31 109.804 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -89.51 7.58 35.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.521 -0.737 . . . . 0.25 110.45 178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 31' ' ' PHE . 33.8 mt -100.02 96.35 4.82 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.09 -1.006 . . . . 0.26000000000000001 109.67 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -62.16 -79.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.649 1.341 . . . . 0.34000000000000002 111.02 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -156.71 -35.87 0.08 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.944 . . . . 0.37 111.273 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -45.79 -30.0 1.51 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.172 -0.955 . . . . 0.39000000000000001 111.087 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 88.2 t90 -75.4 138.3 41.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.25 110.04 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 97.8 m -127.12 -175.1 3.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.11 110.266 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.41 ' SG ' ' CE2' ' A' ' 50' ' ' TYR . 0.5 OUTLIER -81.38 138.73 48.18 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.31 110.283 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HG2' ' CE1' ' A' ' 12' ' ' HIS . 36.9 Cg_endo -71.66 -16.3 30.15 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.488 1.257 . . . . 0.58999999999999997 110.816 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.2 -0.36 15.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.988 . . . . 0.56999999999999995 111.236 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 64.2 m -138.45 -68.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.953 -1.092 . . . . 0.39000000000000001 110.404 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.17 32.26 3.55 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.327 -1.509 . . . . 0.22 109.327 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.89 -168.74 1.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -1.106 . . . . 0.12 110.613 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 p -88.04 178.31 6.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.38 -0.825 . . . . 0.17000000000000001 110.526 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -65.05 -22.28 66.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 0.33000000000000002 110.172 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -58.04 -18.96 27.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.42999999999999999 110.406 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -83.65 -15.47 48.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.42999999999999999 110.661 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.41 ' CE2' ' SG ' ' A' ' 40' ' ' CYS . 1.9 m-85 -99.81 145.24 27.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.046 -1.034 . . . . 0.46999999999999997 111.199 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.402 ' CG2' HG22 ' A' ' 6' ' ' ILE . 32.3 m -145.75 164.56 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.538 -0.727 . . . . 0.48999999999999999 109.905 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.2 tp -69.77 127.76 34.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 0.56999999999999995 110.824 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -88.72 140.77 29.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.56999999999999995 110.202 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -167.08 87.68 0.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.28000000000000003 110.394 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.7 171.64 13.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.245 -0.909 . . . . 0.28000000000000003 110.186 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.972 -1.013 . . . . 0.46000000000000002 110.418 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.28 0.562 . . . . 0.38 110.322 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -70.97 136.53 48.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.177 -0.952 . . . . 0.68999999999999995 110.345 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.8 mp -87.46 -178.27 6.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.358 -0.839 . . . . 0.65000000000000002 110.455 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.41 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 25.0 mttt -142.98 146.6 34.06 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.483 -0.761 . . . . 0.28999999999999998 110.165 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.562 ' CE3' ' CD2' ' A' ' 31' ' ' PHE . 22.7 m95 -130.09 123.6 30.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.29999999999999999 110.078 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -106.63 134.47 48.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.037 -1.04 . . . . 0.46000000000000002 110.278 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.3 t -79.89 96.04 6.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.407 -0.808 . . . . 0.37 110.098 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.7 pt -53.23 -22.6 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.132 -0.98 . . . . 0.41999999999999998 110.146 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.6 m -75.57 -28.16 58.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.295 -0.878 . . . . 0.48999999999999999 110.203 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.4 m -115.24 -50.93 2.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.28000000000000003 110.869 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.4 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . 113.12 19.02 6.95 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.47 -1.452 . . . . 0.17000000000000001 109.47 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -102.0 131.54 48.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -1.22 . . . . 0.20999999999999999 110.002 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 73.0 mt -95.31 136.71 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.16 110.761 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.404 ' OH ' ' CD2' ' A' ' 25' ' ' PHE . 66.1 t80 -99.4 132.53 44.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.10000000000000001 109.959 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -109.7 111.56 23.1 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.511 -0.743 . . . . 0.11 109.703 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.445 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -51.15 -24.06 3.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.12 110.493 -179.233 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.55 17.53 11.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.172 -0.955 . . . . 0.19 110.245 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -177.31 68.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.27000000000000002 109.71 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.28 -137.1 1.73 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.224 -1.151 . . . . 0.20999999999999999 110.224 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 22' ' ' ALA . 11.3 t70 -78.97 158.42 27.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.432 -1.04 . . . . 0.27000000000000002 110.776 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -104.13 -33.29 8.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.38 110.094 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . -80.01 -45.62 18.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.39000000000000001 110.205 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.12 -35.22 71.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -0.928 . . . . 0.39000000000000001 109.976 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.2 20.37 7.53 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.568 -1.413 . . . . 0.28000000000000003 109.568 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.571 ' CE1' ' CD1' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -67.79 77.97 0.2 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.111 -1.229 . . . . 0.31 110.224 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.0 t -52.66 151.65 7.73 Favored Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.444 -0.785 . . . . 0.40000000000000002 110.702 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -58.89 116.77 3.49 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.703 1.37 . . . . 0.25 110.394 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.62 -23.95 5.59 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.346 -1.502 . . . . 0.089999999999999997 109.346 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.7 m -53.26 132.29 38.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -1.152 . . . . 0.14999999999999999 110.235 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.445 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 16.1 mtp180 -115.51 146.29 41.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.853 . . . . 0.23999999999999999 110.394 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.562 ' CD2' ' CE3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -50.93 -33.65 25.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.28000000000000003 110.273 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -53.21 -50.98 63.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.871 . . . . 0.31 110.02 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -70.06 -7.84 44.49 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.416 -0.803 . . . . 0.25 110.471 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.442 ' CG2' ' HB3' ' A' ' 38' ' ' TRP . 30.1 mt -103.4 94.8 6.23 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.156 -0.965 . . . . 0.26000000000000001 110.154 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -67.94 -88.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.663 1.349 . . . . 0.34000000000000002 110.834 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.29 -18.6 2.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.833 -1.167 . . . . 0.37 111.628 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.9 -55.02 12.98 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.796 -1.19 . . . . 0.39000000000000001 110.867 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.571 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 54.9 t90 -69.83 159.81 32.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.196 -0.94 . . . . 0.25 110.126 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -162.16 176.81 10.27 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.373 -0.83 . . . . 0.11 110.361 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.449 ' HB3' ' CB ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -51.55 149.77 7.6 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.85 . . . . 0.31 109.988 178.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.52 -27.85 70.19 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.527 1.278 . . . . 0.58999999999999997 110.74 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.2 57.36 0.89 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.935 . . . . 0.56999999999999995 110.217 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.449 ' CB ' ' HB3' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -152.46 -45.53 0.1 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.259 -0.901 . . . . 0.39000000000000001 110.045 -179.157 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.53 42.65 95.57 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.54 -1.424 . . . . 0.22 109.54 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.41 32.74 5.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -1.198 . . . . 0.12 110.823 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.1 p 44.02 -153.65 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.578 0.704 . . . . 0.17000000000000001 111.101 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -13.08 58.49 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.515 -0.741 . . . . 0.33000000000000002 110.447 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.08 -48.84 43.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.085 -1.009 . . . . 0.42999999999999999 110.794 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -76.64 -16.63 59.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.42999999999999999 110.43 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -93.56 135.92 34.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.042 -1.036 . . . . 0.46999999999999997 110.51 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.4 t -131.59 150.12 33.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.282 -0.886 . . . . 0.48999999999999999 110.232 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.436 HD12 ' N ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -63.63 125.12 23.24 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.352 -0.842 . . . . 0.56999999999999995 110.43 -179.546 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.436 ' N ' HD12 ' A' ' 52' ' ' LEU . 17.1 t80 -71.93 100.27 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 0.56999999999999995 110.38 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -143.19 103.81 4.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.28000000000000003 110.399 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.92 -173.37 4.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.242 -0.911 . . . . 0.28000000000000003 110.327 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.6 tttt . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.917 -1.039 . . . . 0.46000000000000002 110.371 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.215 0.531 . . . . 0.38 110.437 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -77.78 139.72 39.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.32 -0.862 . . . . 0.68999999999999995 110.487 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.7 mp -90.53 171.31 9.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.65000000000000002 110.397 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.438 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 19.6 mttp -136.12 158.37 44.58 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.28999999999999998 109.959 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.531 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 31.2 m95 -127.8 136.44 51.47 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -0.944 . . . . 0.29999999999999999 110.579 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.444 HG21 ' CG2' ' A' ' 51' ' ' VAL . 3.4 tp -106.13 137.87 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.964 -1.085 . . . . 0.46000000000000002 110.568 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 11' ' ' GLY . 7.6 t -83.41 96.13 8.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.547 -0.721 . . . . 0.37 110.25 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.4 tt -56.11 -19.95 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.981 -1.074 . . . . 0.41999999999999998 110.027 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.9 m -77.64 -27.15 50.97 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.325 -0.86 . . . . 0.48999999999999999 110.105 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 64.4 m -123.64 -54.99 1.74 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.338 -0.851 . . . . 0.28000000000000003 110.632 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . 119.83 27.07 2.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.84 -1.304 . . . . 0.17000000000000001 109.84 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.406 ' N ' HD12 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -109.36 144.06 38.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -1.185 . . . . 0.20999999999999999 110.278 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.417 HG13 HD11 ' A' ' 6' ' ' ILE . 7.2 mt -98.41 145.53 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.847 . . . . 0.16 110.968 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -105.7 133.58 50.21 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.369 -0.604 . . . . 0.10000000000000001 109.369 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -101.6 106.76 17.87 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.552 -0.718 . . . . 0.11 110.198 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -50.28 -25.98 4.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.308 -0.87 . . . . 0.12 110.722 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.07 19.97 15.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.19 110.352 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.55 70.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.27000000000000002 110.338 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 25' ' ' PHE . . . -64.24 -135.69 0.01 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.572 -1.411 . . . . 0.20999999999999999 109.572 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -99.39 172.08 7.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -1.169 . . . . 0.27000000000000002 110.702 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.37 -24.18 20.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.38 110.003 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.25 -36.95 17.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.307 -0.87 . . . . 0.39000000000000001 110.106 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -66.91 -21.65 65.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.39000000000000001 110.074 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.16 31.06 53.8 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.258 -1.537 . . . . 0.28000000000000003 109.258 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.476 ' CE1' HD13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -71.72 82.43 0.87 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.15 -1.206 . . . . 0.31 110.141 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.3 t -49.29 142.27 10.87 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.40000000000000002 110.767 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -52.83 108.5 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.555 1.292 . . . . 0.25 110.69 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.01 44.04 0.26 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.602 -1.399 . . . . 0.089999999999999997 109.602 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.5 m -122.63 136.26 54.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -1.165 . . . . 0.14999999999999999 110.555 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -122.87 144.34 49.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.351 -0.843 . . . . 0.23999999999999999 110.224 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.491 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -48.18 -49.13 33.77 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.224 -0.922 . . . . 0.28000000000000003 110.494 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -53.37 -26.8 20.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.31 109.64 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.21 16.73 20.46 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.491 -0.755 . . . . 0.25 110.133 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.476 HD13 ' CE1' ' A' ' 25' ' ' PHE . 92.2 mt -123.88 66.82 40.08 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.26000000000000001 110.327 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -84.68 14.46 2.45 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 123.61 1.321 . . . . 0.34000000000000002 111.412 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.28 41.89 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.879 -1.138 . . . . 0.37 110.886 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.1 t0 48.55 28.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.145 -0.972 . . . . 0.39000000000000001 110.872 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.424 ' NE1' ' CE2' ' A' ' 25' ' ' PHE . 63.7 t90 -53.7 151.64 5.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 0.25 110.28 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 83.4 m -148.65 -167.31 2.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.325 -0.859 . . . . 0.11 110.133 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.24 169.98 18.1 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.232 -0.918 . . . . 0.31 109.981 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -57.94 -47.7 19.53 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.563 1.296 . . . . 0.58999999999999997 110.206 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -178.82 57.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.45 -0.781 . . . . 0.56999999999999995 109.981 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 21.1 p -162.14 -36.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.152 -0.968 . . . . 0.39000000000000001 111.113 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -95.67 -41.53 3.85 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.574 -1.411 . . . . 0.22 109.574 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 56.82 163.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -1.047 . . . . 0.12 110.945 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 44.61 -161.23 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.468 -0.77 . . . . 0.17000000000000001 111.053 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -122.31 -21.53 5.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.338 -0.851 . . . . 0.33000000000000002 110.72 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.49 -28.96 48.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.977 . . . . 0.42999999999999999 110.448 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.07 -17.69 60.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.42999999999999999 110.34 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -97.15 136.41 37.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.095 -1.003 . . . . 0.46999999999999997 110.725 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.444 ' CG2' HG21 ' A' ' 6' ' ' ILE . 26.8 m -136.27 162.83 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.48999999999999999 109.914 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.88 118.84 19.87 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.121 -0.987 . . . . 0.56999999999999995 110.5 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.38 137.92 58.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.56999999999999995 110.518 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 51.49 91.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.28000000000000003 110.485 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -96.54 73.58 2.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 0.28000000000000003 110.432 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.7 mttt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.934 -1.031 . . . . 0.46000000000000002 110.388 179.914 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.217 0.532 . . . . 0.38 110.322 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -131.63 133.84 45.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.68999999999999995 110.466 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.67 167.21 12.7 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.248 -0.907 . . . . 0.65000000000000002 110.272 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -127.4 125.57 40.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.28999999999999998 110.474 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.526 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 23.2 m95 -106.62 179.22 4.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.29999999999999999 110.032 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.51 HG23 HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -157.69 126.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 119.844 -0.742 . . . . 0.46000000000000002 110.193 178.025 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.5 t -73.47 91.1 1.76 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.353 -0.842 . . . . 0.37 109.488 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.5 pt -51.92 -22.95 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.195 -0.941 . . . . 0.41999999999999998 110.334 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 94.4 m -59.03 -27.86 65.87 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.379 -0.825 . . . . 0.48999999999999999 110.714 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -137.11 -36.7 0.66 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.145 -0.972 . . . . 0.28000000000000003 111.243 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.412 ' HA2' HD13 ' A' ' 6' ' ' ILE . . . 117.16 19.78 5.03 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.516 -1.326 . . . . 0.17000000000000001 110.077 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.37 115.1 26.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.047 -1.266 . . . . 0.20999999999999999 110.232 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 74.2 mt -84.2 128.62 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.925 . . . . 0.16 110.539 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.405 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 63.2 t80 -91.74 120.82 32.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.10000000000000001 109.814 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -99.18 103.98 15.91 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.217 -0.927 . . . . 0.11 109.879 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -47.58 -26.57 1.5 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.12 111.075 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.33 19.01 8.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.176 -0.953 . . . . 0.19 110.579 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -176.1 68.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.27000000000000002 110.165 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.16 -143.42 0.79 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.737 -1.345 . . . . 0.20999999999999999 109.737 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.56 165.25 12.43 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.34 -1.094 . . . . 0.27000000000000002 110.297 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.04 -41.79 6.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.237 -0.914 . . . . 0.38 110.346 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.72 -50.2 70.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.39000000000000001 110.26 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.09 -21.07 44.39 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.176 -0.953 . . . . 0.39000000000000001 110.397 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.38 23.25 17.1 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.221 -1.551 . . . . 0.28000000000000003 109.221 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -83.83 78.91 9.64 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.242 -1.151 . . . . 0.31 110.05 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 28' ' ' GLY . 13.4 t -49.24 151.67 2.42 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.357 -0.84 . . . . 0.40000000000000002 110.985 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.68 80.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.713 1.375 . . . . 0.25 110.387 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 26' ' ' THR . . . 153.82 42.11 0.02 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.148 -1.581 . . . . 0.089999999999999997 109.148 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.6 m -112.56 134.44 54.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.35 -1.088 . . . . 0.14999999999999999 110.341 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -111.43 145.96 38.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.829 . . . . 0.23999999999999999 110.163 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.441 ' CD2' ' HD3' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -52.39 -41.21 62.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.919 . . . . 0.28000000000000003 110.251 179.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -53.64 -43.63 68.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.873 . . . . 0.31 110.204 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -79.17 2.03 22.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.25 110.772 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.7 mt -106.26 89.77 4.16 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.0 -1.063 . . . . 0.26000000000000001 110.075 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -68.77 -170.88 0.35 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.672 1.353 . . . . 0.34000000000000002 110.651 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.57 98.3 0.09 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.9 . . . . 0.37 110.329 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.68 -36.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.39000000000000001 110.285 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.573 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 87.9 t90 -90.29 142.35 27.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.837 . . . . 0.25 110.479 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.4 m -133.88 -174.51 3.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.11 110.191 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.55 156.13 65.47 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.077 -1.015 . . . . 0.31 110.286 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.67 -5.14 14.6 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.487 1.256 . . . . 0.58999999999999997 111.201 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 50.1 p30 -146.09 20.6 1.41 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.875 -1.14 . . . . 0.56999999999999995 110.968 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 76.8 m -143.0 -49.03 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.165 -0.959 . . . . 0.39000000000000001 110.424 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.01 33.23 46.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.409 -1.476 . . . . 0.22 109.409 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.57 -172.05 2.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -1.169 . . . . 0.12 110.49 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.97 -171.91 2.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.855 . . . . 0.17000000000000001 110.332 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HD3' ' CD2' ' A' ' 31' ' ' PHE . 20.3 mttt -60.56 -18.8 54.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.35 -0.844 . . . . 0.33000000000000002 110.227 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.24 -41.07 65.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.42999999999999999 110.361 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.29 -24.23 63.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.42999999999999999 109.826 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -92.96 137.88 31.97 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.443 -0.786 . . . . 0.46999999999999997 110.512 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.6 p -129.69 163.68 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 0.48999999999999999 110.032 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.84 108.75 4.1 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.114 -0.991 . . . . 0.56999999999999995 110.084 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -62.82 141.25 58.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.56999999999999995 110.749 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 52.43 89.87 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.85 . . . . 0.28000000000000003 110.557 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -95.42 55.43 1.72 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.161 -0.962 . . . . 0.28000000000000003 110.219 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.976 -1.012 . . . . 0.46000000000000002 110.314 -179.895 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.23 0.538 . . . . 0.38 110.356 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -139.88 134.95 32.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.68999999999999995 110.358 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 mp -81.73 165.93 20.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.65000000000000002 110.759 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.44 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 23.6 mttm -134.38 151.39 51.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.28999999999999998 110.12 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.554 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 20.1 m95 -133.03 127.15 33.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.3 -0.875 . . . . 0.29999999999999999 109.927 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.432 HD11 ' HA2' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -102.64 134.43 43.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.112 -0.992 . . . . 0.46000000000000002 110.898 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 50' ' ' TYR . 16.3 t -79.9 95.71 6.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.579 -0.7 . . . . 0.37 109.588 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 tt -55.26 -20.12 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.41999999999999998 110.628 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.1 m -63.46 -27.98 69.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.28 -0.888 . . . . 0.48999999999999999 110.885 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.5 p -134.09 -35.89 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.967 -1.083 . . . . 0.28000000000000003 111.397 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.432 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 112.21 35.96 1.71 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.533 -1.318 . . . . 0.17000000000000001 109.854 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -112.14 129.26 56.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.128 -1.219 . . . . 0.20999999999999999 110.397 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 13.5 mt -91.58 146.66 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.16 111.096 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -108.68 129.14 55.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.565 -0.709 . . . . 0.10000000000000001 109.809 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -105.32 106.75 17.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.549 -0.719 . . . . 0.11 110.234 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -49.88 -24.54 2.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.12 110.664 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.0 14.25 9.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.19 110.71 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 tp -176.08 67.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.025 -1.047 . . . . 0.27000000000000002 109.955 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.43 -143.03 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.897 -1.281 . . . . 0.20999999999999999 109.897 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.88 165.38 11.59 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.37 -1.076 . . . . 0.27000000000000002 110.525 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -107.19 -20.02 13.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.38 110.545 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.59 -36.0 38.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.151 -0.968 . . . . 0.39000000000000001 110.392 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -81.42 -13.31 58.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.39000000000000001 110.729 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.81 27.7 16.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.073 -1.611 . . . . 0.28000000000000003 109.073 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -82.97 82.77 8.07 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.371 -1.076 . . . . 0.31 110.229 -179.654 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.3 t -49.69 142.34 12.36 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.173 -0.954 . . . . 0.40000000000000002 110.77 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -53.05 109.66 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.559 1.294 . . . . 0.25 110.612 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.92 -14.03 5.23 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.142 -1.183 . . . . 0.089999999999999997 110.142 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -51.53 129.68 26.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.95 -1.324 . . . . 0.14999999999999999 110.804 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -108.83 134.19 51.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.357 -0.84 . . . . 0.23999999999999999 110.003 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.522 ' CD2' ' CD2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -47.06 -51.88 16.48 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.242 -0.911 . . . . 0.28000000000000003 110.947 -179.372 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -51.5 -37.15 47.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 0.31 109.96 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -85.5 8.8 17.82 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.438 -0.789 . . . . 0.25 110.274 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.441 HD13 ' CZ ' ' A' ' 25' ' ' PHE . 78.5 mt -111.82 72.0 1.03 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.98 -1.075 . . . . 0.26000000000000001 110.226 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -71.46 -21.51 26.02 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.622 1.328 . . . . 0.34000000000000002 110.415 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -55.18 -172.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.37 110.447 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.72 43.97 1.04 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.892 . . . . 0.39000000000000001 110.349 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 83.2 t90 -52.6 144.88 12.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.853 . . . . 0.25 110.251 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 91.6 m -130.96 -167.08 1.78 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.11 110.546 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.09 143.29 34.63 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.31 110.375 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -78.28 -17.07 13.42 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.567 1.298 . . . . 0.58999999999999997 111.009 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -28.55 9.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.05 -1.031 . . . . 0.56999999999999995 110.866 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 94.1 m -101.22 -71.99 0.69 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 0.39000000000000001 110.606 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.82 29.38 1.86 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.581 -1.408 . . . . 0.22 109.581 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.51 -173.84 2.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.103 -1.234 . . . . 0.12 110.337 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.1 p -97.12 -170.88 2.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.17000000000000001 110.393 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 5.8 tttt -61.44 -16.66 48.99 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.364 -0.835 . . . . 0.33000000000000002 110.388 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -58.29 -28.38 64.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -0.97 . . . . 0.42999999999999999 110.634 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -86.23 -16.98 35.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.42999999999999999 110.51 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 7' ' ' CYS . 1.9 m-85 -94.34 138.28 32.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -0.932 . . . . 0.46999999999999997 110.86 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.3 t -132.75 163.05 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.775 . . . . 0.48999999999999999 110.047 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.28 117.19 15.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.172 -0.955 . . . . 0.56999999999999995 110.334 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -66.02 118.0 9.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.56999999999999995 110.531 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -112.18 149.03 32.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.28000000000000003 110.158 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -91.42 106.31 18.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.28000000000000003 110.403 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.9 tttt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.994 -1.003 . . . . 0.46000000000000002 110.299 179.87 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.996 0.427 . . . . 0.38 110.385 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.488 ' CD1' ' HB3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER 57.45 152.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.898 0.856 . . . . 0.68999999999999995 111.283 178.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.84 169.39 6.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -0.865 . . . . 0.65000000000000002 110.517 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.71 128.13 15.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.39 -0.819 . . . . 0.28999999999999998 109.947 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.525 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 27.5 m95 -107.42 174.25 5.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.29999999999999999 110.019 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.446 ' CD1' HG13 ' A' ' 13' ' ' ILE . 2.4 tp -149.18 123.31 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.46000000000000002 110.438 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.1 t -69.33 95.12 0.76 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.376 -0.828 . . . . 0.37 109.933 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 9' ' ' THR . 11.0 pt -52.28 -22.76 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.16 -0.963 . . . . 0.41999999999999998 110.174 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.411 ' N ' HG13 ' A' ' 8' ' ' ILE . 34.2 m -61.37 -43.99 97.93 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.445 -0.784 . . . . 0.48999999999999999 110.915 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.9 p -123.59 -32.09 3.39 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.983 . . . . 0.28000000000000003 110.945 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.27 30.66 3.79 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.811 -1.316 . . . . 0.17000000000000001 109.811 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -95.17 112.97 24.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.244 -1.151 . . . . 0.20999999999999999 110.015 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.446 HG13 ' CD1' ' A' ' 6' ' ' ILE . 63.2 mt -80.72 128.73 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.16 110.533 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -92.6 132.25 37.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.519 -0.738 . . . . 0.10000000000000001 110.052 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -101.69 104.57 15.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.541 -0.724 . . . . 0.11 110.102 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.488 ' HB3' ' CD1' ' A' ' 2' ' ' TYR . 10.2 mt-10 -53.4 -27.12 22.54 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.159 -0.963 . . . . 0.12 110.651 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.01 18.73 7.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.143 -0.973 . . . . 0.19 110.452 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -176.39 66.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.883 . . . . 0.27000000000000002 109.843 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.83 -142.64 0.06 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.952 -1.259 . . . . 0.20999999999999999 109.952 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.42 173.76 7.36 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.409 -1.054 . . . . 0.27000000000000002 110.727 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -109.62 -33.43 6.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.324 -0.86 . . . . 0.38 110.167 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.52 -60.44 3.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.39000000000000001 110.363 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -61.3 -17.88 55.82 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.39000000000000001 110.57 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.15 33.34 7.76 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.279 -1.529 . . . . 0.28000000000000003 109.279 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -81.06 76.44 8.01 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.394 -1.062 . . . . 0.31 110.174 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -50.97 151.22 4.67 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.341 -0.849 . . . . 0.40000000000000002 110.912 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.03 123.88 14.68 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.631 1.332 . . . . 0.25 110.466 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.7 23.87 4.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.538 -1.425 . . . . 0.089999999999999997 109.538 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.9 m -94.63 135.83 35.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -1.232 . . . . 0.14999999999999999 110.325 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.66 138.4 47.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.349 -0.844 . . . . 0.23999999999999999 110.428 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.478 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -50.12 -30.97 12.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.219 -0.925 . . . . 0.28000000000000003 110.628 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -61.28 -55.04 36.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.153 -0.967 . . . . 0.31 110.204 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -28.76 69.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.25 110.243 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.471 HD11 ' CE2' ' A' ' 25' ' ' PHE . 82.4 mt -68.33 112.26 10.44 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.26000000000000001 110.288 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -66.29 -153.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.446 1.235 . . . . 0.34000000000000002 110.618 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -92.52 -12.42 31.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.37 110.699 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.27 -51.75 68.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.053 . . . . 0.39000000000000001 110.433 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.533 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 88.2 t90 -56.25 168.7 0.49 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.25 110.532 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.44 ' N ' ' CG ' ' A' ' 38' ' ' TRP . 25.4 p -167.2 -160.65 0.38 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.333 -0.854 . . . . 0.11 110.283 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.7 OUTLIER -87.53 144.13 35.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.397 -0.814 . . . . 0.31 110.307 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.16 9.72 3.97 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.667 1.351 . . . . 0.58999999999999997 111.281 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 37.4 p-10 -152.02 17.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.84 -1.163 . . . . 0.56999999999999995 110.934 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 58.0 m -144.92 -72.3 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.068 . . . . 0.39000000000000001 110.284 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.22 36.76 0.73 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.485 -1.446 . . . . 0.22 109.485 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.35 176.0 5.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -1.156 . . . . 0.12 110.592 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -100.8 -162.68 0.96 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.341 -0.85 . . . . 0.17000000000000001 109.964 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -55.15 -21.79 14.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.125 -0.984 . . . . 0.33000000000000002 109.722 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.56 -27.59 27.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.42999999999999999 109.91 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.85 -21.69 20.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.431 -0.793 . . . . 0.42999999999999999 109.908 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -97.27 137.63 35.98 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.263 -0.898 . . . . 0.46999999999999997 110.655 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.428 ' CG1' HG22 ' A' ' 6' ' ' ILE . 7.2 p -127.23 148.1 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.48999999999999999 110.0 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.67 115.52 4.83 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.141 -0.974 . . . . 0.56999999999999995 110.348 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -70.29 118.02 12.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.37 -0.831 . . . . 0.56999999999999995 110.397 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.28 111.89 20.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.28000000000000003 110.313 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -110.8 135.46 51.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.28000000000000003 110.371 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.023 -0.989 . . . . 0.46000000000000002 110.319 179.828 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.17 0.509 . . . . 0.38 110.362 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -107.06 142.25 37.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.364 -0.835 . . . . 0.68999999999999995 110.39 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.62 170.66 7.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.65000000000000002 110.524 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -127.32 124.01 37.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.28999999999999998 110.372 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.479 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 35.5 m95 -100.94 172.43 7.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.197 -0.939 . . . . 0.29999999999999999 110.025 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.411 HD11 HG13 ' A' ' 13' ' ' ILE . 2.2 tp -147.37 126.47 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.46000000000000002 110.254 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.4 ' O ' ' N ' ' A' ' 11' ' ' GLY . 10.1 t -73.18 89.13 1.5 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.296 -0.877 . . . . 0.37 109.973 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.9 pt -49.77 -25.83 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.066 -1.021 . . . . 0.41999999999999998 109.982 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -75.61 -28.71 58.96 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.606 -0.684 . . . . 0.48999999999999999 110.147 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -112.57 -54.45 2.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.28000000000000003 110.497 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . 115.11 19.65 5.86 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.585 -1.406 . . . . 0.17000000000000001 109.585 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -103.93 136.07 44.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -1.207 . . . . 0.20999999999999999 110.134 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 3.3 mt -93.93 130.05 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.321 -0.862 . . . . 0.16 110.477 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.494 ' CE1' ' HA2' ' A' ' 19' ' ' GLY . 81.0 t80 -97.68 133.14 42.61 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.10000000000000001 109.616 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -111.63 111.15 21.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.11 110.239 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.437 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 66.2 mt-10 -50.56 -23.35 2.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.383 -0.823 . . . . 0.12 110.989 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.65 8.05 15.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.976 -1.077 . . . . 0.19 110.968 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -176.6 68.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.022 -1.049 . . . . 0.27000000000000002 109.625 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.494 ' HA2' ' CE1' ' A' ' 14' ' ' TYR . . . -66.57 -138.39 0.04 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.011 -1.235 . . . . 0.20999999999999999 110.011 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -100.35 172.48 7.12 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.408 -1.054 . . . . 0.27000000000000002 110.812 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.88 -31.68 9.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.384 -0.823 . . . . 0.38 110.318 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.93 -50.37 35.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 0.39000000000000001 110.187 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -60.3 -18.35 48.83 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.304 -0.872 . . . . 0.39000000000000001 110.574 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.14 23.03 23.52 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.389 -1.484 . . . . 0.28000000000000003 109.389 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.584 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 1.8 m-30 -83.07 78.14 9.63 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.269 -1.136 . . . . 0.31 110.411 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.6 t -58.35 155.8 25.27 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.443 -0.785 . . . . 0.40000000000000002 110.678 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -53.75 113.35 1.28 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.619 1.326 . . . . 0.25 110.463 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.7 34.61 1.05 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.276 -1.53 . . . . 0.089999999999999997 109.276 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.4 m -117.2 121.55 41.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -1.163 . . . . 0.14999999999999999 110.351 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.437 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 0.5 OUTLIER -108.61 150.86 26.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.279 -0.888 . . . . 0.23999999999999999 110.353 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.496 ' CZ ' ' CZ3' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -47.58 -42.79 24.61 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.285 -0.885 . . . . 0.28000000000000003 111.015 -179.491 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -60.34 -42.73 96.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.31 110.808 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -78.28 -24.89 46.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.212 -0.93 . . . . 0.25 110.463 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.479 HD13 ' CE2' ' A' ' 25' ' ' PHE . 65.2 mt -63.62 111.12 4.57 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.26000000000000001 110.231 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.78 -174.37 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.41 1.216 . . . . 0.34000000000000002 109.81 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -68.4 -157.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.073 -1.017 . . . . 0.37 110.309 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.9 t0 65.19 9.84 5.91 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.324 -0.86 . . . . 0.39000000000000001 111.423 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.584 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 74.3 t90 -109.82 164.98 12.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.751 -1.218 . . . . 0.25 110.482 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.5 p -167.28 -161.7 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.887 . . . . 0.11 110.335 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 1.4 t -89.99 140.98 27.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.31 110.285 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 7.0 Cg_exo -70.91 -7.2 20.87 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.482 1.254 . . . . 0.58999999999999997 111.378 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -127.73 -9.11 5.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.911 -1.118 . . . . 0.56999999999999995 111.499 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 84.3 m -121.76 -75.62 0.59 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.897 -1.127 . . . . 0.39000000000000001 110.536 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.19 33.46 0.96 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.536 -1.426 . . . . 0.22 109.536 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.22 177.02 4.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -1.205 . . . . 0.12 110.447 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -72.28 -162.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.17000000000000001 110.365 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -75.19 -4.58 39.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.33000000000000002 110.734 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.05 -41.25 62.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.993 -1.067 . . . . 0.42999999999999999 110.453 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.35 -25.66 62.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.42999999999999999 110.008 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -89.06 132.29 34.84 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.296 -0.877 . . . . 0.46999999999999997 110.487 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.1 t -130.28 159.66 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.48999999999999999 110.129 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.7 tp -64.45 117.41 7.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.154 -0.966 . . . . 0.56999999999999995 110.529 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.414 ' CB ' ' O ' ' A' ' 4' ' ' LYS . 28.0 t80 -76.8 125.54 29.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.56999999999999995 110.35 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -142.2 160.58 39.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.28000000000000003 110.285 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -119.94 89.22 3.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.28000000000000003 110.376 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.4 mttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.015 -0.993 . . . . 0.46000000000000002 110.447 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.205 0.526 . . . . 0.38 110.429 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.503 ' CE1' ' NH2' ' A' ' 30' ' ' ARG . 40.6 m-85 -76.29 137.43 39.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.68999999999999995 110.334 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.7 mp -81.32 167.68 19.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.389 -0.819 . . . . 0.65000000000000002 110.465 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.51 124.86 20.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.28999999999999998 110.08 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.501 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 34.4 m95 -100.89 142.14 32.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.29999999999999999 110.266 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.478 HD11 HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -107.52 129.04 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.958 -1.089 . . . . 0.46000000000000002 109.806 178.127 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.409 ' N ' HD13 ' A' ' 6' ' ' ILE . 9.6 t -77.19 87.08 3.64 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.374 -0.829 . . . . 0.37 109.172 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.0 tt -50.47 -22.63 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.15 -0.969 . . . . 0.41999999999999998 110.531 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 m -66.51 -30.23 70.5 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.284 -0.885 . . . . 0.48999999999999999 110.685 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 p -140.15 -15.86 0.98 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.907 -1.121 . . . . 0.28000000000000003 112.662 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.8 -28.3 15.39 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.29 -1.434 . . . . 0.17000000000000001 110.049 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -51.86 135.35 30.18 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.06 -1.259 . . . . 0.20999999999999999 110.415 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.433 ' CG1' HG12 ' A' ' 6' ' ' ILE . 6.7 mt -109.81 142.48 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.82 . . . . 0.16 110.768 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -98.22 123.14 42.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.596 -0.69 . . . . 0.10000000000000001 109.433 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -103.26 108.51 19.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.11 110.137 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -48.23 -25.64 1.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.12 110.764 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.32 21.07 5.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.19 110.234 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 tp -176.24 60.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.27000000000000002 109.988 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.51 -139.55 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.852 -1.299 . . . . 0.20999999999999999 109.852 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.69 172.15 7.01 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.392 -1.064 . . . . 0.27000000000000002 110.561 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.47 -45.07 4.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.353 -0.842 . . . . 0.38 110.356 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.51 -54.64 41.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.39000000000000001 110.354 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -60.57 -16.94 42.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.39000000000000001 110.595 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.33 29.99 23.39 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.935 -1.666 . . . . 0.28000000000000003 108.935 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.415 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -80.94 78.42 7.75 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.441 -1.035 . . . . 0.31 110.291 -179.56 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.4 t -52.06 149.17 9.81 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.327 -0.858 . . . . 0.40000000000000002 110.592 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.86 116.7 3.44 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.675 1.355 . . . . 0.25 110.514 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.47 ' HA2' ' CE1' ' A' ' 2' ' ' TYR . . . 131.97 -23.34 4.17 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.468 -1.453 . . . . 0.089999999999999997 109.468 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 97.3 m -55.95 129.77 41.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -1.092 . . . . 0.14999999999999999 110.458 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.503 ' NH2' ' CE1' ' A' ' 2' ' ' TYR . 47.5 mtt85 -107.94 148.51 29.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.23999999999999999 110.244 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.451 ' CB ' ' CZ2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -49.84 -39.38 38.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 0.28000000000000003 110.627 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.5 -44.9 62.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.31 110.435 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -82.29 5.13 21.08 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.309 -0.869 . . . . 0.25 110.384 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.425 ' CG2' ' HB3' ' A' ' 38' ' ' TRP . 96.1 mt -106.62 99.38 24.69 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.002 -1.061 . . . . 0.26000000000000001 110.231 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -64.17 -163.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.592 1.312 . . . . 0.34000000000000002 110.54 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -77.95 -4.0 44.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.361 -0.837 . . . . 0.37 110.984 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -65.44 -31.46 72.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.95 -1.093 . . . . 0.39000000000000001 110.342 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.425 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 86.2 t90 -82.91 167.35 18.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.25 110.173 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.421 ' O ' ' CE2' ' A' ' 38' ' ' TRP . 25.9 p -159.07 -160.4 0.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.11 110.607 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 2.4 t -95.66 140.98 22.57 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.497 -0.752 . . . . 0.31 110.376 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.36 -2.06 12.16 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.538 1.283 . . . . 0.58999999999999997 111.336 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -132.0 13.9 4.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.891 -1.131 . . . . 0.56999999999999995 111.075 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 64.6 m -147.61 -71.65 0.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.011 -1.055 . . . . 0.39000000000000001 110.377 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.63 33.5 1.0 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.744 -1.342 . . . . 0.22 109.744 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.55 -170.71 1.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -1.201 . . . . 0.12 110.466 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.7 p -107.27 -162.59 0.85 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.344 -0.848 . . . . 0.17000000000000001 110.059 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -57.99 -19.48 31.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.155 -0.966 . . . . 0.33000000000000002 109.847 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -51.92 -40.37 60.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.42999999999999999 110.299 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.02 -23.19 48.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.315 -0.866 . . . . 0.42999999999999999 109.974 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -94.84 138.04 33.14 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.321 -0.862 . . . . 0.46999999999999997 110.406 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.3 t -122.78 160.89 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.299 -0.876 . . . . 0.48999999999999999 110.167 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.04 101.58 2.76 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.262 -0.899 . . . . 0.56999999999999995 110.129 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.42 ' CD1' ' HB ' ' A' ' 6' ' ' ILE . 2.7 t80 -68.39 160.6 29.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.805 . . . . 0.56999999999999995 110.35 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.74 158.77 18.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -0.88 . . . . 0.28000000000000003 110.312 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.21 -177.65 0.14 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.28000000000000003 110.326 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.022 -0.989 . . . . 0.46000000000000002 110.289 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.265 0.555 . . . . 0.38 110.358 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -67.89 135.55 52.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.305 -0.872 . . . . 0.68999999999999995 110.462 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mp -91.85 170.99 9.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.65000000000000002 110.054 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.454 ' CG ' ' HB3' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -130.98 133.61 45.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.106 -0.996 . . . . 0.28999999999999998 110.919 -179.423 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.515 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 24.7 m95 -118.54 178.8 4.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.327 -0.858 . . . . 0.29999999999999999 109.445 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.5 HD11 HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -163.32 124.58 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.297 -0.877 . . . . 0.46000000000000002 110.488 178.207 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.5 t -69.17 93.43 0.61 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.459 -0.775 . . . . 0.37 109.591 178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 9' ' ' THR . 2.6 tt -54.44 -19.67 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 0.41999999999999998 110.576 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.43 ' N ' HG22 ' A' ' 8' ' ' ILE . 76.3 m -65.14 -27.89 69.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.205 -0.935 . . . . 0.48999999999999999 110.95 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.1 p -134.35 -35.35 0.92 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.053 -1.029 . . . . 0.28000000000000003 111.375 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.406 ' HA2' HD12 ' A' ' 6' ' ' ILE . . . 112.95 36.43 1.52 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.445 -1.359 . . . . 0.17000000000000001 109.794 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -106.46 108.96 20.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.104 -1.233 . . . . 0.20999999999999999 110.269 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.497 ' CD1' ' CE1' ' A' ' 53' ' ' TYR . 89.9 mt -81.29 131.58 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.366 -0.834 . . . . 0.16 110.762 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -97.88 128.25 44.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.338 -0.851 . . . . 0.10000000000000001 109.555 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -109.75 110.92 22.08 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.353 -0.842 . . . . 0.11 109.673 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.437 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -49.37 -24.33 1.88 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 0.12 110.824 -178.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.5 9.94 14.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.183 -0.948 . . . . 0.19 110.683 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.87 67.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.029 -1.045 . . . . 0.27000000000000002 109.806 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.08 -140.56 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.008 -1.237 . . . . 0.20999999999999999 110.008 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.05 164.38 23.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.416 -1.049 . . . . 0.27000000000000002 110.728 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -114.4 -25.73 8.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.38 110.158 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.38 -46.88 25.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.39000000000000001 110.185 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -69.56 -34.64 74.48 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.269 -0.894 . . . . 0.39000000000000001 110.358 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.73 32.62 2.63 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.766 -1.334 . . . . 0.28000000000000003 109.766 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.411 ' CE1' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -72.33 82.48 1.04 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.053 -1.263 . . . . 0.31 109.782 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.2 t -48.26 142.64 7.76 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.40000000000000002 111.083 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.28 111.4 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.681 1.358 . . . . 0.25 110.484 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.24 -25.22 3.03 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.422 -1.471 . . . . 0.089999999999999997 109.422 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.6 m -56.68 130.73 46.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -1.108 . . . . 0.14999999999999999 110.349 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.437 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 1.0 OUTLIER -107.13 142.04 37.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.23999999999999999 110.349 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.477 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 0.8 OUTLIER -53.08 -36.46 60.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.28000000000000003 110.168 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -54.74 -26.0 31.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.31 109.797 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -96.17 -21.11 18.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.374 -0.829 . . . . 0.25 110.058 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 31' ' ' PHE . 20.3 mt -60.04 114.53 10.04 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.26000000000000001 109.7 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.66 -162.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.478 1.252 . . . . 0.34000000000000002 110.592 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -95.97 20.48 9.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.905 . . . . 0.37 110.487 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -102.92 -31.44 10.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.938 . . . . 0.39000000000000001 110.281 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.425 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 85.1 t90 -67.29 147.76 52.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.25 110.3 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 92.1 m -148.05 -174.53 4.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -0.871 . . . . 0.11 110.399 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.21 140.62 53.1 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.31 110.335 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -72.16 -19.74 25.73 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.52 1.274 . . . . 0.58999999999999997 110.822 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.31 -22.63 15.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.56999999999999995 110.507 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 75.1 m -116.46 -61.46 1.72 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.39000000000000001 110.381 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.45 36.1 3.65 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.37 -1.492 . . . . 0.22 109.37 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -114.05 159.29 20.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -1.109 . . . . 0.12 110.474 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.8 p -65.35 -160.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.17000000000000001 110.34 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -67.96 -9.62 46.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.33000000000000002 110.775 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -50.76 -40.68 55.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.025 -1.047 . . . . 0.42999999999999999 110.752 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 50' ' ' TYR . 49.0 p-10 -86.76 -15.76 38.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.42999999999999999 110.809 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.419 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 2.2 m-85 -91.95 140.72 29.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.46999999999999997 110.916 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.36 164.93 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.41 -0.806 . . . . 0.48999999999999999 110.203 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.67 122.22 16.33 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.245 -0.909 . . . . 0.56999999999999995 110.649 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.497 ' CE1' ' CD1' ' A' ' 13' ' ' ILE . 77.5 t80 -74.31 116.42 14.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.56999999999999995 110.395 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -133.13 173.13 11.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.885 . . . . 0.28000000000000003 110.493 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -65.27 -164.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.341 -0.849 . . . . 0.28000000000000003 110.394 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 tttp . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.05 -0.976 . . . . 0.46000000000000002 110.351 179.788 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.309 0.576 . . . . 0.38 110.301 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.432 ' CE1' ' HA2' ' A' ' 28' ' ' GLY . 18.1 m-85 -115.87 136.7 52.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.68999999999999995 110.365 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mp -81.9 165.31 20.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -0.852 . . . . 0.65000000000000002 110.527 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -135.61 129.74 33.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 0.28999999999999998 109.885 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.536 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 28.9 m95 -107.24 173.81 6.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.29999999999999999 110.22 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.417 HD13 HG13 ' A' ' 13' ' ' ILE . 1.7 tp -138.99 127.17 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.447 -0.783 . . . . 0.46000000000000002 109.969 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 11' ' ' GLY . 11.5 t -76.93 87.56 3.48 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.367 -0.833 . . . . 0.37 109.807 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.1 pt -49.14 -25.36 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.147 -0.971 . . . . 0.41999999999999998 110.087 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 m -69.27 -28.7 66.54 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.537 -0.727 . . . . 0.48999999999999999 110.131 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 83.6 m -123.36 -50.31 1.89 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.28000000000000003 110.803 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . 120.75 -5.99 11.41 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.253 -1.139 . . . . 0.17000000000000001 110.253 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -76.12 137.82 40.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.851 -1.382 . . . . 0.20999999999999999 110.391 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.417 HG13 HD13 ' A' ' 6' ' ' ILE . 3.7 mt -95.07 127.4 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.16 110.239 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.406 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 82.4 t80 -79.9 121.61 25.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.407 -0.808 . . . . 0.10000000000000001 109.91 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -99.03 104.93 17.0 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.351 -0.843 . . . . 0.11 109.989 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -49.2 -24.28 1.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.466 -0.771 . . . . 0.12 110.771 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.12 17.97 6.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.126 -0.984 . . . . 0.19 110.474 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.78 53.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.27000000000000002 109.797 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.65 -136.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.052 -1.219 . . . . 0.20999999999999999 110.052 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -89.33 165.68 14.23 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.365 -1.08 . . . . 0.27000000000000002 110.412 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.67 -25.47 11.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.38 110.22 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.71 -56.69 5.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.39000000000000001 110.11 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -60.42 -22.09 62.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.172 -0.955 . . . . 0.39000000000000001 110.156 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.16 28.66 8.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.378 -1.489 . . . . 0.28000000000000003 109.378 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.473 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.9 OUTLIER -74.09 75.74 1.74 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.215 -1.168 . . . . 0.31 110.448 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -60.31 151.35 68.64 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.432 -0.793 . . . . 0.40000000000000002 110.581 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -52.02 95.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.585 1.308 . . . . 0.25 110.569 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.432 ' HA2' ' CE1' ' A' ' 2' ' ' TYR . . . 152.68 -21.48 0.81 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.67 -1.372 . . . . 0.089999999999999997 109.67 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 m -64.92 128.99 38.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -1.202 . . . . 0.14999999999999999 110.553 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.31 145.22 43.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.23999999999999999 110.19 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.406 ' CB ' ' CZ2' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -47.96 -47.31 32.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.241 -0.912 . . . . 0.28000000000000003 110.831 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -50.35 -33.72 21.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.876 . . . . 0.31 110.095 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -93.45 12.97 23.12 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.432 -0.792 . . . . 0.25 110.27 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 34' ' ' ILE . 92.8 mt -117.04 62.88 3.06 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.072 -1.017 . . . . 0.26000000000000001 110.358 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.89 -14.74 36.08 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.558 1.294 . . . . 0.34000000000000002 110.638 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -59.56 -159.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.37 110.55 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -107.34 39.68 1.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.341 -0.849 . . . . 0.39000000000000001 110.605 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 78.6 t90 -57.65 146.33 31.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.128 -0.983 . . . . 0.25 110.066 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.3 m -136.7 -178.59 5.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.229 -0.919 . . . . 0.11 110.436 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.42 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -67.32 149.9 98.17 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.288 -0.883 . . . . 0.31 109.999 179.555 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -70.62 -5.14 16.07 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.668 1.351 . . . . 0.58999999999999997 111.513 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -156.18 32.11 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.817 -1.177 . . . . 0.56999999999999995 111.216 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.42 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 57.7 m -141.19 -57.86 0.49 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.015 -1.053 . . . . 0.39000000000000001 110.234 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.56 26.15 7.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.39 -1.484 . . . . 0.22 109.39 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.13 177.19 5.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.171 -1.193 . . . . 0.12 110.359 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.4 p -113.7 -165.15 0.98 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.326 -0.858 . . . . 0.17000000000000001 110.129 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -32.45 44.1 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.296 -0.877 . . . . 0.33000000000000002 110.436 177.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.94 -33.84 11.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.456 -0.778 . . . . 0.42999999999999999 110.294 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.49 -26.19 28.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.42999999999999999 109.785 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -92.59 128.11 38.32 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.374 -0.828 . . . . 0.46999999999999997 110.296 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.2 t -119.47 160.6 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.48999999999999999 110.252 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.68 103.33 6.6 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.167 -0.958 . . . . 0.56999999999999995 110.208 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -59.56 99.0 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.56999999999999995 110.701 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 50.44 81.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.894 . . . . 0.28000000000000003 110.769 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.0 167.53 17.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.28000000000000003 110.128 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.015 -0.993 . . . . 0.46000000000000002 110.384 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.312 0.577 . . . . 0.69 110.409 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.7 mp -92.41 168.86 11.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.864 . . . . 0.65 110.213 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.445 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 4.6 mttt -130.46 155.0 47.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.29 110.422 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.538 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 28.7 m95 -129.39 135.57 48.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.273 -0.892 . . . . 0.3 110.584 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.757 HD13 HG13 ' A' ' 13' ' ' ILE . 2.0 tp -108.06 128.24 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.021 -1.049 . . . . 0.46 110.524 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 10.2 t -74.8 100.12 3.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.877 . . . . 0.37 109.906 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.2 tt -56.11 -20.05 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.42 110.464 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.7 m -65.79 -38.17 88.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.49 110.803 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.4 p -129.23 -34.89 1.83 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.037 -1.04 . . . . 0.28 111.029 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.656 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 110.24 38.45 1.65 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.765 -1.334 . . . . 0.17 109.765 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.412 ' O ' HD12 ' A' ' 6' ' ' ILE . 4.7 t60 -104.1 128.06 51.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -1.165 . . . . 0.21 110.067 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.757 HG13 HD13 ' A' ' 6' ' ' ILE . 5.9 mt -92.18 143.17 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.242 -0.911 . . . . 0.16 110.836 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.484 ' HH ' ' HE2' ' A' ' 25' ' ' PHE . 64.0 t80 -108.76 131.24 55.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.706 -0.621 . . . . 0.1 109.485 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -106.29 107.94 19.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.537 -0.727 . . . . 0.11 109.815 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -50.39 -24.6 3.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 0.12 110.631 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.66 13.18 18.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.19 110.523 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 tp -176.68 62.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.154 -0.966 . . . . 0.27 109.881 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.64 -134.35 0.06 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.025 -1.23 . . . . 0.21 110.025 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -80.41 150.73 29.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.454 -1.027 . . . . 0.27 110.664 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -105.23 -25.07 12.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.872 . . . . 0.38 110.046 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.33 -43.24 28.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.408 -0.808 . . . . 0.39 110.333 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -70.53 -43.36 69.76 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.213 -0.929 . . . . 0.39 110.11 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.66 30.06 1.0 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.162 -1.175 . . . . 0.28 110.162 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CE1' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -73.03 81.39 1.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.85 -1.382 . . . . 0.31 109.944 179.151 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.5 t -49.33 150.89 2.9 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.4 110.989 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.45 95.77 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.703 1.37 . . . . 0.25 110.255 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.1 41.37 0.12 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.509 -1.436 . . . . 0.09 109.509 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -118.21 104.93 11.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -1.148 . . . . 0.15 110.086 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -75.67 141.56 42.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.24 110.649 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.682 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -51.95 -29.62 21.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.359 -0.838 . . . . 0.28 110.39 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -54.12 -50.69 66.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.31 110.386 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -74.96 -2.24 26.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.293 -0.879 . . . . 0.25 110.873 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' A' ' 31' ' ' PHE . 43.9 mt . . . . . 0 N--CA 1.489 1.509 0 O-C-N 120.934 -1.104 . . . . 0.26 110.338 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.552 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 85.5 t90 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.223 0.535 . . . . 0.25 110.245 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 88.4 m -121.21 -170.75 2.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.11 110.394 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 1.3 t -88.11 135.74 32.9 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.31 110.156 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.96 -13.28 28.97 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.458 1.241 . . . . 0.59 110.736 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.82 -25.31 10.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 0.57 110.795 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 85.1 m -111.32 -75.15 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.046 -1.033 . . . . 0.39 110.571 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.03 35.54 0.77 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.444 -1.462 . . . . 0.22 109.444 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.62 -170.45 1.67 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -1.171 . . . . 0.12 110.514 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 p -78.49 -167.45 1.08 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.17 110.383 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -83.65 -16.02 46.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -0.88 . . . . 0.33 110.574 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.79 -22.75 59.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.091 -1.005 . . . . 0.43 110.6 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.481 ' O ' HG22 ' A' ' 8' ' ' ILE . 5.3 m-20 -75.46 -17.81 60.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.43 110.572 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -96.42 134.63 39.35 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.223 -0.923 . . . . 0.47 110.928 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 6' ' ' ILE . 34.2 m -125.67 171.13 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.858 . . . . 0.49 109.972 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.27 130.27 34.82 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.163 -0.961 . . . . 0.57 110.784 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.4 t80 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 0.57 110.383 179.754 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.363 0.602 . . . . 0.69 110.508 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 mp -75.56 162.69 28.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -0.8 . . . . 0.65 110.523 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -134.19 134.91 42.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -0.871 . . . . 0.29 110.231 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.532 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 24.8 m95 -115.24 -178.13 3.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.3 110.229 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.649 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -161.37 124.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.399 -0.813 . . . . 0.46 110.059 178.619 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.649 ' N ' HD13 ' A' ' 6' ' ' ILE . 24.2 t -69.3 100.02 1.27 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.371 -0.831 . . . . 0.37 110.418 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.776 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.1 tt -53.98 -22.06 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.178 -0.951 . . . . 0.42 109.982 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.7 m -80.75 -28.88 36.33 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.25 -0.906 . . . . 0.49 110.175 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 1.6 m -110.2 -53.39 2.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 0.28 110.553 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.617 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 118.72 -11.02 12.25 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.133 -1.187 . . . . 0.17 110.133 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -75.65 138.86 41.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.941 -1.329 . . . . 0.21 110.482 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 5' ' ' TRP . 51.3 mt -97.6 136.91 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.364 -0.835 . . . . 0.16 110.589 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CE1' ' HA2' ' A' ' 19' ' ' GLY . 87.3 t80 -92.18 138.9 31.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.404 -0.81 . . . . 0.1 110.305 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -112.41 108.87 18.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.49 -0.756 . . . . 0.11 109.988 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -50.98 -24.42 3.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.154 -0.966 . . . . 0.12 110.7 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.31 16.43 8.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.19 110.4 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -176.96 69.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.27 109.855 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.5 ' HA2' ' CE1' ' A' ' 14' ' ' TYR . . . -68.37 -137.04 0.07 OUTLIER Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.143 -1.183 . . . . 0.21 110.143 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 22' ' ' ALA . 15.8 t0 -87.07 149.77 24.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.406 -1.055 . . . . 0.27 110.718 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.408 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 36.5 mt-10 -97.17 -30.59 12.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.854 . . . . 0.38 110.023 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.424 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . -75.16 -44.86 44.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.387 -0.821 . . . . 0.39 110.316 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -63.61 -38.94 93.04 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.255 -0.903 . . . . 0.39 110.312 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.13 23.21 4.28 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.677 -1.369 . . . . 0.28 109.677 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.672 ' CE2' HG21 ' A' ' 29' ' ' THR . 0.7 OUTLIER -66.72 83.81 0.11 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.099 -1.236 . . . . 0.31 110.124 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.4 t -49.77 152.54 2.53 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.446 -0.784 . . . . 0.4 110.918 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 28.6 Cg_exo -58.04 106.99 0.28 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.703 1.37 . . . . 0.25 110.468 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.4 38.99 0.46 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.474 -1.45 . . . . 0.09 109.474 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.672 HG21 ' CE2' ' A' ' 25' ' ' PHE . 26.2 m -108.97 134.4 51.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -1.115 . . . . 0.15 110.353 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -117.96 141.02 48.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.24 110.346 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.647 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -48.94 -36.59 17.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.198 -0.939 . . . . 0.28 110.747 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -57.15 -34.79 68.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.237 -0.914 . . . . 0.31 109.989 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -87.37 -23.07 24.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.333 -0.854 . . . . 0.25 110.234 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.647 HD12 ' HA ' ' A' ' 31' ' ' PHE . 20.8 mt . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.26 109.913 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.532 ' CZ3' ' CZ ' ' A' ' 31' ' ' PHE . 79.7 t90 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.336 0.589 . . . . 0.25 110.363 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.473 ' N ' ' CD2' ' A' ' 38' ' ' TRP . 25.3 p -173.94 -160.89 0.11 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.389 -0.819 . . . . 0.11 110.148 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -76.55 143.4 72.06 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.307 -0.87 . . . . 0.31 110.091 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.56 -7.62 19.69 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.664 1.35 . . . . 0.59 111.373 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.8 -32.21 2.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.952 -1.093 . . . . 0.57 111.05 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 63.3 m -92.4 -70.34 0.7 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.07 -1.019 . . . . 0.39 110.407 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.27 25.11 4.83 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.288 -1.525 . . . . 0.22 109.288 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.14 174.4 5.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -1.147 . . . . 0.12 110.569 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.0 p -67.42 -162.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.17 110.345 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -78.65 -2.83 40.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.33 110.769 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -45.03 64.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.957 -1.09 . . . . 0.43 110.463 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.776 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.3 p30 -73.02 -20.25 61.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.43 110.219 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -90.58 129.7 36.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.47 110.495 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 6' ' ' ILE . 27.4 m -128.21 159.97 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.49 110.21 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.42 119.05 17.12 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.195 -0.94 . . . . 0.57 110.383 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.1 t80 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.57 110.628 -179.552 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.785 ' CG ' ' HB2' ' A' ' 17' ' ' ALA . 39.7 m-85 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.389 0.614 . . . . 0.69 110.483 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.514 HD23 HD11 ' A' ' 52' ' ' LEU . 4.3 mp -92.36 163.13 13.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.298 -0.876 . . . . 0.65 110.284 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.73 146.56 50.89 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.244 -0.91 . . . . 0.29 109.809 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.553 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 25.0 m95 -119.82 -176.55 3.2 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.319 -0.863 . . . . 0.3 109.616 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.757 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -152.96 129.42 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.407 -0.917 . . . . 0.46 110.481 178.405 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.757 ' N ' HD13 ' A' ' 6' ' ' ILE . 4.9 t -75.69 92.14 2.96 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.495 -0.753 . . . . 0.37 109.982 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.428 HG13 ' N ' ' A' ' 9' ' ' THR . 15.9 pt -51.67 -23.64 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.009 -1.057 . . . . 0.42 109.928 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.428 ' N ' HG13 ' A' ' 8' ' ' ILE . 45.9 m -68.9 -26.96 65.37 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.495 -0.753 . . . . 0.49 110.295 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.7 m -125.83 -49.99 1.6 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -0.953 . . . . 0.28 111.284 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.668 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 118.97 13.22 6.63 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.905 -1.278 . . . . 0.17 109.905 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.02 125.51 37.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.994 -1.297 . . . . 0.21 110.177 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.436 HG13 HG12 ' A' ' 6' ' ' ILE . 53.4 mt -88.79 141.17 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.16 110.696 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -102.44 148.1 25.91 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.657 0.741 . . . . 0.1 110.35 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -124.15 106.75 10.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.579 -0.701 . . . . 0.11 109.923 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.463 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 98.8 mt-10 -50.26 -24.42 2.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.12 110.565 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.785 ' HB2' ' CG ' ' A' ' 2' ' ' TYR . . . -93.21 20.19 7.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.19 110.257 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tp -176.49 65.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.27 109.966 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.8 -141.56 0.32 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.886 -1.286 . . . . 0.21 109.886 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.02 171.63 7.24 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.38 -1.07 . . . . 0.27 110.543 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -106.42 -35.63 7.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.35 -0.844 . . . . 0.38 110.159 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.36 -41.73 89.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.872 . . . . 0.39 110.171 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -73.91 -3.33 28.26 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.253 -0.904 . . . . 0.39 110.901 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.22 25.19 64.34 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.348 -1.501 . . . . 0.28 109.348 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -82.66 79.99 8.91 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.277 -1.131 . . . . 0.31 109.985 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.0 t -49.46 151.29 2.84 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.389 -0.819 . . . . 0.4 111.004 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 24.9 Cg_exo -60.0 114.97 2.32 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.704 1.371 . . . . 0.25 110.42 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.65 16.58 5.89 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.868 -1.293 . . . . 0.09 109.868 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.711 HG22 HD11 ' A' ' 34' ' ' ILE . 40.3 m -86.01 116.52 24.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.244 . . . . 0.15 110.224 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.463 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 43.6 mtt85 -90.26 140.65 29.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.24 110.576 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.82 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -59.18 -35.14 73.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.888 . . . . 0.28 110.165 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -52.28 -30.64 28.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.31 110.35 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -100.86 19.04 17.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -0.844 . . . . 0.25 110.345 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.82 HD12 ' HA ' ' A' ' 31' ' ' PHE . 92.9 mt . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.26 109.989 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 85.8 t90 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.328 0.585 . . . . 0.25 110.372 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.7 m -128.96 -164.58 1.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.11 110.181 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.451 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -79.95 152.79 74.73 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.128 -0.983 . . . . 0.31 110.236 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -62.97 -12.88 31.74 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.583 1.307 . . . . 0.59 111.325 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -157.49 40.69 0.3 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.91 -1.119 . . . . 0.57 111.185 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.451 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 56.7 m -141.88 -59.51 0.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.034 -1.042 . . . . 0.39 110.184 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.08 25.62 11.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.117 -1.593 . . . . 0.22 109.117 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.12 -170.37 2.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -1.112 . . . . 0.12 110.408 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.2 p -108.89 -173.19 2.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.17 110.372 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -63.04 -16.65 60.58 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.268 -0.895 . . . . 0.33 110.261 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -55.58 -38.77 69.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.43 110.246 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 5.7 m-20 -77.05 -12.88 60.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.31 -0.869 . . . . 0.43 110.473 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.441 ' HE2' ' HG ' ' A' ' 40' ' ' CYS . 3.0 m-85 -100.72 136.82 39.98 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.049 -1.032 . . . . 0.47 110.772 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.5 t -133.15 149.05 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.47 -0.769 . . . . 0.49 109.985 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.514 HD11 HD23 ' A' ' 3' ' ' LEU . 1.1 tt -63.71 120.54 12.02 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.112 -0.992 . . . . 0.57 110.279 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 30.0 t80 . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.335 -0.853 . . . . 0.57 110.375 -179.326 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.532 ' CG ' ' HB2' ' A' ' 17' ' ' ALA . 61.0 m-85 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.329 0.585 . . . . 0.69 110.403 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.529 HD23 HD21 ' A' ' 52' ' ' LEU . 3.3 mp -98.85 170.05 9.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.507 -0.745 . . . . 0.65 110.678 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -134.84 148.93 50.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.29 110.186 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.458 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 48.9 m95 -129.91 178.87 6.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 0.3 110.504 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.854 HD13 HG13 ' A' ' 13' ' ' ILE . 1.2 tp -156.32 120.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.65 -0.656 . . . . 0.46 109.741 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 11' ' ' GLY . 18.9 t -67.67 96.93 0.58 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.372 -0.83 . . . . 0.37 110.313 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.5 tt -54.99 -19.92 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.142 -0.974 . . . . 0.42 110.289 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 m -80.62 -28.35 37.01 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.261 -0.899 . . . . 0.49 110.381 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.4 m -117.23 -46.43 2.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.163 -0.961 . . . . 0.28 110.856 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.474 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 109.0 19.8 8.35 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.678 -1.369 . . . . 0.17 109.678 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -99.65 134.48 42.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -1.21 . . . . 0.21 110.069 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.854 HG13 HD13 ' A' ' 6' ' ' ILE . 4.4 mt -96.24 141.04 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.16 110.656 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -108.21 144.56 35.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.512 -0.742 . . . . 0.1 110.329 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -119.9 109.42 15.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.429 -0.794 . . . . 0.11 110.097 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.428 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 69.8 mt-10 -50.22 -27.85 6.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 0.12 110.474 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.532 ' HB2' ' CG ' ' A' ' 2' ' ' TYR . . . -93.85 12.83 24.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.921 . . . . 0.19 110.617 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.55 68.45 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.12 -0.987 . . . . 0.27 110.42 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.25 -135.5 0.01 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.402 -1.479 . . . . 0.21 109.402 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.25 164.75 12.71 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.225 -1.161 . . . . 0.27 110.287 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -92.81 -22.14 19.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -0.913 . . . . 0.38 110.31 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.67 -36.46 17.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.39 110.366 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -65.19 -26.92 68.35 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.255 -0.903 . . . . 0.39 110.332 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.83 27.47 14.17 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.548 -1.421 . . . . 0.28 109.548 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.513 ' CE1' HG21 ' A' ' 29' ' ' THR . 0.1 OUTLIER -73.51 84.0 1.51 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.108 -1.231 . . . . 0.31 110.208 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.4 t -50.06 143.94 11.58 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.192 -0.943 . . . . 0.4 110.474 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.15 106.57 0.21 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.653 1.344 . . . . 0.25 110.645 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.02 44.42 0.17 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.582 -1.407 . . . . 0.09 109.582 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.513 HG21 ' CE1' ' A' ' 25' ' ' PHE . 1.4 m -130.59 122.87 28.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.11 -1.229 . . . . 0.15 110.511 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.428 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 1.7 ptm180 -103.58 150.91 23.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.24 110.446 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.781 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -48.4 -44.62 35.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.232 -0.917 . . . . 0.28 110.833 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.407 ' HB3' ' HG3' ' A' ' 30' ' ' ARG . 3.0 tm-20 -53.61 -48.73 69.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.31 110.234 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.93 -22.57 66.5 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.265 -0.897 . . . . 0.25 110.217 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.781 HD12 ' HA ' ' A' ' 31' ' ' PHE . 46.8 mt . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.431 -0.793 . . . . 0.26 110.047 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.547 ' CZ3' ' CZ ' ' A' ' 31' ' ' PHE . 79.8 t90 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.234 0.54 . . . . 0.25 110.096 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.6 p -162.36 -160.53 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.11 110.386 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.434 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -86.55 160.95 49.64 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.358 -0.839 . . . . 0.31 110.422 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 3.8 Cg_exo -73.88 -23.05 16.81 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.607 1.319 . . . . 0.59 110.953 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -139.49 30.46 2.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.993 -1.067 . . . . 0.57 111.178 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.434 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 60.6 m -141.57 -46.15 0.37 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.974 -1.079 . . . . 0.39 110.255 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.27 28.92 47.18 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.5 -1.44 . . . . 0.22 109.5 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.32 -171.81 2.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -1.174 . . . . 0.12 110.334 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.4 p -109.25 -159.85 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.17 110.336 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.408 ' HA ' ' HB2' ' A' ' 50' ' ' TYR . 32.7 ttmt -58.34 -18.5 27.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.394 -0.816 . . . . 0.33 110.253 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -50.22 -48.29 54.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.064 -1.022 . . . . 0.43 110.56 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.737 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.8 m-20 -73.03 -20.42 61.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.43 110.154 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.408 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 12.2 m-85 -95.92 137.58 34.78 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.315 -0.866 . . . . 0.47 110.764 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 80.7 t -125.11 158.73 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.388 -0.82 . . . . 0.49 109.931 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.529 HD21 HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -72.33 100.13 2.58 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.179 -0.951 . . . . 0.57 110.083 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.4 ' HD1' HG21 ' A' ' 6' ' ' ILE . 28.6 t80 . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.446 -0.784 . . . . 0.57 110.516 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.338 0.59 . . . . 0.69 110.537 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.64 179.16 7.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.435 -0.791 . . . . 0.65 110.587 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -146.68 138.8 24.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.405 -0.809 . . . . 0.29 110.451 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.54 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 29.2 m95 -118.23 -178.37 3.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -0.822 . . . . 0.3 110.08 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.631 HD11 ' HA2' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -156.55 118.67 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.394 -0.816 . . . . 0.46 110.374 177.632 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.544 ' N ' HD13 ' A' ' 6' ' ' ILE . 6.6 t -63.93 92.2 0.07 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.243 -0.911 . . . . 0.37 109.919 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.604 HG21 HG21 ' A' ' 51' ' ' VAL . 8.6 pt -51.7 -23.71 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.182 -0.949 . . . . 0.42 110.073 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.421 ' N ' HG13 ' A' ' 8' ' ' ILE . 36.3 m -72.48 -29.42 63.63 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.306 -0.871 . . . . 0.49 110.039 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.2 m -114.29 -49.04 2.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.28 110.667 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.631 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 114.22 8.64 16.81 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.032 -1.227 . . . . 0.17 110.032 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -92.25 133.97 35.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.911 -1.347 . . . . 0.21 110.091 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 90.4 mt -93.2 124.43 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.16 110.783 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.476 ' HH ' ' HE2' ' A' ' 25' ' ' PHE . 57.3 t80 -84.55 131.04 34.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.42 -0.8 . . . . 0.1 109.978 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -108.44 111.78 23.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.11 109.815 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.423 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -51.9 -23.95 5.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.12 110.265 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.75 13.55 12.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.19 110.509 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.57 64.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.27 109.756 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.43 -136.29 0.12 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.049 -1.221 . . . . 0.21 110.049 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -84.91 144.53 28.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -1.04 . . . . 0.27 110.598 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -91.07 -22.95 20.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.307 -0.871 . . . . 0.38 110.082 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.8 -39.93 15.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.39 110.302 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -65.96 -32.35 73.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.39 110.259 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.18 29.22 4.63 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.54 -1.424 . . . . 0.28 109.54 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.567 ' CE1' ' CD1' ' A' ' 38' ' ' TRP . 1.5 m-85 -73.69 82.74 1.58 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.111 -1.229 . . . . 0.31 110.181 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.2 t -49.49 149.3 4.16 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.4 110.785 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.17 110.83 0.62 Allowed 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.666 1.351 . . . . 0.25 110.397 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.09 19.82 4.63 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.741 -1.344 . . . . 0.09 109.741 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.3 m -86.58 133.76 33.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.058 -1.26 . . . . 0.15 110.262 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.423 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 2.3 mtp180 -116.12 144.56 43.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.87 . . . . 0.24 110.431 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.559 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -49.57 -25.16 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.314 -0.866 . . . . 0.28 110.525 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.41 -24.33 54.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.895 . . . . 0.31 110.479 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -114.17 11.28 17.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.25 110.836 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.559 HD11 ' HE2' ' A' ' 25' ' ' PHE . 8.6 mt . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.071 -1.018 . . . . 0.26 110.928 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.567 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 82.2 t90 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.351 0.596 . . . . 0.25 110.67 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.433 ' N ' ' CG ' ' A' ' 38' ' ' TRP . 25.0 p -169.66 -161.34 0.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.329 -0.857 . . . . 0.11 110.31 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.438 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -91.82 169.25 11.48 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 0.31 110.227 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.28 -40.53 31.84 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.584 1.307 . . . . 0.59 110.746 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.1 50.76 1.03 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.091 -1.005 . . . . 0.57 110.689 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.438 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 61.7 m -136.58 -45.63 0.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.39 110.086 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.34 32.45 51.69 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.354 -1.498 . . . . 0.22 109.354 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.23 166.72 10.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 0.12 110.443 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.4 p -91.59 -162.15 0.89 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.398 -0.814 . . . . 0.17 110.161 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 50' ' ' TYR . 5.3 ttpp -61.67 -15.47 40.3 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.239 -0.913 . . . . 0.33 110.377 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 49' ' ' ASP . 23.2 pt-20 -51.79 -40.68 60.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.052 -1.03 . . . . 0.43 110.354 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 14.9 m-20 -80.58 -18.37 48.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.231 -0.918 . . . . 0.43 110.368 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.428 ' HE2' ' HG ' ' A' ' 40' ' ' CYS . 4.8 m-85 -95.21 124.17 39.11 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.185 -0.947 . . . . 0.47 110.455 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.604 HG21 HG21 ' A' ' 8' ' ' ILE . 97.9 t -117.21 148.02 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.279 -0.888 . . . . 0.49 110.088 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.76 117.44 9.67 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.152 -0.968 . . . . 0.57 110.096 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 31.7 t80 . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.57 110.535 -178.943 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.422 ' HB3' ' HB2' ' A' ' 16' ' ' GLU . 37.2 m-85 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.304 0.573 . . . . 0.69 110.351 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.851 HD23 HD21 ' A' ' 52' ' ' LEU . 1.5 mp -91.03 164.16 14.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.409 -0.807 . . . . 0.65 110.725 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -122.56 144.76 48.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -0.835 . . . . 0.29 110.07 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.506 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 39.2 m95 -121.5 179.07 4.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 0.3 110.537 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.851 HD13 HG13 ' A' ' 13' ' ' ILE . 2.1 tp -153.88 128.18 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.717 -0.614 . . . . 0.46 110.068 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 45.3 t -76.97 98.03 4.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.37 110.291 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.0 OUTLIER -52.68 -23.3 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.097 -1.002 . . . . 0.42 110.175 179.446 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.4 m -79.82 -30.61 40.52 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.388 -0.82 . . . . 0.49 110.351 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -108.99 -54.44 2.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 0.28 110.569 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.482 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 113.38 13.48 10.63 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.896 -1.281 . . . . 0.17 109.896 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.428 ' O ' HD12 ' A' ' 6' ' ' ILE . 4.2 m80 -99.33 133.82 43.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.934 -1.333 . . . . 0.21 110.047 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.851 HG13 HD13 ' A' ' 6' ' ' ILE . 3.9 mt -89.68 145.68 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.16 110.631 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.43 ' CE1' ' HA2' ' A' ' 19' ' ' GLY . 75.4 t80 -104.82 129.26 53.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.564 -0.71 . . . . 0.1 110.352 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.414 ' HB3' ' HG ' ' A' ' 18' ' ' LEU . 2.4 t0 -102.8 104.39 14.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.301 -0.874 . . . . 0.11 110.006 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 2' ' ' TYR . 18.0 mt-10 -51.89 -23.0 4.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -0.865 . . . . 0.12 110.758 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.31 -2.74 26.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.235 -0.915 . . . . 0.19 110.943 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.433 ' O ' ' CG ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -173.42 68.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.987 -1.071 . . . . 0.27 110.062 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.43 ' HA2' ' CE1' ' A' ' 14' ' ' TYR . . . -62.97 -136.96 0.01 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.328 -1.109 . . . . 0.21 110.328 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -92.71 166.09 12.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.294 -1.121 . . . . 0.27 110.512 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -109.21 -27.1 9.74 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.326 -0.858 . . . . 0.38 110.129 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.74 -54.16 17.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.39 110.172 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -63.56 -24.76 67.94 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.228 -0.92 . . . . 0.39 110.137 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.5 28.99 5.52 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.542 -1.423 . . . . 0.28 109.542 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.688 ' CD1' HG21 ' A' ' 29' ' ' THR . 0.7 OUTLIER -81.49 79.88 7.99 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.153 -1.204 . . . . 0.31 110.442 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -53.26 152.82 7.63 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.254 -0.904 . . . . 0.4 110.511 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -54.54 95.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.608 1.32 . . . . 0.25 110.307 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 144.81 -15.88 1.98 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.815 -1.314 . . . . 0.09 109.815 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.688 HG21 ' CD1' ' A' ' 25' ' ' PHE . 1.6 m -50.45 121.94 6.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.017 -1.284 . . . . 0.15 110.633 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -105.6 139.84 39.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.24 110.266 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.87 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -47.32 -46.77 25.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.337 -0.852 . . . . 0.28 110.835 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.67 -33.57 47.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.284 -0.885 . . . . 0.31 110.233 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.42 11.81 27.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.335 -0.853 . . . . 0.25 110.653 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.87 HD12 ' HA ' ' A' ' 31' ' ' PHE . 91.3 mt . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.011 -1.056 . . . . 0.26 109.971 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 81.0 t90 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.218 0.532 . . . . 0.25 109.993 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 95.3 m -143.38 -175.12 4.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.11 110.401 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -74.08 136.97 75.85 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.31 110.233 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -72.6 -13.05 27.25 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.463 1.244 . . . . 0.59 110.846 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.51 -23.94 11.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.027 -1.046 . . . . 0.57 110.756 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 95.8 m -111.86 -75.04 0.62 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.027 -1.046 . . . . 0.39 110.418 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.38 36.83 0.67 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.402 -1.479 . . . . 0.22 109.402 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.66 -169.17 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -1.166 . . . . 0.12 110.499 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.7 p -88.8 -162.5 0.86 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 0.17 110.4 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.25 -9.79 54.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.853 . . . . 0.33 110.639 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -52.14 -44.76 64.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.984 -1.072 . . . . 0.43 110.463 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.577 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -71.31 -20.6 62.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.161 -0.962 . . . . 0.43 110.033 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -96.06 134.08 39.54 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.248 -0.907 . . . . 0.47 110.662 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.54 171.85 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.831 . . . . 0.49 110.115 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.851 HD21 HD23 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -75.62 118.51 18.54 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.253 -0.904 . . . . 0.57 110.311 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.0 t80 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.57 110.579 -179.442 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.408 0.623 . . . . 0.69 110.35 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.429 HD23 HD11 ' A' ' 52' ' ' LEU . 1.9 mp -104.1 179.79 4.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.65 110.743 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -139.63 145.97 39.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.496 -0.752 . . . . 0.29 110.009 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 34.1 m95 -127.82 134.72 49.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.082 -1.011 . . . . 0.3 110.658 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.741 HD13 HG13 ' A' ' 13' ' ' ILE . 2.6 tp -111.62 132.62 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.023 -1.048 . . . . 0.46 110.297 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.9 t -79.13 100.05 7.24 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.345 -0.847 . . . . 0.37 110.037 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.6 tt -56.17 -18.74 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.917 . . . . 0.42 110.619 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.0 m -70.08 -39.56 75.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.885 . . . . 0.49 110.824 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.9 p -126.8 -35.31 2.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.971 -1.081 . . . . 0.28 111.116 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.614 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 108.97 44.7 1.08 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.852 -1.299 . . . . 0.17 109.852 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 9.5 t60 -108.74 127.7 54.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -1.211 . . . . 0.21 110.142 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.741 HG13 HD13 ' A' ' 6' ' ' ILE . 5.8 mt -93.09 133.52 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.16 110.8 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' OH ' HD11 ' A' ' 34' ' ' ILE . 71.3 t80 -102.84 121.39 42.39 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.506 -0.746 . . . . 0.1 109.295 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -98.98 106.26 18.5 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.415 -0.803 . . . . 0.11 110.19 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.437 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -48.74 -24.16 1.3 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.385 -0.822 . . . . 0.12 111.015 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.65 14.45 8.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.067 -1.021 . . . . 0.19 110.803 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 tt -176.61 69.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.1 -1.0 . . . . 0.27 109.999 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.06 -136.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.842 -1.303 . . . . 0.21 109.842 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.403 ' OD2' ' N ' ' A' ' 23' ' ' GLU . 17.0 t70 -113.37 161.31 17.42 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.347 -1.09 . . . . 0.27 110.179 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -97.27 -27.74 14.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.38 110.36 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.95 -29.03 58.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.92 . . . . 0.39 110.345 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.403 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 11.8 mm-40 -88.9 16.59 6.7 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.298 -0.876 . . . . 0.39 110.805 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.1 28.38 63.87 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.456 -1.458 . . . . 0.28 109.456 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -86.85 82.71 7.72 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.232 -1.158 . . . . 0.31 110.046 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.8 t -47.86 151.4 1.63 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.469 -0.769 . . . . 0.4 110.961 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 36.8 Cg_exo -56.96 104.92 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.701 1.369 . . . . 0.25 110.467 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.1 35.51 0.76 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.622 -1.391 . . . . 0.09 109.622 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.541 HG22 HD11 ' A' ' 34' ' ' ILE . 58.2 m -90.3 134.32 34.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.189 -1.183 . . . . 0.15 110.32 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.437 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -105.72 135.51 47.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 0.24 110.468 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.892 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -51.0 -47.21 61.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.28 110.473 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -54.91 -41.43 70.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.861 . . . . 0.31 110.442 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.98 -24.34 52.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.25 110.394 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.892 HD12 ' HA ' ' A' ' 31' ' ' PHE . 63.4 mt . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.26 110.119 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 89.4 t90 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.27 0.557 . . . . 0.25 110.47 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.8 p -162.24 -160.89 0.7 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.11 110.343 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.56 120.85 70.37 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.401 -0.812 . . . . 0.31 110.173 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.35 -12.82 34.88 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.473 1.249 . . . . 0.59 110.849 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.412 ' OD2' ' ND1' ' A' ' 12' ' ' HIS . 87.8 m-20 -102.55 -26.84 13.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.052 -1.03 . . . . 0.57 110.674 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 96.6 m -114.32 -75.42 0.59 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.139 -0.976 . . . . 0.39 110.327 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.3 40.83 0.35 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.396 -1.482 . . . . 0.22 109.396 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.442 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . . . -122.43 -175.09 3.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -1.173 . . . . 0.12 110.667 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 p -82.55 -166.71 1.36 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.385 -0.822 . . . . 0.17 110.511 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -69.02 -8.76 48.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.32 -0.863 . . . . 0.33 110.551 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -50.95 -42.88 60.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.987 -1.07 . . . . 0.43 110.299 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' O ' HG22 ' A' ' 8' ' ' ILE . 2.8 p30 -76.02 -20.64 57.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.319 -0.863 . . . . 0.43 110.377 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -92.86 131.41 37.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.47 110.596 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 6' ' ' ILE . 35.9 m -124.27 163.19 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.279 -0.888 . . . . 0.49 110.161 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.429 HD11 HD23 ' A' ' 3' ' ' LEU . 0.7 OUTLIER -81.86 120.35 25.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.57 110.581 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.1 t80 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.362 -0.836 . . . . 0.57 110.389 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.589 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 42.6 m-85 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.344 0.592 . . . . 0.69 110.479 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.881 HD23 HD21 ' A' ' 52' ' ' LEU . 1.9 mp -75.04 164.44 26.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.65 110.528 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -130.31 136.58 49.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.29 110.093 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.517 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 29.6 m95 -115.84 170.61 8.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.966 . . . . 0.3 110.283 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.864 HD13 HG13 ' A' ' 13' ' ' ILE . 2.1 tp -144.38 136.27 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.454 -0.779 . . . . 0.46 109.775 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.433 ' H ' HD12 ' A' ' 6' ' ' ILE . 8.4 t -84.44 95.12 8.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.366 -0.834 . . . . 0.37 110.342 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.0 OUTLIER -52.81 -22.88 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.11 -0.993 . . . . 0.42 110.043 179.016 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.2 m -72.72 -28.02 62.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.372 -0.83 . . . . 0.49 110.302 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 78.9 m -124.6 -51.38 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.28 110.64 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.539 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 117.3 19.34 5.11 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.833 -1.307 . . . . 0.17 109.833 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.487 ' O ' HD12 ' A' ' 6' ' ' ILE . 5.8 m-70 -97.57 133.09 42.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.051 -1.264 . . . . 0.21 110.102 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.864 HG13 HD13 ' A' ' 6' ' ' ILE . 3.9 mt -91.28 134.51 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.16 110.504 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.402 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 70.7 t80 -94.33 125.89 39.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.5 -0.75 . . . . 0.1 109.892 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -95.83 102.55 14.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.459 -0.775 . . . . 0.11 110.289 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -49.35 -30.96 8.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.85 . . . . 0.12 110.702 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.589 ' HB2' ' CD2' ' A' ' 2' ' ' TYR . . . -91.74 17.47 8.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.895 . . . . 0.19 110.457 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -177.0 70.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -0.956 . . . . 0.27 110.076 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.87 -135.4 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.89 -1.284 . . . . 0.21 109.89 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD2' ' N ' ' A' ' 22' ' ' ALA . 16.3 t70 -113.12 168.97 9.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.345 -1.091 . . . . 0.27 110.571 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -87.81 -46.62 9.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.27 -0.894 . . . . 0.38 110.073 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . -53.83 -43.76 69.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.337 -0.852 . . . . 0.39 110.205 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -70.88 -30.22 66.54 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.32 -0.862 . . . . 0.39 110.083 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.27 28.85 18.89 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.686 -1.366 . . . . 0.28 109.686 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CE2' ' NE1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -69.19 82.86 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.275 . . . . 0.31 110.064 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.5 t -49.49 145.75 7.57 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.196 -0.94 . . . . 0.4 110.723 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 38.4 Cg_exo -53.51 105.66 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.683 1.359 . . . . 0.25 110.712 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.48 41.98 0.26 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.879 -1.288 . . . . 0.09 109.879 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.19 126.76 44.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -1.218 . . . . 0.15 110.267 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.441 ' HG2' ' CB ' ' A' ' 33' ' ' ASP . 0.4 OUTLIER -118.38 148.68 42.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.24 110.256 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.623 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -47.78 -40.74 21.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.254 -0.904 . . . . 0.28 110.673 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -59.31 -32.38 70.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.191 -0.943 . . . . 0.31 109.983 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.441 ' CB ' ' HG2' ' A' ' 30' ' ' ARG . 21.3 t0 -95.39 12.67 28.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 0.25 110.551 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.662 ' O ' HG22 ' A' ' 34' ' ' ILE . 92.3 mt . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.092 -1.005 . . . . 0.26 110.119 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.424 ' NE1' ' CE2' ' A' ' 25' ' ' PHE . 85.6 t90 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.292 0.568 . . . . 0.25 110.553 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 8.4 m -135.07 172.31 13.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.342 -0.849 . . . . 0.11 110.173 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.439 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -55.92 151.6 23.76 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.31 110.334 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -74.22 -7.77 20.15 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.513 1.27 . . . . 0.59 111.201 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -150.64 32.72 0.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.899 -1.126 . . . . 0.57 111.053 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.439 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 59.0 m -142.11 -65.86 0.41 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.084 -1.01 . . . . 0.39 110.045 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.54 29.4 3.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.496 -1.442 . . . . 0.22 109.496 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HB1' ' OD1' ' A' ' 49' ' ' ASP . . . -105.71 171.01 7.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -1.106 . . . . 0.12 110.462 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.5 p -90.13 -162.39 0.89 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.17 110.205 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 23.0 mttt -68.08 -14.33 62.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.341 -0.849 . . . . 0.33 110.437 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -52.7 -45.87 67.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.098 -1.001 . . . . 0.43 110.215 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.631 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.6 m-20 -70.49 -20.89 62.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.321 -0.862 . . . . 0.43 109.992 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -97.76 134.75 40.51 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.378 -0.826 . . . . 0.47 110.593 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.409 ' CG2' HG23 ' A' ' 6' ' ' ILE . 34.3 m -130.75 170.93 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.49 110.274 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.881 HD21 HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -79.25 119.44 22.33 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.165 -0.959 . . . . 0.57 110.344 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.433 ' N ' HD13 ' A' ' 52' ' ' LEU . 29.8 t80 . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.883 . . . . 0.57 110.529 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.366 0.603 . . . . 0.69 110.512 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.93 157.42 15.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 0.65 110.481 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.431 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 0.9 OUTLIER -121.2 160.36 23.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.29 110.097 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.447 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 55.9 m95 -135.09 127.1 29.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.151 -0.968 . . . . 0.3 110.651 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.804 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -98.83 130.43 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.09 -1.006 . . . . 0.46 110.028 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.804 ' N ' HD13 ' A' ' 6' ' ' ILE . 12.0 t -78.68 92.88 4.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.216 -0.928 . . . . 0.37 109.507 177.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 49' ' ' ASP . 48.0 pt -51.49 -23.99 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.884 -1.135 . . . . 0.42 110.031 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.9 m -77.13 -27.4 53.91 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.546 -0.721 . . . . 0.49 110.195 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 3.7 m -117.03 -47.35 2.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.28 111.503 -178.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.574 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 114.28 -22.14 14.15 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.126 -1.59 . . . . 0.17 109.126 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -69.67 145.3 52.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -1.177 . . . . 0.21 110.213 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.444 HG13 HG12 ' A' ' 6' ' ' ILE . 7.2 mt -108.14 151.84 10.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.391 -0.818 . . . . 0.16 111.041 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -103.82 128.47 51.26 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.701 -0.624 . . . . 0.1 109.992 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -102.89 103.85 14.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.532 -0.73 . . . . 0.11 110.344 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -51.37 -23.45 3.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.389 -0.819 . . . . 0.12 110.717 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.79 11.77 10.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.19 110.897 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -176.47 69.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.27 109.906 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.72 -146.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.011 -1.236 . . . . 0.21 110.011 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.06 172.96 9.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.399 -1.059 . . . . 0.27 110.697 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -110.58 -21.57 12.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.38 110.301 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.11 -59.92 2.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.39 110.399 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -57.68 -21.23 39.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.39 110.3 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.36 31.96 6.92 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.198 -1.561 . . . . 0.28 109.198 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -78.71 76.98 5.2 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.345 -1.091 . . . . 0.31 110.122 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 14.9 t -51.38 148.45 8.89 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.431 -0.793 . . . . 0.4 110.865 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 38.4 Cg_exo -56.51 123.83 14.79 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.695 1.366 . . . . 0.25 110.493 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.6 22.87 5.28 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.572 -1.411 . . . . 0.09 109.572 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.423 HG22 HD11 ' A' ' 34' ' ' ILE . 69.8 m -97.29 132.69 42.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -1.159 . . . . 0.15 110.268 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.8 ttp85 -109.01 142.24 39.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.24 110.394 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.861 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -48.01 -48.25 32.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.266 -0.897 . . . . 0.28 110.821 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.54 -46.82 66.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.89 . . . . 0.31 110.179 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.59 -11.66 60.74 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.4 -0.813 . . . . 0.25 110.378 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 31' ' ' PHE . 77.8 mt . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.026 -1.046 . . . . 0.26 109.973 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 69.2 t90 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.342 0.591 . . . . 0.25 110.241 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.2 p -156.49 -160.38 0.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.11 110.192 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 1.2 t -81.22 145.77 56.82 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 0.31 110.123 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 5.5 Cg_exo -75.16 -12.98 21.22 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.397 1.209 . . . . 0.59 111.194 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -121.23 -12.79 8.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.899 -1.126 . . . . 0.57 111.387 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 99.1 m -116.17 -72.91 0.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.917 -1.114 . . . . 0.39 110.597 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.29 29.65 1.9 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.675 -1.37 . . . . 0.22 109.675 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.552 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . . . -110.87 -174.88 2.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -1.154 . . . . 0.12 110.285 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.7 p -89.82 -158.86 0.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.17 110.315 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 50' ' ' TYR . 11.9 tmtt? -64.22 -12.08 37.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.427 -0.796 . . . . 0.33 110.568 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -48.33 -45.98 35.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.048 -1.032 . . . . 0.43 110.846 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.552 ' OD2' ' HB3' ' A' ' 45' ' ' ALA . 2.7 p30 -79.53 -19.31 49.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.43 110.334 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.416 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 2.7 m-85 -94.13 128.72 40.7 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.118 -0.989 . . . . 0.47 110.573 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 52' ' ' LEU . 95.4 t -123.15 161.86 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.49 110.148 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.437 ' HA ' HD22 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -76.24 110.43 10.74 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.223 -0.923 . . . . 0.57 110.371 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.0 t80 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.57 110.539 -179.787 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.444 ' CE1' ' HA2' ' A' ' 28' ' ' GLY . 34.1 m-85 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.285 0.564 . . . . 0.69 110.383 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.772 HD23 HD21 ' A' ' 52' ' ' LEU . 1.7 mp -84.14 172.34 12.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.373 -0.829 . . . . 0.65 110.689 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -138.08 130.21 28.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.322 -0.861 . . . . 0.29 110.001 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.529 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 30.2 m95 -108.9 179.94 4.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.165 -0.959 . . . . 0.3 110.374 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.905 HD13 HG13 ' A' ' 13' ' ' ILE . 2.7 tp -156.55 129.7 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.584 -0.697 . . . . 0.46 110.209 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.1 t -79.29 98.35 6.63 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.375 -0.828 . . . . 0.37 110.301 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.9 tt -55.96 -20.32 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.961 . . . . 0.42 110.18 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.1 m -75.73 -27.35 58.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.373 -0.83 . . . . 0.49 110.125 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.2 m -120.45 -50.74 2.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.28 110.743 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.516 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 113.06 19.95 6.56 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.17 109.506 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -100.31 120.11 39.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -1.223 . . . . 0.21 110.05 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.905 HG13 HD13 ' A' ' 6' ' ' ILE . 43.5 mt -81.95 134.88 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.93 . . . . 0.16 110.577 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.422 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 48.2 t80 -92.93 125.78 37.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.458 -0.776 . . . . 0.1 110.067 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -99.35 103.55 15.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.499 -0.751 . . . . 0.11 109.975 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -49.57 -24.94 2.39 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.277 -0.89 . . . . 0.12 110.895 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.69 22.52 7.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.19 110.058 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -176.22 66.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.27 110.041 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.89 -140.06 0.67 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.777 -1.329 . . . . 0.21 109.777 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.42 173.24 6.39 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.357 -1.084 . . . . 0.27 110.599 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.58 -23.38 12.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.365 -0.834 . . . . 0.38 110.159 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.18 -29.42 28.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.39 110.329 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -87.39 14.03 8.81 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.303 -0.873 . . . . 0.39 110.823 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.85 28.39 68.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.406 -1.478 . . . . 0.28 109.406 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.562 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -86.85 79.1 8.91 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.24 -1.153 . . . . 0.31 110.316 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 15.3 t -60.77 154.51 57.46 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.403 -0.811 . . . . 0.4 110.76 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 23.7 Cg_exo -60.7 119.29 6.38 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.751 1.395 . . . . 0.25 110.484 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.444 ' HA2' ' CE1' ' A' ' 2' ' ' TYR . . . 113.2 38.33 1.25 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.474 -1.45 . . . . 0.09 109.474 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.4 m -114.58 130.84 56.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -1.158 . . . . 0.15 110.391 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -108.5 142.15 39.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.24 110.282 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.762 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -48.24 -43.88 32.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.124 -0.985 . . . . 0.28 110.668 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -54.76 -22.7 14.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.941 . . . . 0.31 109.774 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.56 22.07 16.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.343 -0.848 . . . . 0.25 110.161 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.762 HD12 ' HA ' ' A' ' 31' ' ' PHE . 89.7 mt . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.26 110.471 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.562 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 59.5 t90 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.148 0.499 . . . . 0.25 109.966 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 88.6 m -132.47 -169.26 2.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.137 -0.977 . . . . 0.11 110.768 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.468 ' HB3' ' CB ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -82.19 163.06 54.57 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.31 110.375 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -67.66 -33.91 26.63 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.609 1.32 . . . . 0.59 110.222 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -150.25 57.63 0.95 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.57 109.947 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.468 ' CB ' ' HB3' ' A' ' 40' ' ' CYS . 1.8 t -141.58 -56.0 0.47 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.347 -0.845 . . . . 0.39 110.248 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.6 41.13 5.49 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.46 -1.456 . . . . 0.22 109.46 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.27 171.1 8.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.16 -1.2 . . . . 0.12 110.494 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.0 p -92.09 -172.51 3.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.17 110.427 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -15.75 48.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.33 110.261 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -54.41 -38.44 66.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.43 110.223 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.528 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -76.45 -19.3 58.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.43 110.449 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.41 ' CZ ' ' CH2' ' A' ' 38' ' ' TRP . 4.0 m-85 -95.3 129.86 42.27 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.162 -0.961 . . . . 0.47 110.591 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 6' ' ' ILE . 33.2 m -125.6 172.8 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.49 110.246 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.772 HD21 HD23 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -78.84 116.57 19.26 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.299 -0.876 . . . . 0.57 110.252 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.6 t80 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.57 110.633 -179.145 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.413 0.625 . . . . 0.69 110.505 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.411 ' O ' ' CG ' ' A' ' 16' ' ' GLU . 6.9 mp -108.96 159.55 16.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.44 -0.788 . . . . 0.65 110.582 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.442 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 9.5 mttp -113.9 160.45 18.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.237 -0.915 . . . . 0.29 109.832 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.527 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 29.1 m95 -128.2 133.07 48.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.093 -1.004 . . . . 0.3 110.598 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.75 HD13 HG13 ' A' ' 13' ' ' ILE . 3.5 tp -104.02 141.62 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.093 -1.004 . . . . 0.46 111.016 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.454 ' H ' HD12 ' A' ' 6' ' ' ILE . 16.1 t -92.35 102.35 14.84 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.385 -0.822 . . . . 0.37 109.978 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.9 tt -55.79 -20.09 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.952 . . . . 0.42 110.595 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.3 m -67.55 -36.73 81.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.49 110.936 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.3 p -131.33 -34.4 1.41 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.984 -1.073 . . . . 0.28 111.157 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.624 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 107.81 41.65 1.55 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.489 -1.444 . . . . 0.17 109.489 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.458 ' CE1' ' HG2' ' A' ' 41' ' ' PRO . 13.7 t-80 -105.06 126.68 52.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -1.113 . . . . 0.21 110.113 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.75 HG13 HD13 ' A' ' 6' ' ' ILE . 6.0 mt -93.69 133.18 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.16 110.685 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.469 ' HH ' ' HD2' ' A' ' 25' ' ' PHE . 72.5 t80 -97.33 132.23 43.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.571 -0.705 . . . . 0.1 109.538 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.526 ' OD1' ' HB3' ' A' ' 17' ' ' ALA . 10.3 t70 -102.69 103.62 13.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.529 -0.732 . . . . 0.11 110.165 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 3' ' ' LEU . 26.0 mt-10 -52.2 -22.91 4.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.901 . . . . 0.12 110.596 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.526 ' HB3' ' OD1' ' A' ' 15' ' ' ASP . . . -88.25 12.68 13.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.19 110.699 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tp -177.25 68.81 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.172 -0.955 . . . . 0.27 109.655 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.99 -139.54 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.254 -1.139 . . . . 0.21 110.254 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -89.37 164.35 14.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.44 -1.035 . . . . 0.27 110.809 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -107.12 -31.98 8.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.444 -0.785 . . . . 0.38 109.93 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.29 -53.46 19.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.311 -0.868 . . . . 0.39 110.264 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -60.86 -27.78 68.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.39 110.072 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.12 28.41 6.87 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.601 -1.4 . . . . 0.28 109.601 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.541 ' HE2' HD11 ' A' ' 34' ' ' ILE . 0.5 OUTLIER -66.67 83.53 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.066 -1.255 . . . . 0.31 110.128 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 14.0 t -50.79 145.83 10.95 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.456 -0.777 . . . . 0.4 110.74 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 34.7 Cg_exo -55.56 116.84 3.44 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.631 1.332 . . . . 0.25 110.431 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 116.11 24.46 3.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.663 -1.375 . . . . 0.09 109.663 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.8 m -98.13 116.2 29.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -1.198 . . . . 0.15 110.149 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.406 ' HA ' ' HG2' ' A' ' 16' ' ' GLU . 15.2 ttp180 -94.99 142.66 27.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.244 -0.91 . . . . 0.24 110.626 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.733 ' HA ' HD12 ' A' ' 34' ' ' ILE . 1.2 t80 -50.57 -27.19 6.29 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.282 -0.887 . . . . 0.28 110.252 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.08 -33.8 58.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -0.971 . . . . 0.31 109.804 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -89.51 7.58 35.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.521 -0.737 . . . . 0.25 110.45 178.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.733 HD12 ' HA ' ' A' ' 31' ' ' PHE . 33.8 mt . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.09 -1.006 . . . . 0.26 109.67 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.414 ' HB3' HG23 ' A' ' 34' ' ' ILE . 88.2 t90 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.239 0.542 . . . . 0.25 110.04 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.407 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 97.8 m -127.12 -175.1 3.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.11 110.266 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.38 138.73 48.18 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.31 110.283 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.458 ' HG2' ' CE1' ' A' ' 12' ' ' HIS . 36.9 Cg_endo -71.66 -16.3 30.15 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.488 1.257 . . . . 0.59 110.816 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.2 -0.36 15.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.988 . . . . 0.57 111.236 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 64.2 m -138.45 -68.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.953 -1.092 . . . . 0.39 110.404 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 39' ' ' CYS . . . 107.17 32.26 3.55 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.327 -1.509 . . . . 0.22 109.327 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.89 -168.74 1.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -1.106 . . . . 0.12 110.613 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 p -88.04 178.31 6.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.38 -0.825 . . . . 0.17 110.526 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -65.05 -22.28 66.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 0.33 110.172 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -58.04 -18.96 27.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.43 110.406 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.464 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.1 m-20 -83.65 -15.47 48.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.43 110.661 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -99.81 145.24 27.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.046 -1.034 . . . . 0.47 111.199 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.3 m -145.75 164.56 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.538 -0.727 . . . . 0.49 109.905 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 53' ' ' TYR . 2.2 tp -69.77 127.76 34.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 0.57 110.824 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.557 ' HD1' HG21 ' A' ' 6' ' ' ILE . 7.3 t80 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.57 110.202 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 24.7 m-85 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.441 0.638 . . . . 0.69 110.345 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.699 HD23 HD21 ' A' ' 52' ' ' LEU . 4.8 mp -87.46 -178.27 6.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.358 -0.839 . . . . 0.65 110.455 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.41 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 25.0 mttt -142.98 146.6 34.06 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.483 -0.761 . . . . 0.29 110.165 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.562 ' CE3' ' CD2' ' A' ' 31' ' ' PHE . 22.7 m95 -130.09 123.6 30.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.3 110.078 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.826 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -106.63 134.47 48.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.037 -1.04 . . . . 0.46 110.278 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.826 ' N ' HD13 ' A' ' 6' ' ' ILE . 4.3 t -79.89 96.04 6.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.407 -0.808 . . . . 0.37 110.098 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.7 pt -53.23 -22.6 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.132 -0.98 . . . . 0.42 110.146 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.6 m -75.57 -28.16 58.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.295 -0.878 . . . . 0.49 110.203 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.4 m -115.24 -50.93 2.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.28 110.869 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.56 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 113.12 19.02 6.95 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.47 -1.452 . . . . 0.17 109.47 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 1.9 m170 -102.0 131.54 48.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -1.22 . . . . 0.21 110.002 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.418 HG13 HG12 ' A' ' 6' ' ' ILE . 73.0 mt -95.31 136.71 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.16 110.761 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.479 ' HH ' ' HE2' ' A' ' 25' ' ' PHE . 66.1 t80 -99.4 132.53 44.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.1 109.959 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -109.7 111.56 23.1 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.511 -0.743 . . . . 0.11 109.703 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -51.15 -24.06 3.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.12 110.493 -179.233 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 2' ' ' TYR . . . -93.55 17.53 11.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.172 -0.955 . . . . 0.19 110.245 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -177.31 68.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.27 109.71 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.28 -137.1 1.73 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.224 -1.151 . . . . 0.21 110.224 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 22' ' ' ALA . 11.3 t70 -78.97 158.42 27.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.432 -1.04 . . . . 0.27 110.776 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -104.13 -33.29 8.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.38 110.094 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . -80.01 -45.62 18.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.39 110.205 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.12 -35.22 71.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -0.928 . . . . 0.39 109.976 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.2 20.37 7.53 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.568 -1.413 . . . . 0.28 109.568 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.571 ' CE1' ' CD1' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -67.79 77.97 0.2 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.111 -1.229 . . . . 0.31 110.224 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.0 t -52.66 151.65 7.73 Favored Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.444 -0.785 . . . . 0.4 110.702 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -58.89 116.77 3.49 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.703 1.37 . . . . 0.25 110.394 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.62 -23.95 5.59 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.346 -1.502 . . . . 0.09 109.346 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.539 HG22 HD11 ' A' ' 34' ' ' ILE . 6.7 m -53.26 132.29 38.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -1.152 . . . . 0.15 110.235 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.453 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 16.1 mtp180 -115.51 146.29 41.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.853 . . . . 0.24 110.394 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.562 ' CD2' ' CE3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -50.93 -33.65 25.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.28 110.273 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -53.21 -50.98 63.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.871 . . . . 0.31 110.02 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -70.06 -7.84 44.49 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.416 -0.803 . . . . 0.25 110.471 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.543 HG23 ' HB3' ' A' ' 38' ' ' TRP . 30.1 mt . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.156 -0.965 . . . . 0.26 110.154 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.571 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 54.9 t90 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.286 0.565 . . . . 0.25 110.126 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -162.16 176.81 10.27 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.373 -0.83 . . . . 0.11 110.361 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -51.55 149.77 7.6 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.85 . . . . 0.31 109.988 178.648 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.52 -27.85 70.19 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.527 1.278 . . . . 0.59 110.74 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.2 57.36 0.89 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.935 . . . . 0.57 110.217 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.469 ' CB ' ' HB3' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -152.46 -45.53 0.1 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.259 -0.901 . . . . 0.39 110.045 -179.157 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.53 42.65 95.57 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.54 -1.424 . . . . 0.22 109.54 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.41 32.74 5.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -1.198 . . . . 0.12 110.823 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.1 p 44.02 -153.65 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.578 0.704 . . . . 0.17 111.101 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -81.56 -13.08 58.49 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.515 -0.741 . . . . 0.33 110.447 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.08 -48.84 43.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.085 -1.009 . . . . 0.43 110.794 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 9.8 m-20 -76.64 -16.63 59.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.43 110.43 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.41 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 1.8 m-85 -93.56 135.92 34.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.042 -1.036 . . . . 0.47 110.51 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 71.4 t -131.59 150.12 33.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.282 -0.886 . . . . 0.49 110.232 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.699 HD21 HD23 ' A' ' 3' ' ' LEU . 0.5 OUTLIER -63.63 125.12 23.24 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.352 -0.842 . . . . 0.57 110.43 -179.546 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.644 ' N ' HD13 ' A' ' 52' ' ' LEU . 17.1 t80 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 0.57 110.38 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.518 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 55.9 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.356 0.598 . . . . 0.69 110.487 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 3' ' ' LEU . 8.7 mp -90.53 171.31 9.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.65 110.397 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.438 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 19.6 mttp -136.12 158.37 44.58 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.29 109.959 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.531 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 31.2 m95 -127.8 136.44 51.47 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -0.944 . . . . 0.3 110.579 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.729 HD13 HG13 ' A' ' 13' ' ' ILE . 3.4 tp -106.13 137.87 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.964 -1.085 . . . . 0.46 110.568 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 11' ' ' GLY . 7.6 t -83.41 96.13 8.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.547 -0.721 . . . . 0.37 110.25 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 49' ' ' ASP . 2.4 tt -56.11 -19.95 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.981 -1.074 . . . . 0.42 110.027 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.9 m -77.64 -27.15 50.97 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.325 -0.86 . . . . 0.49 110.105 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 64.4 m -123.64 -54.99 1.74 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.338 -0.851 . . . . 0.28 110.632 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.526 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 119.83 27.07 2.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.84 -1.304 . . . . 0.17 109.84 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.664 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -109.36 144.06 38.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -1.185 . . . . 0.21 110.278 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.729 HG13 HD13 ' A' ' 6' ' ' ILE . 7.2 mt -98.41 145.53 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.847 . . . . 0.16 110.968 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 58.1 t80 -105.7 133.58 50.21 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.369 -0.604 . . . . 0.1 109.369 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -101.6 106.76 17.87 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.552 -0.718 . . . . 0.11 110.198 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 30' ' ' ARG . 24.3 mt-10 -50.28 -25.98 4.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.308 -0.87 . . . . 0.12 110.722 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.518 ' HB2' ' CD2' ' A' ' 2' ' ' TYR . . . -100.07 19.97 15.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.19 110.352 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.489 ' HA ' HD22 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -177.55 70.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.27 110.338 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' A' ' 25' ' ' PHE . . . -64.24 -135.69 0.01 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.572 -1.411 . . . . 0.21 109.572 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -99.39 172.08 7.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -1.169 . . . . 0.27 110.702 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.37 -24.18 20.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.38 110.003 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.25 -36.95 17.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.307 -0.87 . . . . 0.39 110.106 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -66.91 -21.65 65.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.39 110.074 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.16 31.06 53.8 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.258 -1.537 . . . . 0.28 109.258 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.654 ' CE1' HG21 ' A' ' 29' ' ' THR . 0.1 OUTLIER -71.72 82.43 0.87 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.15 -1.206 . . . . 0.31 110.141 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.3 t -49.29 142.27 10.87 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.4 110.767 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 39.0 Cg_exo -52.83 108.5 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.555 1.292 . . . . 0.25 110.69 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.01 44.04 0.26 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.602 -1.399 . . . . 0.09 109.602 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.654 HG21 ' CE1' ' A' ' 25' ' ' PHE . 1.5 m -122.63 136.26 54.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -1.165 . . . . 0.15 110.555 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.401 ' HA ' ' HG2' ' A' ' 16' ' ' GLU . 8.9 mtp180 -122.87 144.34 49.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.351 -0.843 . . . . 0.24 110.224 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.593 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -48.18 -49.13 33.77 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.224 -0.922 . . . . 0.28 110.494 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -53.37 -26.8 20.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.31 109.64 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.21 16.73 20.46 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.491 -0.755 . . . . 0.25 110.133 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.644 ' O ' HG22 ' A' ' 34' ' ' ILE . 92.2 mt . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.26 110.327 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.424 ' NE1' ' CE2' ' A' ' 25' ' ' PHE . 63.7 t90 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.371 0.605 . . . . 0.25 110.28 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 83.4 m -148.65 -167.31 2.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.325 -0.859 . . . . 0.11 110.133 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.24 169.98 18.1 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.232 -0.918 . . . . 0.31 109.981 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -57.94 -47.7 19.53 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.563 1.296 . . . . 0.59 110.206 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -178.82 57.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.45 -0.781 . . . . 0.57 109.981 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 21.1 p -162.14 -36.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.152 -0.968 . . . . 0.39 111.113 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -95.67 -41.53 3.85 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.574 -1.411 . . . . 0.22 109.574 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 56.82 163.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -1.047 . . . . 0.12 110.945 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 44.61 -161.23 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.468 -0.77 . . . . 0.17 111.053 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -122.31 -21.53 5.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.338 -0.851 . . . . 0.33 110.72 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.49 -28.96 48.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.977 . . . . 0.43 110.448 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.749 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.5 m-20 -74.07 -17.69 60.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.43 110.34 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -97.15 136.41 37.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.095 -1.003 . . . . 0.47 110.725 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.27 162.83 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.49 109.914 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.88 118.84 19.87 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.121 -0.987 . . . . 0.57 110.5 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.1 t80 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.57 110.518 -179.741 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.413 0.625 . . . . 0.69 110.466 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.049 HD23 HD21 ' A' ' 52' ' ' LEU . 0.7 OUTLIER -90.67 167.21 12.7 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.248 -0.907 . . . . 0.65 110.272 179.869 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -127.4 125.57 40.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.29 110.474 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.526 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 23.2 m95 -106.62 179.22 4.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.3 110.032 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.731 HD11 ' HA2' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -157.69 126.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 119.844 -0.742 . . . . 0.46 110.193 178.025 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.664 ' N ' HD13 ' A' ' 6' ' ' ILE . 12.5 t -73.47 91.1 1.76 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.353 -0.842 . . . . 0.37 109.488 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.5 pt -51.92 -22.95 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.195 -0.941 . . . . 0.42 110.334 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 94.4 m -59.03 -27.86 65.87 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.379 -0.825 . . . . 0.49 110.714 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -137.11 -36.7 0.66 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.145 -0.972 . . . . 0.28 111.243 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.731 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 117.16 19.78 5.03 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.516 -1.326 . . . . 0.17 110.077 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.37 115.1 26.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.047 -1.266 . . . . 0.21 110.232 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.2 mt -84.2 128.62 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.925 . . . . 0.16 110.539 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 63.2 t80 -91.74 120.82 32.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.1 109.814 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -99.18 103.98 15.91 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.217 -0.927 . . . . 0.11 109.879 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -47.58 -26.57 1.5 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.12 111.075 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.33 19.01 8.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.176 -0.953 . . . . 0.19 110.579 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -176.1 68.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.27 110.165 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.16 -143.42 0.79 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.737 -1.345 . . . . 0.21 109.737 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.56 165.25 12.43 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.34 -1.094 . . . . 0.27 110.297 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.04 -41.79 6.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.237 -0.914 . . . . 0.38 110.346 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.72 -50.2 70.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.39 110.26 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.09 -21.07 44.39 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.176 -0.953 . . . . 0.39 110.397 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.38 23.25 17.1 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.221 -1.551 . . . . 0.28 109.221 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -83.83 78.91 9.64 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.242 -1.151 . . . . 0.31 110.05 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.4 t -49.24 151.67 2.42 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.357 -0.84 . . . . 0.4 110.985 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 23.6 Cg_exo -60.68 80.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.713 1.375 . . . . 0.25 110.387 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 26' ' ' THR . . . 153.82 42.11 0.02 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.148 -1.581 . . . . 0.09 109.148 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.6 m -112.56 134.44 54.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.35 -1.088 . . . . 0.15 110.341 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -111.43 145.96 38.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.829 . . . . 0.24 110.163 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.685 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -52.39 -41.21 62.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.919 . . . . 0.28 110.251 179.641 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -53.64 -43.63 68.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.873 . . . . 0.31 110.204 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -79.17 2.03 22.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.25 110.772 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 31' ' ' PHE . 88.7 mt . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.0 -1.063 . . . . 0.26 110.075 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.573 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 87.9 t90 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.299 0.571 . . . . 0.25 110.479 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.408 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 67.4 m -133.88 -174.51 3.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.11 110.191 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -83.55 156.13 65.47 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.077 -1.015 . . . . 0.31 110.286 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.67 -5.14 14.6 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.487 1.256 . . . . 0.59 111.201 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 50.1 p30 -146.09 20.6 1.41 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.875 -1.14 . . . . 0.57 110.968 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 76.8 m -143.0 -49.03 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.165 -0.959 . . . . 0.39 110.424 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 39' ' ' CYS . . . 77.01 33.23 46.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.409 -1.476 . . . . 0.22 109.409 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.549 ' HB1' ' OD1' ' A' ' 49' ' ' ASP . . . -102.57 -172.05 2.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -1.169 . . . . 0.12 110.49 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.97 -171.91 2.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.855 . . . . 0.17 110.332 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.454 ' HD3' ' CD2' ' A' ' 31' ' ' PHE . 20.3 mttt -60.56 -18.8 54.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.35 -0.844 . . . . 0.33 110.227 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.24 -41.07 65.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.43 110.361 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.549 ' OD1' ' HB1' ' A' ' 45' ' ' ALA . 2.1 m-20 -69.29 -24.23 63.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.43 109.826 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -92.96 137.88 31.97 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.443 -0.786 . . . . 0.47 110.512 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.427 HG22 ' N ' ' A' ' 52' ' ' LEU . 8.6 p -129.69 163.68 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 0.49 110.032 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.049 HD21 HD23 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -69.84 108.75 4.1 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.114 -0.991 . . . . 0.57 110.084 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.57 110.749 -178.926 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.513 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 23.0 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.324 0.583 . . . . 0.69 110.358 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.45 HD23 HD21 ' A' ' 52' ' ' LEU . 2.6 mp -81.73 165.93 20.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.65 110.759 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.44 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 23.6 mttm -134.38 151.39 51.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.29 110.12 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 20.1 m95 -133.03 127.15 33.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.3 -0.875 . . . . 0.3 109.927 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.845 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -102.64 134.43 43.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.112 -0.992 . . . . 0.46 110.898 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.845 ' N ' HD13 ' A' ' 6' ' ' ILE . 16.3 t -79.9 95.71 6.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.579 -0.7 . . . . 0.37 109.588 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.534 HG22 ' O ' ' A' ' 49' ' ' ASP . 2.1 tt -55.26 -20.12 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.42 110.628 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.1 m -63.46 -27.98 69.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.28 -0.888 . . . . 0.49 110.885 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.5 p -134.09 -35.89 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.967 -1.083 . . . . 0.28 111.397 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.568 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 112.21 35.96 1.71 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.533 -1.318 . . . . 0.17 109.854 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 4.2 t-80 -112.14 129.26 56.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.128 -1.219 . . . . 0.21 110.397 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.424 HG13 HG12 ' A' ' 6' ' ' ILE . 13.5 mt -91.58 146.66 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.16 111.096 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -108.68 129.14 55.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.565 -0.709 . . . . 0.1 109.809 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -105.32 106.75 17.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.549 -0.719 . . . . 0.11 110.234 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 2' ' ' TYR . 19.1 mt-10 -49.88 -24.54 2.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.12 110.664 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.513 ' HB2' ' CD2' ' A' ' 2' ' ' TYR . . . -88.0 14.25 9.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.19 110.71 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 tp -176.08 67.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.025 -1.047 . . . . 0.27 109.955 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.43 -143.03 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.897 -1.281 . . . . 0.21 109.897 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.88 165.38 11.59 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.37 -1.076 . . . . 0.27 110.525 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -107.19 -20.02 13.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.38 110.545 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.59 -36.0 38.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.151 -0.968 . . . . 0.39 110.392 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -81.42 -13.31 58.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.39 110.729 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.81 27.7 16.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.073 -1.611 . . . . 0.28 109.073 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -82.97 82.77 8.07 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.371 -1.076 . . . . 0.31 110.229 -179.654 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.3 t -49.69 142.34 12.36 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.173 -0.954 . . . . 0.4 110.77 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 36.8 Cg_exo -53.05 109.66 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.559 1.294 . . . . 0.25 110.612 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.92 -14.03 5.23 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.142 -1.183 . . . . 0.09 110.142 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.509 HG22 HD11 ' A' ' 34' ' ' ILE . 1.3 m -51.53 129.68 26.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.95 -1.324 . . . . 0.15 110.804 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -108.83 134.19 51.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.357 -0.84 . . . . 0.24 110.003 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.684 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -47.06 -51.88 16.48 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.242 -0.911 . . . . 0.28 110.947 -179.372 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -51.5 -37.15 47.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 0.31 109.96 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -85.5 8.8 17.82 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.438 -0.789 . . . . 0.25 110.274 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.684 HD12 ' HA ' ' A' ' 31' ' ' PHE . 78.5 mt . . . . . 0 N--CA 1.491 1.593 0 O-C-N 120.98 -1.075 . . . . 0.26 110.226 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 83.2 t90 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.152 0.501 . . . . 0.25 110.251 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 91.6 m -130.96 -167.08 1.78 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.11 110.546 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -87.09 143.29 34.63 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.31 110.375 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -78.28 -17.07 13.42 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.567 1.298 . . . . 0.59 111.009 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -28.55 9.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.05 -1.031 . . . . 0.57 110.866 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 94.1 m -101.22 -71.99 0.69 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 0.39 110.606 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.82 29.38 1.86 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.581 -1.408 . . . . 0.22 109.581 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.51 -173.84 2.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.103 -1.234 . . . . 0.12 110.337 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.1 p -97.12 -170.88 2.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.17 110.393 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.501 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 5.8 tttt -61.44 -16.66 48.99 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.364 -0.835 . . . . 0.33 110.388 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -58.29 -28.38 64.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -0.97 . . . . 0.43 110.634 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.534 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.5 m-20 -86.23 -16.98 35.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.43 110.51 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 7' ' ' CYS . 1.9 m-85 -94.34 138.28 32.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -0.932 . . . . 0.47 110.86 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 52' ' ' LEU . 87.3 t -132.75 163.05 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.775 . . . . 0.49 110.047 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.453 ' HA ' HD22 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -74.28 117.19 15.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.172 -0.955 . . . . 0.57 110.334 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.422 ' N ' HD13 ' A' ' 52' ' ' LEU . 29.7 t80 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.57 110.531 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.513 ' CD1' ' HB3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.898 0.856 . . . . 0.69 111.283 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.84 169.39 6.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -0.865 . . . . 0.65 110.517 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.71 128.13 15.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.39 -0.819 . . . . 0.29 109.947 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.525 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 27.5 m95 -107.42 174.25 5.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.3 110.019 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.922 HD13 HG13 ' A' ' 13' ' ' ILE . 2.4 tp -149.18 123.31 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.46 110.438 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 9.1 t -69.33 95.12 0.76 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.376 -0.828 . . . . 0.37 109.933 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 9' ' ' THR . 11.0 pt -52.28 -22.76 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.16 -0.963 . . . . 0.42 110.174 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.42 ' N ' HG13 ' A' ' 8' ' ' ILE . 34.2 m -61.37 -43.99 97.93 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.445 -0.784 . . . . 0.49 110.915 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.9 p -123.59 -32.09 3.39 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.983 . . . . 0.28 110.945 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.677 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 108.27 30.66 3.79 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.811 -1.316 . . . . 0.17 109.811 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -95.17 112.97 24.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.244 -1.151 . . . . 0.21 110.015 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.922 HG13 HD13 ' A' ' 6' ' ' ILE . 63.2 mt -80.72 128.73 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.16 110.533 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.416 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 63.1 t80 -92.6 132.25 37.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.519 -0.738 . . . . 0.1 110.052 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -101.69 104.57 15.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.541 -0.724 . . . . 0.11 110.102 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.513 ' HB3' ' CD1' ' A' ' 2' ' ' TYR . 10.2 mt-10 -53.4 -27.12 22.54 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.159 -0.963 . . . . 0.12 110.651 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.464 ' HB2' ' HB2' ' A' ' 2' ' ' TYR . . . -92.01 18.73 7.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.143 -0.973 . . . . 0.19 110.452 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -176.39 66.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.883 . . . . 0.27 109.843 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.83 -142.64 0.06 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.952 -1.259 . . . . 0.21 109.952 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.42 173.76 7.36 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.409 -1.054 . . . . 0.27 110.727 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -109.62 -33.43 6.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.324 -0.86 . . . . 0.38 110.167 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.52 -60.44 3.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.39 110.363 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -61.3 -17.88 55.82 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.39 110.57 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.15 33.34 7.76 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.279 -1.529 . . . . 0.28 109.279 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -81.06 76.44 8.01 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.394 -1.062 . . . . 0.31 110.174 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -50.97 151.22 4.67 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.341 -0.849 . . . . 0.4 110.912 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.03 123.88 14.68 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.631 1.332 . . . . 0.25 110.466 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.7 23.87 4.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.538 -1.425 . . . . 0.09 109.538 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.9 m -94.63 135.83 35.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -1.232 . . . . 0.15 110.325 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.66 138.4 47.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.349 -0.844 . . . . 0.24 110.428 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.878 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -50.12 -30.97 12.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.219 -0.925 . . . . 0.28 110.628 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -61.28 -55.04 36.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.153 -0.967 . . . . 0.31 110.204 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -28.76 69.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.25 110.243 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.878 HD12 ' HA ' ' A' ' 31' ' ' PHE . 82.4 mt . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.26 110.288 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.533 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 88.2 t90 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.296 0.569 . . . . 0.25 110.532 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.44 ' N ' ' CG ' ' A' ' 38' ' ' TRP . 25.4 p -167.2 -160.65 0.38 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.333 -0.854 . . . . 0.11 110.283 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.7 OUTLIER -87.53 144.13 35.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.397 -0.814 . . . . 0.31 110.307 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.16 9.72 3.97 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.667 1.351 . . . . 0.59 111.281 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 37.4 p-10 -152.02 17.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.84 -1.163 . . . . 0.57 110.934 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 58.0 m -144.92 -72.3 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.068 . . . . 0.39 110.284 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.22 36.76 0.73 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.485 -1.446 . . . . 0.22 109.485 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.451 ' HB1' ' OE2' ' A' ' 48' ' ' GLU . . . -121.35 176.0 5.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -1.156 . . . . 0.12 110.592 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -100.8 -162.68 0.96 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.341 -0.85 . . . . 0.17 109.964 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -55.15 -21.79 14.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.125 -0.984 . . . . 0.33 109.722 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.451 ' OE2' ' HB1' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -53.56 -27.59 27.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.43 109.91 179.293 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 4.4 m-20 -91.85 -21.69 20.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.431 -0.793 . . . . 0.43 109.908 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -97.27 137.63 35.98 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.263 -0.898 . . . . 0.47 110.655 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.464 ' CG1' HG23 ' A' ' 6' ' ' ILE . 7.2 p -127.23 148.1 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.49 110.0 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.67 115.52 4.83 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.141 -0.974 . . . . 0.57 110.348 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.7 t80 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.37 -0.831 . . . . 0.57 110.397 -179.379 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.394 0.616 . . . . 0.69 110.39 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.62 170.66 7.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.65 110.524 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -127.32 124.01 37.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.29 110.372 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 35.5 m95 -100.94 172.43 7.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.197 -0.939 . . . . 0.3 110.025 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.833 HD13 HG13 ' A' ' 13' ' ' ILE . 2.2 tp -147.37 126.47 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.46 110.254 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 10.1 t -73.18 89.13 1.5 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.296 -0.877 . . . . 0.37 109.973 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.9 pt -49.77 -25.83 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.066 -1.021 . . . . 0.42 109.982 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -75.61 -28.71 58.96 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.606 -0.684 . . . . 0.49 110.147 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 1.5 m -112.57 -54.45 2.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.28 110.497 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . 115.11 19.65 5.86 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.585 -1.406 . . . . 0.17 109.585 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.55 ' O ' HD12 ' A' ' 6' ' ' ILE . 13.8 m80 -103.93 136.07 44.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -1.207 . . . . 0.21 110.134 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.833 HG13 HD13 ' A' ' 6' ' ' ILE . 3.3 mt -93.93 130.05 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.321 -0.862 . . . . 0.16 110.477 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.526 ' CE1' ' HA2' ' A' ' 19' ' ' GLY . 81.0 t80 -97.68 133.14 42.61 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.1 109.616 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -111.63 111.15 21.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.11 110.239 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 66.2 mt-10 -50.56 -23.35 2.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.383 -0.823 . . . . 0.12 110.989 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.65 8.05 15.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.976 -1.077 . . . . 0.19 110.968 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.486 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -176.6 68.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.022 -1.049 . . . . 0.27 109.625 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.526 ' HA2' ' CE1' ' A' ' 14' ' ' TYR . . . -66.57 -138.39 0.04 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.011 -1.235 . . . . 0.21 110.011 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -100.35 172.48 7.12 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.408 -1.054 . . . . 0.27 110.812 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.88 -31.68 9.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.384 -0.823 . . . . 0.38 110.318 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.93 -50.37 35.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 0.39 110.187 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -60.3 -18.35 48.83 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.304 -0.872 . . . . 0.39 110.574 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.14 23.03 23.52 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.389 -1.484 . . . . 0.28 109.389 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.584 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 1.8 m-30 -83.07 78.14 9.63 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.269 -1.136 . . . . 0.31 110.411 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.401 ' OG1' ' HD2' ' A' ' 27' ' ' PRO . 14.6 t -58.35 155.8 25.27 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.443 -0.785 . . . . 0.4 110.678 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD2' ' OG1' ' A' ' 26' ' ' THR . 33.4 Cg_exo -53.75 113.35 1.28 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.619 1.326 . . . . 0.25 110.463 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.7 34.61 1.05 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.276 -1.53 . . . . 0.09 109.276 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.469 HG22 ' CG1' ' A' ' 34' ' ' ILE . 30.4 m -117.2 121.55 41.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -1.163 . . . . 0.15 110.351 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.453 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 0.5 OUTLIER -108.61 150.86 26.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.279 -0.888 . . . . 0.24 110.353 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.852 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -47.58 -42.79 24.61 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.285 -0.885 . . . . 0.28 111.015 -179.491 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -60.34 -42.73 96.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.31 110.808 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -78.28 -24.89 46.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.212 -0.93 . . . . 0.25 110.463 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.852 HD12 ' HA ' ' A' ' 31' ' ' PHE . 65.2 mt . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.26 110.231 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.584 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 74.3 t90 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.323 0.582 . . . . 0.25 110.482 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.5 p -167.28 -161.7 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.887 . . . . 0.11 110.335 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 1.4 t -89.99 140.98 27.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.31 110.285 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 7.0 Cg_exo -70.91 -7.2 20.87 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.482 1.254 . . . . 0.59 111.378 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -127.73 -9.11 5.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.911 -1.118 . . . . 0.57 111.499 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 84.3 m -121.76 -75.62 0.59 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.897 -1.127 . . . . 0.39 110.536 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.19 33.46 0.96 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.536 -1.426 . . . . 0.22 109.536 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.22 177.02 4.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -1.205 . . . . 0.12 110.447 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -72.28 -162.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.17 110.365 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -75.19 -4.58 39.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.33 110.734 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.05 -41.25 62.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.993 -1.067 . . . . 0.43 110.453 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 1.6 m-20 -71.35 -25.66 62.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.43 110.008 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -89.06 132.29 34.84 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.296 -0.877 . . . . 0.47 110.487 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 87.1 t -130.28 159.66 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.49 110.129 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.7 tp -64.45 117.41 7.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.154 -0.966 . . . . 0.57 110.529 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.414 ' CB ' ' O ' ' A' ' 4' ' ' LYS . 28.0 t80 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.57 110.35 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.503 ' CE1' ' NH2' ' A' ' 30' ' ' ARG . 40.6 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.351 0.596 . . . . 0.69 110.334 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.507 HD23 HD21 ' A' ' 52' ' ' LEU . 6.7 mp -81.32 167.68 19.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.389 -0.819 . . . . 0.65 110.465 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.41 ' HG3' ' HA ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER -138.51 124.86 20.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.29 110.08 179.479 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.501 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 34.4 m95 -100.89 142.14 32.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.3 110.266 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.789 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -107.52 129.04 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.958 -1.089 . . . . 0.46 109.806 178.127 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.789 ' N ' HD13 ' A' ' 6' ' ' ILE . 9.6 t -77.19 87.08 3.64 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.374 -0.829 . . . . 0.37 109.172 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 49' ' ' ASP . 2.0 tt -50.47 -22.63 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.15 -0.969 . . . . 0.42 110.531 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 m -66.51 -30.23 70.5 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.284 -0.885 . . . . 0.49 110.685 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 p -140.15 -15.86 0.98 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.907 -1.121 . . . . 0.28 112.662 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.656 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 104.8 -28.3 15.39 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.29 -1.434 . . . . 0.17 110.049 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -51.86 135.35 30.18 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.06 -1.259 . . . . 0.21 110.415 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.44 ' CG1' HG12 ' A' ' 6' ' ' ILE . 6.7 mt -109.81 142.48 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.82 . . . . 0.16 110.768 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -98.22 123.14 42.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.596 -0.69 . . . . 0.1 109.433 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.41 ' HA ' ' HG3' ' A' ' 4' ' ' LYS . 5.1 m-20 -103.26 108.51 19.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.11 110.137 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -48.23 -25.64 1.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.12 110.764 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.431 ' HB2' ' CD2' ' A' ' 2' ' ' TYR . . . -92.32 21.07 5.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.19 110.234 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 tp -176.24 60.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.27 109.988 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.51 -139.55 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.852 -1.299 . . . . 0.21 109.852 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.69 172.15 7.01 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.392 -1.064 . . . . 0.27 110.561 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.47 -45.07 4.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.353 -0.842 . . . . 0.38 110.356 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.51 -54.64 41.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.39 110.354 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -60.57 -16.94 42.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.39 110.595 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.33 29.99 23.39 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.935 -1.666 . . . . 0.28 108.935 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.415 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -80.94 78.42 7.75 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.441 -1.035 . . . . 0.31 110.291 -179.56 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.4 t -52.06 149.17 9.81 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.327 -0.858 . . . . 0.4 110.592 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.86 116.7 3.44 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.675 1.355 . . . . 0.25 110.514 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.483 ' HA2' ' CE1' ' A' ' 2' ' ' TYR . . . 131.97 -23.34 4.17 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.468 -1.453 . . . . 0.09 109.468 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.56 HG22 HD11 ' A' ' 34' ' ' ILE . 97.3 m -55.95 129.77 41.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -1.092 . . . . 0.15 110.458 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.503 ' NH2' ' CE1' ' A' ' 2' ' ' TYR . 47.5 mtt85 -107.94 148.51 29.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.24 110.244 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.83 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -49.84 -39.38 38.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 0.28 110.627 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.5 -44.9 62.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.31 110.435 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -82.29 5.13 21.08 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.309 -0.869 . . . . 0.25 110.384 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.83 HD12 ' HA ' ' A' ' 31' ' ' PHE . 96.1 mt . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.002 -1.061 . . . . 0.26 110.231 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.444 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 86.2 t90 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.223 0.535 . . . . 0.25 110.173 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.421 ' O ' ' CE2' ' A' ' 38' ' ' TRP . 25.9 p -159.07 -160.4 0.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.11 110.607 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 2.4 t -95.66 140.98 22.57 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.497 -0.752 . . . . 0.31 110.376 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.36 -2.06 12.16 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.538 1.283 . . . . 0.59 111.336 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -132.0 13.9 4.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.891 -1.131 . . . . 0.57 111.075 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 64.6 m -147.61 -71.65 0.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.011 -1.055 . . . . 0.39 110.377 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.63 33.5 1.0 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.744 -1.342 . . . . 0.22 109.744 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.55 -170.71 1.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -1.201 . . . . 0.12 110.466 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.7 p -107.27 -162.59 0.85 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.344 -0.848 . . . . 0.17 110.059 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -57.99 -19.48 31.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.155 -0.966 . . . . 0.33 109.847 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -51.92 -40.37 60.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.43 110.299 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.655 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.6 m-20 -78.02 -23.19 48.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.315 -0.866 . . . . 0.43 109.974 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -94.84 138.04 33.14 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.321 -0.862 . . . . 0.47 110.406 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.3 t -122.78 160.89 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.299 -0.876 . . . . 0.49 110.167 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.507 HD21 HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -72.04 101.58 2.76 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.262 -0.899 . . . . 0.57 110.129 179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.428 ' CD1' ' HB ' ' A' ' 6' ' ' ILE . 2.7 t80 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.805 . . . . 0.57 110.35 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.356 0.598 . . . . 0.69 110.462 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mp -91.85 170.99 9.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.65 110.054 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.57 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -130.98 133.61 45.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.106 -0.996 . . . . 0.29 110.919 -179.423 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.515 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 24.7 m95 -118.54 178.8 4.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.327 -0.858 . . . . 0.3 109.445 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.716 HD11 ' HA2' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -163.32 124.58 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.297 -0.877 . . . . 0.46 110.488 178.207 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.629 ' N ' HD13 ' A' ' 6' ' ' ILE . 15.5 t -69.17 93.43 0.61 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.459 -0.775 . . . . 0.37 109.591 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 49' ' ' ASP . 2.6 tt -54.44 -19.67 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 0.42 110.576 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.405 ' OG1' ' HB2' ' A' ' 49' ' ' ASP . 76.3 m -65.14 -27.89 69.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.205 -0.935 . . . . 0.49 110.95 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.1 p -134.35 -35.35 0.92 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.053 -1.029 . . . . 0.28 111.375 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.716 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 112.95 36.43 1.52 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.445 -1.359 . . . . 0.17 109.794 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.439 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -106.46 108.96 20.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.104 -1.233 . . . . 0.21 110.269 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.497 ' CD1' ' CE1' ' A' ' 53' ' ' TYR . 89.9 mt -81.29 131.58 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.366 -0.834 . . . . 0.16 110.762 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.48 ' HH ' ' HD2' ' A' ' 25' ' ' PHE . 81.2 t80 -97.88 128.25 44.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.338 -0.851 . . . . 0.1 109.555 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -109.75 110.92 22.08 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.353 -0.842 . . . . 0.11 109.673 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.451 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -49.37 -24.33 1.88 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 0.12 110.824 -178.812 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.5 9.94 14.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.183 -0.948 . . . . 0.19 110.683 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.87 67.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.029 -1.045 . . . . 0.27 109.806 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.08 -140.56 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.008 -1.237 . . . . 0.21 110.008 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.05 164.38 23.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.416 -1.049 . . . . 0.27 110.728 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -114.4 -25.73 8.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.38 110.158 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.38 -46.88 25.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.39 110.185 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -69.56 -34.64 74.48 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.269 -0.894 . . . . 0.39 110.358 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.73 32.62 2.63 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.766 -1.334 . . . . 0.28 109.766 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.563 ' HE2' HD11 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -72.33 82.48 1.04 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.053 -1.263 . . . . 0.31 109.782 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.2 t -48.26 142.64 7.76 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.4 111.083 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 27.8 Cg_exo -58.28 111.4 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.681 1.358 . . . . 0.25 110.484 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.24 -25.22 3.03 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.422 -1.471 . . . . 0.09 109.422 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.6 m -56.68 130.73 46.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -1.108 . . . . 0.15 110.349 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.451 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 1.0 OUTLIER -107.13 142.04 37.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.24 110.349 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.574 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -53.08 -36.46 60.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.28 110.168 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -54.74 -26.0 31.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.31 109.797 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -96.17 -21.11 18.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.374 -0.829 . . . . 0.25 110.058 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 31' ' ' PHE . 20.3 mt . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.26 109.7 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.441 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 85.1 t90 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.282 0.563 . . . . 0.25 110.3 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 92.1 m -148.05 -174.53 4.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -0.871 . . . . 0.11 110.399 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.21 140.62 53.1 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.31 110.335 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -72.16 -19.74 25.73 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.52 1.274 . . . . 0.59 110.822 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.31 -22.63 15.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.57 110.507 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 75.1 m -116.46 -61.46 1.72 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.39 110.381 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.45 36.1 3.65 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.37 -1.492 . . . . 0.22 109.37 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.41 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . . . -114.05 159.29 20.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -1.109 . . . . 0.12 110.474 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.8 p -65.35 -160.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.17 110.34 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 50' ' ' TYR . 32.6 ttpt -67.96 -9.62 46.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.33 110.775 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -50.76 -40.68 55.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.025 -1.047 . . . . 0.43 110.752 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.526 ' O ' HG22 ' A' ' 8' ' ' ILE . 49.0 p-10 -86.76 -15.76 38.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.43 110.809 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.419 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 2.2 m-85 -91.95 140.72 29.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.47 110.916 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 6' ' ' ILE . 34.7 m -140.36 164.93 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.41 -0.806 . . . . 0.49 110.203 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.57 HD12 ' O ' ' A' ' 4' ' ' LYS . 0.9 OUTLIER -64.67 122.22 16.33 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.245 -0.909 . . . . 0.57 110.649 -179.646 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.548 ' N ' HD12 ' A' ' 52' ' ' LEU . 77.5 t80 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.57 110.395 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.445 ' CE1' ' HA2' ' A' ' 28' ' ' GLY . 18.1 m-85 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.406 0.622 . . . . 0.69 110.365 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mp -81.9 165.31 20.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -0.852 . . . . 0.65 110.527 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -135.61 129.74 33.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 0.29 109.885 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.536 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 28.9 m95 -107.24 173.81 6.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.3 110.22 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.745 HD13 HG13 ' A' ' 13' ' ' ILE . 1.7 tp -138.99 127.17 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.447 -0.783 . . . . 0.46 109.969 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 11.5 t -76.93 87.56 3.48 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.367 -0.833 . . . . 0.37 109.807 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.483 HG21 HG21 ' A' ' 51' ' ' VAL . 38.1 pt -49.14 -25.36 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.147 -0.971 . . . . 0.42 110.087 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 m -69.27 -28.7 66.54 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.537 -0.727 . . . . 0.49 110.131 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 83.6 m -123.36 -50.31 1.89 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.28 110.803 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.475 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 120.75 -5.99 11.41 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.253 -1.139 . . . . 0.17 110.253 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -76.12 137.82 40.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.851 -1.382 . . . . 0.21 110.391 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.745 HG13 HD13 ' A' ' 6' ' ' ILE . 3.7 mt -95.07 127.4 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.16 110.239 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.426 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 82.4 t80 -79.9 121.61 25.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.407 -0.808 . . . . 0.1 109.91 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -99.03 104.93 17.0 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.351 -0.843 . . . . 0.11 109.989 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 2' ' ' TYR . 20.4 mt-10 -49.2 -24.28 1.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.466 -0.771 . . . . 0.12 110.771 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.12 17.97 6.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.126 -0.984 . . . . 0.19 110.474 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.78 53.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.27 109.797 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.65 -136.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.052 -1.219 . . . . 0.21 110.052 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 11.2 t0 -89.33 165.68 14.23 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.365 -1.08 . . . . 0.27 110.412 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.67 -25.47 11.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.38 110.22 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.71 -56.69 5.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.39 110.11 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -60.42 -22.09 62.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.172 -0.955 . . . . 0.39 110.156 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.16 28.66 8.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.378 -1.489 . . . . 0.28 109.378 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.524 ' CZ ' HD13 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -74.09 75.74 1.74 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.215 -1.168 . . . . 0.31 110.448 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -60.31 151.35 68.64 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.432 -0.793 . . . . 0.4 110.581 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -52.02 95.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.585 1.308 . . . . 0.25 110.569 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.445 ' HA2' ' CE1' ' A' ' 2' ' ' TYR . . . 152.68 -21.48 0.81 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.67 -1.372 . . . . 0.09 109.67 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.633 HG22 HD11 ' A' ' 34' ' ' ILE . 24.4 m -64.92 128.99 38.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -1.202 . . . . 0.15 110.553 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.412 ' HG2' ' CB ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -116.31 145.22 43.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.24 110.19 179.452 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.701 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -47.96 -47.31 32.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.241 -0.912 . . . . 0.28 110.831 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -50.35 -33.72 21.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.876 . . . . 0.31 110.095 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.412 ' CB ' ' HG2' ' A' ' 30' ' ' ARG . 10.3 t0 -93.45 12.97 23.12 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.432 -0.792 . . . . 0.25 110.27 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 31' ' ' PHE . 92.8 mt . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.072 -1.017 . . . . 0.26 110.358 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 78.6 t90 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.226 0.536 . . . . 0.25 110.066 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.3 m -136.7 -178.59 5.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.229 -0.919 . . . . 0.11 110.436 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.425 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -67.32 149.9 98.17 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.288 -0.883 . . . . 0.31 109.999 179.555 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -70.62 -5.14 16.07 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.668 1.351 . . . . 0.59 111.513 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -156.18 32.11 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.817 -1.177 . . . . 0.57 111.216 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.425 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 57.7 m -141.19 -57.86 0.49 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.015 -1.053 . . . . 0.39 110.234 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.56 26.15 7.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.39 -1.484 . . . . 0.22 109.39 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.561 ' HB1' ' CG ' ' A' ' 49' ' ' ASP . . . -99.13 177.19 5.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.171 -1.193 . . . . 0.12 110.359 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.4 p -113.7 -165.15 0.98 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.326 -0.858 . . . . 0.17 110.129 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -32.45 44.1 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.296 -0.877 . . . . 0.33 110.436 177.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.94 -33.84 11.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.456 -0.778 . . . . 0.43 110.294 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.561 ' CG ' ' HB1' ' A' ' 45' ' ' ALA . 2.4 m-20 -84.49 -26.19 28.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.43 109.785 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -92.59 128.11 38.32 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.374 -0.828 . . . . 0.47 110.296 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.483 HG21 HG21 ' A' ' 8' ' ' ILE . 94.2 t -119.47 160.6 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.49 110.252 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -76.68 103.33 6.6 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.167 -0.958 . . . . 0.57 110.208 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.9 t80 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.57 110.701 -179.269 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.496 ' O ' HD12 ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.287 0.565 . . . . 0.38 110.418 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -59.32 131.42 50.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.203 -0.935 . . . . 0.69 110.409 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 1' ' ' ALA . 9.7 mp -92.41 168.86 11.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.864 . . . . 0.65 110.213 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.445 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 4.6 mttt -130.46 155.0 47.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.29 110.422 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.538 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 28.7 m95 -129.39 135.57 48.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.273 -0.892 . . . . 0.3 110.584 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.757 HD13 HG13 ' A' ' 13' ' ' ILE . 2.0 tp -108.06 128.24 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.021 -1.049 . . . . 0.46 110.524 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 10.2 t -74.8 100.12 3.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.877 . . . . 0.37 109.906 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.2 tt -56.11 -20.05 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.42 110.464 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.7 m -65.79 -38.17 88.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.49 110.803 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.4 p -129.23 -34.89 1.83 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.037 -1.04 . . . . 0.28 111.029 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.656 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 110.24 38.45 1.65 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.765 -1.334 . . . . 0.17 109.765 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.412 ' O ' HD12 ' A' ' 6' ' ' ILE . 4.7 t60 -104.1 128.06 51.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -1.165 . . . . 0.21 110.067 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.757 HG13 HD13 ' A' ' 6' ' ' ILE . 5.9 mt -92.18 143.17 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.242 -0.911 . . . . 0.16 110.836 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.484 ' HH ' ' HE2' ' A' ' 25' ' ' PHE . 64.0 t80 -108.76 131.24 55.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.706 -0.621 . . . . 0.1 109.485 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -106.29 107.94 19.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.537 -0.727 . . . . 0.11 109.815 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -50.39 -24.6 3.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 0.12 110.631 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.66 13.18 18.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.19 110.523 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 tp -176.68 62.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.154 -0.966 . . . . 0.27 109.881 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.64 -134.35 0.06 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.025 -1.23 . . . . 0.21 110.025 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -80.41 150.73 29.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.454 -1.027 . . . . 0.27 110.664 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -105.23 -25.07 12.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.872 . . . . 0.38 110.046 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.33 -43.24 28.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.408 -0.808 . . . . 0.39 110.333 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -70.53 -43.36 69.76 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.213 -0.929 . . . . 0.39 110.11 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.66 30.06 1.0 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.162 -1.175 . . . . 0.28 110.162 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CE1' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -73.03 81.39 1.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.85 -1.382 . . . . 0.31 109.944 179.151 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.5 t -49.33 150.89 2.9 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.4 110.989 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.45 95.77 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.703 1.37 . . . . 0.25 110.255 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.1 41.37 0.12 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.509 -1.436 . . . . 0.09 109.509 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -118.21 104.93 11.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -1.148 . . . . 0.15 110.086 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -75.67 141.56 42.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.24 110.649 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.682 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -51.95 -29.62 21.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.359 -0.838 . . . . 0.28 110.39 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -54.12 -50.69 66.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.31 110.386 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -74.96 -2.24 26.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.293 -0.879 . . . . 0.25 110.873 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' A' ' 31' ' ' PHE . 43.9 mt -103.79 90.51 2.91 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 120.934 -1.104 . . . . 0.26 110.338 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -62.12 -163.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.648 1.341 . . . . 0.34 110.543 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -69.4 -15.96 63.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.37 110.708 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -50.03 -29.28 8.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.004 . . . . 0.39 110.649 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.552 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 85.5 t90 -89.84 140.75 29.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.25 110.245 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 88.4 m -121.21 -170.75 2.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.11 110.394 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 1.3 t -88.11 135.74 32.9 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.31 110.156 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.96 -13.28 28.97 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.458 1.241 . . . . 0.59 110.736 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.82 -25.31 10.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 0.57 110.795 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 85.1 m -111.32 -75.15 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.046 -1.033 . . . . 0.39 110.571 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.03 35.54 0.77 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.444 -1.462 . . . . 0.22 109.444 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.62 -170.45 1.67 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -1.171 . . . . 0.12 110.514 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 p -78.49 -167.45 1.08 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.17 110.383 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -83.65 -16.02 46.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -0.88 . . . . 0.33 110.574 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.79 -22.75 59.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.091 -1.005 . . . . 0.43 110.6 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.481 ' O ' HG22 ' A' ' 8' ' ' ILE . 5.3 m-20 -75.46 -17.81 60.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.43 110.572 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -96.42 134.63 39.35 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.223 -0.923 . . . . 0.47 110.928 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 6' ' ' ILE . 34.2 m -125.67 171.13 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.858 . . . . 0.49 109.972 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.27 130.27 34.82 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.163 -0.961 . . . . 0.57 110.784 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -85.06 113.1 21.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 0.57 110.383 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 54.23 172.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.28 110.47 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 47.69 56.73 6.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.28 111.002 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.965 -1.016 . . . . 0.46 110.346 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.201 0.524 . . . . 0.38 110.377 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -146.93 136.9 23.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.69 110.508 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 mp -75.56 162.69 28.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -0.8 . . . . 0.65 110.523 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -134.19 134.91 42.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -0.871 . . . . 0.29 110.231 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.532 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 24.8 m95 -115.24 -178.13 3.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.3 110.229 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.649 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -161.37 124.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.399 -0.813 . . . . 0.46 110.059 178.619 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.649 ' N ' HD13 ' A' ' 6' ' ' ILE . 24.2 t -69.3 100.02 1.27 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.371 -0.831 . . . . 0.37 110.418 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.776 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.1 tt -53.98 -22.06 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.178 -0.951 . . . . 0.42 109.982 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.7 m -80.75 -28.88 36.33 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.25 -0.906 . . . . 0.49 110.175 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 1.6 m -110.2 -53.39 2.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 0.28 110.553 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.617 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 118.72 -11.02 12.25 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.133 -1.187 . . . . 0.17 110.133 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -75.65 138.86 41.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.941 -1.329 . . . . 0.21 110.482 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 5' ' ' TRP . 51.3 mt -97.6 136.91 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.364 -0.835 . . . . 0.16 110.589 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CE1' ' HA2' ' A' ' 19' ' ' GLY . 87.3 t80 -92.18 138.9 31.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.404 -0.81 . . . . 0.1 110.305 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -112.41 108.87 18.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.49 -0.756 . . . . 0.11 109.988 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -50.98 -24.42 3.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.154 -0.966 . . . . 0.12 110.7 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.31 16.43 8.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.19 110.4 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -176.96 69.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.27 109.855 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.5 ' HA2' ' CE1' ' A' ' 14' ' ' TYR . . . -68.37 -137.04 0.07 OUTLIER Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.143 -1.183 . . . . 0.21 110.143 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 22' ' ' ALA . 15.8 t0 -87.07 149.77 24.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.406 -1.055 . . . . 0.27 110.718 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.408 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 36.5 mt-10 -97.17 -30.59 12.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.854 . . . . 0.38 110.023 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.424 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . -75.16 -44.86 44.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.387 -0.821 . . . . 0.39 110.316 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -63.61 -38.94 93.04 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.255 -0.903 . . . . 0.39 110.312 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.13 23.21 4.28 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.677 -1.369 . . . . 0.28 109.677 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.672 ' CE2' HG21 ' A' ' 29' ' ' THR . 0.7 OUTLIER -66.72 83.81 0.11 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.099 -1.236 . . . . 0.31 110.124 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.4 t -49.77 152.54 2.53 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.446 -0.784 . . . . 0.4 110.918 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 28.6 Cg_exo -58.04 106.99 0.28 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.703 1.37 . . . . 0.25 110.468 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.4 38.99 0.46 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.474 -1.45 . . . . 0.09 109.474 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.672 HG21 ' CE2' ' A' ' 25' ' ' PHE . 26.2 m -108.97 134.4 51.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -1.115 . . . . 0.15 110.353 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -117.96 141.02 48.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.24 110.346 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.647 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -48.94 -36.59 17.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.198 -0.939 . . . . 0.28 110.747 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -57.15 -34.79 68.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.237 -0.914 . . . . 0.31 109.989 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -87.37 -23.07 24.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.333 -0.854 . . . . 0.25 110.234 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.647 HD12 ' HA ' ' A' ' 31' ' ' PHE . 20.8 mt -58.68 109.82 2.15 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.26 109.913 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -62.02 -161.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.458 1.241 . . . . 0.34 110.492 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.47 -25.14 21.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.37 110.26 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -55.51 -30.61 60.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.39 110.443 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.532 ' CZ3' ' CZ ' ' A' ' 31' ' ' PHE . 79.7 t90 -75.86 169.52 17.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.933 . . . . 0.25 110.363 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.473 ' N ' ' CD2' ' A' ' 38' ' ' TRP . 25.3 p -173.94 -160.89 0.11 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.389 -0.819 . . . . 0.11 110.148 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -76.55 143.4 72.06 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.307 -0.87 . . . . 0.31 110.091 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.56 -7.62 19.69 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.664 1.35 . . . . 0.59 111.373 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.8 -32.21 2.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.952 -1.093 . . . . 0.57 111.05 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 63.3 m -92.4 -70.34 0.7 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.07 -1.019 . . . . 0.39 110.407 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.27 25.11 4.83 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.288 -1.525 . . . . 0.22 109.288 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.14 174.4 5.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -1.147 . . . . 0.12 110.569 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.0 p -67.42 -162.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.17 110.345 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -78.65 -2.83 40.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.33 110.769 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -45.03 64.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.957 -1.09 . . . . 0.43 110.463 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.776 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.3 p30 -73.02 -20.25 61.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.43 110.219 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -90.58 129.7 36.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.47 110.495 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 6' ' ' ILE . 27.4 m -128.21 159.97 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.49 110.21 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.42 119.05 17.12 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.195 -0.94 . . . . 0.57 110.383 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -69.93 129.53 39.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.57 110.628 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -107.56 122.06 45.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.28 110.219 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.79 118.86 12.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -0.873 . . . . 0.28 110.503 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.941 -1.028 . . . . 0.46 110.363 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.221 0.534 . . . . 0.38 110.476 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.785 ' CG ' ' HB2' ' A' ' 17' ' ' ALA . 39.7 m-85 -104.2 134.99 46.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.69 110.483 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.514 HD23 HD11 ' A' ' 52' ' ' LEU . 4.3 mp -92.36 163.13 13.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.298 -0.876 . . . . 0.65 110.284 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.73 146.56 50.89 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.244 -0.91 . . . . 0.29 109.809 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.553 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 25.0 m95 -119.82 -176.55 3.2 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.319 -0.863 . . . . 0.3 109.616 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.757 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -152.96 129.42 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.407 -0.917 . . . . 0.46 110.481 178.405 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.757 ' N ' HD13 ' A' ' 6' ' ' ILE . 4.9 t -75.69 92.14 2.96 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.495 -0.753 . . . . 0.37 109.982 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.428 HG13 ' N ' ' A' ' 9' ' ' THR . 15.9 pt -51.67 -23.64 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.009 -1.057 . . . . 0.42 109.928 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.428 ' N ' HG13 ' A' ' 8' ' ' ILE . 45.9 m -68.9 -26.96 65.37 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.495 -0.753 . . . . 0.49 110.295 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.7 m -125.83 -49.99 1.6 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -0.953 . . . . 0.28 111.284 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.668 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 118.97 13.22 6.63 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.905 -1.278 . . . . 0.17 109.905 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.02 125.51 37.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.994 -1.297 . . . . 0.21 110.177 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.436 HG13 HG12 ' A' ' 6' ' ' ILE . 53.4 mt -88.79 141.17 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.16 110.696 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -102.44 148.1 25.91 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.657 0.741 . . . . 0.1 110.35 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -124.15 106.75 10.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.579 -0.701 . . . . 0.11 109.923 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.463 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 98.8 mt-10 -50.26 -24.42 2.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.12 110.565 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.785 ' HB2' ' CG ' ' A' ' 2' ' ' TYR . . . -93.21 20.19 7.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.19 110.257 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tp -176.49 65.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.27 109.966 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.8 -141.56 0.32 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.886 -1.286 . . . . 0.21 109.886 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.02 171.63 7.24 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.38 -1.07 . . . . 0.27 110.543 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -106.42 -35.63 7.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.35 -0.844 . . . . 0.38 110.159 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.36 -41.73 89.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.872 . . . . 0.39 110.171 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -73.91 -3.33 28.26 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.253 -0.904 . . . . 0.39 110.901 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.22 25.19 64.34 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.348 -1.501 . . . . 0.28 109.348 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -82.66 79.99 8.91 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.277 -1.131 . . . . 0.31 109.985 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.0 t -49.46 151.29 2.84 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.389 -0.819 . . . . 0.4 111.004 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 24.9 Cg_exo -60.0 114.97 2.32 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.704 1.371 . . . . 0.25 110.42 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.65 16.58 5.89 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.868 -1.293 . . . . 0.09 109.868 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.711 HG22 HD11 ' A' ' 34' ' ' ILE . 40.3 m -86.01 116.52 24.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.244 . . . . 0.15 110.224 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.463 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 43.6 mtt85 -90.26 140.65 29.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.24 110.576 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.82 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -59.18 -35.14 73.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.888 . . . . 0.28 110.165 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -52.28 -30.64 28.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.31 110.35 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -100.86 19.04 17.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -0.844 . . . . 0.25 110.345 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.82 HD12 ' HA ' ' A' ' 31' ' ' PHE . 92.9 mt -116.4 104.97 51.17 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.26 109.989 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -58.83 -155.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.604 1.318 . . . . 0.34 110.684 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -93.75 18.43 10.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.908 . . . . 0.37 110.54 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -81.32 -48.84 11.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.39 110.289 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 85.8 t90 -62.78 144.92 56.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.366 -0.834 . . . . 0.25 110.372 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.7 m -128.96 -164.58 1.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.11 110.181 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.451 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -79.95 152.79 74.73 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.128 -0.983 . . . . 0.31 110.236 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -62.97 -12.88 31.74 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.583 1.307 . . . . 0.59 111.325 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -157.49 40.69 0.3 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.91 -1.119 . . . . 0.57 111.185 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.451 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 56.7 m -141.88 -59.51 0.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.034 -1.042 . . . . 0.39 110.184 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.08 25.62 11.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.117 -1.593 . . . . 0.22 109.117 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.12 -170.37 2.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -1.112 . . . . 0.12 110.408 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.2 p -108.89 -173.19 2.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.17 110.372 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -63.04 -16.65 60.58 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.268 -0.895 . . . . 0.33 110.261 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -55.58 -38.77 69.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.43 110.246 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 5.7 m-20 -77.05 -12.88 60.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.31 -0.869 . . . . 0.43 110.473 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -100.72 136.82 39.98 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.049 -1.032 . . . . 0.47 110.772 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.5 t -133.15 149.05 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.47 -0.769 . . . . 0.49 109.985 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.514 HD11 HD23 ' A' ' 3' ' ' LEU . 1.1 tt -63.71 120.54 12.02 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.112 -0.992 . . . . 0.57 110.279 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -76.63 118.46 19.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.335 -0.853 . . . . 0.57 110.375 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.01 72.08 0.19 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.28 110.361 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -68.01 108.87 3.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.28 110.302 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.979 -1.01 . . . . 0.46 110.335 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.24 0.543 . . . . 0.38 110.25 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.532 ' CG ' ' HB2' ' A' ' 17' ' ' ALA . 61.0 m-85 -65.73 141.08 58.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.894 . . . . 0.69 110.403 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.529 HD23 HD21 ' A' ' 52' ' ' LEU . 3.3 mp -98.85 170.05 9.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.507 -0.745 . . . . 0.65 110.678 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -134.84 148.93 50.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.29 110.186 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.458 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 48.9 m95 -129.91 178.87 6.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 0.3 110.504 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.854 HD13 HG13 ' A' ' 13' ' ' ILE . 1.2 tp -156.32 120.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.65 -0.656 . . . . 0.46 109.741 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 11' ' ' GLY . 18.9 t -67.67 96.93 0.58 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.372 -0.83 . . . . 0.37 110.313 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.5 tt -54.99 -19.92 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.142 -0.974 . . . . 0.42 110.289 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 m -80.62 -28.35 37.01 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.261 -0.899 . . . . 0.49 110.381 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.4 m -117.23 -46.43 2.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.163 -0.961 . . . . 0.28 110.856 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.474 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 109.0 19.8 8.35 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.678 -1.369 . . . . 0.17 109.678 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -99.65 134.48 42.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -1.21 . . . . 0.21 110.069 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.854 HG13 HD13 ' A' ' 6' ' ' ILE . 4.4 mt -96.24 141.04 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.16 110.656 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -108.21 144.56 35.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.512 -0.742 . . . . 0.1 110.329 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -119.9 109.42 15.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.429 -0.794 . . . . 0.11 110.097 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.428 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 69.8 mt-10 -50.22 -27.85 6.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 0.12 110.474 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.532 ' HB2' ' CG ' ' A' ' 2' ' ' TYR . . . -93.85 12.83 24.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.921 . . . . 0.19 110.617 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.55 68.45 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.12 -0.987 . . . . 0.27 110.42 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.25 -135.5 0.01 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.402 -1.479 . . . . 0.21 109.402 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.25 164.75 12.71 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.225 -1.161 . . . . 0.27 110.287 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -92.81 -22.14 19.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -0.913 . . . . 0.38 110.31 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.67 -36.46 17.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.39 110.366 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -65.19 -26.92 68.35 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.255 -0.903 . . . . 0.39 110.332 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.83 27.47 14.17 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.548 -1.421 . . . . 0.28 109.548 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.513 ' CE1' HG21 ' A' ' 29' ' ' THR . 0.1 OUTLIER -73.51 84.0 1.51 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.108 -1.231 . . . . 0.31 110.208 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.4 t -50.06 143.94 11.58 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.192 -0.943 . . . . 0.4 110.474 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.15 106.57 0.21 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.653 1.344 . . . . 0.25 110.645 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.02 44.42 0.17 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.582 -1.407 . . . . 0.09 109.582 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.513 HG21 ' CE1' ' A' ' 25' ' ' PHE . 1.4 m -130.59 122.87 28.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.11 -1.229 . . . . 0.15 110.511 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.428 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 1.7 ptm180 -103.58 150.91 23.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.24 110.446 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.781 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -48.4 -44.62 35.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.232 -0.917 . . . . 0.28 110.833 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.407 ' HB3' ' HG3' ' A' ' 30' ' ' ARG . 3.0 tm-20 -53.61 -48.73 69.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.31 110.234 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.4 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 31.8 t70 -65.93 -22.57 66.5 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.265 -0.897 . . . . 0.25 110.217 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.781 HD12 ' HA ' ' A' ' 31' ' ' PHE . 46.8 mt -80.53 111.03 19.4 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.431 -0.793 . . . . 0.26 110.047 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 33' ' ' ASP . 33.7 Cg_endo -69.52 -169.72 0.33 Allowed 'Trans proline' 0 C--N 1.314 -1.278 0 O-C-N 123.493 1.259 . . . . 0.34 110.853 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.4 ' OD1' HG22 ' A' ' 46' ' ' THR . 27.2 t0 -72.04 -17.32 62.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 0.37 110.49 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -52.31 -31.49 33.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.094 -1.004 . . . . 0.39 110.151 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.547 ' CZ3' ' CZ ' ' A' ' 31' ' ' PHE . 79.8 t90 -83.02 160.69 21.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.421 -0.799 . . . . 0.25 110.096 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.6 p -162.36 -160.53 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.11 110.386 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.434 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -86.55 160.95 49.64 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.358 -0.839 . . . . 0.31 110.422 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 3.8 Cg_exo -73.88 -23.05 16.81 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.607 1.319 . . . . 0.59 110.953 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -139.49 30.46 2.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.993 -1.067 . . . . 0.57 111.178 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.434 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 60.6 m -141.57 -46.15 0.37 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.974 -1.079 . . . . 0.39 110.255 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.27 28.92 47.18 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.5 -1.44 . . . . 0.22 109.5 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.32 -171.81 2.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -1.174 . . . . 0.12 110.334 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.4 HG22 ' OD1' ' A' ' 36' ' ' ASP . 47.4 p -109.25 -159.85 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.17 110.336 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.408 ' HA ' ' HB2' ' A' ' 50' ' ' TYR . 32.7 ttmt -58.34 -18.5 27.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.394 -0.816 . . . . 0.33 110.253 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -50.22 -48.29 54.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.064 -1.022 . . . . 0.43 110.56 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.737 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.8 m-20 -73.03 -20.42 61.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.43 110.154 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.408 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 12.2 m-85 -95.92 137.58 34.78 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.315 -0.866 . . . . 0.47 110.764 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 80.7 t -125.11 158.73 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.388 -0.82 . . . . 0.49 109.931 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.529 HD21 HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -72.33 100.13 2.58 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.179 -0.951 . . . . 0.57 110.083 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.4 ' HD1' HG21 ' A' ' 6' ' ' ILE . 28.6 t80 -52.77 135.14 36.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.446 -0.784 . . . . 0.57 110.516 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -98.1 107.59 20.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.28 110.287 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -110.49 101.88 10.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.28 110.386 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.8 tttm . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 118.024 -0.989 . . . . 0.46 110.358 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.264 0.555 . . . . 0.38 110.409 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -103.21 138.82 39.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.69 110.537 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.64 179.16 7.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.435 -0.791 . . . . 0.65 110.587 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -146.68 138.8 24.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.405 -0.809 . . . . 0.29 110.451 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.54 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 29.2 m95 -118.23 -178.37 3.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -0.822 . . . . 0.3 110.08 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.631 HD11 ' HA2' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -156.55 118.67 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.394 -0.816 . . . . 0.46 110.374 177.632 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.544 ' N ' HD13 ' A' ' 6' ' ' ILE . 6.6 t -63.93 92.2 0.07 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.243 -0.911 . . . . 0.37 109.919 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.604 HG21 HG21 ' A' ' 51' ' ' VAL . 8.6 pt -51.7 -23.71 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.182 -0.949 . . . . 0.42 110.073 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.421 ' N ' HG13 ' A' ' 8' ' ' ILE . 36.3 m -72.48 -29.42 63.63 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.306 -0.871 . . . . 0.49 110.039 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.2 m -114.29 -49.04 2.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.28 110.667 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.631 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 114.22 8.64 16.81 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.032 -1.227 . . . . 0.17 110.032 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -92.25 133.97 35.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.911 -1.347 . . . . 0.21 110.091 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 90.4 mt -93.2 124.43 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.16 110.783 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.476 ' HH ' ' HE2' ' A' ' 25' ' ' PHE . 57.3 t80 -84.55 131.04 34.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.42 -0.8 . . . . 0.1 109.978 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -108.44 111.78 23.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.11 109.815 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.423 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -51.9 -23.95 5.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.12 110.265 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.75 13.55 12.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.19 110.509 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.57 64.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.27 109.756 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.43 -136.29 0.12 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.049 -1.221 . . . . 0.21 110.049 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -84.91 144.53 28.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -1.04 . . . . 0.27 110.598 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -91.07 -22.95 20.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.307 -0.871 . . . . 0.38 110.082 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.8 -39.93 15.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.39 110.302 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -65.96 -32.35 73.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.39 110.259 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.18 29.22 4.63 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.54 -1.424 . . . . 0.28 109.54 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.567 ' CE1' ' CD1' ' A' ' 38' ' ' TRP . 1.5 m-85 -73.69 82.74 1.58 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.111 -1.229 . . . . 0.31 110.181 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.2 t -49.49 149.3 4.16 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.4 110.785 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.17 110.83 0.62 Allowed 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.666 1.351 . . . . 0.25 110.397 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.09 19.82 4.63 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.741 -1.344 . . . . 0.09 109.741 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.3 m -86.58 133.76 33.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.058 -1.26 . . . . 0.15 110.262 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.423 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 2.3 mtp180 -116.12 144.56 43.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.87 . . . . 0.24 110.431 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.559 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -49.57 -25.16 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.314 -0.866 . . . . 0.28 110.525 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.41 -24.33 54.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.895 . . . . 0.31 110.479 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -114.17 11.28 17.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.25 110.836 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.559 HD11 ' HE2' ' A' ' 25' ' ' PHE . 8.6 mt -81.18 -44.19 1.17 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.071 -1.018 . . . . 0.26 110.928 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 34' ' ' ILE . 78.1 Cg_exo -46.94 94.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.09 0 O-C-N 123.035 1.019 . . . . 0.34 111.209 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 34' ' ' ILE . 25.8 t0 -175.48 -46.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.419 -0.801 . . . . 0.37 109.879 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.58 32.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.862 . . . . 0.39 109.962 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.567 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 82.2 t90 -112.13 170.26 8.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.411 -0.806 . . . . 0.25 110.67 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.433 ' N ' ' CG ' ' A' ' 38' ' ' TRP . 25.0 p -169.66 -161.34 0.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.329 -0.857 . . . . 0.11 110.31 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.438 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -91.82 169.25 11.48 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 0.31 110.227 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.28 -40.53 31.84 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.584 1.307 . . . . 0.59 110.746 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.1 50.76 1.03 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.091 -1.005 . . . . 0.57 110.689 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.438 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 61.7 m -136.58 -45.63 0.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.39 110.086 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.34 32.45 51.69 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.354 -1.498 . . . . 0.22 109.354 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.23 166.72 10.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 0.12 110.443 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.4 p -91.59 -162.15 0.89 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.398 -0.814 . . . . 0.17 110.161 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 50' ' ' TYR . 5.3 ttpp -61.67 -15.47 40.3 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.239 -0.913 . . . . 0.33 110.377 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 49' ' ' ASP . 23.2 pt-20 -51.79 -40.68 60.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.052 -1.03 . . . . 0.43 110.354 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 14.9 m-20 -80.58 -18.37 48.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.231 -0.918 . . . . 0.43 110.368 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.419 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 4.8 m-85 -95.21 124.17 39.11 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.185 -0.947 . . . . 0.47 110.455 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.604 HG21 HG21 ' A' ' 8' ' ' ILE . 97.9 t -117.21 148.02 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.279 -0.888 . . . . 0.49 110.088 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.76 117.44 9.67 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.152 -0.968 . . . . 0.57 110.096 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -67.72 141.92 56.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.57 110.535 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.84 126.7 0.47 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.324 -0.86 . . . . 0.28 110.406 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.56 52.66 0.83 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.28 110.457 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.2 pttt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.96 -1.019 . . . . 0.46 110.39 179.951 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.277 0.56 . . . . 0.38 110.356 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.422 ' HB3' ' HB2' ' A' ' 16' ' ' GLU . 37.2 m-85 -122.18 138.41 54.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -0.877 . . . . 0.69 110.351 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.851 HD23 HD21 ' A' ' 52' ' ' LEU . 1.5 mp -91.03 164.16 14.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.409 -0.807 . . . . 0.65 110.725 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -122.56 144.76 48.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -0.835 . . . . 0.29 110.07 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.506 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 39.2 m95 -121.5 179.07 4.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 0.3 110.537 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.851 HD13 HG13 ' A' ' 13' ' ' ILE . 2.1 tp -153.88 128.18 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.717 -0.614 . . . . 0.46 110.068 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 45.3 t -76.97 98.03 4.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.37 110.291 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.0 OUTLIER -52.68 -23.3 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.097 -1.002 . . . . 0.42 110.175 179.446 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.4 m -79.82 -30.61 40.52 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.388 -0.82 . . . . 0.49 110.351 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -108.99 -54.44 2.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 0.28 110.569 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.482 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 113.38 13.48 10.63 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.896 -1.281 . . . . 0.17 109.896 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.428 ' O ' HD12 ' A' ' 6' ' ' ILE . 4.2 m80 -99.33 133.82 43.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.934 -1.333 . . . . 0.21 110.047 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.851 HG13 HD13 ' A' ' 6' ' ' ILE . 3.9 mt -89.68 145.68 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.16 110.631 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.43 ' CE1' ' HA2' ' A' ' 19' ' ' GLY . 75.4 t80 -104.82 129.26 53.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.564 -0.71 . . . . 0.1 110.352 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.414 ' HB3' ' HG ' ' A' ' 18' ' ' LEU . 2.4 t0 -102.8 104.39 14.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.301 -0.874 . . . . 0.11 110.006 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 2' ' ' TYR . 18.0 mt-10 -51.89 -23.0 4.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -0.865 . . . . 0.12 110.758 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.31 -2.74 26.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.235 -0.915 . . . . 0.19 110.943 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.433 ' O ' ' CG ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -173.42 68.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.987 -1.071 . . . . 0.27 110.062 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.43 ' HA2' ' CE1' ' A' ' 14' ' ' TYR . . . -62.97 -136.96 0.01 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.328 -1.109 . . . . 0.21 110.328 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -92.71 166.09 12.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.294 -1.121 . . . . 0.27 110.512 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -109.21 -27.1 9.74 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.326 -0.858 . . . . 0.38 110.129 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.74 -54.16 17.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.39 110.172 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -63.56 -24.76 67.94 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.228 -0.92 . . . . 0.39 110.137 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.5 28.99 5.52 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.542 -1.423 . . . . 0.28 109.542 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.688 ' CD1' HG21 ' A' ' 29' ' ' THR . 0.7 OUTLIER -81.49 79.88 7.99 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.153 -1.204 . . . . 0.31 110.442 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -53.26 152.82 7.63 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.254 -0.904 . . . . 0.4 110.511 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -54.54 95.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.608 1.32 . . . . 0.25 110.307 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 144.81 -15.88 1.98 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.815 -1.314 . . . . 0.09 109.815 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.688 HG21 ' CD1' ' A' ' 25' ' ' PHE . 1.6 m -50.45 121.94 6.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.017 -1.284 . . . . 0.15 110.633 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -105.6 139.84 39.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.24 110.266 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.87 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -47.32 -46.77 25.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.337 -0.852 . . . . 0.28 110.835 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.67 -33.57 47.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.284 -0.885 . . . . 0.31 110.233 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.42 11.81 27.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.335 -0.853 . . . . 0.25 110.653 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.87 HD12 ' HA ' ' A' ' 31' ' ' PHE . 91.3 mt -109.44 108.17 59.83 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.011 -1.056 . . . . 0.26 109.971 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 34' ' ' ILE . 15.0 Cg_endo -61.82 -164.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.482 1.254 . . . . 0.34 110.785 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.16 -17.81 48.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.37 110.735 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.72 -43.58 62.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.13 -0.981 . . . . 0.39 110.465 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 81.0 t90 -69.97 144.88 52.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.25 109.993 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 95.3 m -143.38 -175.12 4.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.11 110.401 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -74.08 136.97 75.85 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.31 110.233 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -72.6 -13.05 27.25 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.463 1.244 . . . . 0.59 110.846 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.51 -23.94 11.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.027 -1.046 . . . . 0.57 110.756 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 95.8 m -111.86 -75.04 0.62 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.027 -1.046 . . . . 0.39 110.418 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.38 36.83 0.67 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.402 -1.479 . . . . 0.22 109.402 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.66 -169.17 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -1.166 . . . . 0.12 110.499 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.7 p -88.8 -162.5 0.86 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 0.17 110.4 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.25 -9.79 54.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.853 . . . . 0.33 110.639 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -52.14 -44.76 64.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.984 -1.072 . . . . 0.43 110.463 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.577 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -71.31 -20.6 62.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.161 -0.962 . . . . 0.43 110.033 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -96.06 134.08 39.54 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.248 -0.907 . . . . 0.47 110.662 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.54 171.85 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.831 . . . . 0.49 110.115 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.851 HD21 HD23 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -75.62 118.51 18.54 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.253 -0.904 . . . . 0.57 110.311 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -63.12 105.42 0.7 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.57 110.579 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.461 ' HG3' HD12 ' A' ' 52' ' ' LEU . 3.3 mt-10 -144.72 103.89 3.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.845 . . . . 0.28 110.176 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.14 137.73 26.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.28 110.484 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.018 -0.991 . . . . 0.46 110.266 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.198 0.523 . . . . 0.38 110.414 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -122.35 139.64 53.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.69 110.35 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.429 HD23 HD11 ' A' ' 52' ' ' LEU . 1.9 mp -104.1 179.79 4.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.65 110.743 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -139.63 145.97 39.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.496 -0.752 . . . . 0.29 110.009 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 34.1 m95 -127.82 134.72 49.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.082 -1.011 . . . . 0.3 110.658 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.741 HD13 HG13 ' A' ' 13' ' ' ILE . 2.6 tp -111.62 132.62 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.023 -1.048 . . . . 0.46 110.297 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.9 t -79.13 100.05 7.24 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.345 -0.847 . . . . 0.37 110.037 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.6 tt -56.17 -18.74 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.917 . . . . 0.42 110.619 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.0 m -70.08 -39.56 75.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.885 . . . . 0.49 110.824 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.9 p -126.8 -35.31 2.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.971 -1.081 . . . . 0.28 111.116 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.614 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 108.97 44.7 1.08 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.852 -1.299 . . . . 0.17 109.852 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 9.5 t60 -108.74 127.7 54.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -1.211 . . . . 0.21 110.142 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.741 HG13 HD13 ' A' ' 6' ' ' ILE . 5.8 mt -93.09 133.52 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.16 110.8 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' OH ' HD11 ' A' ' 34' ' ' ILE . 71.3 t80 -102.84 121.39 42.39 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.506 -0.746 . . . . 0.1 109.295 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -98.98 106.26 18.5 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.415 -0.803 . . . . 0.11 110.19 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.437 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -48.74 -24.16 1.3 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.385 -0.822 . . . . 0.12 111.015 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.65 14.45 8.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.067 -1.021 . . . . 0.19 110.803 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 tt -176.61 69.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.1 -1.0 . . . . 0.27 109.999 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.06 -136.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.842 -1.303 . . . . 0.21 109.842 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.403 ' OD2' ' N ' ' A' ' 23' ' ' GLU . 17.0 t70 -113.37 161.31 17.42 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.347 -1.09 . . . . 0.27 110.179 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -97.27 -27.74 14.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.38 110.36 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.95 -29.03 58.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.92 . . . . 0.39 110.345 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.403 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 11.8 mm-40 -88.9 16.59 6.7 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.298 -0.876 . . . . 0.39 110.805 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.1 28.38 63.87 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.456 -1.458 . . . . 0.28 109.456 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -86.85 82.71 7.72 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.232 -1.158 . . . . 0.31 110.046 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.8 t -47.86 151.4 1.63 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.469 -0.769 . . . . 0.4 110.961 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 36.8 Cg_exo -56.96 104.92 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.701 1.369 . . . . 0.25 110.467 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.1 35.51 0.76 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.622 -1.391 . . . . 0.09 109.622 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.541 HG22 HD11 ' A' ' 34' ' ' ILE . 58.2 m -90.3 134.32 34.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.189 -1.183 . . . . 0.15 110.32 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.437 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -105.72 135.51 47.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 0.24 110.468 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.892 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -51.0 -47.21 61.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.28 110.473 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -54.91 -41.43 70.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.861 . . . . 0.31 110.442 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.98 -24.34 52.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.25 110.394 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.892 HD12 ' HA ' ' A' ' 31' ' ' PHE . 63.4 mt -68.88 118.36 60.39 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.26 110.119 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -62.91 -150.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 O-C-N 123.446 1.235 . . . . 0.34 110.512 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -100.12 -19.86 16.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.37 110.525 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.52 -40.04 58.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.187 -0.946 . . . . 0.39 110.591 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 89.4 t90 -67.65 164.11 19.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.278 -0.889 . . . . 0.25 110.47 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.8 p -162.24 -160.89 0.7 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.11 110.343 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.56 120.85 70.37 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.401 -0.812 . . . . 0.31 110.173 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.35 -12.82 34.88 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.473 1.249 . . . . 0.59 110.849 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.412 ' OD2' ' ND1' ' A' ' 12' ' ' HIS . 87.8 m-20 -102.55 -26.84 13.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.052 -1.03 . . . . 0.57 110.674 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 96.6 m -114.32 -75.42 0.59 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.139 -0.976 . . . . 0.39 110.327 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.3 40.83 0.35 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.396 -1.482 . . . . 0.22 109.396 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.442 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . . . -122.43 -175.09 3.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -1.173 . . . . 0.12 110.667 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 p -82.55 -166.71 1.36 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.385 -0.822 . . . . 0.17 110.511 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -69.02 -8.76 48.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.32 -0.863 . . . . 0.33 110.551 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -50.95 -42.88 60.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.987 -1.07 . . . . 0.43 110.299 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' O ' HG22 ' A' ' 8' ' ' ILE . 2.8 p30 -76.02 -20.64 57.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.319 -0.863 . . . . 0.43 110.377 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -92.86 131.41 37.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.47 110.596 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 6' ' ' ILE . 35.9 m -124.27 163.19 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.279 -0.888 . . . . 0.49 110.161 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.429 HD11 HD23 ' A' ' 3' ' ' LEU . 0.7 OUTLIER -81.86 120.35 25.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.57 110.581 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -75.38 113.68 13.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -0.836 . . . . 0.57 110.389 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.34 148.32 25.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 0.28 110.446 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -98.99 57.87 1.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.28 110.3 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.963 -1.018 . . . . 0.46 110.35 -179.898 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.273 0.559 . . . . 0.38 110.366 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.589 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 42.6 m-85 -95.02 133.68 38.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.925 . . . . 0.69 110.479 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.881 HD23 HD21 ' A' ' 52' ' ' LEU . 1.9 mp -75.04 164.44 26.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.65 110.528 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -130.31 136.58 49.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.29 110.093 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.517 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 29.6 m95 -115.84 170.61 8.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.966 . . . . 0.3 110.283 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.864 HD13 HG13 ' A' ' 13' ' ' ILE . 2.1 tp -144.38 136.27 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.454 -0.779 . . . . 0.46 109.775 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.433 ' H ' HD12 ' A' ' 6' ' ' ILE . 8.4 t -84.44 95.12 8.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.366 -0.834 . . . . 0.37 110.342 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.0 OUTLIER -52.81 -22.88 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.11 -0.993 . . . . 0.42 110.043 179.016 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.2 m -72.72 -28.02 62.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.372 -0.83 . . . . 0.49 110.302 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 78.9 m -124.6 -51.38 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.28 110.64 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.539 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 117.3 19.34 5.11 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.833 -1.307 . . . . 0.17 109.833 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.487 ' O ' HD12 ' A' ' 6' ' ' ILE . 5.8 m-70 -97.57 133.09 42.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.051 -1.264 . . . . 0.21 110.102 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.864 HG13 HD13 ' A' ' 6' ' ' ILE . 3.9 mt -91.28 134.51 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.16 110.504 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.402 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 70.7 t80 -94.33 125.89 39.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.5 -0.75 . . . . 0.1 109.892 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -95.83 102.55 14.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.459 -0.775 . . . . 0.11 110.289 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -49.35 -30.96 8.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.85 . . . . 0.12 110.702 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.589 ' HB2' ' CD2' ' A' ' 2' ' ' TYR . . . -91.74 17.47 8.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.895 . . . . 0.19 110.457 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -177.0 70.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -0.956 . . . . 0.27 110.076 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.87 -135.4 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.89 -1.284 . . . . 0.21 109.89 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD2' ' N ' ' A' ' 22' ' ' ALA . 16.3 t70 -113.12 168.97 9.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.345 -1.091 . . . . 0.27 110.571 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -87.81 -46.62 9.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.27 -0.894 . . . . 0.38 110.073 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . -53.83 -43.76 69.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.337 -0.852 . . . . 0.39 110.205 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -70.88 -30.22 66.54 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.32 -0.862 . . . . 0.39 110.083 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.27 28.85 18.89 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.686 -1.366 . . . . 0.28 109.686 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CE2' ' NE1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -69.19 82.86 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.275 . . . . 0.31 110.064 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.5 t -49.49 145.75 7.57 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.196 -0.94 . . . . 0.4 110.723 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 38.4 Cg_exo -53.51 105.66 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.683 1.359 . . . . 0.25 110.712 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.48 41.98 0.26 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.879 -1.288 . . . . 0.09 109.879 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.19 126.76 44.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -1.218 . . . . 0.15 110.267 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.441 ' HG2' ' CB ' ' A' ' 33' ' ' ASP . 0.4 OUTLIER -118.38 148.68 42.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.24 110.256 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.623 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -47.78 -40.74 21.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.254 -0.904 . . . . 0.28 110.673 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -59.31 -32.38 70.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.191 -0.943 . . . . 0.31 109.983 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.441 ' CB ' ' HG2' ' A' ' 30' ' ' ARG . 21.3 t0 -95.39 12.67 28.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 0.25 110.551 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.662 ' O ' HG22 ' A' ' 34' ' ' ILE . 92.3 mt -113.83 64.21 1.17 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.092 -1.005 . . . . 0.26 110.119 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -66.05 -21.24 56.53 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.538 1.283 . . . . 0.34 110.508 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.92 -175.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.37 110.45 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.26 42.16 1.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.297 -0.877 . . . . 0.39 110.175 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.424 ' NE1' ' CE2' ' A' ' 25' ' ' PHE . 85.6 t90 -51.92 143.54 13.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.25 110.553 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 8.4 m -135.07 172.31 13.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.342 -0.849 . . . . 0.11 110.173 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.439 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -55.92 151.6 23.76 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.31 110.334 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -74.22 -7.77 20.15 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.513 1.27 . . . . 0.59 111.201 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -150.64 32.72 0.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.899 -1.126 . . . . 0.57 111.053 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.439 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 59.0 m -142.11 -65.86 0.41 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.084 -1.01 . . . . 0.39 110.045 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.54 29.4 3.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.496 -1.442 . . . . 0.22 109.496 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HB1' ' OD1' ' A' ' 49' ' ' ASP . . . -105.71 171.01 7.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -1.106 . . . . 0.12 110.462 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.5 p -90.13 -162.39 0.89 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.17 110.205 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 23.0 mttt -68.08 -14.33 62.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.341 -0.849 . . . . 0.33 110.437 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -52.7 -45.87 67.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.098 -1.001 . . . . 0.43 110.215 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.631 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.6 m-20 -70.49 -20.89 62.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.321 -0.862 . . . . 0.43 109.992 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -97.76 134.75 40.51 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.378 -0.826 . . . . 0.47 110.593 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.409 ' CG2' HG23 ' A' ' 6' ' ' ILE . 34.3 m -130.75 170.93 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.49 110.274 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.881 HD21 HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -79.25 119.44 22.33 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.165 -0.959 . . . . 0.57 110.344 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.433 ' N ' HD13 ' A' ' 52' ' ' LEU . 29.8 t80 -76.28 162.33 28.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.883 . . . . 0.57 110.529 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -126.03 106.92 9.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.28 110.238 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -81.36 158.39 24.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.28 110.48 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.933 -1.032 . . . . 0.46 110.418 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.309 0.576 . . . . 0.38 110.441 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -65.76 137.11 57.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.69 110.512 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.93 157.42 15.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 0.65 110.481 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.431 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 0.9 OUTLIER -121.2 160.36 23.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.29 110.097 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.447 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 55.9 m95 -135.09 127.1 29.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.151 -0.968 . . . . 0.3 110.651 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.804 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -98.83 130.43 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.09 -1.006 . . . . 0.46 110.028 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.804 ' N ' HD13 ' A' ' 6' ' ' ILE . 12.0 t -78.68 92.88 4.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.216 -0.928 . . . . 0.37 109.507 177.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 49' ' ' ASP . 48.0 pt -51.49 -23.99 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.884 -1.135 . . . . 0.42 110.031 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.9 m -77.13 -27.4 53.91 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.546 -0.721 . . . . 0.49 110.195 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 3.7 m -117.03 -47.35 2.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.28 111.503 -178.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.574 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 114.28 -22.14 14.15 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.126 -1.59 . . . . 0.17 109.126 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -69.67 145.3 52.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -1.177 . . . . 0.21 110.213 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.444 HG13 HG12 ' A' ' 6' ' ' ILE . 7.2 mt -108.14 151.84 10.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.391 -0.818 . . . . 0.16 111.041 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -103.82 128.47 51.26 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.701 -0.624 . . . . 0.1 109.992 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -102.89 103.85 14.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.532 -0.73 . . . . 0.11 110.344 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -51.37 -23.45 3.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.389 -0.819 . . . . 0.12 110.717 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.79 11.77 10.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.19 110.897 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -176.47 69.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.27 109.906 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.72 -146.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.011 -1.236 . . . . 0.21 110.011 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.06 172.96 9.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.399 -1.059 . . . . 0.27 110.697 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -110.58 -21.57 12.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.38 110.301 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.11 -59.92 2.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.39 110.399 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -57.68 -21.23 39.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.39 110.3 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.36 31.96 6.92 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.198 -1.561 . . . . 0.28 109.198 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -78.71 76.98 5.2 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.345 -1.091 . . . . 0.31 110.122 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 14.9 t -51.38 148.45 8.89 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.431 -0.793 . . . . 0.4 110.865 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 38.4 Cg_exo -56.51 123.83 14.79 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.695 1.366 . . . . 0.25 110.493 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.6 22.87 5.28 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.572 -1.411 . . . . 0.09 109.572 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.423 HG22 HD11 ' A' ' 34' ' ' ILE . 69.8 m -97.29 132.69 42.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -1.159 . . . . 0.15 110.268 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.8 ttp85 -109.01 142.24 39.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.24 110.394 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.861 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -48.01 -48.25 32.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.266 -0.897 . . . . 0.28 110.821 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.54 -46.82 66.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.89 . . . . 0.31 110.179 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.59 -11.66 60.74 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.4 -0.813 . . . . 0.25 110.378 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 31' ' ' PHE . 77.8 mt -87.46 121.53 71.11 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.026 -1.046 . . . . 0.26 109.973 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.8 -174.9 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.402 1.212 . . . . 0.34 110.505 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.37 -20.28 54.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 0.37 110.369 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -50.0 -37.32 32.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.39 110.53 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 69.2 t90 -77.19 157.31 30.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.323 -0.861 . . . . 0.25 110.241 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.2 p -156.49 -160.38 0.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.11 110.192 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 1.2 t -81.22 145.77 56.82 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 0.31 110.123 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 5.5 Cg_exo -75.16 -12.98 21.22 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.397 1.209 . . . . 0.59 111.194 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -121.23 -12.79 8.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.899 -1.126 . . . . 0.57 111.387 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 99.1 m -116.17 -72.91 0.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.917 -1.114 . . . . 0.39 110.597 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.29 29.65 1.9 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.675 -1.37 . . . . 0.22 109.675 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.552 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . . . -110.87 -174.88 2.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -1.154 . . . . 0.12 110.285 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.7 p -89.82 -158.86 0.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.17 110.315 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 50' ' ' TYR . 11.9 tmtt? -64.22 -12.08 37.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.427 -0.796 . . . . 0.33 110.568 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -48.33 -45.98 35.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.048 -1.032 . . . . 0.43 110.846 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.552 ' OD2' ' HB3' ' A' ' 45' ' ' ALA . 2.7 p30 -79.53 -19.31 49.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.43 110.334 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.416 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 2.7 m-85 -94.13 128.72 40.7 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.118 -0.989 . . . . 0.47 110.573 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 52' ' ' LEU . 95.4 t -123.15 161.86 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.49 110.148 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.437 ' HA ' HD22 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -76.24 110.43 10.74 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.223 -0.923 . . . . 0.57 110.371 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -51.33 144.21 10.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.57 110.539 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -153.71 135.05 14.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.28 110.385 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -77.81 100.76 6.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.28 110.459 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.1 mttt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.943 -1.027 . . . . 0.46 110.414 179.852 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.268 0.556 . . . . 0.38 110.344 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.444 ' CE1' ' HA2' ' A' ' 28' ' ' GLY . 34.1 m-85 -121.22 134.38 55.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.69 110.383 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.772 HD23 HD21 ' A' ' 52' ' ' LEU . 1.7 mp -84.14 172.34 12.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.373 -0.829 . . . . 0.65 110.689 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -138.08 130.21 28.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.322 -0.861 . . . . 0.29 110.001 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.529 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 30.2 m95 -108.9 179.94 4.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.165 -0.959 . . . . 0.3 110.374 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.905 HD13 HG13 ' A' ' 13' ' ' ILE . 2.7 tp -156.55 129.7 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.584 -0.697 . . . . 0.46 110.209 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.1 t -79.29 98.35 6.63 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.375 -0.828 . . . . 0.37 110.301 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.9 tt -55.96 -20.32 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.961 . . . . 0.42 110.18 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.1 m -75.73 -27.35 58.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.373 -0.83 . . . . 0.49 110.125 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.2 m -120.45 -50.74 2.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.28 110.743 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.516 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 113.06 19.95 6.56 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.17 109.506 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -100.31 120.11 39.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -1.223 . . . . 0.21 110.05 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.905 HG13 HD13 ' A' ' 6' ' ' ILE . 43.5 mt -81.95 134.88 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.93 . . . . 0.16 110.577 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.422 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 48.2 t80 -92.93 125.78 37.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.458 -0.776 . . . . 0.1 110.067 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -99.35 103.55 15.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.499 -0.751 . . . . 0.11 109.975 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -49.57 -24.94 2.39 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.277 -0.89 . . . . 0.12 110.895 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.69 22.52 7.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.19 110.058 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -176.22 66.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.27 110.041 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.89 -140.06 0.67 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.777 -1.329 . . . . 0.21 109.777 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.42 173.24 6.39 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.357 -1.084 . . . . 0.27 110.599 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.58 -23.38 12.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.365 -0.834 . . . . 0.38 110.159 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.18 -29.42 28.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.39 110.329 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -87.39 14.03 8.81 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.303 -0.873 . . . . 0.39 110.823 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.85 28.39 68.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.406 -1.478 . . . . 0.28 109.406 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.562 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -86.85 79.1 8.91 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.24 -1.153 . . . . 0.31 110.316 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 15.3 t -60.77 154.51 57.46 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.403 -0.811 . . . . 0.4 110.76 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 23.7 Cg_exo -60.7 119.29 6.38 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.751 1.395 . . . . 0.25 110.484 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.444 ' HA2' ' CE1' ' A' ' 2' ' ' TYR . . . 113.2 38.33 1.25 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.474 -1.45 . . . . 0.09 109.474 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.4 m -114.58 130.84 56.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -1.158 . . . . 0.15 110.391 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -108.5 142.15 39.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.24 110.282 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.762 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -48.24 -43.88 32.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.124 -0.985 . . . . 0.28 110.668 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -54.76 -22.7 14.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.941 . . . . 0.31 109.774 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.56 22.07 16.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.343 -0.848 . . . . 0.25 110.161 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.762 HD12 ' HA ' ' A' ' 31' ' ' PHE . 89.7 mt -120.11 70.64 15.49 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.26 110.471 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -85.05 13.36 2.8 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.543 1.286 . . . . 0.34 111.146 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.27 30.23 1.3 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.979 -1.076 . . . . 0.37 110.91 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 t70 51.49 44.72 28.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.11 -0.994 . . . . 0.39 110.742 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.562 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 59.5 t90 -52.37 151.3 4.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.25 109.966 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 88.6 m -132.47 -169.26 2.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.137 -0.977 . . . . 0.11 110.768 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.468 ' HB3' ' CB ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -82.19 163.06 54.57 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.31 110.375 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -67.66 -33.91 26.63 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.609 1.32 . . . . 0.59 110.222 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -150.25 57.63 0.95 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.57 109.947 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' CB ' ' HB3' ' A' ' 40' ' ' CYS . 1.8 t -141.58 -56.0 0.47 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.347 -0.845 . . . . 0.39 110.248 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.6 41.13 5.49 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.46 -1.456 . . . . 0.22 109.46 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.27 171.1 8.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.16 -1.2 . . . . 0.12 110.494 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.0 p -92.09 -172.51 3.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.17 110.427 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -15.75 48.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.33 110.261 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -54.41 -38.44 66.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.43 110.223 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.528 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -76.45 -19.3 58.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.43 110.449 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.41 ' CZ ' ' CH2' ' A' ' 38' ' ' TRP . 4.0 m-85 -95.3 129.86 42.27 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.162 -0.961 . . . . 0.47 110.591 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 6' ' ' ILE . 33.2 m -125.6 172.8 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.49 110.246 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.772 HD21 HD23 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -78.84 116.57 19.26 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.299 -0.876 . . . . 0.57 110.252 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -69.83 139.69 53.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.57 110.633 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 49.63 91.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.383 -0.823 . . . . 0.28 110.737 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -57.07 114.3 2.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.28 110.135 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.109 -0.948 . . . . 0.46 110.435 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.288 0.566 . . . . 0.38 110.427 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -120.22 142.26 49.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 0.69 110.505 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.411 ' O ' ' CG ' ' A' ' 16' ' ' GLU . 6.9 mp -108.96 159.55 16.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.44 -0.788 . . . . 0.65 110.582 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.442 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 9.5 mttp -113.9 160.45 18.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.237 -0.915 . . . . 0.29 109.832 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.527 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 29.1 m95 -128.2 133.07 48.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.093 -1.004 . . . . 0.3 110.598 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.75 HD13 HG13 ' A' ' 13' ' ' ILE . 3.5 tp -104.02 141.62 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.093 -1.004 . . . . 0.46 111.016 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.454 ' H ' HD12 ' A' ' 6' ' ' ILE . 16.1 t -92.35 102.35 14.84 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.385 -0.822 . . . . 0.37 109.978 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.9 tt -55.79 -20.09 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.952 . . . . 0.42 110.595 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.3 m -67.55 -36.73 81.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.49 110.936 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.3 p -131.33 -34.4 1.41 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.984 -1.073 . . . . 0.28 111.157 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.624 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 107.81 41.65 1.55 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.489 -1.444 . . . . 0.17 109.489 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.458 ' CE1' ' HG2' ' A' ' 41' ' ' PRO . 13.7 t-80 -105.06 126.68 52.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -1.113 . . . . 0.21 110.113 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.75 HG13 HD13 ' A' ' 6' ' ' ILE . 6.0 mt -93.69 133.18 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.16 110.685 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.469 ' HH ' ' HD2' ' A' ' 25' ' ' PHE . 72.5 t80 -97.33 132.23 43.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.571 -0.705 . . . . 0.1 109.538 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.526 ' OD1' ' HB3' ' A' ' 17' ' ' ALA . 10.3 t70 -102.69 103.62 13.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.529 -0.732 . . . . 0.11 110.165 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 3' ' ' LEU . 26.0 mt-10 -52.2 -22.91 4.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.901 . . . . 0.12 110.596 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.526 ' HB3' ' OD1' ' A' ' 15' ' ' ASP . . . -88.25 12.68 13.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.19 110.699 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tp -177.25 68.81 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.172 -0.955 . . . . 0.27 109.655 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.99 -139.54 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.254 -1.139 . . . . 0.21 110.254 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -89.37 164.35 14.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.44 -1.035 . . . . 0.27 110.809 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -107.12 -31.98 8.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.444 -0.785 . . . . 0.38 109.93 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.29 -53.46 19.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.311 -0.868 . . . . 0.39 110.264 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -60.86 -27.78 68.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.39 110.072 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.12 28.41 6.87 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.601 -1.4 . . . . 0.28 109.601 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.541 ' HE2' HD11 ' A' ' 34' ' ' ILE . 0.5 OUTLIER -66.67 83.53 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.066 -1.255 . . . . 0.31 110.128 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 14.0 t -50.79 145.83 10.95 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.456 -0.777 . . . . 0.4 110.74 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 34.7 Cg_exo -55.56 116.84 3.44 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.631 1.332 . . . . 0.25 110.431 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 116.11 24.46 3.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.663 -1.375 . . . . 0.09 109.663 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.8 m -98.13 116.2 29.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -1.198 . . . . 0.15 110.149 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.406 ' HA ' ' HG2' ' A' ' 16' ' ' GLU . 15.2 ttp180 -94.99 142.66 27.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.244 -0.91 . . . . 0.24 110.626 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.733 ' HA ' HD12 ' A' ' 34' ' ' ILE . 1.2 t80 -50.57 -27.19 6.29 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.282 -0.887 . . . . 0.28 110.252 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.08 -33.8 58.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -0.971 . . . . 0.31 109.804 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.412 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 5.2 t0 -89.51 7.58 35.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.521 -0.737 . . . . 0.25 110.45 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.733 HD12 ' HA ' ' A' ' 31' ' ' PHE . 33.8 mt -100.02 96.35 4.82 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.09 -1.006 . . . . 0.26 109.67 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 34' ' ' ILE . 16.3 Cg_endo -62.16 -79.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.649 1.341 . . . . 0.34 111.02 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -156.71 -35.87 0.08 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.944 . . . . 0.37 111.273 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -45.79 -30.0 1.51 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.172 -0.955 . . . . 0.39 111.087 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.414 ' HB3' HG23 ' A' ' 34' ' ' ILE . 88.2 t90 -75.4 138.3 41.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.25 110.04 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.407 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 97.8 m -127.12 -175.1 3.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.11 110.266 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.41 ' SG ' ' CE2' ' A' ' 50' ' ' TYR . 0.5 OUTLIER -81.38 138.73 48.18 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.31 110.283 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.458 ' HG2' ' CE1' ' A' ' 12' ' ' HIS . 36.9 Cg_endo -71.66 -16.3 30.15 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.488 1.257 . . . . 0.59 110.816 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.2 -0.36 15.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.988 . . . . 0.57 111.236 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 64.2 m -138.45 -68.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.953 -1.092 . . . . 0.39 110.404 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 39' ' ' CYS . . . 107.17 32.26 3.55 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.327 -1.509 . . . . 0.22 109.327 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.89 -168.74 1.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -1.106 . . . . 0.12 110.613 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 p -88.04 178.31 6.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.38 -0.825 . . . . 0.17 110.526 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -65.05 -22.28 66.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 0.33 110.172 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -58.04 -18.96 27.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.43 110.406 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.464 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.1 m-20 -83.65 -15.47 48.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.43 110.661 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.41 ' CE2' ' SG ' ' A' ' 40' ' ' CYS . 1.9 m-85 -99.81 145.24 27.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.046 -1.034 . . . . 0.47 111.199 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.3 m -145.75 164.56 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.538 -0.727 . . . . 0.49 109.905 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 53' ' ' TYR . 2.2 tp -69.77 127.76 34.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 0.57 110.824 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.557 ' HD1' HG21 ' A' ' 6' ' ' ILE . 7.3 t80 -88.72 140.77 29.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.57 110.202 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -167.08 87.68 0.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.28 110.394 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.7 171.64 13.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.245 -0.909 . . . . 0.28 110.186 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.972 -1.013 . . . . 0.46 110.418 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.28 0.562 . . . . 0.38 110.322 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 24.7 m-85 -70.97 136.53 48.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.177 -0.952 . . . . 0.69 110.345 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.699 HD23 HD21 ' A' ' 52' ' ' LEU . 4.8 mp -87.46 -178.27 6.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.358 -0.839 . . . . 0.65 110.455 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.41 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 25.0 mttt -142.98 146.6 34.06 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.483 -0.761 . . . . 0.29 110.165 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.562 ' CE3' ' CD2' ' A' ' 31' ' ' PHE . 22.7 m95 -130.09 123.6 30.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.3 110.078 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.826 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -106.63 134.47 48.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.037 -1.04 . . . . 0.46 110.278 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.826 ' N ' HD13 ' A' ' 6' ' ' ILE . 4.3 t -79.89 96.04 6.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.407 -0.808 . . . . 0.37 110.098 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.7 pt -53.23 -22.6 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.132 -0.98 . . . . 0.42 110.146 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.6 m -75.57 -28.16 58.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.295 -0.878 . . . . 0.49 110.203 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.4 m -115.24 -50.93 2.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.28 110.869 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.56 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 113.12 19.02 6.95 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.47 -1.452 . . . . 0.17 109.47 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 1.9 m170 -102.0 131.54 48.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -1.22 . . . . 0.21 110.002 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.418 HG13 HG12 ' A' ' 6' ' ' ILE . 73.0 mt -95.31 136.71 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.16 110.761 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.479 ' HH ' ' HE2' ' A' ' 25' ' ' PHE . 66.1 t80 -99.4 132.53 44.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.1 109.959 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -109.7 111.56 23.1 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.511 -0.743 . . . . 0.11 109.703 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -51.15 -24.06 3.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.12 110.493 -179.233 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 2' ' ' TYR . . . -93.55 17.53 11.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.172 -0.955 . . . . 0.19 110.245 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -177.31 68.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.27 109.71 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.28 -137.1 1.73 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.224 -1.151 . . . . 0.21 110.224 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 22' ' ' ALA . 11.3 t70 -78.97 158.42 27.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.432 -1.04 . . . . 0.27 110.776 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -104.13 -33.29 8.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.38 110.094 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . -80.01 -45.62 18.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.39 110.205 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.12 -35.22 71.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -0.928 . . . . 0.39 109.976 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.2 20.37 7.53 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.568 -1.413 . . . . 0.28 109.568 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.571 ' CE1' ' CD1' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -67.79 77.97 0.2 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.111 -1.229 . . . . 0.31 110.224 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.0 t -52.66 151.65 7.73 Favored Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.444 -0.785 . . . . 0.4 110.702 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -58.89 116.77 3.49 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.703 1.37 . . . . 0.25 110.394 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.62 -23.95 5.59 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.346 -1.502 . . . . 0.09 109.346 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.539 HG22 HD11 ' A' ' 34' ' ' ILE . 6.7 m -53.26 132.29 38.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -1.152 . . . . 0.15 110.235 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.453 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 16.1 mtp180 -115.51 146.29 41.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.853 . . . . 0.24 110.394 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.562 ' CD2' ' CE3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -50.93 -33.65 25.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.28 110.273 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -53.21 -50.98 63.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.871 . . . . 0.31 110.02 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.416 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 4.5 t70 -70.06 -7.84 44.49 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.416 -0.803 . . . . 0.25 110.471 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.543 HG23 ' HB3' ' A' ' 38' ' ' TRP . 30.1 mt -103.4 94.8 6.23 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.156 -0.965 . . . . 0.26 110.154 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 33' ' ' ASP . 30.0 Cg_endo -67.94 -88.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.663 1.349 . . . . 0.34 110.834 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.29 -18.6 2.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.833 -1.167 . . . . 0.37 111.628 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.9 -55.02 12.98 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.796 -1.19 . . . . 0.39 110.867 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.571 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 54.9 t90 -69.83 159.81 32.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.196 -0.94 . . . . 0.25 110.126 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -162.16 176.81 10.27 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.373 -0.83 . . . . 0.11 110.361 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -51.55 149.77 7.6 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.85 . . . . 0.31 109.988 178.648 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.52 -27.85 70.19 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.527 1.278 . . . . 0.59 110.74 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.2 57.36 0.89 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.935 . . . . 0.57 110.217 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.469 ' CB ' ' HB3' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -152.46 -45.53 0.1 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.259 -0.901 . . . . 0.39 110.045 -179.157 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.53 42.65 95.57 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.54 -1.424 . . . . 0.22 109.54 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.41 32.74 5.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -1.198 . . . . 0.12 110.823 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.1 p 44.02 -153.65 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.578 0.704 . . . . 0.17 111.101 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -81.56 -13.08 58.49 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.515 -0.741 . . . . 0.33 110.447 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.08 -48.84 43.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.085 -1.009 . . . . 0.43 110.794 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 9.8 m-20 -76.64 -16.63 59.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.43 110.43 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.41 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 1.8 m-85 -93.56 135.92 34.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.042 -1.036 . . . . 0.47 110.51 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 71.4 t -131.59 150.12 33.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.282 -0.886 . . . . 0.49 110.232 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.699 HD21 HD23 ' A' ' 3' ' ' LEU . 0.5 OUTLIER -63.63 125.12 23.24 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.352 -0.842 . . . . 0.57 110.43 -179.546 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.644 ' N ' HD13 ' A' ' 52' ' ' LEU . 17.1 t80 -71.93 100.27 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 0.57 110.38 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -143.19 103.81 4.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.28 110.399 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.92 -173.37 4.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.242 -0.911 . . . . 0.28 110.327 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.6 tttt . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.917 -1.039 . . . . 0.46 110.371 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.215 0.531 . . . . 0.38 110.437 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.518 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 55.9 m-85 -77.78 139.72 39.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.32 -0.862 . . . . 0.69 110.487 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 3' ' ' LEU . 8.7 mp -90.53 171.31 9.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.65 110.397 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.438 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 19.6 mttp -136.12 158.37 44.58 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.29 109.959 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.531 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 31.2 m95 -127.8 136.44 51.47 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -0.944 . . . . 0.3 110.579 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.729 HD13 HG13 ' A' ' 13' ' ' ILE . 3.4 tp -106.13 137.87 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.964 -1.085 . . . . 0.46 110.568 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 11' ' ' GLY . 7.6 t -83.41 96.13 8.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.547 -0.721 . . . . 0.37 110.25 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 49' ' ' ASP . 2.4 tt -56.11 -19.95 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.981 -1.074 . . . . 0.42 110.027 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.9 m -77.64 -27.15 50.97 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.325 -0.86 . . . . 0.49 110.105 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 64.4 m -123.64 -54.99 1.74 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.338 -0.851 . . . . 0.28 110.632 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.526 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 119.83 27.07 2.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.84 -1.304 . . . . 0.17 109.84 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.664 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -109.36 144.06 38.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -1.185 . . . . 0.21 110.278 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.729 HG13 HD13 ' A' ' 6' ' ' ILE . 7.2 mt -98.41 145.53 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.847 . . . . 0.16 110.968 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 58.1 t80 -105.7 133.58 50.21 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.369 -0.604 . . . . 0.1 109.369 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -101.6 106.76 17.87 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.552 -0.718 . . . . 0.11 110.198 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 30' ' ' ARG . 24.3 mt-10 -50.28 -25.98 4.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.308 -0.87 . . . . 0.12 110.722 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.518 ' HB2' ' CD2' ' A' ' 2' ' ' TYR . . . -100.07 19.97 15.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.19 110.352 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.489 ' HA ' HD22 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -177.55 70.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.27 110.338 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' A' ' 25' ' ' PHE . . . -64.24 -135.69 0.01 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.572 -1.411 . . . . 0.21 109.572 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -99.39 172.08 7.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -1.169 . . . . 0.27 110.702 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.37 -24.18 20.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.38 110.003 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.25 -36.95 17.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.307 -0.87 . . . . 0.39 110.106 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -66.91 -21.65 65.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.39 110.074 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.16 31.06 53.8 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.258 -1.537 . . . . 0.28 109.258 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.654 ' CE1' HG21 ' A' ' 29' ' ' THR . 0.1 OUTLIER -71.72 82.43 0.87 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.15 -1.206 . . . . 0.31 110.141 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.3 t -49.29 142.27 10.87 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.4 110.767 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 39.0 Cg_exo -52.83 108.5 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.555 1.292 . . . . 0.25 110.69 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.01 44.04 0.26 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.602 -1.399 . . . . 0.09 109.602 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.654 HG21 ' CE1' ' A' ' 25' ' ' PHE . 1.5 m -122.63 136.26 54.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -1.165 . . . . 0.15 110.555 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.401 ' HA ' ' HG2' ' A' ' 16' ' ' GLU . 8.9 mtp180 -122.87 144.34 49.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.351 -0.843 . . . . 0.24 110.224 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.593 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -48.18 -49.13 33.77 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.224 -0.922 . . . . 0.28 110.494 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -53.37 -26.8 20.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.31 109.64 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.21 16.73 20.46 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.491 -0.755 . . . . 0.25 110.133 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.644 ' O ' HG22 ' A' ' 34' ' ' ILE . 92.2 mt -123.88 66.82 40.08 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.26 110.327 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -84.68 14.46 2.45 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 123.61 1.321 . . . . 0.34 111.412 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.28 41.89 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.879 -1.138 . . . . 0.37 110.886 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.1 t0 48.55 28.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.145 -0.972 . . . . 0.39 110.872 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.424 ' NE1' ' CE2' ' A' ' 25' ' ' PHE . 63.7 t90 -53.7 151.64 5.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 0.25 110.28 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 83.4 m -148.65 -167.31 2.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.325 -0.859 . . . . 0.11 110.133 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.24 169.98 18.1 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.232 -0.918 . . . . 0.31 109.981 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -57.94 -47.7 19.53 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.563 1.296 . . . . 0.59 110.206 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -178.82 57.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.45 -0.781 . . . . 0.57 109.981 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 21.1 p -162.14 -36.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.152 -0.968 . . . . 0.39 111.113 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -95.67 -41.53 3.85 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.574 -1.411 . . . . 0.22 109.574 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 56.82 163.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -1.047 . . . . 0.12 110.945 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 44.61 -161.23 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.468 -0.77 . . . . 0.17 111.053 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -122.31 -21.53 5.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.338 -0.851 . . . . 0.33 110.72 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.49 -28.96 48.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.977 . . . . 0.43 110.448 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.749 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.5 m-20 -74.07 -17.69 60.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.43 110.34 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -97.15 136.41 37.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.095 -1.003 . . . . 0.47 110.725 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.27 162.83 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.49 109.914 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.88 118.84 19.87 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.121 -0.987 . . . . 0.57 110.5 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.38 137.92 58.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.57 110.518 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 51.49 91.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.28 110.485 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -96.54 73.58 2.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 0.28 110.432 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.7 mttt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.934 -1.031 . . . . 0.46 110.388 179.914 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.217 0.532 . . . . 0.38 110.322 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -131.63 133.84 45.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.69 110.466 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.049 HD23 HD21 ' A' ' 52' ' ' LEU . 0.7 OUTLIER -90.67 167.21 12.7 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.248 -0.907 . . . . 0.65 110.272 179.869 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -127.4 125.57 40.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.29 110.474 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.526 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 23.2 m95 -106.62 179.22 4.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.3 110.032 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.731 HD11 ' HA2' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -157.69 126.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 119.844 -0.742 . . . . 0.46 110.193 178.025 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.664 ' N ' HD13 ' A' ' 6' ' ' ILE . 12.5 t -73.47 91.1 1.76 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.353 -0.842 . . . . 0.37 109.488 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.5 pt -51.92 -22.95 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.195 -0.941 . . . . 0.42 110.334 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 94.4 m -59.03 -27.86 65.87 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.379 -0.825 . . . . 0.49 110.714 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -137.11 -36.7 0.66 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.145 -0.972 . . . . 0.28 111.243 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.731 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 117.16 19.78 5.03 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.516 -1.326 . . . . 0.17 110.077 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.37 115.1 26.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.047 -1.266 . . . . 0.21 110.232 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.2 mt -84.2 128.62 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.925 . . . . 0.16 110.539 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 63.2 t80 -91.74 120.82 32.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.1 109.814 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -99.18 103.98 15.91 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.217 -0.927 . . . . 0.11 109.879 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -47.58 -26.57 1.5 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.12 111.075 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.33 19.01 8.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.176 -0.953 . . . . 0.19 110.579 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -176.1 68.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.27 110.165 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.16 -143.42 0.79 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.737 -1.345 . . . . 0.21 109.737 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.56 165.25 12.43 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.34 -1.094 . . . . 0.27 110.297 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.04 -41.79 6.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.237 -0.914 . . . . 0.38 110.346 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.72 -50.2 70.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.39 110.26 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.09 -21.07 44.39 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.176 -0.953 . . . . 0.39 110.397 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.38 23.25 17.1 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.221 -1.551 . . . . 0.28 109.221 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -83.83 78.91 9.64 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.242 -1.151 . . . . 0.31 110.05 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.4 t -49.24 151.67 2.42 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.357 -0.84 . . . . 0.4 110.985 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 23.6 Cg_exo -60.68 80.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.713 1.375 . . . . 0.25 110.387 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 26' ' ' THR . . . 153.82 42.11 0.02 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.148 -1.581 . . . . 0.09 109.148 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.6 m -112.56 134.44 54.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.35 -1.088 . . . . 0.15 110.341 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -111.43 145.96 38.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.829 . . . . 0.24 110.163 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.685 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -52.39 -41.21 62.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.919 . . . . 0.28 110.251 179.641 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -53.64 -43.63 68.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.873 . . . . 0.31 110.204 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.41 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 3.2 t0 -79.17 2.03 22.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.25 110.772 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 31' ' ' PHE . 88.7 mt -106.26 89.77 4.16 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.0 -1.063 . . . . 0.26 110.075 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 33' ' ' ASP . 28.5 Cg_endo -68.77 -170.88 0.35 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.672 1.353 . . . . 0.34 110.651 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.57 98.3 0.09 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.9 . . . . 0.37 110.329 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.68 -36.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.39 110.285 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.573 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 87.9 t90 -90.29 142.35 27.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.837 . . . . 0.25 110.479 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.408 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 67.4 m -133.88 -174.51 3.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.11 110.191 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -83.55 156.13 65.47 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.077 -1.015 . . . . 0.31 110.286 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.67 -5.14 14.6 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.487 1.256 . . . . 0.59 111.201 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 50.1 p30 -146.09 20.6 1.41 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.875 -1.14 . . . . 0.57 110.968 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 76.8 m -143.0 -49.03 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.165 -0.959 . . . . 0.39 110.424 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 39' ' ' CYS . . . 77.01 33.23 46.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.409 -1.476 . . . . 0.22 109.409 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.549 ' HB1' ' OD1' ' A' ' 49' ' ' ASP . . . -102.57 -172.05 2.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -1.169 . . . . 0.12 110.49 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.97 -171.91 2.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.855 . . . . 0.17 110.332 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.454 ' HD3' ' CD2' ' A' ' 31' ' ' PHE . 20.3 mttt -60.56 -18.8 54.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.35 -0.844 . . . . 0.33 110.227 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.24 -41.07 65.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.43 110.361 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.549 ' OD1' ' HB1' ' A' ' 45' ' ' ALA . 2.1 m-20 -69.29 -24.23 63.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.43 109.826 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -92.96 137.88 31.97 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.443 -0.786 . . . . 0.47 110.512 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.427 HG22 ' N ' ' A' ' 52' ' ' LEU . 8.6 p -129.69 163.68 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 0.49 110.032 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.049 HD21 HD23 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -69.84 108.75 4.1 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.114 -0.991 . . . . 0.57 110.084 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -62.82 141.25 58.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.57 110.749 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 52.43 89.87 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.85 . . . . 0.28 110.557 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -95.42 55.43 1.72 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.161 -0.962 . . . . 0.28 110.219 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.976 -1.012 . . . . 0.46 110.314 -179.895 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.23 0.538 . . . . 0.38 110.356 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.513 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 23.0 m-85 -139.88 134.95 32.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.69 110.358 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.45 HD23 HD21 ' A' ' 52' ' ' LEU . 2.6 mp -81.73 165.93 20.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.65 110.759 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.44 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 23.6 mttm -134.38 151.39 51.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.29 110.12 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 20.1 m95 -133.03 127.15 33.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.3 -0.875 . . . . 0.3 109.927 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.845 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -102.64 134.43 43.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.112 -0.992 . . . . 0.46 110.898 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.845 ' N ' HD13 ' A' ' 6' ' ' ILE . 16.3 t -79.9 95.71 6.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.579 -0.7 . . . . 0.37 109.588 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.534 HG22 ' O ' ' A' ' 49' ' ' ASP . 2.1 tt -55.26 -20.12 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.42 110.628 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.1 m -63.46 -27.98 69.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.28 -0.888 . . . . 0.49 110.885 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.5 p -134.09 -35.89 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.967 -1.083 . . . . 0.28 111.397 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.568 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 112.21 35.96 1.71 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.533 -1.318 . . . . 0.17 109.854 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 4.2 t-80 -112.14 129.26 56.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.128 -1.219 . . . . 0.21 110.397 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.424 HG13 HG12 ' A' ' 6' ' ' ILE . 13.5 mt -91.58 146.66 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.16 111.096 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -108.68 129.14 55.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.565 -0.709 . . . . 0.1 109.809 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -105.32 106.75 17.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.549 -0.719 . . . . 0.11 110.234 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 2' ' ' TYR . 19.1 mt-10 -49.88 -24.54 2.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.12 110.664 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.513 ' HB2' ' CD2' ' A' ' 2' ' ' TYR . . . -88.0 14.25 9.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.19 110.71 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 tp -176.08 67.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.025 -1.047 . . . . 0.27 109.955 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.43 -143.03 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.897 -1.281 . . . . 0.21 109.897 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.88 165.38 11.59 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.37 -1.076 . . . . 0.27 110.525 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -107.19 -20.02 13.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.38 110.545 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.59 -36.0 38.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.151 -0.968 . . . . 0.39 110.392 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -81.42 -13.31 58.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.39 110.729 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.81 27.7 16.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.073 -1.611 . . . . 0.28 109.073 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -82.97 82.77 8.07 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.371 -1.076 . . . . 0.31 110.229 -179.654 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.3 t -49.69 142.34 12.36 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.173 -0.954 . . . . 0.4 110.77 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 36.8 Cg_exo -53.05 109.66 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.559 1.294 . . . . 0.25 110.612 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.92 -14.03 5.23 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.142 -1.183 . . . . 0.09 110.142 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.509 HG22 HD11 ' A' ' 34' ' ' ILE . 1.3 m -51.53 129.68 26.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.95 -1.324 . . . . 0.15 110.804 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -108.83 134.19 51.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.357 -0.84 . . . . 0.24 110.003 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.684 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -47.06 -51.88 16.48 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.242 -0.911 . . . . 0.28 110.947 -179.372 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -51.5 -37.15 47.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 0.31 109.96 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -85.5 8.8 17.82 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.438 -0.789 . . . . 0.25 110.274 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.684 HD12 ' HA ' ' A' ' 31' ' ' PHE . 78.5 mt -111.82 72.0 1.03 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.98 -1.075 . . . . 0.26 110.226 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -71.46 -21.51 26.02 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.622 1.328 . . . . 0.34 110.415 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -55.18 -172.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.37 110.447 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.72 43.97 1.04 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.892 . . . . 0.39 110.349 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 83.2 t90 -52.6 144.88 12.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.853 . . . . 0.25 110.251 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 91.6 m -130.96 -167.08 1.78 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.11 110.546 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -87.09 143.29 34.63 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.31 110.375 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -78.28 -17.07 13.42 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.567 1.298 . . . . 0.59 111.009 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -28.55 9.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.05 -1.031 . . . . 0.57 110.866 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 94.1 m -101.22 -71.99 0.69 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 0.39 110.606 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.82 29.38 1.86 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.581 -1.408 . . . . 0.22 109.581 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.51 -173.84 2.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.103 -1.234 . . . . 0.12 110.337 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.1 p -97.12 -170.88 2.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.17 110.393 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.501 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 5.8 tttt -61.44 -16.66 48.99 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.364 -0.835 . . . . 0.33 110.388 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -58.29 -28.38 64.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -0.97 . . . . 0.43 110.634 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.534 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.5 m-20 -86.23 -16.98 35.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.43 110.51 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 7' ' ' CYS . 1.9 m-85 -94.34 138.28 32.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -0.932 . . . . 0.47 110.86 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 52' ' ' LEU . 87.3 t -132.75 163.05 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.775 . . . . 0.49 110.047 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.453 ' HA ' HD22 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -74.28 117.19 15.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.172 -0.955 . . . . 0.57 110.334 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.422 ' N ' HD13 ' A' ' 52' ' ' LEU . 29.7 t80 -66.02 118.0 9.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.57 110.531 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -112.18 149.03 32.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.28 110.158 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -91.42 106.31 18.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.28 110.403 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.9 tttt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.994 -1.003 . . . . 0.46 110.299 179.87 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.996 0.427 . . . . 0.38 110.385 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.513 ' CD1' ' HB3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER 57.45 152.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.898 0.856 . . . . 0.69 111.283 178.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.84 169.39 6.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -0.865 . . . . 0.65 110.517 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.71 128.13 15.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.39 -0.819 . . . . 0.29 109.947 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.525 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 27.5 m95 -107.42 174.25 5.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.3 110.019 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.922 HD13 HG13 ' A' ' 13' ' ' ILE . 2.4 tp -149.18 123.31 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.46 110.438 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 9.1 t -69.33 95.12 0.76 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.376 -0.828 . . . . 0.37 109.933 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 9' ' ' THR . 11.0 pt -52.28 -22.76 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.16 -0.963 . . . . 0.42 110.174 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.42 ' N ' HG13 ' A' ' 8' ' ' ILE . 34.2 m -61.37 -43.99 97.93 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.445 -0.784 . . . . 0.49 110.915 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.9 p -123.59 -32.09 3.39 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.983 . . . . 0.28 110.945 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.677 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 108.27 30.66 3.79 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.811 -1.316 . . . . 0.17 109.811 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -95.17 112.97 24.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.244 -1.151 . . . . 0.21 110.015 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.922 HG13 HD13 ' A' ' 6' ' ' ILE . 63.2 mt -80.72 128.73 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.16 110.533 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.416 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 63.1 t80 -92.6 132.25 37.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.519 -0.738 . . . . 0.1 110.052 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -101.69 104.57 15.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.541 -0.724 . . . . 0.11 110.102 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.513 ' HB3' ' CD1' ' A' ' 2' ' ' TYR . 10.2 mt-10 -53.4 -27.12 22.54 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.159 -0.963 . . . . 0.12 110.651 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.464 ' HB2' ' HB2' ' A' ' 2' ' ' TYR . . . -92.01 18.73 7.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.143 -0.973 . . . . 0.19 110.452 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -176.39 66.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.883 . . . . 0.27 109.843 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.83 -142.64 0.06 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.952 -1.259 . . . . 0.21 109.952 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.42 173.76 7.36 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.409 -1.054 . . . . 0.27 110.727 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -109.62 -33.43 6.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.324 -0.86 . . . . 0.38 110.167 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.52 -60.44 3.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.39 110.363 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -61.3 -17.88 55.82 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.39 110.57 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.15 33.34 7.76 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.279 -1.529 . . . . 0.28 109.279 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -81.06 76.44 8.01 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.394 -1.062 . . . . 0.31 110.174 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -50.97 151.22 4.67 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.341 -0.849 . . . . 0.4 110.912 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.03 123.88 14.68 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.631 1.332 . . . . 0.25 110.466 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.7 23.87 4.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.538 -1.425 . . . . 0.09 109.538 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.9 m -94.63 135.83 35.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -1.232 . . . . 0.15 110.325 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.66 138.4 47.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.349 -0.844 . . . . 0.24 110.428 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.878 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -50.12 -30.97 12.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.219 -0.925 . . . . 0.28 110.628 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -61.28 -55.04 36.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.153 -0.967 . . . . 0.31 110.204 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -28.76 69.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.25 110.243 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.878 HD12 ' HA ' ' A' ' 31' ' ' PHE . 82.4 mt -68.33 112.26 10.44 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.26 110.288 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -66.29 -153.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.446 1.235 . . . . 0.34 110.618 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -92.52 -12.42 31.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.37 110.699 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.27 -51.75 68.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.053 . . . . 0.39 110.433 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.533 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 88.2 t90 -56.25 168.7 0.49 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.25 110.532 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.44 ' N ' ' CG ' ' A' ' 38' ' ' TRP . 25.4 p -167.2 -160.65 0.38 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.333 -0.854 . . . . 0.11 110.283 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.7 OUTLIER -87.53 144.13 35.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.397 -0.814 . . . . 0.31 110.307 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.16 9.72 3.97 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.667 1.351 . . . . 0.59 111.281 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 37.4 p-10 -152.02 17.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.84 -1.163 . . . . 0.57 110.934 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 58.0 m -144.92 -72.3 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.068 . . . . 0.39 110.284 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.22 36.76 0.73 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.485 -1.446 . . . . 0.22 109.485 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.451 ' HB1' ' OE2' ' A' ' 48' ' ' GLU . . . -121.35 176.0 5.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -1.156 . . . . 0.12 110.592 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -100.8 -162.68 0.96 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.341 -0.85 . . . . 0.17 109.964 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -55.15 -21.79 14.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.125 -0.984 . . . . 0.33 109.722 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.451 ' OE2' ' HB1' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -53.56 -27.59 27.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.43 109.91 179.293 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 4.4 m-20 -91.85 -21.69 20.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.431 -0.793 . . . . 0.43 109.908 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -97.27 137.63 35.98 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.263 -0.898 . . . . 0.47 110.655 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.464 ' CG1' HG23 ' A' ' 6' ' ' ILE . 7.2 p -127.23 148.1 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.49 110.0 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.67 115.52 4.83 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.141 -0.974 . . . . 0.57 110.348 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -70.29 118.02 12.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.37 -0.831 . . . . 0.57 110.397 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.28 111.89 20.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.28 110.313 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -110.8 135.46 51.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.28 110.371 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.023 -0.989 . . . . 0.46 110.319 179.828 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.17 0.509 . . . . 0.38 110.362 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -107.06 142.25 37.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.364 -0.835 . . . . 0.69 110.39 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.62 170.66 7.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.65 110.524 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -127.32 124.01 37.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.29 110.372 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 35.5 m95 -100.94 172.43 7.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.197 -0.939 . . . . 0.3 110.025 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.833 HD13 HG13 ' A' ' 13' ' ' ILE . 2.2 tp -147.37 126.47 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.46 110.254 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 10.1 t -73.18 89.13 1.5 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.296 -0.877 . . . . 0.37 109.973 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.9 pt -49.77 -25.83 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.066 -1.021 . . . . 0.42 109.982 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -75.61 -28.71 58.96 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.606 -0.684 . . . . 0.49 110.147 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 1.5 m -112.57 -54.45 2.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.28 110.497 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . 115.11 19.65 5.86 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.585 -1.406 . . . . 0.17 109.585 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.55 ' O ' HD12 ' A' ' 6' ' ' ILE . 13.8 m80 -103.93 136.07 44.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -1.207 . . . . 0.21 110.134 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.833 HG13 HD13 ' A' ' 6' ' ' ILE . 3.3 mt -93.93 130.05 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.321 -0.862 . . . . 0.16 110.477 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.526 ' CE1' ' HA2' ' A' ' 19' ' ' GLY . 81.0 t80 -97.68 133.14 42.61 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.1 109.616 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -111.63 111.15 21.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.11 110.239 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 66.2 mt-10 -50.56 -23.35 2.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.383 -0.823 . . . . 0.12 110.989 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.65 8.05 15.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.976 -1.077 . . . . 0.19 110.968 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.486 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -176.6 68.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.022 -1.049 . . . . 0.27 109.625 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.526 ' HA2' ' CE1' ' A' ' 14' ' ' TYR . . . -66.57 -138.39 0.04 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.011 -1.235 . . . . 0.21 110.011 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -100.35 172.48 7.12 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.408 -1.054 . . . . 0.27 110.812 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.88 -31.68 9.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.384 -0.823 . . . . 0.38 110.318 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.93 -50.37 35.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 0.39 110.187 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -60.3 -18.35 48.83 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.304 -0.872 . . . . 0.39 110.574 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.14 23.03 23.52 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.389 -1.484 . . . . 0.28 109.389 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.584 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 1.8 m-30 -83.07 78.14 9.63 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.269 -1.136 . . . . 0.31 110.411 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.401 ' OG1' ' HD2' ' A' ' 27' ' ' PRO . 14.6 t -58.35 155.8 25.27 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.443 -0.785 . . . . 0.4 110.678 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD2' ' OG1' ' A' ' 26' ' ' THR . 33.4 Cg_exo -53.75 113.35 1.28 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.619 1.326 . . . . 0.25 110.463 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.7 34.61 1.05 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.276 -1.53 . . . . 0.09 109.276 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.469 HG22 ' CG1' ' A' ' 34' ' ' ILE . 30.4 m -117.2 121.55 41.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -1.163 . . . . 0.15 110.351 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.453 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 0.5 OUTLIER -108.61 150.86 26.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.279 -0.888 . . . . 0.24 110.353 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.852 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -47.58 -42.79 24.61 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.285 -0.885 . . . . 0.28 111.015 -179.491 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -60.34 -42.73 96.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.31 110.808 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -78.28 -24.89 46.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.212 -0.93 . . . . 0.25 110.463 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.852 HD12 ' HA ' ' A' ' 31' ' ' PHE . 65.2 mt -63.62 111.12 4.57 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.26 110.231 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 34' ' ' ILE . 28.8 Cg_endo -66.78 -174.37 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.41 1.216 . . . . 0.34 109.81 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -68.4 -157.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.073 -1.017 . . . . 0.37 110.309 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.9 t0 65.19 9.84 5.91 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.324 -0.86 . . . . 0.39 111.423 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.584 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 74.3 t90 -109.82 164.98 12.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.751 -1.218 . . . . 0.25 110.482 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.5 p -167.28 -161.7 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.887 . . . . 0.11 110.335 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 1.4 t -89.99 140.98 27.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.31 110.285 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 7.0 Cg_exo -70.91 -7.2 20.87 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.482 1.254 . . . . 0.59 111.378 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -127.73 -9.11 5.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.911 -1.118 . . . . 0.57 111.499 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 84.3 m -121.76 -75.62 0.59 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.897 -1.127 . . . . 0.39 110.536 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.19 33.46 0.96 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.536 -1.426 . . . . 0.22 109.536 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.22 177.02 4.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -1.205 . . . . 0.12 110.447 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -72.28 -162.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.17 110.365 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -75.19 -4.58 39.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.33 110.734 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.05 -41.25 62.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.993 -1.067 . . . . 0.43 110.453 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 1.6 m-20 -71.35 -25.66 62.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.43 110.008 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -89.06 132.29 34.84 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.296 -0.877 . . . . 0.47 110.487 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 87.1 t -130.28 159.66 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.49 110.129 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.7 tp -64.45 117.41 7.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.154 -0.966 . . . . 0.57 110.529 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.414 ' CB ' ' O ' ' A' ' 4' ' ' LYS . 28.0 t80 -76.8 125.54 29.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.57 110.35 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -142.2 160.58 39.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.28 110.285 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -119.94 89.22 3.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.28 110.376 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.4 mttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.015 -0.993 . . . . 0.46 110.447 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.205 0.526 . . . . 0.38 110.429 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.503 ' CE1' ' NH2' ' A' ' 30' ' ' ARG . 40.6 m-85 -76.29 137.43 39.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.69 110.334 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.507 HD23 HD21 ' A' ' 52' ' ' LEU . 6.7 mp -81.32 167.68 19.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.389 -0.819 . . . . 0.65 110.465 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.41 ' HG3' ' HA ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER -138.51 124.86 20.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.29 110.08 179.479 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.501 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 34.4 m95 -100.89 142.14 32.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.3 110.266 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.789 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -107.52 129.04 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.958 -1.089 . . . . 0.46 109.806 178.127 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.789 ' N ' HD13 ' A' ' 6' ' ' ILE . 9.6 t -77.19 87.08 3.64 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.374 -0.829 . . . . 0.37 109.172 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 49' ' ' ASP . 2.0 tt -50.47 -22.63 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.15 -0.969 . . . . 0.42 110.531 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 m -66.51 -30.23 70.5 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.284 -0.885 . . . . 0.49 110.685 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 p -140.15 -15.86 0.98 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.907 -1.121 . . . . 0.28 112.662 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.656 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 104.8 -28.3 15.39 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.29 -1.434 . . . . 0.17 110.049 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -51.86 135.35 30.18 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.06 -1.259 . . . . 0.21 110.415 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.44 ' CG1' HG12 ' A' ' 6' ' ' ILE . 6.7 mt -109.81 142.48 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.82 . . . . 0.16 110.768 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -98.22 123.14 42.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.596 -0.69 . . . . 0.1 109.433 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.41 ' HA ' ' HG3' ' A' ' 4' ' ' LYS . 5.1 m-20 -103.26 108.51 19.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.11 110.137 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -48.23 -25.64 1.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.12 110.764 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.431 ' HB2' ' CD2' ' A' ' 2' ' ' TYR . . . -92.32 21.07 5.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.19 110.234 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 tp -176.24 60.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.27 109.988 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.51 -139.55 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.852 -1.299 . . . . 0.21 109.852 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.69 172.15 7.01 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.392 -1.064 . . . . 0.27 110.561 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.47 -45.07 4.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.353 -0.842 . . . . 0.38 110.356 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.51 -54.64 41.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.39 110.354 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -60.57 -16.94 42.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.39 110.595 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.33 29.99 23.39 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.935 -1.666 . . . . 0.28 108.935 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.415 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -80.94 78.42 7.75 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.441 -1.035 . . . . 0.31 110.291 -179.56 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.4 t -52.06 149.17 9.81 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.327 -0.858 . . . . 0.4 110.592 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.86 116.7 3.44 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.675 1.355 . . . . 0.25 110.514 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.483 ' HA2' ' CE1' ' A' ' 2' ' ' TYR . . . 131.97 -23.34 4.17 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.468 -1.453 . . . . 0.09 109.468 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.56 HG22 HD11 ' A' ' 34' ' ' ILE . 97.3 m -55.95 129.77 41.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -1.092 . . . . 0.15 110.458 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.503 ' NH2' ' CE1' ' A' ' 2' ' ' TYR . 47.5 mtt85 -107.94 148.51 29.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.24 110.244 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.83 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -49.84 -39.38 38.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 0.28 110.627 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.5 -44.9 62.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.31 110.435 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -82.29 5.13 21.08 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.309 -0.869 . . . . 0.25 110.384 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.83 HD12 ' HA ' ' A' ' 31' ' ' PHE . 96.1 mt -106.62 99.38 24.69 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.002 -1.061 . . . . 0.26 110.231 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -64.17 -163.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.592 1.312 . . . . 0.34 110.54 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -77.95 -4.0 44.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.361 -0.837 . . . . 0.37 110.984 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -65.44 -31.46 72.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.95 -1.093 . . . . 0.39 110.342 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.444 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 86.2 t90 -82.91 167.35 18.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.25 110.173 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.421 ' O ' ' CE2' ' A' ' 38' ' ' TRP . 25.9 p -159.07 -160.4 0.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.11 110.607 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 2.4 t -95.66 140.98 22.57 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.497 -0.752 . . . . 0.31 110.376 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.36 -2.06 12.16 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.538 1.283 . . . . 0.59 111.336 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -132.0 13.9 4.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.891 -1.131 . . . . 0.57 111.075 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 64.6 m -147.61 -71.65 0.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.011 -1.055 . . . . 0.39 110.377 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.63 33.5 1.0 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.744 -1.342 . . . . 0.22 109.744 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.55 -170.71 1.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -1.201 . . . . 0.12 110.466 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.7 p -107.27 -162.59 0.85 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.344 -0.848 . . . . 0.17 110.059 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -57.99 -19.48 31.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.155 -0.966 . . . . 0.33 109.847 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -51.92 -40.37 60.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.43 110.299 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.655 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.6 m-20 -78.02 -23.19 48.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.315 -0.866 . . . . 0.43 109.974 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -94.84 138.04 33.14 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.321 -0.862 . . . . 0.47 110.406 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.3 t -122.78 160.89 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.299 -0.876 . . . . 0.49 110.167 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.507 HD21 HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -72.04 101.58 2.76 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.262 -0.899 . . . . 0.57 110.129 179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.428 ' CD1' ' HB ' ' A' ' 6' ' ' ILE . 2.7 t80 -68.39 160.6 29.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.805 . . . . 0.57 110.35 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.74 158.77 18.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -0.88 . . . . 0.28 110.312 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.21 -177.65 0.14 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.28 110.326 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.022 -0.989 . . . . 0.46 110.289 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.265 0.555 . . . . 0.38 110.358 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -67.89 135.55 52.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.305 -0.872 . . . . 0.69 110.462 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mp -91.85 170.99 9.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.65 110.054 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.57 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -130.98 133.61 45.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.106 -0.996 . . . . 0.29 110.919 -179.423 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.515 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 24.7 m95 -118.54 178.8 4.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.327 -0.858 . . . . 0.3 109.445 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.716 HD11 ' HA2' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -163.32 124.58 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.297 -0.877 . . . . 0.46 110.488 178.207 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.629 ' N ' HD13 ' A' ' 6' ' ' ILE . 15.5 t -69.17 93.43 0.61 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.459 -0.775 . . . . 0.37 109.591 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 49' ' ' ASP . 2.6 tt -54.44 -19.67 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 0.42 110.576 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.405 ' OG1' ' HB2' ' A' ' 49' ' ' ASP . 76.3 m -65.14 -27.89 69.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.205 -0.935 . . . . 0.49 110.95 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.1 p -134.35 -35.35 0.92 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.053 -1.029 . . . . 0.28 111.375 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.716 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 112.95 36.43 1.52 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.445 -1.359 . . . . 0.17 109.794 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.439 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -106.46 108.96 20.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.104 -1.233 . . . . 0.21 110.269 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.497 ' CD1' ' CE1' ' A' ' 53' ' ' TYR . 89.9 mt -81.29 131.58 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.366 -0.834 . . . . 0.16 110.762 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.48 ' HH ' ' HD2' ' A' ' 25' ' ' PHE . 81.2 t80 -97.88 128.25 44.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.338 -0.851 . . . . 0.1 109.555 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -109.75 110.92 22.08 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.353 -0.842 . . . . 0.11 109.673 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.451 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -49.37 -24.33 1.88 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 0.12 110.824 -178.812 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.5 9.94 14.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.183 -0.948 . . . . 0.19 110.683 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.87 67.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.029 -1.045 . . . . 0.27 109.806 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.08 -140.56 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.008 -1.237 . . . . 0.21 110.008 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.05 164.38 23.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.416 -1.049 . . . . 0.27 110.728 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -114.4 -25.73 8.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.38 110.158 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.38 -46.88 25.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.39 110.185 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -69.56 -34.64 74.48 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.269 -0.894 . . . . 0.39 110.358 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.73 32.62 2.63 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.766 -1.334 . . . . 0.28 109.766 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.563 ' HE2' HD11 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -72.33 82.48 1.04 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.053 -1.263 . . . . 0.31 109.782 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.2 t -48.26 142.64 7.76 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.4 111.083 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 27.8 Cg_exo -58.28 111.4 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.681 1.358 . . . . 0.25 110.484 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.24 -25.22 3.03 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.422 -1.471 . . . . 0.09 109.422 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.6 m -56.68 130.73 46.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -1.108 . . . . 0.15 110.349 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.451 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 1.0 OUTLIER -107.13 142.04 37.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.24 110.349 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.574 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -53.08 -36.46 60.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.28 110.168 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -54.74 -26.0 31.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.31 109.797 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -96.17 -21.11 18.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.374 -0.829 . . . . 0.25 110.058 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 31' ' ' PHE . 20.3 mt -60.04 114.53 10.04 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.26 109.7 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.66 -162.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.478 1.252 . . . . 0.34 110.592 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -95.97 20.48 9.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.905 . . . . 0.37 110.487 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -102.92 -31.44 10.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.938 . . . . 0.39 110.281 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.441 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 85.1 t90 -67.29 147.76 52.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.25 110.3 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 92.1 m -148.05 -174.53 4.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -0.871 . . . . 0.11 110.399 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.21 140.62 53.1 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.31 110.335 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -72.16 -19.74 25.73 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.52 1.274 . . . . 0.59 110.822 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.31 -22.63 15.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.57 110.507 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 75.1 m -116.46 -61.46 1.72 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.39 110.381 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.45 36.1 3.65 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.37 -1.492 . . . . 0.22 109.37 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.41 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . . . -114.05 159.29 20.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -1.109 . . . . 0.12 110.474 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.8 p -65.35 -160.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.17 110.34 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 50' ' ' TYR . 32.6 ttpt -67.96 -9.62 46.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.33 110.775 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -50.76 -40.68 55.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.025 -1.047 . . . . 0.43 110.752 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.526 ' O ' HG22 ' A' ' 8' ' ' ILE . 49.0 p-10 -86.76 -15.76 38.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.43 110.809 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.419 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 2.2 m-85 -91.95 140.72 29.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.47 110.916 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 6' ' ' ILE . 34.7 m -140.36 164.93 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.41 -0.806 . . . . 0.49 110.203 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.57 HD12 ' O ' ' A' ' 4' ' ' LYS . 0.9 OUTLIER -64.67 122.22 16.33 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.245 -0.909 . . . . 0.57 110.649 -179.646 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.548 ' N ' HD12 ' A' ' 52' ' ' LEU . 77.5 t80 -74.31 116.42 14.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.57 110.395 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -133.13 173.13 11.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.885 . . . . 0.28 110.493 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -65.27 -164.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.341 -0.849 . . . . 0.28 110.394 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 tttp . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.05 -0.976 . . . . 0.46 110.351 179.788 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.309 0.576 . . . . 0.38 110.301 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.445 ' CE1' ' HA2' ' A' ' 28' ' ' GLY . 18.1 m-85 -115.87 136.7 52.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.69 110.365 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mp -81.9 165.31 20.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -0.852 . . . . 0.65 110.527 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -135.61 129.74 33.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 0.29 109.885 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.536 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 28.9 m95 -107.24 173.81 6.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.3 110.22 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.745 HD13 HG13 ' A' ' 13' ' ' ILE . 1.7 tp -138.99 127.17 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.447 -0.783 . . . . 0.46 109.969 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 11.5 t -76.93 87.56 3.48 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.367 -0.833 . . . . 0.37 109.807 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.483 HG21 HG21 ' A' ' 51' ' ' VAL . 38.1 pt -49.14 -25.36 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.147 -0.971 . . . . 0.42 110.087 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 m -69.27 -28.7 66.54 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.537 -0.727 . . . . 0.49 110.131 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 83.6 m -123.36 -50.31 1.89 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.28 110.803 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.475 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 120.75 -5.99 11.41 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.253 -1.139 . . . . 0.17 110.253 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -76.12 137.82 40.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.851 -1.382 . . . . 0.21 110.391 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.745 HG13 HD13 ' A' ' 6' ' ' ILE . 3.7 mt -95.07 127.4 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.16 110.239 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.426 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 82.4 t80 -79.9 121.61 25.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.407 -0.808 . . . . 0.1 109.91 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -99.03 104.93 17.0 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.351 -0.843 . . . . 0.11 109.989 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 2' ' ' TYR . 20.4 mt-10 -49.2 -24.28 1.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.466 -0.771 . . . . 0.12 110.771 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.12 17.97 6.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.126 -0.984 . . . . 0.19 110.474 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.78 53.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.27 109.797 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.65 -136.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.052 -1.219 . . . . 0.21 110.052 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 11.2 t0 -89.33 165.68 14.23 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.365 -1.08 . . . . 0.27 110.412 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.67 -25.47 11.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.38 110.22 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.71 -56.69 5.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.39 110.11 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -60.42 -22.09 62.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.172 -0.955 . . . . 0.39 110.156 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.16 28.66 8.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.378 -1.489 . . . . 0.28 109.378 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.524 ' CZ ' HD13 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -74.09 75.74 1.74 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.215 -1.168 . . . . 0.31 110.448 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -60.31 151.35 68.64 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.432 -0.793 . . . . 0.4 110.581 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -52.02 95.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.585 1.308 . . . . 0.25 110.569 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.445 ' HA2' ' CE1' ' A' ' 2' ' ' TYR . . . 152.68 -21.48 0.81 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.67 -1.372 . . . . 0.09 109.67 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.633 HG22 HD11 ' A' ' 34' ' ' ILE . 24.4 m -64.92 128.99 38.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -1.202 . . . . 0.15 110.553 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.412 ' HG2' ' CB ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -116.31 145.22 43.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.24 110.19 179.452 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.701 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -47.96 -47.31 32.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.241 -0.912 . . . . 0.28 110.831 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -50.35 -33.72 21.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.876 . . . . 0.31 110.095 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.412 ' CB ' ' HG2' ' A' ' 30' ' ' ARG . 10.3 t0 -93.45 12.97 23.12 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.432 -0.792 . . . . 0.25 110.27 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 31' ' ' PHE . 92.8 mt -117.04 62.88 3.06 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.072 -1.017 . . . . 0.26 110.358 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.89 -14.74 36.08 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.558 1.294 . . . . 0.34 110.638 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -59.56 -159.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.37 110.55 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -107.34 39.68 1.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.341 -0.849 . . . . 0.39 110.605 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 78.6 t90 -57.65 146.33 31.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.128 -0.983 . . . . 0.25 110.066 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.3 m -136.7 -178.59 5.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.229 -0.919 . . . . 0.11 110.436 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.425 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -67.32 149.9 98.17 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.288 -0.883 . . . . 0.31 109.999 179.555 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -70.62 -5.14 16.07 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.668 1.351 . . . . 0.59 111.513 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -156.18 32.11 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.817 -1.177 . . . . 0.57 111.216 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.425 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 57.7 m -141.19 -57.86 0.49 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.015 -1.053 . . . . 0.39 110.234 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.56 26.15 7.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.39 -1.484 . . . . 0.22 109.39 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.561 ' HB1' ' CG ' ' A' ' 49' ' ' ASP . . . -99.13 177.19 5.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.171 -1.193 . . . . 0.12 110.359 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.4 p -113.7 -165.15 0.98 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.326 -0.858 . . . . 0.17 110.129 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -32.45 44.1 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.296 -0.877 . . . . 0.33 110.436 177.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.94 -33.84 11.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.456 -0.778 . . . . 0.43 110.294 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.561 ' CG ' ' HB1' ' A' ' 45' ' ' ALA . 2.4 m-20 -84.49 -26.19 28.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.43 109.785 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -92.59 128.11 38.32 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.374 -0.828 . . . . 0.47 110.296 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.483 HG21 HG21 ' A' ' 8' ' ' ILE . 94.2 t -119.47 160.6 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.49 110.252 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -76.68 103.33 6.6 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.167 -0.958 . . . . 0.57 110.208 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -59.56 99.0 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.57 110.701 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 50.44 81.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.894 . . . . 0.28 110.769 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.0 167.53 17.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.28 110.128 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.015 -0.993 . . . . 0.46 110.384 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.312 0.577 . . . . 0.68999999999999995 110.409 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.7 mp -92.41 168.86 11.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.864 . . . . 0.65000000000000002 110.213 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.445 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 4.6 mttt -130.46 155.0 47.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.28999999999999998 110.422 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.538 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 28.7 m95 -129.39 135.57 48.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.273 -0.892 . . . . 0.29999999999999999 110.584 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.757 HD13 HG13 ' A' ' 13' ' ' ILE . 2.0 tp -108.06 128.24 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.021 -1.049 . . . . 0.46000000000000002 110.524 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 10.2 t -74.8 100.12 3.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.877 . . . . 0.37 109.906 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.2 tt -56.11 -20.05 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.41999999999999998 110.464 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.7 m -65.79 -38.17 88.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.48999999999999999 110.803 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.4 p -129.23 -34.89 1.83 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.037 -1.04 . . . . 0.28000000000000003 111.029 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.656 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 110.24 38.45 1.65 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.765 -1.334 . . . . 0.17000000000000001 109.765 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.412 ' O ' HD12 ' A' ' 6' ' ' ILE . 4.1 t-160 -104.1 128.06 51.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -1.165 . . . . 0.20999999999999999 110.067 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.757 HG13 HD13 ' A' ' 6' ' ' ILE . 5.9 mt -92.18 143.17 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.242 -0.911 . . . . 0.16 110.836 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.484 ' HH ' ' HE2' ' A' ' 25' ' ' PHE . 64.0 t80 -108.76 131.24 55.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.706 -0.621 . . . . 0.10000000000000001 109.485 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -106.29 107.94 19.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.537 -0.727 . . . . 0.11 109.815 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -50.39 -24.6 3.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 0.12 110.631 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.66 13.18 18.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.19 110.523 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 tp -176.68 62.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.154 -0.966 . . . . 0.27000000000000002 109.881 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.64 -134.35 0.06 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.025 -1.23 . . . . 0.20999999999999999 110.025 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -80.41 150.73 29.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.454 -1.027 . . . . 0.27000000000000002 110.664 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -105.23 -25.07 12.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.872 . . . . 0.38 110.046 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.33 -43.24 28.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.408 -0.808 . . . . 0.39000000000000001 110.333 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -70.53 -43.36 69.76 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.213 -0.929 . . . . 0.39000000000000001 110.11 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.66 30.06 1.0 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.162 -1.175 . . . . 0.28000000000000003 110.162 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CE1' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -73.03 81.39 1.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.85 -1.382 . . . . 0.31 109.944 179.151 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.5 t -49.33 150.89 2.9 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.40000000000000002 110.989 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.45 95.77 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.703 1.37 . . . . 0.25 110.255 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.1 41.37 0.12 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.509 -1.436 . . . . 0.089999999999999997 109.509 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -118.21 104.93 11.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -1.148 . . . . 0.14999999999999999 110.086 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -75.67 141.56 42.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.23999999999999999 110.649 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.682 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -51.95 -29.62 21.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.359 -0.838 . . . . 0.28000000000000003 110.39 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -54.12 -50.69 66.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.31 110.386 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -74.96 -2.24 26.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.293 -0.879 . . . . 0.25 110.873 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' A' ' 31' ' ' PHE . 43.9 mt . . . . . 0 N--CA 1.489 1.509 0 O-C-N 120.934 -1.104 . . . . 0.26000000000000001 110.338 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.552 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 85.5 t90 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.223 0.535 . . . . 0.25 110.245 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 88.4 m -121.21 -170.75 2.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.11 110.394 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 1.3 t -88.11 135.74 32.9 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.31 110.156 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.96 -13.28 28.97 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.458 1.241 . . . . 0.58999999999999997 110.736 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.82 -25.31 10.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 0.56999999999999995 110.795 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 85.1 m -111.32 -75.15 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.046 -1.033 . . . . 0.39000000000000001 110.571 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.03 35.54 0.77 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.444 -1.462 . . . . 0.22 109.444 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.62 -170.45 1.67 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -1.171 . . . . 0.12 110.514 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 p -78.49 -167.45 1.08 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.17000000000000001 110.383 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -83.65 -16.02 46.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -0.88 . . . . 0.33000000000000002 110.574 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.79 -22.75 59.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.091 -1.005 . . . . 0.42999999999999999 110.6 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.481 ' O ' HG22 ' A' ' 8' ' ' ILE . 5.3 m-20 -75.46 -17.81 60.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.42999999999999999 110.572 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -96.42 134.63 39.35 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.223 -0.923 . . . . 0.46999999999999997 110.928 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 6' ' ' ILE . 34.2 m -125.67 171.13 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.858 . . . . 0.48999999999999999 109.972 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.27 130.27 34.82 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.163 -0.961 . . . . 0.56999999999999995 110.784 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.4 t80 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 0.56999999999999995 110.383 179.754 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.363 0.602 . . . . 0.68999999999999995 110.508 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 mp -75.56 162.69 28.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -0.8 . . . . 0.65000000000000002 110.523 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -134.19 134.91 42.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -0.871 . . . . 0.28999999999999998 110.231 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.532 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 24.8 m95 -115.24 -178.13 3.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.29999999999999999 110.229 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.649 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -161.37 124.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.399 -0.813 . . . . 0.46000000000000002 110.059 178.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.649 ' N ' HD13 ' A' ' 6' ' ' ILE . 24.2 t -69.3 100.02 1.27 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.371 -0.831 . . . . 0.37 110.418 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.776 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.1 tt -53.98 -22.06 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.178 -0.951 . . . . 0.41999999999999998 109.982 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.7 m -80.75 -28.88 36.33 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.25 -0.906 . . . . 0.48999999999999999 110.175 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 1.6 m -110.2 -53.39 2.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 0.28000000000000003 110.553 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.617 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 118.72 -11.02 12.25 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.133 -1.187 . . . . 0.17000000000000001 110.133 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -75.65 138.86 41.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.941 -1.329 . . . . 0.20999999999999999 110.482 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 5' ' ' TRP . 51.3 mt -97.6 136.91 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.364 -0.835 . . . . 0.16 110.589 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CE1' ' HA2' ' A' ' 19' ' ' GLY . 87.3 t80 -92.18 138.9 31.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.404 -0.81 . . . . 0.10000000000000001 110.305 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -112.41 108.87 18.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.49 -0.756 . . . . 0.11 109.988 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -50.98 -24.42 3.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.154 -0.966 . . . . 0.12 110.7 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.31 16.43 8.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.19 110.4 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -176.96 69.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.27000000000000002 109.855 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.5 ' HA2' ' CE1' ' A' ' 14' ' ' TYR . . . -68.37 -137.04 0.07 OUTLIER Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.143 -1.183 . . . . 0.20999999999999999 110.143 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 22' ' ' ALA . 15.8 t0 -87.07 149.77 24.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.406 -1.055 . . . . 0.27000000000000002 110.718 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.408 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 36.5 mt-10 -97.17 -30.59 12.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.854 . . . . 0.38 110.023 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.424 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . -75.16 -44.86 44.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.387 -0.821 . . . . 0.39000000000000001 110.316 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -63.61 -38.94 93.04 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.255 -0.903 . . . . 0.39000000000000001 110.312 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.13 23.21 4.28 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.677 -1.369 . . . . 0.28000000000000003 109.677 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.672 ' CE2' HG21 ' A' ' 29' ' ' THR . 0.7 OUTLIER -66.72 83.81 0.11 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.099 -1.236 . . . . 0.31 110.124 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.4 t -49.77 152.54 2.53 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.446 -0.784 . . . . 0.40000000000000002 110.918 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 28.6 Cg_exo -58.04 106.99 0.28 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.703 1.37 . . . . 0.25 110.468 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.4 38.99 0.46 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.474 -1.45 . . . . 0.089999999999999997 109.474 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.672 HG21 ' CE2' ' A' ' 25' ' ' PHE . 26.2 m -108.97 134.4 51.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -1.115 . . . . 0.14999999999999999 110.353 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -117.96 141.02 48.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.23999999999999999 110.346 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.647 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -48.94 -36.59 17.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.198 -0.939 . . . . 0.28000000000000003 110.747 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -57.15 -34.79 68.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.237 -0.914 . . . . 0.31 109.989 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -87.37 -23.07 24.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.333 -0.854 . . . . 0.25 110.234 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.647 HD12 ' HA ' ' A' ' 31' ' ' PHE . 20.8 mt . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.26000000000000001 109.913 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.532 ' CZ3' ' CZ ' ' A' ' 31' ' ' PHE . 79.7 t90 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.336 0.589 . . . . 0.25 110.363 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.473 ' N ' ' CD2' ' A' ' 38' ' ' TRP . 25.3 p -173.94 -160.89 0.11 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.389 -0.819 . . . . 0.11 110.148 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -76.55 143.4 72.06 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.307 -0.87 . . . . 0.31 110.091 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.56 -7.62 19.69 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.664 1.35 . . . . 0.58999999999999997 111.373 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.8 -32.21 2.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.952 -1.093 . . . . 0.56999999999999995 111.05 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 63.3 m -92.4 -70.34 0.7 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.07 -1.019 . . . . 0.39000000000000001 110.407 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.27 25.11 4.83 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.288 -1.525 . . . . 0.22 109.288 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.14 174.4 5.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -1.147 . . . . 0.12 110.569 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.0 p -67.42 -162.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.17000000000000001 110.345 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -78.65 -2.83 40.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.33000000000000002 110.769 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -45.03 64.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.957 -1.09 . . . . 0.42999999999999999 110.463 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.776 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.3 p30 -73.02 -20.25 61.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.42999999999999999 110.219 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -90.58 129.7 36.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.46999999999999997 110.495 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 6' ' ' ILE . 27.4 m -128.21 159.97 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.48999999999999999 110.21 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.42 119.05 17.12 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.195 -0.94 . . . . 0.56999999999999995 110.383 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.1 t80 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.56999999999999995 110.628 -179.552 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.785 ' CG ' ' HB2' ' A' ' 17' ' ' ALA . 39.7 m-85 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.389 0.614 . . . . 0.68999999999999995 110.483 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.514 HD23 HD11 ' A' ' 52' ' ' LEU . 4.3 mp -92.36 163.13 13.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.298 -0.876 . . . . 0.65000000000000002 110.284 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.73 146.56 50.89 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.244 -0.91 . . . . 0.28999999999999998 109.809 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.553 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 25.0 m95 -119.82 -176.55 3.2 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.319 -0.863 . . . . 0.29999999999999999 109.616 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.757 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -152.96 129.42 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.407 -0.917 . . . . 0.46000000000000002 110.481 178.405 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.757 ' N ' HD13 ' A' ' 6' ' ' ILE . 4.9 t -75.69 92.14 2.96 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.495 -0.753 . . . . 0.37 109.982 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.428 HG13 ' N ' ' A' ' 9' ' ' THR . 15.9 pt -51.67 -23.64 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.009 -1.057 . . . . 0.41999999999999998 109.928 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.428 ' N ' HG13 ' A' ' 8' ' ' ILE . 45.9 m -68.9 -26.96 65.37 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.495 -0.753 . . . . 0.48999999999999999 110.295 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.7 m -125.83 -49.99 1.6 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -0.953 . . . . 0.28000000000000003 111.284 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.668 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 118.97 13.22 6.63 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.905 -1.278 . . . . 0.17000000000000001 109.905 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.02 125.51 37.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.994 -1.297 . . . . 0.20999999999999999 110.177 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.436 HG13 HG12 ' A' ' 6' ' ' ILE . 53.4 mt -88.79 141.17 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.16 110.696 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -102.44 148.1 25.91 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.657 0.741 . . . . 0.10000000000000001 110.35 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -124.15 106.75 10.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.579 -0.701 . . . . 0.11 109.923 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.463 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 98.8 mt-10 -50.26 -24.42 2.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.12 110.565 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.785 ' HB2' ' CG ' ' A' ' 2' ' ' TYR . . . -93.21 20.19 7.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.19 110.257 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tp -176.49 65.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.27000000000000002 109.966 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.8 -141.56 0.32 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.886 -1.286 . . . . 0.20999999999999999 109.886 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.02 171.63 7.24 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.38 -1.07 . . . . 0.27000000000000002 110.543 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -106.42 -35.63 7.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.35 -0.844 . . . . 0.38 110.159 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.36 -41.73 89.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.872 . . . . 0.39000000000000001 110.171 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -73.91 -3.33 28.26 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.253 -0.904 . . . . 0.39000000000000001 110.901 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.22 25.19 64.34 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.348 -1.501 . . . . 0.28000000000000003 109.348 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -82.66 79.99 8.91 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.277 -1.131 . . . . 0.31 109.985 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.0 t -49.46 151.29 2.84 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.389 -0.819 . . . . 0.40000000000000002 111.004 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 24.9 Cg_exo -60.0 114.97 2.32 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.704 1.371 . . . . 0.25 110.42 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.65 16.58 5.89 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.868 -1.293 . . . . 0.089999999999999997 109.868 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.711 HG22 HD11 ' A' ' 34' ' ' ILE . 40.3 m -86.01 116.52 24.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.244 . . . . 0.14999999999999999 110.224 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.463 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 43.6 mtt85 -90.26 140.65 29.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.23999999999999999 110.576 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.82 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -59.18 -35.14 73.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.888 . . . . 0.28000000000000003 110.165 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -52.28 -30.64 28.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.31 110.35 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -100.86 19.04 17.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -0.844 . . . . 0.25 110.345 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.82 HD12 ' HA ' ' A' ' 31' ' ' PHE . 92.9 mt . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.26000000000000001 109.989 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 85.8 t90 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.328 0.585 . . . . 0.25 110.372 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.7 m -128.96 -164.58 1.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.11 110.181 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.451 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -79.95 152.79 74.73 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.128 -0.983 . . . . 0.31 110.236 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -62.97 -12.88 31.74 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.583 1.307 . . . . 0.58999999999999997 111.325 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -157.49 40.69 0.3 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.91 -1.119 . . . . 0.56999999999999995 111.185 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.451 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 56.7 m -141.88 -59.51 0.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.034 -1.042 . . . . 0.39000000000000001 110.184 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.08 25.62 11.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.117 -1.593 . . . . 0.22 109.117 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.12 -170.37 2.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -1.112 . . . . 0.12 110.408 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.2 p -108.89 -173.19 2.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.17000000000000001 110.372 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -63.04 -16.65 60.58 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.268 -0.895 . . . . 0.33000000000000002 110.261 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -55.58 -38.77 69.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.42999999999999999 110.246 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 5.7 m-20 -77.05 -12.88 60.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.31 -0.869 . . . . 0.42999999999999999 110.473 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.441 ' HE2' ' HG ' ' A' ' 40' ' ' CYS . 3.0 m-85 -100.72 136.82 39.98 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.049 -1.032 . . . . 0.46999999999999997 110.772 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.5 t -133.15 149.05 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.47 -0.769 . . . . 0.48999999999999999 109.985 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.514 HD11 HD23 ' A' ' 3' ' ' LEU . 1.1 tt -63.71 120.54 12.02 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.112 -0.992 . . . . 0.56999999999999995 110.279 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 30.0 t80 . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.335 -0.853 . . . . 0.56999999999999995 110.375 -179.326 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.532 ' CG ' ' HB2' ' A' ' 17' ' ' ALA . 61.0 m-85 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.329 0.585 . . . . 0.68999999999999995 110.403 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.529 HD23 HD21 ' A' ' 52' ' ' LEU . 3.3 mp -98.85 170.05 9.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.507 -0.745 . . . . 0.65000000000000002 110.678 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -134.84 148.93 50.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.28999999999999998 110.186 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.458 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 48.9 m95 -129.91 178.87 6.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 0.29999999999999999 110.504 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.854 HD13 HG13 ' A' ' 13' ' ' ILE . 1.2 tp -156.32 120.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.65 -0.656 . . . . 0.46000000000000002 109.741 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 11' ' ' GLY . 18.9 t -67.67 96.93 0.58 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.372 -0.83 . . . . 0.37 110.313 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.5 tt -54.99 -19.92 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.142 -0.974 . . . . 0.41999999999999998 110.289 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 m -80.62 -28.35 37.01 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.261 -0.899 . . . . 0.48999999999999999 110.381 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.4 m -117.23 -46.43 2.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.163 -0.961 . . . . 0.28000000000000003 110.856 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.474 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 109.0 19.8 8.35 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.678 -1.369 . . . . 0.17000000000000001 109.678 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -99.65 134.48 42.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -1.21 . . . . 0.20999999999999999 110.069 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.854 HG13 HD13 ' A' ' 6' ' ' ILE . 4.4 mt -96.24 141.04 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.16 110.656 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -108.21 144.56 35.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.512 -0.742 . . . . 0.10000000000000001 110.329 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -119.9 109.42 15.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.429 -0.794 . . . . 0.11 110.097 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.428 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 69.8 mt-10 -50.22 -27.85 6.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 0.12 110.474 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.532 ' HB2' ' CG ' ' A' ' 2' ' ' TYR . . . -93.85 12.83 24.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.921 . . . . 0.19 110.617 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.55 68.45 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.12 -0.987 . . . . 0.27000000000000002 110.42 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.25 -135.5 0.01 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.402 -1.479 . . . . 0.20999999999999999 109.402 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.25 164.75 12.71 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.225 -1.161 . . . . 0.27000000000000002 110.287 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -92.81 -22.14 19.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -0.913 . . . . 0.38 110.31 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.67 -36.46 17.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.39000000000000001 110.366 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -65.19 -26.92 68.35 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.255 -0.903 . . . . 0.39000000000000001 110.332 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.83 27.47 14.17 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.548 -1.421 . . . . 0.28000000000000003 109.548 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.513 ' CE1' HG21 ' A' ' 29' ' ' THR . 0.1 OUTLIER -73.51 84.0 1.51 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.108 -1.231 . . . . 0.31 110.208 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.4 t -50.06 143.94 11.58 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.192 -0.943 . . . . 0.40000000000000002 110.474 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.15 106.57 0.21 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.653 1.344 . . . . 0.25 110.645 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.02 44.42 0.17 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.582 -1.407 . . . . 0.089999999999999997 109.582 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.513 HG21 ' CE1' ' A' ' 25' ' ' PHE . 1.4 m -130.59 122.87 28.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.11 -1.229 . . . . 0.14999999999999999 110.511 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.428 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 1.7 ptm180 -103.58 150.91 23.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.23999999999999999 110.446 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.781 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -48.4 -44.62 35.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.232 -0.917 . . . . 0.28000000000000003 110.833 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.407 ' HB3' ' HG3' ' A' ' 30' ' ' ARG . 3.0 tm-20 -53.61 -48.73 69.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.31 110.234 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -65.93 -22.57 66.5 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.265 -0.897 . . . . 0.25 110.217 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.781 HD12 ' HA ' ' A' ' 31' ' ' PHE . 46.8 mt . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.431 -0.793 . . . . 0.26000000000000001 110.047 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.547 ' CZ3' ' CZ ' ' A' ' 31' ' ' PHE . 79.8 t90 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.234 0.54 . . . . 0.25 110.096 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.6 p -162.36 -160.53 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.11 110.386 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.434 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -86.55 160.95 49.64 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.358 -0.839 . . . . 0.31 110.422 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 3.8 Cg_exo -73.88 -23.05 16.81 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.607 1.319 . . . . 0.58999999999999997 110.953 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -139.49 30.46 2.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.993 -1.067 . . . . 0.56999999999999995 111.178 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.434 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 60.6 m -141.57 -46.15 0.37 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.974 -1.079 . . . . 0.39000000000000001 110.255 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.27 28.92 47.18 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.5 -1.44 . . . . 0.22 109.5 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.32 -171.81 2.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -1.174 . . . . 0.12 110.334 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.4 p -109.25 -159.85 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.17000000000000001 110.336 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.408 ' HA ' ' HB2' ' A' ' 50' ' ' TYR . 32.7 ttmt -58.34 -18.5 27.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.394 -0.816 . . . . 0.33000000000000002 110.253 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -50.22 -48.29 54.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.064 -1.022 . . . . 0.42999999999999999 110.56 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.737 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.8 m-20 -73.03 -20.42 61.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.42999999999999999 110.154 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.408 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 12.2 m-85 -95.92 137.58 34.78 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.315 -0.866 . . . . 0.46999999999999997 110.764 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 80.7 t -125.11 158.73 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.388 -0.82 . . . . 0.48999999999999999 109.931 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.529 HD21 HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -72.33 100.13 2.58 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.179 -0.951 . . . . 0.56999999999999995 110.083 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.4 ' HD1' HG21 ' A' ' 6' ' ' ILE . 28.6 t80 . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.446 -0.784 . . . . 0.56999999999999995 110.516 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.338 0.59 . . . . 0.68999999999999995 110.537 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.64 179.16 7.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.435 -0.791 . . . . 0.65000000000000002 110.587 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -146.68 138.8 24.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.405 -0.809 . . . . 0.28999999999999998 110.451 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.54 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 29.2 m95 -118.23 -178.37 3.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -0.822 . . . . 0.29999999999999999 110.08 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.631 HD11 ' HA2' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -156.55 118.67 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.394 -0.816 . . . . 0.46000000000000002 110.374 177.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.544 ' N ' HD13 ' A' ' 6' ' ' ILE . 6.6 t -63.93 92.2 0.07 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.243 -0.911 . . . . 0.37 109.919 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.604 HG21 HG21 ' A' ' 51' ' ' VAL . 8.6 pt -51.7 -23.71 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.182 -0.949 . . . . 0.41999999999999998 110.073 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.421 ' N ' HG13 ' A' ' 8' ' ' ILE . 36.3 m -72.48 -29.42 63.63 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.306 -0.871 . . . . 0.48999999999999999 110.039 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.2 m -114.29 -49.04 2.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.28000000000000003 110.667 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.631 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 114.22 8.64 16.81 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.032 -1.227 . . . . 0.17000000000000001 110.032 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -92.25 133.97 35.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.911 -1.347 . . . . 0.20999999999999999 110.091 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 90.4 mt -93.2 124.43 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.16 110.783 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.476 ' HH ' ' HE2' ' A' ' 25' ' ' PHE . 57.3 t80 -84.55 131.04 34.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.42 -0.8 . . . . 0.10000000000000001 109.978 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -108.44 111.78 23.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.11 109.815 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.423 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -51.9 -23.95 5.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.12 110.265 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.75 13.55 12.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.19 110.509 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.57 64.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.27000000000000002 109.756 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.43 -136.29 0.12 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.049 -1.221 . . . . 0.20999999999999999 110.049 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -84.91 144.53 28.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -1.04 . . . . 0.27000000000000002 110.598 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -91.07 -22.95 20.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.307 -0.871 . . . . 0.38 110.082 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.8 -39.93 15.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.39000000000000001 110.302 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -65.96 -32.35 73.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.39000000000000001 110.259 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.18 29.22 4.63 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.54 -1.424 . . . . 0.28000000000000003 109.54 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.567 ' CE1' ' CD1' ' A' ' 38' ' ' TRP . 1.5 m-85 -73.69 82.74 1.58 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.111 -1.229 . . . . 0.31 110.181 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.2 t -49.49 149.3 4.16 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.40000000000000002 110.785 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.17 110.83 0.62 Allowed 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.666 1.351 . . . . 0.25 110.397 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.09 19.82 4.63 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.741 -1.344 . . . . 0.089999999999999997 109.741 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.3 m -86.58 133.76 33.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.058 -1.26 . . . . 0.14999999999999999 110.262 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.423 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 2.3 mtp180 -116.12 144.56 43.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.87 . . . . 0.23999999999999999 110.431 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.559 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -49.57 -25.16 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.314 -0.866 . . . . 0.28000000000000003 110.525 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.41 -24.33 54.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.895 . . . . 0.31 110.479 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -114.17 11.28 17.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.25 110.836 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.559 HD11 ' HE2' ' A' ' 25' ' ' PHE . 8.6 mt . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.071 -1.018 . . . . 0.26000000000000001 110.928 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.567 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 82.2 t90 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.351 0.596 . . . . 0.25 110.67 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.433 ' N ' ' CG ' ' A' ' 38' ' ' TRP . 25.0 p -169.66 -161.34 0.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.329 -0.857 . . . . 0.11 110.31 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.438 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -91.82 169.25 11.48 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 0.31 110.227 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.28 -40.53 31.84 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.584 1.307 . . . . 0.58999999999999997 110.746 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.1 50.76 1.03 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.091 -1.005 . . . . 0.56999999999999995 110.689 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.438 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 61.7 m -136.58 -45.63 0.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.39000000000000001 110.086 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.34 32.45 51.69 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.354 -1.498 . . . . 0.22 109.354 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.23 166.72 10.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 0.12 110.443 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.4 p -91.59 -162.15 0.89 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.398 -0.814 . . . . 0.17000000000000001 110.161 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 50' ' ' TYR . 5.3 ttpp -61.67 -15.47 40.3 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.239 -0.913 . . . . 0.33000000000000002 110.377 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 49' ' ' ASP . 23.2 pt-20 -51.79 -40.68 60.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.052 -1.03 . . . . 0.42999999999999999 110.354 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 14.9 m-20 -80.58 -18.37 48.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.231 -0.918 . . . . 0.42999999999999999 110.368 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.428 ' HE2' ' HG ' ' A' ' 40' ' ' CYS . 4.8 m-85 -95.21 124.17 39.11 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.185 -0.947 . . . . 0.46999999999999997 110.455 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.604 HG21 HG21 ' A' ' 8' ' ' ILE . 97.9 t -117.21 148.02 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.279 -0.888 . . . . 0.48999999999999999 110.088 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.76 117.44 9.67 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.152 -0.968 . . . . 0.56999999999999995 110.096 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 31.7 t80 . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.56999999999999995 110.535 -178.943 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.422 ' HB3' ' HB2' ' A' ' 16' ' ' GLU . 37.2 m-85 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.304 0.573 . . . . 0.68999999999999995 110.351 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.851 HD23 HD21 ' A' ' 52' ' ' LEU . 1.5 mp -91.03 164.16 14.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.409 -0.807 . . . . 0.65000000000000002 110.725 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -122.56 144.76 48.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -0.835 . . . . 0.28999999999999998 110.07 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.506 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 39.2 m95 -121.5 179.07 4.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 0.29999999999999999 110.537 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.851 HD13 HG13 ' A' ' 13' ' ' ILE . 2.1 tp -153.88 128.18 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.717 -0.614 . . . . 0.46000000000000002 110.068 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 45.3 t -76.97 98.03 4.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.37 110.291 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.0 OUTLIER -52.68 -23.3 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.097 -1.002 . . . . 0.41999999999999998 110.175 179.446 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.4 m -79.82 -30.61 40.52 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.388 -0.82 . . . . 0.48999999999999999 110.351 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -108.99 -54.44 2.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 0.28000000000000003 110.569 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.482 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 113.38 13.48 10.63 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.896 -1.281 . . . . 0.17000000000000001 109.896 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.428 ' O ' HD12 ' A' ' 6' ' ' ILE . 4.2 m80 -99.33 133.82 43.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.934 -1.333 . . . . 0.20999999999999999 110.047 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.851 HG13 HD13 ' A' ' 6' ' ' ILE . 3.9 mt -89.68 145.68 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.16 110.631 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.43 ' CE1' ' HA2' ' A' ' 19' ' ' GLY . 75.4 t80 -104.82 129.26 53.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.564 -0.71 . . . . 0.10000000000000001 110.352 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.414 ' HB3' ' HG ' ' A' ' 18' ' ' LEU . 2.4 t0 -102.8 104.39 14.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.301 -0.874 . . . . 0.11 110.006 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 2' ' ' TYR . 18.0 mt-10 -51.89 -23.0 4.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -0.865 . . . . 0.12 110.758 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.31 -2.74 26.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.235 -0.915 . . . . 0.19 110.943 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.433 ' O ' ' CG ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -173.42 68.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.987 -1.071 . . . . 0.27000000000000002 110.062 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.43 ' HA2' ' CE1' ' A' ' 14' ' ' TYR . . . -62.97 -136.96 0.01 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.328 -1.109 . . . . 0.20999999999999999 110.328 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -92.71 166.09 12.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.294 -1.121 . . . . 0.27000000000000002 110.512 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -109.21 -27.1 9.74 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.326 -0.858 . . . . 0.38 110.129 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.74 -54.16 17.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.39000000000000001 110.172 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -63.56 -24.76 67.94 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.228 -0.92 . . . . 0.39000000000000001 110.137 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.5 28.99 5.52 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.542 -1.423 . . . . 0.28000000000000003 109.542 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.688 ' CD1' HG21 ' A' ' 29' ' ' THR . 0.7 OUTLIER -81.49 79.88 7.99 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.153 -1.204 . . . . 0.31 110.442 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -53.26 152.82 7.63 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.254 -0.904 . . . . 0.40000000000000002 110.511 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -54.54 95.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.608 1.32 . . . . 0.25 110.307 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 144.81 -15.88 1.98 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.815 -1.314 . . . . 0.089999999999999997 109.815 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.688 HG21 ' CD1' ' A' ' 25' ' ' PHE . 1.6 m -50.45 121.94 6.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.017 -1.284 . . . . 0.14999999999999999 110.633 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -105.6 139.84 39.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.23999999999999999 110.266 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.87 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -47.32 -46.77 25.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.337 -0.852 . . . . 0.28000000000000003 110.835 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.67 -33.57 47.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.284 -0.885 . . . . 0.31 110.233 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.42 11.81 27.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.335 -0.853 . . . . 0.25 110.653 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.87 HD12 ' HA ' ' A' ' 31' ' ' PHE . 91.3 mt . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.011 -1.056 . . . . 0.26000000000000001 109.971 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 81.0 t90 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.218 0.532 . . . . 0.25 109.993 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 95.3 m -143.38 -175.12 4.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.11 110.401 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -74.08 136.97 75.85 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.31 110.233 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -72.6 -13.05 27.25 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.463 1.244 . . . . 0.58999999999999997 110.846 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.51 -23.94 11.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.027 -1.046 . . . . 0.56999999999999995 110.756 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 95.8 m -111.86 -75.04 0.62 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.027 -1.046 . . . . 0.39000000000000001 110.418 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.38 36.83 0.67 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.402 -1.479 . . . . 0.22 109.402 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.66 -169.17 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -1.166 . . . . 0.12 110.499 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.7 p -88.8 -162.5 0.86 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 0.17000000000000001 110.4 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.25 -9.79 54.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.853 . . . . 0.33000000000000002 110.639 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -52.14 -44.76 64.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.984 -1.072 . . . . 0.42999999999999999 110.463 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.577 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -71.31 -20.6 62.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.161 -0.962 . . . . 0.42999999999999999 110.033 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -96.06 134.08 39.54 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.248 -0.907 . . . . 0.46999999999999997 110.662 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.54 171.85 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.831 . . . . 0.48999999999999999 110.115 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.851 HD21 HD23 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -75.62 118.51 18.54 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.253 -0.904 . . . . 0.56999999999999995 110.311 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.0 t80 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.56999999999999995 110.579 -179.442 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.408 0.623 . . . . 0.68999999999999995 110.35 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.429 HD23 HD11 ' A' ' 52' ' ' LEU . 1.9 mp -104.1 179.79 4.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.65000000000000002 110.743 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -139.63 145.97 39.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.496 -0.752 . . . . 0.28999999999999998 110.009 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.524 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 34.1 m95 -127.82 134.72 49.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.082 -1.011 . . . . 0.29999999999999999 110.658 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.741 HD13 HG13 ' A' ' 13' ' ' ILE . 2.6 tp -111.62 132.62 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.023 -1.048 . . . . 0.46000000000000002 110.297 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.9 t -79.13 100.05 7.24 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.345 -0.847 . . . . 0.37 110.037 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.6 tt -56.17 -18.74 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.917 . . . . 0.41999999999999998 110.619 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.0 m -70.08 -39.56 75.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.885 . . . . 0.48999999999999999 110.824 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.9 p -126.8 -35.31 2.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.971 -1.081 . . . . 0.28000000000000003 111.116 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.614 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 108.97 44.7 1.08 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.852 -1.299 . . . . 0.17000000000000001 109.852 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 9.5 t60 -108.74 127.7 54.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -1.211 . . . . 0.20999999999999999 110.142 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.741 HG13 HD13 ' A' ' 6' ' ' ILE . 5.8 mt -93.09 133.52 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.16 110.8 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' OH ' HD11 ' A' ' 34' ' ' ILE . 71.3 t80 -102.84 121.39 42.39 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.506 -0.746 . . . . 0.10000000000000001 109.295 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -98.98 106.26 18.5 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.415 -0.803 . . . . 0.11 110.19 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.437 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -48.74 -24.16 1.3 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.385 -0.822 . . . . 0.12 111.015 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.65 14.45 8.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.067 -1.021 . . . . 0.19 110.803 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 tt -176.61 69.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.1 -1.0 . . . . 0.27000000000000002 109.999 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.06 -136.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.842 -1.303 . . . . 0.20999999999999999 109.842 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.403 ' OD2' ' N ' ' A' ' 23' ' ' GLU . 17.0 t70 -113.37 161.31 17.42 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.347 -1.09 . . . . 0.27000000000000002 110.179 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -97.27 -27.74 14.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.38 110.36 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.95 -29.03 58.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.92 . . . . 0.39000000000000001 110.345 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.403 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 11.8 mm-40 -88.9 16.59 6.7 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.298 -0.876 . . . . 0.39000000000000001 110.805 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.1 28.38 63.87 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.456 -1.458 . . . . 0.28000000000000003 109.456 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -86.85 82.71 7.72 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.232 -1.158 . . . . 0.31 110.046 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.8 t -47.86 151.4 1.63 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.469 -0.769 . . . . 0.40000000000000002 110.961 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 36.8 Cg_exo -56.96 104.92 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.701 1.369 . . . . 0.25 110.467 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.1 35.51 0.76 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.622 -1.391 . . . . 0.089999999999999997 109.622 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.541 HG22 HD11 ' A' ' 34' ' ' ILE . 58.2 m -90.3 134.32 34.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.189 -1.183 . . . . 0.14999999999999999 110.32 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.437 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -105.72 135.51 47.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 0.23999999999999999 110.468 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.892 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -51.0 -47.21 61.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.28000000000000003 110.473 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -54.91 -41.43 70.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.861 . . . . 0.31 110.442 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.98 -24.34 52.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.25 110.394 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.892 HD12 ' HA ' ' A' ' 31' ' ' PHE . 63.4 mt . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.26000000000000001 110.119 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 89.4 t90 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.27 0.557 . . . . 0.25 110.47 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.8 p -162.24 -160.89 0.7 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.11 110.343 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.56 120.85 70.37 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.401 -0.812 . . . . 0.31 110.173 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.35 -12.82 34.88 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.473 1.249 . . . . 0.58999999999999997 110.849 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.412 ' OD2' ' ND1' ' A' ' 12' ' ' HIS . 87.8 m-20 -102.55 -26.84 13.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.052 -1.03 . . . . 0.56999999999999995 110.674 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 96.6 m -114.32 -75.42 0.59 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.139 -0.976 . . . . 0.39000000000000001 110.327 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.3 40.83 0.35 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.396 -1.482 . . . . 0.22 109.396 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.442 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . . . -122.43 -175.09 3.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -1.173 . . . . 0.12 110.667 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 p -82.55 -166.71 1.36 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.385 -0.822 . . . . 0.17000000000000001 110.511 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -69.02 -8.76 48.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.32 -0.863 . . . . 0.33000000000000002 110.551 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -50.95 -42.88 60.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.987 -1.07 . . . . 0.42999999999999999 110.299 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.567 ' O ' HG22 ' A' ' 8' ' ' ILE . 2.8 p30 -76.02 -20.64 57.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.319 -0.863 . . . . 0.42999999999999999 110.377 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -92.86 131.41 37.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.46999999999999997 110.596 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 6' ' ' ILE . 35.9 m -124.27 163.19 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.279 -0.888 . . . . 0.48999999999999999 110.161 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.429 HD11 HD23 ' A' ' 3' ' ' LEU . 0.7 OUTLIER -81.86 120.35 25.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.56999999999999995 110.581 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.1 t80 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.362 -0.836 . . . . 0.56999999999999995 110.389 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.589 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 42.6 m-85 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.344 0.592 . . . . 0.68999999999999995 110.479 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.881 HD23 HD21 ' A' ' 52' ' ' LEU . 1.9 mp -75.04 164.44 26.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.65000000000000002 110.528 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -130.31 136.58 49.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.28999999999999998 110.093 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.517 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 29.6 m95 -115.84 170.61 8.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.966 . . . . 0.29999999999999999 110.283 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.864 HD13 HG13 ' A' ' 13' ' ' ILE . 2.1 tp -144.38 136.27 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.454 -0.779 . . . . 0.46000000000000002 109.775 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.433 ' H ' HD12 ' A' ' 6' ' ' ILE . 8.4 t -84.44 95.12 8.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.366 -0.834 . . . . 0.37 110.342 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.0 OUTLIER -52.81 -22.88 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.11 -0.993 . . . . 0.41999999999999998 110.043 179.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.2 m -72.72 -28.02 62.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.372 -0.83 . . . . 0.48999999999999999 110.302 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 78.9 m -124.6 -51.38 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.28000000000000003 110.64 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.539 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 117.3 19.34 5.11 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.833 -1.307 . . . . 0.17000000000000001 109.833 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.487 ' O ' HD12 ' A' ' 6' ' ' ILE . 5.8 m-70 -97.57 133.09 42.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.051 -1.264 . . . . 0.20999999999999999 110.102 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.864 HG13 HD13 ' A' ' 6' ' ' ILE . 3.9 mt -91.28 134.51 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.16 110.504 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.402 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 70.7 t80 -94.33 125.89 39.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.5 -0.75 . . . . 0.10000000000000001 109.892 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -95.83 102.55 14.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.459 -0.775 . . . . 0.11 110.289 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -49.35 -30.96 8.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.85 . . . . 0.12 110.702 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.589 ' HB2' ' CD2' ' A' ' 2' ' ' TYR . . . -91.74 17.47 8.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.895 . . . . 0.19 110.457 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -177.0 70.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -0.956 . . . . 0.27000000000000002 110.076 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.87 -135.4 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.89 -1.284 . . . . 0.20999999999999999 109.89 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD2' ' N ' ' A' ' 22' ' ' ALA . 16.3 t70 -113.12 168.97 9.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.345 -1.091 . . . . 0.27000000000000002 110.571 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -87.81 -46.62 9.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.27 -0.894 . . . . 0.38 110.073 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . -53.83 -43.76 69.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.337 -0.852 . . . . 0.39000000000000001 110.205 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -70.88 -30.22 66.54 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.32 -0.862 . . . . 0.39000000000000001 110.083 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.27 28.85 18.89 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.686 -1.366 . . . . 0.28000000000000003 109.686 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CE2' ' NE1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -69.19 82.86 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.275 . . . . 0.31 110.064 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.5 t -49.49 145.75 7.57 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.196 -0.94 . . . . 0.40000000000000002 110.723 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 38.4 Cg_exo -53.51 105.66 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.683 1.359 . . . . 0.25 110.712 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.48 41.98 0.26 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.879 -1.288 . . . . 0.089999999999999997 109.879 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.19 126.76 44.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -1.218 . . . . 0.14999999999999999 110.267 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.441 ' HG2' ' CB ' ' A' ' 33' ' ' ASP . 0.4 OUTLIER -118.38 148.68 42.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.23999999999999999 110.256 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.623 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -47.78 -40.74 21.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.254 -0.904 . . . . 0.28000000000000003 110.673 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -59.31 -32.38 70.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.191 -0.943 . . . . 0.31 109.983 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.441 ' CB ' ' HG2' ' A' ' 30' ' ' ARG . 21.3 t0 -95.39 12.67 28.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 0.25 110.551 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.662 ' O ' HG22 ' A' ' 34' ' ' ILE . 92.3 mt . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.092 -1.005 . . . . 0.26000000000000001 110.119 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.424 ' NE1' ' CE2' ' A' ' 25' ' ' PHE . 85.6 t90 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.292 0.568 . . . . 0.25 110.553 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 8.4 m -135.07 172.31 13.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.342 -0.849 . . . . 0.11 110.173 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.439 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -55.92 151.6 23.76 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.31 110.334 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -74.22 -7.77 20.15 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.513 1.27 . . . . 0.58999999999999997 111.201 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -150.64 32.72 0.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.899 -1.126 . . . . 0.56999999999999995 111.053 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.439 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 59.0 m -142.11 -65.86 0.41 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.084 -1.01 . . . . 0.39000000000000001 110.045 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.54 29.4 3.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.496 -1.442 . . . . 0.22 109.496 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HB1' ' OD1' ' A' ' 49' ' ' ASP . . . -105.71 171.01 7.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -1.106 . . . . 0.12 110.462 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.5 p -90.13 -162.39 0.89 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.17000000000000001 110.205 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 23.0 mttt -68.08 -14.33 62.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.341 -0.849 . . . . 0.33000000000000002 110.437 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -52.7 -45.87 67.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.098 -1.001 . . . . 0.42999999999999999 110.215 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.631 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.6 m-20 -70.49 -20.89 62.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.321 -0.862 . . . . 0.42999999999999999 109.992 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -97.76 134.75 40.51 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.378 -0.826 . . . . 0.46999999999999997 110.593 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.409 ' CG2' HG23 ' A' ' 6' ' ' ILE . 34.3 m -130.75 170.93 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.48999999999999999 110.274 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.881 HD21 HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -79.25 119.44 22.33 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.165 -0.959 . . . . 0.56999999999999995 110.344 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.433 ' N ' HD13 ' A' ' 52' ' ' LEU . 29.8 t80 . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.883 . . . . 0.56999999999999995 110.529 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.366 0.603 . . . . 0.68999999999999995 110.512 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.93 157.42 15.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 0.65000000000000002 110.481 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.431 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 0.9 OUTLIER -121.2 160.36 23.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.28999999999999998 110.097 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.447 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 55.9 m95 -135.09 127.1 29.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.151 -0.968 . . . . 0.29999999999999999 110.651 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.804 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -98.83 130.43 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.09 -1.006 . . . . 0.46000000000000002 110.028 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.804 ' N ' HD13 ' A' ' 6' ' ' ILE . 12.0 t -78.68 92.88 4.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.216 -0.928 . . . . 0.37 109.507 177.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 49' ' ' ASP . 48.0 pt -51.49 -23.99 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.884 -1.135 . . . . 0.41999999999999998 110.031 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.9 m -77.13 -27.4 53.91 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.546 -0.721 . . . . 0.48999999999999999 110.195 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 3.7 m -117.03 -47.35 2.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.28000000000000003 111.503 -178.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.574 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 114.28 -22.14 14.15 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.126 -1.59 . . . . 0.17000000000000001 109.126 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 13' ' ' ILE . 8.8 t60 -69.67 145.3 52.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -1.177 . . . . 0.20999999999999999 110.213 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.454 ' O ' ' CD2' ' A' ' 12' ' ' HIS . 7.2 mt -108.14 151.84 10.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.391 -0.818 . . . . 0.16 111.041 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -103.82 128.47 51.26 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.701 -0.624 . . . . 0.10000000000000001 109.992 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -102.89 103.85 14.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.532 -0.73 . . . . 0.11 110.344 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -51.37 -23.45 3.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.389 -0.819 . . . . 0.12 110.717 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.79 11.77 10.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.19 110.897 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -176.47 69.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.27000000000000002 109.906 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.72 -146.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.011 -1.236 . . . . 0.20999999999999999 110.011 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.06 172.96 9.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.399 -1.059 . . . . 0.27000000000000002 110.697 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -110.58 -21.57 12.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.38 110.301 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.11 -59.92 2.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.39000000000000001 110.399 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -57.68 -21.23 39.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.39000000000000001 110.3 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.36 31.96 6.92 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.198 -1.561 . . . . 0.28000000000000003 109.198 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -78.71 76.98 5.2 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.345 -1.091 . . . . 0.31 110.122 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 14.9 t -51.38 148.45 8.89 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.431 -0.793 . . . . 0.40000000000000002 110.865 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 38.4 Cg_exo -56.51 123.83 14.79 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.695 1.366 . . . . 0.25 110.493 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.6 22.87 5.28 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.572 -1.411 . . . . 0.089999999999999997 109.572 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.423 HG22 HD11 ' A' ' 34' ' ' ILE . 69.8 m -97.29 132.69 42.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -1.159 . . . . 0.14999999999999999 110.268 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.8 ttp85 -109.01 142.24 39.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.23999999999999999 110.394 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.861 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -48.01 -48.25 32.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.266 -0.897 . . . . 0.28000000000000003 110.821 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.54 -46.82 66.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.89 . . . . 0.31 110.179 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.59 -11.66 60.74 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.4 -0.813 . . . . 0.25 110.378 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 31' ' ' PHE . 77.8 mt . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.026 -1.046 . . . . 0.26000000000000001 109.973 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 69.2 t90 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.342 0.591 . . . . 0.25 110.241 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.2 p -156.49 -160.38 0.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.11 110.192 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 1.2 t -81.22 145.77 56.82 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 0.31 110.123 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 5.5 Cg_exo -75.16 -12.98 21.22 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.397 1.209 . . . . 0.58999999999999997 111.194 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -121.23 -12.79 8.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.899 -1.126 . . . . 0.56999999999999995 111.387 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 99.1 m -116.17 -72.91 0.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.917 -1.114 . . . . 0.39000000000000001 110.597 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.29 29.65 1.9 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.675 -1.37 . . . . 0.22 109.675 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.552 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . . . -110.87 -174.88 2.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -1.154 . . . . 0.12 110.285 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.7 p -89.82 -158.86 0.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.17000000000000001 110.315 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 50' ' ' TYR . 11.9 tmtt? -64.22 -12.08 37.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.427 -0.796 . . . . 0.33000000000000002 110.568 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -48.33 -45.98 35.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.048 -1.032 . . . . 0.42999999999999999 110.846 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.552 ' OD2' ' HB3' ' A' ' 45' ' ' ALA . 2.7 p30 -79.53 -19.31 49.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.42999999999999999 110.334 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.416 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 2.7 m-85 -94.13 128.72 40.7 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.118 -0.989 . . . . 0.46999999999999997 110.573 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 52' ' ' LEU . 95.4 t -123.15 161.86 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.48999999999999999 110.148 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.437 ' HA ' HD22 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -76.24 110.43 10.74 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.223 -0.923 . . . . 0.56999999999999995 110.371 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.0 t80 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.56999999999999995 110.539 -179.787 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.444 ' CE1' ' HA2' ' A' ' 28' ' ' GLY . 34.1 m-85 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.285 0.564 . . . . 0.68999999999999995 110.383 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.772 HD23 HD21 ' A' ' 52' ' ' LEU . 1.7 mp -84.14 172.34 12.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.373 -0.829 . . . . 0.65000000000000002 110.689 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -138.08 130.21 28.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.322 -0.861 . . . . 0.28999999999999998 110.001 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.529 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 30.2 m95 -108.9 179.94 4.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.165 -0.959 . . . . 0.29999999999999999 110.374 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.905 HD13 HG13 ' A' ' 13' ' ' ILE . 2.7 tp -156.55 129.7 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.584 -0.697 . . . . 0.46000000000000002 110.209 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.1 t -79.29 98.35 6.63 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.375 -0.828 . . . . 0.37 110.301 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.9 tt -55.96 -20.32 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.961 . . . . 0.41999999999999998 110.18 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.1 m -75.73 -27.35 58.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.373 -0.83 . . . . 0.48999999999999999 110.125 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.2 m -120.45 -50.74 2.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.28000000000000003 110.743 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.516 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 113.06 19.95 6.56 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.17000000000000001 109.506 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -100.31 120.11 39.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -1.223 . . . . 0.20999999999999999 110.05 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.905 HG13 HD13 ' A' ' 6' ' ' ILE . 43.5 mt -81.95 134.88 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.93 . . . . 0.16 110.577 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.422 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 48.2 t80 -92.93 125.78 37.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.458 -0.776 . . . . 0.10000000000000001 110.067 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -99.35 103.55 15.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.499 -0.751 . . . . 0.11 109.975 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -49.57 -24.94 2.39 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.277 -0.89 . . . . 0.12 110.895 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.69 22.52 7.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.19 110.058 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.454 ' HA ' HD22 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -176.22 66.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.27000000000000002 110.041 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.89 -140.06 0.67 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.777 -1.329 . . . . 0.20999999999999999 109.777 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.42 173.24 6.39 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.357 -1.084 . . . . 0.27000000000000002 110.599 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.58 -23.38 12.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.365 -0.834 . . . . 0.38 110.159 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.18 -29.42 28.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.39000000000000001 110.329 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -87.39 14.03 8.81 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.303 -0.873 . . . . 0.39000000000000001 110.823 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.85 28.39 68.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.406 -1.478 . . . . 0.28000000000000003 109.406 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.562 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -86.85 79.1 8.91 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.24 -1.153 . . . . 0.31 110.316 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 15.3 t -60.77 154.51 57.46 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.403 -0.811 . . . . 0.40000000000000002 110.76 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 23.7 Cg_exo -60.7 119.29 6.38 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.751 1.395 . . . . 0.25 110.484 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.444 ' HA2' ' CE1' ' A' ' 2' ' ' TYR . . . 113.2 38.33 1.25 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.474 -1.45 . . . . 0.089999999999999997 109.474 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.4 m -114.58 130.84 56.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -1.158 . . . . 0.14999999999999999 110.391 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -108.5 142.15 39.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.23999999999999999 110.282 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.762 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -48.24 -43.88 32.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.124 -0.985 . . . . 0.28000000000000003 110.668 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -54.76 -22.7 14.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.941 . . . . 0.31 109.774 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.56 22.07 16.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.343 -0.848 . . . . 0.25 110.161 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.762 HD12 ' HA ' ' A' ' 31' ' ' PHE . 89.7 mt . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.26000000000000001 110.471 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.562 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 59.5 t90 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.148 0.499 . . . . 0.25 109.966 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 88.6 m -132.47 -169.26 2.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.137 -0.977 . . . . 0.11 110.768 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.468 ' HB3' ' CB ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -82.19 163.06 54.57 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.31 110.375 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -67.66 -33.91 26.63 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.609 1.32 . . . . 0.58999999999999997 110.222 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -150.25 57.63 0.95 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.56999999999999995 109.947 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.468 ' CB ' ' HB3' ' A' ' 40' ' ' CYS . 1.8 t -141.58 -56.0 0.47 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.347 -0.845 . . . . 0.39000000000000001 110.248 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.6 41.13 5.49 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.46 -1.456 . . . . 0.22 109.46 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.27 171.1 8.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.16 -1.2 . . . . 0.12 110.494 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.0 p -92.09 -172.51 3.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.17000000000000001 110.427 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -15.75 48.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.33000000000000002 110.261 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -54.41 -38.44 66.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.42999999999999999 110.223 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.528 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -76.45 -19.3 58.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.42999999999999999 110.449 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.41 ' CZ ' ' CH2' ' A' ' 38' ' ' TRP . 4.0 m-85 -95.3 129.86 42.27 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.162 -0.961 . . . . 0.46999999999999997 110.591 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 6' ' ' ILE . 33.2 m -125.6 172.8 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.48999999999999999 110.246 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.772 HD21 HD23 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -78.84 116.57 19.26 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.299 -0.876 . . . . 0.56999999999999995 110.252 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.6 t80 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.56999999999999995 110.633 -179.145 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.413 0.625 . . . . 0.68999999999999995 110.505 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.411 ' O ' ' CG ' ' A' ' 16' ' ' GLU . 6.9 mp -108.96 159.55 16.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.44 -0.788 . . . . 0.65000000000000002 110.582 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.442 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 9.5 mttp -113.9 160.45 18.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.237 -0.915 . . . . 0.28999999999999998 109.832 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.527 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 29.1 m95 -128.2 133.07 48.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.093 -1.004 . . . . 0.29999999999999999 110.598 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.75 HD13 HG13 ' A' ' 13' ' ' ILE . 3.5 tp -104.02 141.62 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.093 -1.004 . . . . 0.46000000000000002 111.016 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.454 ' H ' HD12 ' A' ' 6' ' ' ILE . 16.1 t -92.35 102.35 14.84 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.385 -0.822 . . . . 0.37 109.978 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.9 tt -55.79 -20.09 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.952 . . . . 0.41999999999999998 110.595 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.3 m -67.55 -36.73 81.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.48999999999999999 110.936 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.3 p -131.33 -34.4 1.41 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.984 -1.073 . . . . 0.28000000000000003 111.157 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.624 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 107.81 41.65 1.55 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.489 -1.444 . . . . 0.17000000000000001 109.489 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.458 ' CE1' ' HG2' ' A' ' 41' ' ' PRO . 13.7 t-80 -105.06 126.68 52.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -1.113 . . . . 0.20999999999999999 110.113 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.75 HG13 HD13 ' A' ' 6' ' ' ILE . 6.0 mt -93.69 133.18 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.16 110.685 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.469 ' HH ' ' HD2' ' A' ' 25' ' ' PHE . 72.5 t80 -97.33 132.23 43.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.571 -0.705 . . . . 0.10000000000000001 109.538 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.526 ' OD1' ' HB3' ' A' ' 17' ' ' ALA . 10.3 t70 -102.69 103.62 13.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.529 -0.732 . . . . 0.11 110.165 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 3' ' ' LEU . 26.0 mt-10 -52.2 -22.91 4.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.901 . . . . 0.12 110.596 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.526 ' HB3' ' OD1' ' A' ' 15' ' ' ASP . . . -88.25 12.68 13.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.19 110.699 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tp -177.25 68.81 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.172 -0.955 . . . . 0.27000000000000002 109.655 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.99 -139.54 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.254 -1.139 . . . . 0.20999999999999999 110.254 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -89.37 164.35 14.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.44 -1.035 . . . . 0.27000000000000002 110.809 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -107.12 -31.98 8.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.444 -0.785 . . . . 0.38 109.93 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.29 -53.46 19.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.311 -0.868 . . . . 0.39000000000000001 110.264 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -60.86 -27.78 68.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.39000000000000001 110.072 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.12 28.41 6.87 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.601 -1.4 . . . . 0.28000000000000003 109.601 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.541 ' HE2' HD11 ' A' ' 34' ' ' ILE . 0.5 OUTLIER -66.67 83.53 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.066 -1.255 . . . . 0.31 110.128 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 14.0 t -50.79 145.83 10.95 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.456 -0.777 . . . . 0.40000000000000002 110.74 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 34.7 Cg_exo -55.56 116.84 3.44 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.631 1.332 . . . . 0.25 110.431 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 116.11 24.46 3.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.663 -1.375 . . . . 0.089999999999999997 109.663 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.8 m -98.13 116.2 29.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -1.198 . . . . 0.14999999999999999 110.149 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.406 ' HA ' ' HG2' ' A' ' 16' ' ' GLU . 15.2 ttp180 -94.99 142.66 27.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.244 -0.91 . . . . 0.23999999999999999 110.626 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.733 ' HA ' HD12 ' A' ' 34' ' ' ILE . 1.2 t80 -50.57 -27.19 6.29 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.282 -0.887 . . . . 0.28000000000000003 110.252 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.08 -33.8 58.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -0.971 . . . . 0.31 109.804 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -89.51 7.58 35.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.521 -0.737 . . . . 0.25 110.45 178.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.733 HD12 ' HA ' ' A' ' 31' ' ' PHE . 33.8 mt . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.09 -1.006 . . . . 0.26000000000000001 109.67 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.414 ' HB3' HG23 ' A' ' 34' ' ' ILE . 88.2 t90 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.239 0.542 . . . . 0.25 110.04 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.407 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 97.8 m -127.12 -175.1 3.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.11 110.266 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.38 138.73 48.18 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.31 110.283 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.458 ' HG2' ' CE1' ' A' ' 12' ' ' HIS . 36.9 Cg_endo -71.66 -16.3 30.15 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.488 1.257 . . . . 0.58999999999999997 110.816 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.2 -0.36 15.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.988 . . . . 0.56999999999999995 111.236 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 64.2 m -138.45 -68.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.953 -1.092 . . . . 0.39000000000000001 110.404 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 39' ' ' CYS . . . 107.17 32.26 3.55 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.327 -1.509 . . . . 0.22 109.327 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.89 -168.74 1.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -1.106 . . . . 0.12 110.613 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 p -88.04 178.31 6.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.38 -0.825 . . . . 0.17000000000000001 110.526 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -65.05 -22.28 66.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 0.33000000000000002 110.172 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -58.04 -18.96 27.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.42999999999999999 110.406 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.464 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.1 m-20 -83.65 -15.47 48.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.42999999999999999 110.661 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -99.81 145.24 27.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.046 -1.034 . . . . 0.46999999999999997 111.199 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.3 m -145.75 164.56 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.538 -0.727 . . . . 0.48999999999999999 109.905 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 53' ' ' TYR . 2.2 tp -69.77 127.76 34.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 0.56999999999999995 110.824 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.557 ' HD1' HG21 ' A' ' 6' ' ' ILE . 7.3 t80 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.56999999999999995 110.202 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 24.7 m-85 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.441 0.638 . . . . 0.68999999999999995 110.345 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.699 HD23 HD21 ' A' ' 52' ' ' LEU . 4.8 mp -87.46 -178.27 6.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.358 -0.839 . . . . 0.65000000000000002 110.455 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.41 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 25.0 mttt -142.98 146.6 34.06 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.483 -0.761 . . . . 0.28999999999999998 110.165 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.562 ' CE3' ' CD2' ' A' ' 31' ' ' PHE . 22.7 m95 -130.09 123.6 30.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.29999999999999999 110.078 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.826 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -106.63 134.47 48.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.037 -1.04 . . . . 0.46000000000000002 110.278 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.826 ' N ' HD13 ' A' ' 6' ' ' ILE . 4.3 t -79.89 96.04 6.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.407 -0.808 . . . . 0.37 110.098 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.7 pt -53.23 -22.6 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.132 -0.98 . . . . 0.41999999999999998 110.146 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.6 m -75.57 -28.16 58.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.295 -0.878 . . . . 0.48999999999999999 110.203 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.4 m -115.24 -50.93 2.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.28000000000000003 110.869 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.56 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 113.12 19.02 6.95 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.47 -1.452 . . . . 0.17000000000000001 109.47 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 1.9 m170 -102.0 131.54 48.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -1.22 . . . . 0.20999999999999999 110.002 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.418 HG13 HG12 ' A' ' 6' ' ' ILE . 73.0 mt -95.31 136.71 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.16 110.761 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.479 ' HH ' ' HE2' ' A' ' 25' ' ' PHE . 66.1 t80 -99.4 132.53 44.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.10000000000000001 109.959 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -109.7 111.56 23.1 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.511 -0.743 . . . . 0.11 109.703 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -51.15 -24.06 3.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.12 110.493 -179.233 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 2' ' ' TYR . . . -93.55 17.53 11.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.172 -0.955 . . . . 0.19 110.245 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -177.31 68.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.27000000000000002 109.71 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.28 -137.1 1.73 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.224 -1.151 . . . . 0.20999999999999999 110.224 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 22' ' ' ALA . 11.3 t70 -78.97 158.42 27.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.432 -1.04 . . . . 0.27000000000000002 110.776 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -104.13 -33.29 8.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.38 110.094 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . -80.01 -45.62 18.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.39000000000000001 110.205 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.12 -35.22 71.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -0.928 . . . . 0.39000000000000001 109.976 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.2 20.37 7.53 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.568 -1.413 . . . . 0.28000000000000003 109.568 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.571 ' CE1' ' CD1' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -67.79 77.97 0.2 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.111 -1.229 . . . . 0.31 110.224 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.0 t -52.66 151.65 7.73 Favored Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.444 -0.785 . . . . 0.40000000000000002 110.702 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -58.89 116.77 3.49 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.703 1.37 . . . . 0.25 110.394 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.62 -23.95 5.59 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.346 -1.502 . . . . 0.089999999999999997 109.346 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.539 HG22 HD11 ' A' ' 34' ' ' ILE . 6.7 m -53.26 132.29 38.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -1.152 . . . . 0.14999999999999999 110.235 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.453 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 16.1 mtp180 -115.51 146.29 41.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.853 . . . . 0.23999999999999999 110.394 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.562 ' CD2' ' CE3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -50.93 -33.65 25.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.28000000000000003 110.273 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -53.21 -50.98 63.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.871 . . . . 0.31 110.02 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -70.06 -7.84 44.49 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.416 -0.803 . . . . 0.25 110.471 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.543 HG23 ' HB3' ' A' ' 38' ' ' TRP . 30.1 mt . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.156 -0.965 . . . . 0.26000000000000001 110.154 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.571 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 54.9 t90 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.286 0.565 . . . . 0.25 110.126 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -162.16 176.81 10.27 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.373 -0.83 . . . . 0.11 110.361 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -51.55 149.77 7.6 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.85 . . . . 0.31 109.988 178.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.52 -27.85 70.19 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.527 1.278 . . . . 0.58999999999999997 110.74 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.2 57.36 0.89 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.935 . . . . 0.56999999999999995 110.217 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.469 ' CB ' ' HB3' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -152.46 -45.53 0.1 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.259 -0.901 . . . . 0.39000000000000001 110.045 -179.157 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.53 42.65 95.57 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.54 -1.424 . . . . 0.22 109.54 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.41 32.74 5.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -1.198 . . . . 0.12 110.823 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.1 p 44.02 -153.65 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.578 0.704 . . . . 0.17000000000000001 111.101 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -81.56 -13.08 58.49 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.515 -0.741 . . . . 0.33000000000000002 110.447 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.08 -48.84 43.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.085 -1.009 . . . . 0.42999999999999999 110.794 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 9.8 m-20 -76.64 -16.63 59.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.42999999999999999 110.43 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.41 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 1.8 m-85 -93.56 135.92 34.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.042 -1.036 . . . . 0.46999999999999997 110.51 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 71.4 t -131.59 150.12 33.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.282 -0.886 . . . . 0.48999999999999999 110.232 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.699 HD21 HD23 ' A' ' 3' ' ' LEU . 0.5 OUTLIER -63.63 125.12 23.24 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.352 -0.842 . . . . 0.56999999999999995 110.43 -179.546 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.644 ' N ' HD13 ' A' ' 52' ' ' LEU . 17.1 t80 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 0.56999999999999995 110.38 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.518 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 55.9 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.356 0.598 . . . . 0.68999999999999995 110.487 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 3' ' ' LEU . 8.7 mp -90.53 171.31 9.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.65000000000000002 110.397 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.438 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 19.6 mttp -136.12 158.37 44.58 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.28999999999999998 109.959 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.531 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 31.2 m95 -127.8 136.44 51.47 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -0.944 . . . . 0.29999999999999999 110.579 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.729 HD13 HG13 ' A' ' 13' ' ' ILE . 3.4 tp -106.13 137.87 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.964 -1.085 . . . . 0.46000000000000002 110.568 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 11' ' ' GLY . 7.6 t -83.41 96.13 8.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.547 -0.721 . . . . 0.37 110.25 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 49' ' ' ASP . 2.4 tt -56.11 -19.95 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.981 -1.074 . . . . 0.41999999999999998 110.027 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.9 m -77.64 -27.15 50.97 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.325 -0.86 . . . . 0.48999999999999999 110.105 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 64.4 m -123.64 -54.99 1.74 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.338 -0.851 . . . . 0.28000000000000003 110.632 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.526 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 119.83 27.07 2.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.84 -1.304 . . . . 0.17000000000000001 109.84 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.664 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -109.36 144.06 38.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -1.185 . . . . 0.20999999999999999 110.278 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.729 HG13 HD13 ' A' ' 6' ' ' ILE . 7.2 mt -98.41 145.53 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.847 . . . . 0.16 110.968 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 58.1 t80 -105.7 133.58 50.21 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.369 -0.604 . . . . 0.10000000000000001 109.369 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -101.6 106.76 17.87 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.552 -0.718 . . . . 0.11 110.198 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 30' ' ' ARG . 24.3 mt-10 -50.28 -25.98 4.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.308 -0.87 . . . . 0.12 110.722 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.518 ' HB2' ' CD2' ' A' ' 2' ' ' TYR . . . -100.07 19.97 15.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.19 110.352 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.489 ' HA ' HD22 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -177.55 70.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.27000000000000002 110.338 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' A' ' 25' ' ' PHE . . . -64.24 -135.69 0.01 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.572 -1.411 . . . . 0.20999999999999999 109.572 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -99.39 172.08 7.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -1.169 . . . . 0.27000000000000002 110.702 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.37 -24.18 20.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.38 110.003 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.25 -36.95 17.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.307 -0.87 . . . . 0.39000000000000001 110.106 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -66.91 -21.65 65.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.39000000000000001 110.074 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.16 31.06 53.8 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.258 -1.537 . . . . 0.28000000000000003 109.258 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.654 ' CE1' HG21 ' A' ' 29' ' ' THR . 0.1 OUTLIER -71.72 82.43 0.87 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.15 -1.206 . . . . 0.31 110.141 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.3 t -49.29 142.27 10.87 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.40000000000000002 110.767 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 39.0 Cg_exo -52.83 108.5 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.555 1.292 . . . . 0.25 110.69 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.01 44.04 0.26 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.602 -1.399 . . . . 0.089999999999999997 109.602 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.654 HG21 ' CE1' ' A' ' 25' ' ' PHE . 1.5 m -122.63 136.26 54.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -1.165 . . . . 0.14999999999999999 110.555 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.401 ' HA ' ' HG2' ' A' ' 16' ' ' GLU . 8.9 mtp180 -122.87 144.34 49.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.351 -0.843 . . . . 0.23999999999999999 110.224 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.593 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -48.18 -49.13 33.77 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.224 -0.922 . . . . 0.28000000000000003 110.494 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -53.37 -26.8 20.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.31 109.64 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.21 16.73 20.46 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.491 -0.755 . . . . 0.25 110.133 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.644 ' O ' HG22 ' A' ' 34' ' ' ILE . 92.2 mt . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.26000000000000001 110.327 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.424 ' NE1' ' CE2' ' A' ' 25' ' ' PHE . 63.7 t90 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.371 0.605 . . . . 0.25 110.28 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 83.4 m -148.65 -167.31 2.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.325 -0.859 . . . . 0.11 110.133 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.24 169.98 18.1 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.232 -0.918 . . . . 0.31 109.981 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -57.94 -47.7 19.53 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.563 1.296 . . . . 0.58999999999999997 110.206 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -178.82 57.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.45 -0.781 . . . . 0.56999999999999995 109.981 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 21.1 p -162.14 -36.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.152 -0.968 . . . . 0.39000000000000001 111.113 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -95.67 -41.53 3.85 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.574 -1.411 . . . . 0.22 109.574 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 56.82 163.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -1.047 . . . . 0.12 110.945 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 44.61 -161.23 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.468 -0.77 . . . . 0.17000000000000001 111.053 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -122.31 -21.53 5.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.338 -0.851 . . . . 0.33000000000000002 110.72 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.49 -28.96 48.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.977 . . . . 0.42999999999999999 110.448 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.749 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.5 m-20 -74.07 -17.69 60.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.42999999999999999 110.34 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -97.15 136.41 37.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.095 -1.003 . . . . 0.46999999999999997 110.725 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.27 162.83 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.48999999999999999 109.914 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.88 118.84 19.87 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.121 -0.987 . . . . 0.56999999999999995 110.5 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.1 t80 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.56999999999999995 110.518 -179.741 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.413 0.625 . . . . 0.68999999999999995 110.466 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.049 HD23 HD21 ' A' ' 52' ' ' LEU . 0.7 OUTLIER -90.67 167.21 12.7 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.248 -0.907 . . . . 0.65000000000000002 110.272 179.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -127.4 125.57 40.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.28999999999999998 110.474 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.526 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 23.2 m95 -106.62 179.22 4.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.29999999999999999 110.032 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.731 HD11 ' HA2' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -157.69 126.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 119.844 -0.742 . . . . 0.46000000000000002 110.193 178.025 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.664 ' N ' HD13 ' A' ' 6' ' ' ILE . 12.5 t -73.47 91.1 1.76 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.353 -0.842 . . . . 0.37 109.488 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.5 pt -51.92 -22.95 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.195 -0.941 . . . . 0.41999999999999998 110.334 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 94.4 m -59.03 -27.86 65.87 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.379 -0.825 . . . . 0.48999999999999999 110.714 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -137.11 -36.7 0.66 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.145 -0.972 . . . . 0.28000000000000003 111.243 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.731 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 117.16 19.78 5.03 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.516 -1.326 . . . . 0.17000000000000001 110.077 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.37 115.1 26.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.047 -1.266 . . . . 0.20999999999999999 110.232 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.2 mt -84.2 128.62 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.925 . . . . 0.16 110.539 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 63.2 t80 -91.74 120.82 32.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.10000000000000001 109.814 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -99.18 103.98 15.91 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.217 -0.927 . . . . 0.11 109.879 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -47.58 -26.57 1.5 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.12 111.075 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.33 19.01 8.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.176 -0.953 . . . . 0.19 110.579 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -176.1 68.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.27000000000000002 110.165 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.16 -143.42 0.79 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.737 -1.345 . . . . 0.20999999999999999 109.737 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.56 165.25 12.43 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.34 -1.094 . . . . 0.27000000000000002 110.297 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.04 -41.79 6.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.237 -0.914 . . . . 0.38 110.346 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.72 -50.2 70.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.39000000000000001 110.26 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.09 -21.07 44.39 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.176 -0.953 . . . . 0.39000000000000001 110.397 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.38 23.25 17.1 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.221 -1.551 . . . . 0.28000000000000003 109.221 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -83.83 78.91 9.64 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.242 -1.151 . . . . 0.31 110.05 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.4 t -49.24 151.67 2.42 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.357 -0.84 . . . . 0.40000000000000002 110.985 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 23.6 Cg_exo -60.68 80.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.713 1.375 . . . . 0.25 110.387 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 26' ' ' THR . . . 153.82 42.11 0.02 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.148 -1.581 . . . . 0.089999999999999997 109.148 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.6 m -112.56 134.44 54.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.35 -1.088 . . . . 0.14999999999999999 110.341 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -111.43 145.96 38.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.829 . . . . 0.23999999999999999 110.163 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.685 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -52.39 -41.21 62.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.919 . . . . 0.28000000000000003 110.251 179.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -53.64 -43.63 68.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.873 . . . . 0.31 110.204 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -79.17 2.03 22.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.25 110.772 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 31' ' ' PHE . 88.7 mt . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.0 -1.063 . . . . 0.26000000000000001 110.075 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.573 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 87.9 t90 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.299 0.571 . . . . 0.25 110.479 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.408 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 67.4 m -133.88 -174.51 3.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.11 110.191 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -83.55 156.13 65.47 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.077 -1.015 . . . . 0.31 110.286 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.67 -5.14 14.6 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.487 1.256 . . . . 0.58999999999999997 111.201 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 50.1 p30 -146.09 20.6 1.41 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.875 -1.14 . . . . 0.56999999999999995 110.968 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 76.8 m -143.0 -49.03 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.165 -0.959 . . . . 0.39000000000000001 110.424 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 39' ' ' CYS . . . 77.01 33.23 46.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.409 -1.476 . . . . 0.22 109.409 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.549 ' HB1' ' OD1' ' A' ' 49' ' ' ASP . . . -102.57 -172.05 2.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -1.169 . . . . 0.12 110.49 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.97 -171.91 2.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.855 . . . . 0.17000000000000001 110.332 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.454 ' HD3' ' CD2' ' A' ' 31' ' ' PHE . 20.3 mttt -60.56 -18.8 54.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.35 -0.844 . . . . 0.33000000000000002 110.227 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.24 -41.07 65.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.42999999999999999 110.361 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.549 ' OD1' ' HB1' ' A' ' 45' ' ' ALA . 2.1 m-20 -69.29 -24.23 63.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.42999999999999999 109.826 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -92.96 137.88 31.97 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.443 -0.786 . . . . 0.46999999999999997 110.512 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.427 HG22 ' N ' ' A' ' 52' ' ' LEU . 8.6 p -129.69 163.68 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 0.48999999999999999 110.032 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.049 HD21 HD23 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -69.84 108.75 4.1 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.114 -0.991 . . . . 0.56999999999999995 110.084 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.56999999999999995 110.749 -178.926 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.513 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 23.0 m-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.324 0.583 . . . . 0.68999999999999995 110.358 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.45 HD23 HD21 ' A' ' 52' ' ' LEU . 2.6 mp -81.73 165.93 20.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.65000000000000002 110.759 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.44 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 23.6 mttm -134.38 151.39 51.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.28999999999999998 110.12 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.554 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 20.1 m95 -133.03 127.15 33.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.3 -0.875 . . . . 0.29999999999999999 109.927 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.845 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -102.64 134.43 43.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.112 -0.992 . . . . 0.46000000000000002 110.898 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.845 ' N ' HD13 ' A' ' 6' ' ' ILE . 16.3 t -79.9 95.71 6.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.579 -0.7 . . . . 0.37 109.588 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.534 HG22 ' O ' ' A' ' 49' ' ' ASP . 2.1 tt -55.26 -20.12 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.41999999999999998 110.628 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.1 m -63.46 -27.98 69.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.28 -0.888 . . . . 0.48999999999999999 110.885 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.5 p -134.09 -35.89 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.967 -1.083 . . . . 0.28000000000000003 111.397 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.568 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 112.21 35.96 1.71 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.533 -1.318 . . . . 0.17000000000000001 109.854 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 4.2 t-80 -112.14 129.26 56.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.128 -1.219 . . . . 0.20999999999999999 110.397 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.424 HG13 HG12 ' A' ' 6' ' ' ILE . 13.5 mt -91.58 146.66 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.16 111.096 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -108.68 129.14 55.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.565 -0.709 . . . . 0.10000000000000001 109.809 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -105.32 106.75 17.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.549 -0.719 . . . . 0.11 110.234 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 2' ' ' TYR . 19.1 mt-10 -49.88 -24.54 2.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.12 110.664 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.513 ' HB2' ' CD2' ' A' ' 2' ' ' TYR . . . -88.0 14.25 9.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.19 110.71 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 tp -176.08 67.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.025 -1.047 . . . . 0.27000000000000002 109.955 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.43 -143.03 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.897 -1.281 . . . . 0.20999999999999999 109.897 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.88 165.38 11.59 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.37 -1.076 . . . . 0.27000000000000002 110.525 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -107.19 -20.02 13.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.38 110.545 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.59 -36.0 38.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.151 -0.968 . . . . 0.39000000000000001 110.392 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -81.42 -13.31 58.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.39000000000000001 110.729 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.81 27.7 16.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.073 -1.611 . . . . 0.28000000000000003 109.073 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -82.97 82.77 8.07 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.371 -1.076 . . . . 0.31 110.229 -179.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.3 t -49.69 142.34 12.36 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.173 -0.954 . . . . 0.40000000000000002 110.77 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 36.8 Cg_exo -53.05 109.66 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.559 1.294 . . . . 0.25 110.612 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.92 -14.03 5.23 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.142 -1.183 . . . . 0.089999999999999997 110.142 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.509 HG22 HD11 ' A' ' 34' ' ' ILE . 1.3 m -51.53 129.68 26.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.95 -1.324 . . . . 0.14999999999999999 110.804 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -108.83 134.19 51.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.357 -0.84 . . . . 0.23999999999999999 110.003 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.684 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -47.06 -51.88 16.48 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.242 -0.911 . . . . 0.28000000000000003 110.947 -179.372 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -51.5 -37.15 47.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 0.31 109.96 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -85.5 8.8 17.82 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.438 -0.789 . . . . 0.25 110.274 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.684 HD12 ' HA ' ' A' ' 31' ' ' PHE . 78.5 mt . . . . . 0 N--CA 1.491 1.593 0 O-C-N 120.98 -1.075 . . . . 0.26000000000000001 110.226 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 83.2 t90 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.152 0.501 . . . . 0.25 110.251 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 91.6 m -130.96 -167.08 1.78 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.11 110.546 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -87.09 143.29 34.63 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.31 110.375 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -78.28 -17.07 13.42 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.567 1.298 . . . . 0.58999999999999997 111.009 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -28.55 9.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.05 -1.031 . . . . 0.56999999999999995 110.866 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 94.1 m -101.22 -71.99 0.69 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 0.39000000000000001 110.606 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.82 29.38 1.86 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.581 -1.408 . . . . 0.22 109.581 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.51 -173.84 2.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.103 -1.234 . . . . 0.12 110.337 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.1 p -97.12 -170.88 2.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.17000000000000001 110.393 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.501 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 5.8 tttt -61.44 -16.66 48.99 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.364 -0.835 . . . . 0.33000000000000002 110.388 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -58.29 -28.38 64.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -0.97 . . . . 0.42999999999999999 110.634 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.534 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.5 m-20 -86.23 -16.98 35.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.42999999999999999 110.51 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 7' ' ' CYS . 1.9 m-85 -94.34 138.28 32.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -0.932 . . . . 0.46999999999999997 110.86 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 52' ' ' LEU . 87.3 t -132.75 163.05 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.775 . . . . 0.48999999999999999 110.047 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.453 ' HA ' HD22 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -74.28 117.19 15.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.172 -0.955 . . . . 0.56999999999999995 110.334 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.422 ' N ' HD13 ' A' ' 52' ' ' LEU . 29.7 t80 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.56999999999999995 110.531 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.513 ' CD1' ' HB3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.898 0.856 . . . . 0.68999999999999995 111.283 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.84 169.39 6.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -0.865 . . . . 0.65000000000000002 110.517 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.71 128.13 15.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.39 -0.819 . . . . 0.28999999999999998 109.947 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.525 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 27.5 m95 -107.42 174.25 5.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.29999999999999999 110.019 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.922 HD13 HG13 ' A' ' 13' ' ' ILE . 2.4 tp -149.18 123.31 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.46000000000000002 110.438 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 9.1 t -69.33 95.12 0.76 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.376 -0.828 . . . . 0.37 109.933 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 9' ' ' THR . 11.0 pt -52.28 -22.76 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.16 -0.963 . . . . 0.41999999999999998 110.174 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.42 ' N ' HG13 ' A' ' 8' ' ' ILE . 34.2 m -61.37 -43.99 97.93 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.445 -0.784 . . . . 0.48999999999999999 110.915 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.9 p -123.59 -32.09 3.39 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.983 . . . . 0.28000000000000003 110.945 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.677 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 108.27 30.66 3.79 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.811 -1.316 . . . . 0.17000000000000001 109.811 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -95.17 112.97 24.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.244 -1.151 . . . . 0.20999999999999999 110.015 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.922 HG13 HD13 ' A' ' 6' ' ' ILE . 63.2 mt -80.72 128.73 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.16 110.533 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.416 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 63.1 t80 -92.6 132.25 37.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.519 -0.738 . . . . 0.10000000000000001 110.052 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -101.69 104.57 15.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.541 -0.724 . . . . 0.11 110.102 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.513 ' HB3' ' CD1' ' A' ' 2' ' ' TYR . 10.2 mt-10 -53.4 -27.12 22.54 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.159 -0.963 . . . . 0.12 110.651 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.464 ' HB2' ' HB2' ' A' ' 2' ' ' TYR . . . -92.01 18.73 7.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.143 -0.973 . . . . 0.19 110.452 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -176.39 66.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.883 . . . . 0.27000000000000002 109.843 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.83 -142.64 0.06 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.952 -1.259 . . . . 0.20999999999999999 109.952 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.42 173.76 7.36 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.409 -1.054 . . . . 0.27000000000000002 110.727 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -109.62 -33.43 6.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.324 -0.86 . . . . 0.38 110.167 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.52 -60.44 3.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.39000000000000001 110.363 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -61.3 -17.88 55.82 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.39000000000000001 110.57 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.15 33.34 7.76 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.279 -1.529 . . . . 0.28000000000000003 109.279 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -81.06 76.44 8.01 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.394 -1.062 . . . . 0.31 110.174 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -50.97 151.22 4.67 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.341 -0.849 . . . . 0.40000000000000002 110.912 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.03 123.88 14.68 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.631 1.332 . . . . 0.25 110.466 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.7 23.87 4.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.538 -1.425 . . . . 0.089999999999999997 109.538 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.9 m -94.63 135.83 35.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -1.232 . . . . 0.14999999999999999 110.325 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.66 138.4 47.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.349 -0.844 . . . . 0.23999999999999999 110.428 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.878 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -50.12 -30.97 12.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.219 -0.925 . . . . 0.28000000000000003 110.628 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -61.28 -55.04 36.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.153 -0.967 . . . . 0.31 110.204 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -28.76 69.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.25 110.243 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.878 HD12 ' HA ' ' A' ' 31' ' ' PHE . 82.4 mt . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.26000000000000001 110.288 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.533 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 88.2 t90 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.296 0.569 . . . . 0.25 110.532 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.44 ' N ' ' CG ' ' A' ' 38' ' ' TRP . 25.4 p -167.2 -160.65 0.38 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.333 -0.854 . . . . 0.11 110.283 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.7 OUTLIER -87.53 144.13 35.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.397 -0.814 . . . . 0.31 110.307 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.16 9.72 3.97 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.667 1.351 . . . . 0.58999999999999997 111.281 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 37.4 p-10 -152.02 17.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.84 -1.163 . . . . 0.56999999999999995 110.934 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 58.0 m -144.92 -72.3 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.068 . . . . 0.39000000000000001 110.284 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.22 36.76 0.73 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.485 -1.446 . . . . 0.22 109.485 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.451 ' HB1' ' OE2' ' A' ' 48' ' ' GLU . . . -121.35 176.0 5.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -1.156 . . . . 0.12 110.592 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -100.8 -162.68 0.96 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.341 -0.85 . . . . 0.17000000000000001 109.964 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -55.15 -21.79 14.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.125 -0.984 . . . . 0.33000000000000002 109.722 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.451 ' OE2' ' HB1' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -53.56 -27.59 27.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.42999999999999999 109.91 179.293 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 4.4 m-20 -91.85 -21.69 20.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.431 -0.793 . . . . 0.42999999999999999 109.908 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -97.27 137.63 35.98 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.263 -0.898 . . . . 0.46999999999999997 110.655 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.464 ' CG1' HG23 ' A' ' 6' ' ' ILE . 7.2 p -127.23 148.1 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.48999999999999999 110.0 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.67 115.52 4.83 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.141 -0.974 . . . . 0.56999999999999995 110.348 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.7 t80 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.37 -0.831 . . . . 0.56999999999999995 110.397 -179.379 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.394 0.616 . . . . 0.68999999999999995 110.39 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.62 170.66 7.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.65000000000000002 110.524 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -127.32 124.01 37.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.28999999999999998 110.372 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.479 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 35.5 m95 -100.94 172.43 7.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.197 -0.939 . . . . 0.29999999999999999 110.025 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.833 HD13 HG13 ' A' ' 13' ' ' ILE . 2.2 tp -147.37 126.47 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.46000000000000002 110.254 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 10.1 t -73.18 89.13 1.5 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.296 -0.877 . . . . 0.37 109.973 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.9 pt -49.77 -25.83 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.066 -1.021 . . . . 0.41999999999999998 109.982 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -75.61 -28.71 58.96 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.606 -0.684 . . . . 0.48999999999999999 110.147 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 1.5 m -112.57 -54.45 2.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.28000000000000003 110.497 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . 115.11 19.65 5.86 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.585 -1.406 . . . . 0.17000000000000001 109.585 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.55 ' O ' HD12 ' A' ' 6' ' ' ILE . 13.8 m80 -103.93 136.07 44.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -1.207 . . . . 0.20999999999999999 110.134 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.833 HG13 HD13 ' A' ' 6' ' ' ILE . 3.3 mt -93.93 130.05 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.321 -0.862 . . . . 0.16 110.477 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.526 ' CE1' ' HA2' ' A' ' 19' ' ' GLY . 81.0 t80 -97.68 133.14 42.61 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.10000000000000001 109.616 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -111.63 111.15 21.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.11 110.239 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 66.2 mt-10 -50.56 -23.35 2.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.383 -0.823 . . . . 0.12 110.989 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.65 8.05 15.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.976 -1.077 . . . . 0.19 110.968 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.486 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -176.6 68.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.022 -1.049 . . . . 0.27000000000000002 109.625 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.526 ' HA2' ' CE1' ' A' ' 14' ' ' TYR . . . -66.57 -138.39 0.04 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.011 -1.235 . . . . 0.20999999999999999 110.011 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -100.35 172.48 7.12 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.408 -1.054 . . . . 0.27000000000000002 110.812 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.88 -31.68 9.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.384 -0.823 . . . . 0.38 110.318 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.93 -50.37 35.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 0.39000000000000001 110.187 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -60.3 -18.35 48.83 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.304 -0.872 . . . . 0.39000000000000001 110.574 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.14 23.03 23.52 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.389 -1.484 . . . . 0.28000000000000003 109.389 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.584 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 1.8 m-30 -83.07 78.14 9.63 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.269 -1.136 . . . . 0.31 110.411 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.401 ' OG1' ' HD2' ' A' ' 27' ' ' PRO . 14.6 t -58.35 155.8 25.27 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.443 -0.785 . . . . 0.40000000000000002 110.678 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD2' ' OG1' ' A' ' 26' ' ' THR . 33.4 Cg_exo -53.75 113.35 1.28 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.619 1.326 . . . . 0.25 110.463 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.7 34.61 1.05 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.276 -1.53 . . . . 0.089999999999999997 109.276 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.469 HG22 ' CG1' ' A' ' 34' ' ' ILE . 30.4 m -117.2 121.55 41.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -1.163 . . . . 0.14999999999999999 110.351 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.453 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 0.5 OUTLIER -108.61 150.86 26.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.279 -0.888 . . . . 0.23999999999999999 110.353 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.852 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -47.58 -42.79 24.61 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.285 -0.885 . . . . 0.28000000000000003 111.015 -179.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -60.34 -42.73 96.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.31 110.808 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -78.28 -24.89 46.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.212 -0.93 . . . . 0.25 110.463 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.852 HD12 ' HA ' ' A' ' 31' ' ' PHE . 65.2 mt . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.26000000000000001 110.231 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.584 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 74.3 t90 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.323 0.582 . . . . 0.25 110.482 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.5 p -167.28 -161.7 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.887 . . . . 0.11 110.335 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 1.4 t -89.99 140.98 27.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.31 110.285 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 7.0 Cg_exo -70.91 -7.2 20.87 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.482 1.254 . . . . 0.58999999999999997 111.378 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -127.73 -9.11 5.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.911 -1.118 . . . . 0.56999999999999995 111.499 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 84.3 m -121.76 -75.62 0.59 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.897 -1.127 . . . . 0.39000000000000001 110.536 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.19 33.46 0.96 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.536 -1.426 . . . . 0.22 109.536 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.22 177.02 4.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -1.205 . . . . 0.12 110.447 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -72.28 -162.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.17000000000000001 110.365 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -75.19 -4.58 39.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.33000000000000002 110.734 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.05 -41.25 62.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.993 -1.067 . . . . 0.42999999999999999 110.453 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 1.6 m-20 -71.35 -25.66 62.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.42999999999999999 110.008 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -89.06 132.29 34.84 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.296 -0.877 . . . . 0.46999999999999997 110.487 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 87.1 t -130.28 159.66 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.48999999999999999 110.129 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.7 tp -64.45 117.41 7.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.154 -0.966 . . . . 0.56999999999999995 110.529 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.414 ' CB ' ' O ' ' A' ' 4' ' ' LYS . 28.0 t80 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.56999999999999995 110.35 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.503 ' CE1' ' NH2' ' A' ' 30' ' ' ARG . 40.6 m-85 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.351 0.596 . . . . 0.68999999999999995 110.334 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.507 HD23 HD21 ' A' ' 52' ' ' LEU . 6.7 mp -81.32 167.68 19.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.389 -0.819 . . . . 0.65000000000000002 110.465 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.41 ' HG3' ' HA ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER -138.51 124.86 20.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.28999999999999998 110.08 179.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.501 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 34.4 m95 -100.89 142.14 32.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.29999999999999999 110.266 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.789 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -107.52 129.04 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.958 -1.089 . . . . 0.46000000000000002 109.806 178.127 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.789 ' N ' HD13 ' A' ' 6' ' ' ILE . 9.6 t -77.19 87.08 3.64 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.374 -0.829 . . . . 0.37 109.172 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 49' ' ' ASP . 2.0 tt -50.47 -22.63 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.15 -0.969 . . . . 0.41999999999999998 110.531 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 m -66.51 -30.23 70.5 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.284 -0.885 . . . . 0.48999999999999999 110.685 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 p -140.15 -15.86 0.98 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.907 -1.121 . . . . 0.28000000000000003 112.662 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.656 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 104.8 -28.3 15.39 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.29 -1.434 . . . . 0.17000000000000001 110.049 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -51.86 135.35 30.18 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.06 -1.259 . . . . 0.20999999999999999 110.415 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.44 ' CG1' HG12 ' A' ' 6' ' ' ILE . 6.7 mt -109.81 142.48 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.82 . . . . 0.16 110.768 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -98.22 123.14 42.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.596 -0.69 . . . . 0.10000000000000001 109.433 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.41 ' HA ' ' HG3' ' A' ' 4' ' ' LYS . 5.1 m-20 -103.26 108.51 19.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.11 110.137 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -48.23 -25.64 1.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.12 110.764 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.431 ' HB2' ' CD2' ' A' ' 2' ' ' TYR . . . -92.32 21.07 5.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.19 110.234 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 tp -176.24 60.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.27000000000000002 109.988 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.51 -139.55 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.852 -1.299 . . . . 0.20999999999999999 109.852 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.69 172.15 7.01 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.392 -1.064 . . . . 0.27000000000000002 110.561 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.47 -45.07 4.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.353 -0.842 . . . . 0.38 110.356 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.51 -54.64 41.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.39000000000000001 110.354 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -60.57 -16.94 42.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.39000000000000001 110.595 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.33 29.99 23.39 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.935 -1.666 . . . . 0.28000000000000003 108.935 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.415 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -80.94 78.42 7.75 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.441 -1.035 . . . . 0.31 110.291 -179.56 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.4 t -52.06 149.17 9.81 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.327 -0.858 . . . . 0.40000000000000002 110.592 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.86 116.7 3.44 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.675 1.355 . . . . 0.25 110.514 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.483 ' HA2' ' CE1' ' A' ' 2' ' ' TYR . . . 131.97 -23.34 4.17 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.468 -1.453 . . . . 0.089999999999999997 109.468 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.56 HG22 HD11 ' A' ' 34' ' ' ILE . 97.3 m -55.95 129.77 41.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -1.092 . . . . 0.14999999999999999 110.458 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.503 ' NH2' ' CE1' ' A' ' 2' ' ' TYR . 47.5 mtt85 -107.94 148.51 29.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.23999999999999999 110.244 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.83 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -49.84 -39.38 38.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 0.28000000000000003 110.627 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.5 -44.9 62.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.31 110.435 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -82.29 5.13 21.08 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.309 -0.869 . . . . 0.25 110.384 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.83 HD12 ' HA ' ' A' ' 31' ' ' PHE . 96.1 mt . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.002 -1.061 . . . . 0.26000000000000001 110.231 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.444 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 86.2 t90 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.223 0.535 . . . . 0.25 110.173 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.421 ' O ' ' CE2' ' A' ' 38' ' ' TRP . 25.9 p -159.07 -160.4 0.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.11 110.607 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 2.4 t -95.66 140.98 22.57 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.497 -0.752 . . . . 0.31 110.376 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.36 -2.06 12.16 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.538 1.283 . . . . 0.58999999999999997 111.336 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -132.0 13.9 4.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.891 -1.131 . . . . 0.56999999999999995 111.075 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 64.6 m -147.61 -71.65 0.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.011 -1.055 . . . . 0.39000000000000001 110.377 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.63 33.5 1.0 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.744 -1.342 . . . . 0.22 109.744 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.55 -170.71 1.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -1.201 . . . . 0.12 110.466 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.7 p -107.27 -162.59 0.85 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.344 -0.848 . . . . 0.17000000000000001 110.059 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -57.99 -19.48 31.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.155 -0.966 . . . . 0.33000000000000002 109.847 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -51.92 -40.37 60.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.42999999999999999 110.299 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.655 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.6 m-20 -78.02 -23.19 48.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.315 -0.866 . . . . 0.42999999999999999 109.974 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -94.84 138.04 33.14 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.321 -0.862 . . . . 0.46999999999999997 110.406 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.3 t -122.78 160.89 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.299 -0.876 . . . . 0.48999999999999999 110.167 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.507 HD21 HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -72.04 101.58 2.76 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.262 -0.899 . . . . 0.56999999999999995 110.129 179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.428 ' CD1' ' HB ' ' A' ' 6' ' ' ILE . 2.7 t80 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.805 . . . . 0.56999999999999995 110.35 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.356 0.598 . . . . 0.68999999999999995 110.462 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mp -91.85 170.99 9.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.65000000000000002 110.054 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.57 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -130.98 133.61 45.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.106 -0.996 . . . . 0.28999999999999998 110.919 -179.423 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.515 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 24.7 m95 -118.54 178.8 4.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.327 -0.858 . . . . 0.29999999999999999 109.445 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.716 HD11 ' HA2' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -163.32 124.58 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.297 -0.877 . . . . 0.46000000000000002 110.488 178.207 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.629 ' N ' HD13 ' A' ' 6' ' ' ILE . 15.5 t -69.17 93.43 0.61 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.459 -0.775 . . . . 0.37 109.591 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 49' ' ' ASP . 2.6 tt -54.44 -19.67 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 0.41999999999999998 110.576 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.405 ' OG1' ' HB2' ' A' ' 49' ' ' ASP . 76.3 m -65.14 -27.89 69.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.205 -0.935 . . . . 0.48999999999999999 110.95 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.1 p -134.35 -35.35 0.92 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.053 -1.029 . . . . 0.28000000000000003 111.375 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.716 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 112.95 36.43 1.52 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.445 -1.359 . . . . 0.17000000000000001 109.794 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.439 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 10.1 m170 -106.46 108.96 20.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.104 -1.233 . . . . 0.20999999999999999 110.269 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.497 ' CD1' ' CE1' ' A' ' 53' ' ' TYR . 89.9 mt -81.29 131.58 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.366 -0.834 . . . . 0.16 110.762 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.48 ' HH ' ' HD2' ' A' ' 25' ' ' PHE . 81.2 t80 -97.88 128.25 44.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.338 -0.851 . . . . 0.10000000000000001 109.555 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -109.75 110.92 22.08 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.353 -0.842 . . . . 0.11 109.673 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.451 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -49.37 -24.33 1.88 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 0.12 110.824 -178.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.5 9.94 14.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.183 -0.948 . . . . 0.19 110.683 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.87 67.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.029 -1.045 . . . . 0.27000000000000002 109.806 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.08 -140.56 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.008 -1.237 . . . . 0.20999999999999999 110.008 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.05 164.38 23.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.416 -1.049 . . . . 0.27000000000000002 110.728 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -114.4 -25.73 8.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.38 110.158 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.38 -46.88 25.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.39000000000000001 110.185 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -69.56 -34.64 74.48 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.269 -0.894 . . . . 0.39000000000000001 110.358 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.73 32.62 2.63 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.766 -1.334 . . . . 0.28000000000000003 109.766 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.563 ' HE2' HD11 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -72.33 82.48 1.04 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.053 -1.263 . . . . 0.31 109.782 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.2 t -48.26 142.64 7.76 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.40000000000000002 111.083 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 27.8 Cg_exo -58.28 111.4 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.681 1.358 . . . . 0.25 110.484 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.24 -25.22 3.03 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.422 -1.471 . . . . 0.089999999999999997 109.422 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.6 m -56.68 130.73 46.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -1.108 . . . . 0.14999999999999999 110.349 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.451 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 1.0 OUTLIER -107.13 142.04 37.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.23999999999999999 110.349 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.574 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -53.08 -36.46 60.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.28000000000000003 110.168 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -54.74 -26.0 31.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.31 109.797 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -96.17 -21.11 18.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.374 -0.829 . . . . 0.25 110.058 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 31' ' ' PHE . 20.3 mt . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.26000000000000001 109.7 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.441 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 85.1 t90 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.282 0.563 . . . . 0.25 110.3 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 92.1 m -148.05 -174.53 4.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -0.871 . . . . 0.11 110.399 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.21 140.62 53.1 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.31 110.335 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -72.16 -19.74 25.73 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.52 1.274 . . . . 0.58999999999999997 110.822 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.31 -22.63 15.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.56999999999999995 110.507 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 75.1 m -116.46 -61.46 1.72 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.39000000000000001 110.381 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.45 36.1 3.65 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.37 -1.492 . . . . 0.22 109.37 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.41 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . . . -114.05 159.29 20.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -1.109 . . . . 0.12 110.474 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.8 p -65.35 -160.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.17000000000000001 110.34 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 50' ' ' TYR . 32.6 ttpt -67.96 -9.62 46.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.33000000000000002 110.775 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -50.76 -40.68 55.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.025 -1.047 . . . . 0.42999999999999999 110.752 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.526 ' O ' HG22 ' A' ' 8' ' ' ILE . 49.0 p-10 -86.76 -15.76 38.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.42999999999999999 110.809 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.419 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 2.2 m-85 -91.95 140.72 29.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.46999999999999997 110.916 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 6' ' ' ILE . 34.7 m -140.36 164.93 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.41 -0.806 . . . . 0.48999999999999999 110.203 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.57 HD12 ' O ' ' A' ' 4' ' ' LYS . 0.9 OUTLIER -64.67 122.22 16.33 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.245 -0.909 . . . . 0.56999999999999995 110.649 -179.646 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.548 ' N ' HD12 ' A' ' 52' ' ' LEU . 77.5 t80 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.56999999999999995 110.395 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.445 ' CE1' ' HA2' ' A' ' 28' ' ' GLY . 18.1 m-85 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.406 0.622 . . . . 0.68999999999999995 110.365 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mp -81.9 165.31 20.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -0.852 . . . . 0.65000000000000002 110.527 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -135.61 129.74 33.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 0.28999999999999998 109.885 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.536 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 28.9 m95 -107.24 173.81 6.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.29999999999999999 110.22 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.745 HD13 HG13 ' A' ' 13' ' ' ILE . 1.7 tp -138.99 127.17 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.447 -0.783 . . . . 0.46000000000000002 109.969 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 11.5 t -76.93 87.56 3.48 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.367 -0.833 . . . . 0.37 109.807 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.483 HG21 HG21 ' A' ' 51' ' ' VAL . 38.1 pt -49.14 -25.36 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.147 -0.971 . . . . 0.41999999999999998 110.087 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 m -69.27 -28.7 66.54 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.537 -0.727 . . . . 0.48999999999999999 110.131 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 83.6 m -123.36 -50.31 1.89 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.28000000000000003 110.803 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.475 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 120.75 -5.99 11.41 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.253 -1.139 . . . . 0.17000000000000001 110.253 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -76.12 137.82 40.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.851 -1.382 . . . . 0.20999999999999999 110.391 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.745 HG13 HD13 ' A' ' 6' ' ' ILE . 3.7 mt -95.07 127.4 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.16 110.239 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.426 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 82.4 t80 -79.9 121.61 25.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.407 -0.808 . . . . 0.10000000000000001 109.91 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -99.03 104.93 17.0 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.351 -0.843 . . . . 0.11 109.989 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 2' ' ' TYR . 20.4 mt-10 -49.2 -24.28 1.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.466 -0.771 . . . . 0.12 110.771 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.12 17.97 6.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.126 -0.984 . . . . 0.19 110.474 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.78 53.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.27000000000000002 109.797 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.65 -136.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.052 -1.219 . . . . 0.20999999999999999 110.052 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 11.2 t0 -89.33 165.68 14.23 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.365 -1.08 . . . . 0.27000000000000002 110.412 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.67 -25.47 11.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.38 110.22 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.71 -56.69 5.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.39000000000000001 110.11 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -60.42 -22.09 62.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.172 -0.955 . . . . 0.39000000000000001 110.156 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.16 28.66 8.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.378 -1.489 . . . . 0.28000000000000003 109.378 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.524 ' CZ ' HD13 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -74.09 75.74 1.74 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.215 -1.168 . . . . 0.31 110.448 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -60.31 151.35 68.64 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.432 -0.793 . . . . 0.40000000000000002 110.581 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -52.02 95.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.585 1.308 . . . . 0.25 110.569 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.445 ' HA2' ' CE1' ' A' ' 2' ' ' TYR . . . 152.68 -21.48 0.81 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.67 -1.372 . . . . 0.089999999999999997 109.67 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.633 HG22 HD11 ' A' ' 34' ' ' ILE . 24.4 m -64.92 128.99 38.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -1.202 . . . . 0.14999999999999999 110.553 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.412 ' HG2' ' CB ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -116.31 145.22 43.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.23999999999999999 110.19 179.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.701 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -47.96 -47.31 32.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.241 -0.912 . . . . 0.28000000000000003 110.831 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -50.35 -33.72 21.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.876 . . . . 0.31 110.095 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.412 ' CB ' ' HG2' ' A' ' 30' ' ' ARG . 10.3 t0 -93.45 12.97 23.12 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.432 -0.792 . . . . 0.25 110.27 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 31' ' ' PHE . 92.8 mt . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.072 -1.017 . . . . 0.26000000000000001 110.358 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 78.6 t90 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.226 0.536 . . . . 0.25 110.066 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.3 m -136.7 -178.59 5.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.229 -0.919 . . . . 0.11 110.436 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.425 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -67.32 149.9 98.17 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.288 -0.883 . . . . 0.31 109.999 179.555 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -70.62 -5.14 16.07 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.668 1.351 . . . . 0.58999999999999997 111.513 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -156.18 32.11 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.817 -1.177 . . . . 0.56999999999999995 111.216 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.425 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 57.7 m -141.19 -57.86 0.49 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.015 -1.053 . . . . 0.39000000000000001 110.234 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.56 26.15 7.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.39 -1.484 . . . . 0.22 109.39 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.561 ' HB1' ' CG ' ' A' ' 49' ' ' ASP . . . -99.13 177.19 5.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.171 -1.193 . . . . 0.12 110.359 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.4 p -113.7 -165.15 0.98 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.326 -0.858 . . . . 0.17000000000000001 110.129 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -32.45 44.1 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.296 -0.877 . . . . 0.33000000000000002 110.436 177.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.94 -33.84 11.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.456 -0.778 . . . . 0.42999999999999999 110.294 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.561 ' CG ' ' HB1' ' A' ' 45' ' ' ALA . 2.4 m-20 -84.49 -26.19 28.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.42999999999999999 109.785 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -92.59 128.11 38.32 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.374 -0.828 . . . . 0.46999999999999997 110.296 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.483 HG21 HG21 ' A' ' 8' ' ' ILE . 94.2 t -119.47 160.6 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.48999999999999999 110.252 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -76.68 103.33 6.6 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.167 -0.958 . . . . 0.56999999999999995 110.208 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.9 t80 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.56999999999999995 110.701 -179.269 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.496 ' O ' HD12 ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.287 0.565 . . . . 0.38 110.418 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -59.32 131.42 50.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.203 -0.935 . . . . 0.68999999999999995 110.409 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 1' ' ' ALA . 9.7 mp -92.41 168.86 11.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.317 -0.864 . . . . 0.65000000000000002 110.213 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.445 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 4.6 mttt -130.46 155.0 47.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.28999999999999998 110.422 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.538 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 28.7 m95 -129.39 135.57 48.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.273 -0.892 . . . . 0.29999999999999999 110.584 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.757 HD13 HG13 ' A' ' 13' ' ' ILE . 2.0 tp -108.06 128.24 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.021 -1.049 . . . . 0.46000000000000002 110.524 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 10.2 t -74.8 100.12 3.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.877 . . . . 0.37 109.906 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.2 tt -56.11 -20.05 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.41999999999999998 110.464 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.7 m -65.79 -38.17 88.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.48999999999999999 110.803 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.4 p -129.23 -34.89 1.83 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.037 -1.04 . . . . 0.28000000000000003 111.029 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.656 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 110.24 38.45 1.65 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.765 -1.334 . . . . 0.17000000000000001 109.765 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.412 ' O ' HD12 ' A' ' 6' ' ' ILE . 4.1 t-160 -104.1 128.06 51.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -1.165 . . . . 0.20999999999999999 110.067 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.757 HG13 HD13 ' A' ' 6' ' ' ILE . 5.9 mt -92.18 143.17 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.242 -0.911 . . . . 0.16 110.836 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.484 ' HH ' ' HE2' ' A' ' 25' ' ' PHE . 64.0 t80 -108.76 131.24 55.14 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.706 -0.621 . . . . 0.10000000000000001 109.485 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -106.29 107.94 19.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.537 -0.727 . . . . 0.11 109.815 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -50.39 -24.6 3.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 0.12 110.631 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.66 13.18 18.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.19 110.523 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 tp -176.68 62.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.154 -0.966 . . . . 0.27000000000000002 109.881 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.64 -134.35 0.06 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.025 -1.23 . . . . 0.20999999999999999 110.025 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -80.41 150.73 29.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.454 -1.027 . . . . 0.27000000000000002 110.664 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -105.23 -25.07 12.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.872 . . . . 0.38 110.046 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.33 -43.24 28.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.408 -0.808 . . . . 0.39000000000000001 110.333 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -70.53 -43.36 69.76 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.213 -0.929 . . . . 0.39000000000000001 110.11 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.66 30.06 1.0 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.162 -1.175 . . . . 0.28000000000000003 110.162 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CE1' ' CD1' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -73.03 81.39 1.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.85 -1.382 . . . . 0.31 109.944 179.151 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.5 t -49.33 150.89 2.9 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.40000000000000002 110.989 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.45 95.77 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.703 1.37 . . . . 0.25 110.255 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.1 41.37 0.12 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.509 -1.436 . . . . 0.089999999999999997 109.509 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -118.21 104.93 11.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -1.148 . . . . 0.14999999999999999 110.086 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -75.67 141.56 42.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.23999999999999999 110.649 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.682 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -51.95 -29.62 21.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.359 -0.838 . . . . 0.28000000000000003 110.39 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -54.12 -50.69 66.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.31 110.386 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -74.96 -2.24 26.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.293 -0.879 . . . . 0.25 110.873 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' A' ' 31' ' ' PHE . 43.9 mt -103.79 90.51 2.91 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 120.934 -1.104 . . . . 0.26000000000000001 110.338 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -62.12 -163.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.648 1.341 . . . . 0.34000000000000002 110.543 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -69.4 -15.96 63.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.37 110.708 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -50.03 -29.28 8.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.094 -1.004 . . . . 0.39000000000000001 110.649 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.552 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 85.5 t90 -89.84 140.75 29.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.25 110.245 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 88.4 m -121.21 -170.75 2.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.11 110.394 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 1.3 t -88.11 135.74 32.9 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.31 110.156 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -71.96 -13.28 28.97 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.458 1.241 . . . . 0.58999999999999997 110.736 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.82 -25.31 10.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.079 -1.013 . . . . 0.56999999999999995 110.795 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 85.1 m -111.32 -75.15 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.046 -1.033 . . . . 0.39000000000000001 110.571 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.03 35.54 0.77 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.444 -1.462 . . . . 0.22 109.444 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.62 -170.45 1.67 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -1.171 . . . . 0.12 110.514 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 p -78.49 -167.45 1.08 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.17000000000000001 110.383 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -83.65 -16.02 46.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -0.88 . . . . 0.33000000000000002 110.574 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.79 -22.75 59.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.091 -1.005 . . . . 0.42999999999999999 110.6 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.481 ' O ' HG22 ' A' ' 8' ' ' ILE . 5.3 m-20 -75.46 -17.81 60.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.42999999999999999 110.572 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -96.42 134.63 39.35 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.223 -0.923 . . . . 0.46999999999999997 110.928 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 6' ' ' ILE . 34.2 m -125.67 171.13 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.858 . . . . 0.48999999999999999 109.972 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.27 130.27 34.82 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.163 -0.961 . . . . 0.56999999999999995 110.784 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -85.06 113.1 21.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 0.56999999999999995 110.383 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 54.23 172.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.28000000000000003 110.47 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 47.69 56.73 6.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.28000000000000003 111.002 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.965 -1.016 . . . . 0.46000000000000002 110.346 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.201 0.524 . . . . 0.38 110.377 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -146.93 136.9 23.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.68999999999999995 110.508 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 mp -75.56 162.69 28.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -0.8 . . . . 0.65000000000000002 110.523 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -134.19 134.91 42.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.306 -0.871 . . . . 0.28999999999999998 110.231 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.532 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 24.8 m95 -115.24 -178.13 3.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.29999999999999999 110.229 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.649 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -161.37 124.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.399 -0.813 . . . . 0.46000000000000002 110.059 178.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.649 ' N ' HD13 ' A' ' 6' ' ' ILE . 24.2 t -69.3 100.02 1.27 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.371 -0.831 . . . . 0.37 110.418 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.776 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.1 tt -53.98 -22.06 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.178 -0.951 . . . . 0.41999999999999998 109.982 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.7 m -80.75 -28.88 36.33 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.25 -0.906 . . . . 0.48999999999999999 110.175 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 1.6 m -110.2 -53.39 2.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 0.28000000000000003 110.553 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.617 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 118.72 -11.02 12.25 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.133 -1.187 . . . . 0.17000000000000001 110.133 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -75.65 138.86 41.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.941 -1.329 . . . . 0.20999999999999999 110.482 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 5' ' ' TRP . 51.3 mt -97.6 136.91 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.364 -0.835 . . . . 0.16 110.589 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CE1' ' HA2' ' A' ' 19' ' ' GLY . 87.3 t80 -92.18 138.9 31.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.404 -0.81 . . . . 0.10000000000000001 110.305 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -112.41 108.87 18.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.49 -0.756 . . . . 0.11 109.988 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -50.98 -24.42 3.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.154 -0.966 . . . . 0.12 110.7 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.31 16.43 8.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.19 110.4 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -176.96 69.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.27000000000000002 109.855 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.5 ' HA2' ' CE1' ' A' ' 14' ' ' TYR . . . -68.37 -137.04 0.07 OUTLIER Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.143 -1.183 . . . . 0.20999999999999999 110.143 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 22' ' ' ALA . 15.8 t0 -87.07 149.77 24.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.406 -1.055 . . . . 0.27000000000000002 110.718 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.408 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 36.5 mt-10 -97.17 -30.59 12.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.854 . . . . 0.38 110.023 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.424 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . -75.16 -44.86 44.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.387 -0.821 . . . . 0.39000000000000001 110.316 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -63.61 -38.94 93.04 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.255 -0.903 . . . . 0.39000000000000001 110.312 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.13 23.21 4.28 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.677 -1.369 . . . . 0.28000000000000003 109.677 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.672 ' CE2' HG21 ' A' ' 29' ' ' THR . 0.7 OUTLIER -66.72 83.81 0.11 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.099 -1.236 . . . . 0.31 110.124 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.4 t -49.77 152.54 2.53 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.446 -0.784 . . . . 0.40000000000000002 110.918 -179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 28.6 Cg_exo -58.04 106.99 0.28 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.703 1.37 . . . . 0.25 110.468 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.4 38.99 0.46 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.474 -1.45 . . . . 0.089999999999999997 109.474 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.672 HG21 ' CE2' ' A' ' 25' ' ' PHE . 26.2 m -108.97 134.4 51.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -1.115 . . . . 0.14999999999999999 110.353 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -117.96 141.02 48.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.23999999999999999 110.346 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.647 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -48.94 -36.59 17.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.198 -0.939 . . . . 0.28000000000000003 110.747 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -57.15 -34.79 68.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.237 -0.914 . . . . 0.31 109.989 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -87.37 -23.07 24.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.333 -0.854 . . . . 0.25 110.234 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.647 HD12 ' HA ' ' A' ' 31' ' ' PHE . 20.8 mt -58.68 109.82 2.15 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.26000000000000001 109.913 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -62.02 -161.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.458 1.241 . . . . 0.34000000000000002 110.492 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.47 -25.14 21.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.37 110.26 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -55.51 -30.61 60.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.39000000000000001 110.443 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.532 ' CZ3' ' CZ ' ' A' ' 31' ' ' PHE . 79.7 t90 -75.86 169.52 17.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.933 . . . . 0.25 110.363 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.473 ' N ' ' CD2' ' A' ' 38' ' ' TRP . 25.3 p -173.94 -160.89 0.11 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.389 -0.819 . . . . 0.11 110.148 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -76.55 143.4 72.06 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.307 -0.87 . . . . 0.31 110.091 179.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.56 -7.62 19.69 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.664 1.35 . . . . 0.58999999999999997 111.373 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.8 -32.21 2.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.952 -1.093 . . . . 0.56999999999999995 111.05 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 63.3 m -92.4 -70.34 0.7 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.07 -1.019 . . . . 0.39000000000000001 110.407 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.27 25.11 4.83 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.288 -1.525 . . . . 0.22 109.288 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.14 174.4 5.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -1.147 . . . . 0.12 110.569 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.0 p -67.42 -162.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.17000000000000001 110.345 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -78.65 -2.83 40.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.33000000000000002 110.769 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -45.03 64.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.957 -1.09 . . . . 0.42999999999999999 110.463 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.776 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.3 p30 -73.02 -20.25 61.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.42999999999999999 110.219 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -90.58 129.7 36.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.46999999999999997 110.495 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 6' ' ' ILE . 27.4 m -128.21 159.97 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.48999999999999999 110.21 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.42 119.05 17.12 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.195 -0.94 . . . . 0.56999999999999995 110.383 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -69.93 129.53 39.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.56999999999999995 110.628 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -107.56 122.06 45.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.28000000000000003 110.219 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.79 118.86 12.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -0.873 . . . . 0.28000000000000003 110.503 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.941 -1.028 . . . . 0.46000000000000002 110.363 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.221 0.534 . . . . 0.38 110.476 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.785 ' CG ' ' HB2' ' A' ' 17' ' ' ALA . 39.7 m-85 -104.2 134.99 46.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.68999999999999995 110.483 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.514 HD23 HD11 ' A' ' 52' ' ' LEU . 4.3 mp -92.36 163.13 13.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.298 -0.876 . . . . 0.65000000000000002 110.284 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.73 146.56 50.89 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.244 -0.91 . . . . 0.28999999999999998 109.809 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.553 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 25.0 m95 -119.82 -176.55 3.2 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.319 -0.863 . . . . 0.29999999999999999 109.616 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.757 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -152.96 129.42 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 119.407 -0.917 . . . . 0.46000000000000002 110.481 178.405 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.757 ' N ' HD13 ' A' ' 6' ' ' ILE . 4.9 t -75.69 92.14 2.96 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.495 -0.753 . . . . 0.37 109.982 179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.428 HG13 ' N ' ' A' ' 9' ' ' THR . 15.9 pt -51.67 -23.64 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.009 -1.057 . . . . 0.41999999999999998 109.928 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.428 ' N ' HG13 ' A' ' 8' ' ' ILE . 45.9 m -68.9 -26.96 65.37 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.495 -0.753 . . . . 0.48999999999999999 110.295 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.7 m -125.83 -49.99 1.6 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -0.953 . . . . 0.28000000000000003 111.284 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.668 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 118.97 13.22 6.63 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.905 -1.278 . . . . 0.17000000000000001 109.905 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.02 125.51 37.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.994 -1.297 . . . . 0.20999999999999999 110.177 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.436 HG13 HG12 ' A' ' 6' ' ' ILE . 53.4 mt -88.79 141.17 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.16 110.696 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -102.44 148.1 25.91 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.657 0.741 . . . . 0.10000000000000001 110.35 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -124.15 106.75 10.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.579 -0.701 . . . . 0.11 109.923 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.463 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 98.8 mt-10 -50.26 -24.42 2.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.12 110.565 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.785 ' HB2' ' CG ' ' A' ' 2' ' ' TYR . . . -93.21 20.19 7.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.901 . . . . 0.19 110.257 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 tp -176.49 65.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.27000000000000002 109.966 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.8 -141.56 0.32 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.886 -1.286 . . . . 0.20999999999999999 109.886 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.02 171.63 7.24 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.38 -1.07 . . . . 0.27000000000000002 110.543 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -106.42 -35.63 7.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.35 -0.844 . . . . 0.38 110.159 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.36 -41.73 89.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.872 . . . . 0.39000000000000001 110.171 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -73.91 -3.33 28.26 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.253 -0.904 . . . . 0.39000000000000001 110.901 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.22 25.19 64.34 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.348 -1.501 . . . . 0.28000000000000003 109.348 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -82.66 79.99 8.91 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.277 -1.131 . . . . 0.31 109.985 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.0 t -49.46 151.29 2.84 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.389 -0.819 . . . . 0.40000000000000002 111.004 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 24.9 Cg_exo -60.0 114.97 2.32 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.704 1.371 . . . . 0.25 110.42 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.65 16.58 5.89 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.868 -1.293 . . . . 0.089999999999999997 109.868 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.711 HG22 HD11 ' A' ' 34' ' ' ILE . 40.3 m -86.01 116.52 24.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.244 . . . . 0.14999999999999999 110.224 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.463 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 43.6 mtt85 -90.26 140.65 29.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.23999999999999999 110.576 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.82 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -59.18 -35.14 73.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.888 . . . . 0.28000000000000003 110.165 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -52.28 -30.64 28.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.31 110.35 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -100.86 19.04 17.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -0.844 . . . . 0.25 110.345 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.82 HD12 ' HA ' ' A' ' 31' ' ' PHE . 92.9 mt -116.4 104.97 51.17 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 0.26000000000000001 109.989 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -58.83 -155.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.604 1.318 . . . . 0.34000000000000002 110.684 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -93.75 18.43 10.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.908 . . . . 0.37 110.54 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -81.32 -48.84 11.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.39000000000000001 110.289 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 85.8 t90 -62.78 144.92 56.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.366 -0.834 . . . . 0.25 110.372 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.7 m -128.96 -164.58 1.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.11 110.181 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.451 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -79.95 152.79 74.73 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.128 -0.983 . . . . 0.31 110.236 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -62.97 -12.88 31.74 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.583 1.307 . . . . 0.58999999999999997 111.325 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -157.49 40.69 0.3 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.91 -1.119 . . . . 0.56999999999999995 111.185 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.451 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 56.7 m -141.88 -59.51 0.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.034 -1.042 . . . . 0.39000000000000001 110.184 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.08 25.62 11.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.117 -1.593 . . . . 0.22 109.117 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.12 -170.37 2.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -1.112 . . . . 0.12 110.408 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.2 p -108.89 -173.19 2.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.17000000000000001 110.372 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -63.04 -16.65 60.58 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.268 -0.895 . . . . 0.33000000000000002 110.261 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -55.58 -38.77 69.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.42999999999999999 110.246 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 5.7 m-20 -77.05 -12.88 60.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.31 -0.869 . . . . 0.42999999999999999 110.473 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -100.72 136.82 39.98 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.049 -1.032 . . . . 0.46999999999999997 110.772 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.5 t -133.15 149.05 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.47 -0.769 . . . . 0.48999999999999999 109.985 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.514 HD11 HD23 ' A' ' 3' ' ' LEU . 1.1 tt -63.71 120.54 12.02 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.112 -0.992 . . . . 0.56999999999999995 110.279 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -76.63 118.46 19.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.335 -0.853 . . . . 0.56999999999999995 110.375 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.01 72.08 0.19 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.28000000000000003 110.361 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -68.01 108.87 3.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.28000000000000003 110.302 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.979 -1.01 . . . . 0.46000000000000002 110.335 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.24 0.543 . . . . 0.38 110.25 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.532 ' CG ' ' HB2' ' A' ' 17' ' ' ALA . 61.0 m-85 -65.73 141.08 58.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.894 . . . . 0.68999999999999995 110.403 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.529 HD23 HD21 ' A' ' 52' ' ' LEU . 3.3 mp -98.85 170.05 9.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.507 -0.745 . . . . 0.65000000000000002 110.678 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -134.84 148.93 50.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.329 -0.857 . . . . 0.28999999999999998 110.186 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.458 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 48.9 m95 -129.91 178.87 6.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 0.29999999999999999 110.504 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.854 HD13 HG13 ' A' ' 13' ' ' ILE . 1.2 tp -156.32 120.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.65 -0.656 . . . . 0.46000000000000002 109.741 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 11' ' ' GLY . 18.9 t -67.67 96.93 0.58 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.372 -0.83 . . . . 0.37 110.313 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.5 tt -54.99 -19.92 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.142 -0.974 . . . . 0.41999999999999998 110.289 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 m -80.62 -28.35 37.01 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.261 -0.899 . . . . 0.48999999999999999 110.381 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.4 m -117.23 -46.43 2.7 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.163 -0.961 . . . . 0.28000000000000003 110.856 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.474 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 109.0 19.8 8.35 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.678 -1.369 . . . . 0.17000000000000001 109.678 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -99.65 134.48 42.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -1.21 . . . . 0.20999999999999999 110.069 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.854 HG13 HD13 ' A' ' 6' ' ' ILE . 4.4 mt -96.24 141.04 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.16 110.656 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -108.21 144.56 35.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.512 -0.742 . . . . 0.10000000000000001 110.329 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -119.9 109.42 15.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.429 -0.794 . . . . 0.11 110.097 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.428 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 69.8 mt-10 -50.22 -27.85 6.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 0.12 110.474 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.532 ' HB2' ' CG ' ' A' ' 2' ' ' TYR . . . -93.85 12.83 24.5 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.921 . . . . 0.19 110.617 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -175.55 68.45 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.12 -0.987 . . . . 0.27000000000000002 110.42 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.25 -135.5 0.01 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.402 -1.479 . . . . 0.20999999999999999 109.402 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.25 164.75 12.71 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.225 -1.161 . . . . 0.27000000000000002 110.287 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -92.81 -22.14 19.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.239 -0.913 . . . . 0.38 110.31 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.67 -36.46 17.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.39000000000000001 110.366 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -65.19 -26.92 68.35 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.255 -0.903 . . . . 0.39000000000000001 110.332 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.83 27.47 14.17 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.548 -1.421 . . . . 0.28000000000000003 109.548 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.513 ' CE1' HG21 ' A' ' 29' ' ' THR . 0.1 OUTLIER -73.51 84.0 1.51 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.108 -1.231 . . . . 0.31 110.208 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.4 t -50.06 143.94 11.58 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.192 -0.943 . . . . 0.40000000000000002 110.474 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.15 106.57 0.21 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.653 1.344 . . . . 0.25 110.645 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.02 44.42 0.17 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.582 -1.407 . . . . 0.089999999999999997 109.582 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.513 HG21 ' CE1' ' A' ' 25' ' ' PHE . 1.4 m -130.59 122.87 28.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.11 -1.229 . . . . 0.14999999999999999 110.511 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.428 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 1.7 ptm180 -103.58 150.91 23.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.23999999999999999 110.446 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.781 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -48.4 -44.62 35.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.232 -0.917 . . . . 0.28000000000000003 110.833 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.407 ' HB3' ' HG3' ' A' ' 30' ' ' ARG . 3.0 tm-20 -53.61 -48.73 69.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.31 110.234 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.4 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 31.8 t70 -65.93 -22.57 66.5 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.265 -0.897 . . . . 0.25 110.217 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.781 HD12 ' HA ' ' A' ' 31' ' ' PHE . 46.8 mt -80.53 111.03 19.4 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.431 -0.793 . . . . 0.26000000000000001 110.047 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 33' ' ' ASP . 33.7 Cg_endo -69.52 -169.72 0.33 Allowed 'Trans proline' 0 C--N 1.314 -1.278 0 O-C-N 123.493 1.259 . . . . 0.34000000000000002 110.853 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.4 ' OD1' HG22 ' A' ' 46' ' ' THR . 27.2 t0 -72.04 -17.32 62.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 0.37 110.49 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -52.31 -31.49 33.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.094 -1.004 . . . . 0.39000000000000001 110.151 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.547 ' CZ3' ' CZ ' ' A' ' 31' ' ' PHE . 79.8 t90 -83.02 160.69 21.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.421 -0.799 . . . . 0.25 110.096 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.6 p -162.36 -160.53 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.11 110.386 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.434 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -86.55 160.95 49.64 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.358 -0.839 . . . . 0.31 110.422 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 3.8 Cg_exo -73.88 -23.05 16.81 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.607 1.319 . . . . 0.58999999999999997 110.953 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -139.49 30.46 2.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.993 -1.067 . . . . 0.56999999999999995 111.178 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.434 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 60.6 m -141.57 -46.15 0.37 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.974 -1.079 . . . . 0.39000000000000001 110.255 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.27 28.92 47.18 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.5 -1.44 . . . . 0.22 109.5 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.32 -171.81 2.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -1.174 . . . . 0.12 110.334 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.4 HG22 ' OD1' ' A' ' 36' ' ' ASP . 47.4 p -109.25 -159.85 0.7 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.218 -0.926 . . . . 0.17000000000000001 110.336 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.408 ' HA ' ' HB2' ' A' ' 50' ' ' TYR . 32.7 ttmt -58.34 -18.5 27.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.394 -0.816 . . . . 0.33000000000000002 110.253 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -50.22 -48.29 54.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.064 -1.022 . . . . 0.42999999999999999 110.56 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.737 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.8 m-20 -73.03 -20.42 61.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.42999999999999999 110.154 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.408 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 12.2 m-85 -95.92 137.58 34.78 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.315 -0.866 . . . . 0.46999999999999997 110.764 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 80.7 t -125.11 158.73 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.388 -0.82 . . . . 0.48999999999999999 109.931 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.529 HD21 HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -72.33 100.13 2.58 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.179 -0.951 . . . . 0.56999999999999995 110.083 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.4 ' HD1' HG21 ' A' ' 6' ' ' ILE . 28.6 t80 -52.77 135.14 36.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.446 -0.784 . . . . 0.56999999999999995 110.516 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -98.1 107.59 20.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.28000000000000003 110.287 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -110.49 101.88 10.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.28000000000000003 110.386 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.8 tttm . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 118.024 -0.989 . . . . 0.46000000000000002 110.358 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.264 0.555 . . . . 0.38 110.409 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -103.21 138.82 39.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.68999999999999995 110.537 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.64 179.16 7.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.435 -0.791 . . . . 0.65000000000000002 110.587 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -146.68 138.8 24.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.405 -0.809 . . . . 0.28999999999999998 110.451 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.54 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 29.2 m95 -118.23 -178.37 3.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -0.822 . . . . 0.29999999999999999 110.08 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.631 HD11 ' HA2' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -156.55 118.67 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.394 -0.816 . . . . 0.46000000000000002 110.374 177.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.544 ' N ' HD13 ' A' ' 6' ' ' ILE . 6.6 t -63.93 92.2 0.07 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.243 -0.911 . . . . 0.37 109.919 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.604 HG21 HG21 ' A' ' 51' ' ' VAL . 8.6 pt -51.7 -23.71 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.182 -0.949 . . . . 0.41999999999999998 110.073 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.421 ' N ' HG13 ' A' ' 8' ' ' ILE . 36.3 m -72.48 -29.42 63.63 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.306 -0.871 . . . . 0.48999999999999999 110.039 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.2 m -114.29 -49.04 2.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.28000000000000003 110.667 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.631 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 114.22 8.64 16.81 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.032 -1.227 . . . . 0.17000000000000001 110.032 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -92.25 133.97 35.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.911 -1.347 . . . . 0.20999999999999999 110.091 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 5' ' ' TRP . 90.4 mt -93.2 124.43 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.16 110.783 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.476 ' HH ' ' HE2' ' A' ' 25' ' ' PHE . 57.3 t80 -84.55 131.04 34.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.42 -0.8 . . . . 0.10000000000000001 109.978 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -108.44 111.78 23.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.11 109.815 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.423 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -51.9 -23.95 5.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.12 110.265 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.75 13.55 12.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.19 110.509 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.57 64.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.27000000000000002 109.756 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.43 -136.29 0.12 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.049 -1.221 . . . . 0.20999999999999999 110.049 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -84.91 144.53 28.3 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -1.04 . . . . 0.27000000000000002 110.598 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -91.07 -22.95 20.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.307 -0.871 . . . . 0.38 110.082 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.8 -39.93 15.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.39000000000000001 110.302 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -65.96 -32.35 73.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.39000000000000001 110.259 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.18 29.22 4.63 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.54 -1.424 . . . . 0.28000000000000003 109.54 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.567 ' CE1' ' CD1' ' A' ' 38' ' ' TRP . 1.5 m-85 -73.69 82.74 1.58 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.111 -1.229 . . . . 0.31 110.181 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.2 t -49.49 149.3 4.16 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.40000000000000002 110.785 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.17 110.83 0.62 Allowed 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.666 1.351 . . . . 0.25 110.397 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.09 19.82 4.63 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.741 -1.344 . . . . 0.089999999999999997 109.741 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.3 m -86.58 133.76 33.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.058 -1.26 . . . . 0.14999999999999999 110.262 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.423 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 2.3 mtp180 -116.12 144.56 43.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.87 . . . . 0.23999999999999999 110.431 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.559 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -49.57 -25.16 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.314 -0.866 . . . . 0.28000000000000003 110.525 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.41 -24.33 54.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.895 . . . . 0.31 110.479 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -114.17 11.28 17.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.25 110.836 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.559 HD11 ' HE2' ' A' ' 25' ' ' PHE . 8.6 mt -81.18 -44.19 1.17 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.071 -1.018 . . . . 0.26000000000000001 110.928 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 34' ' ' ILE . 78.1 Cg_exo -46.94 94.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.09 0 O-C-N 123.035 1.019 . . . . 0.34000000000000002 111.209 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 34' ' ' ILE . 25.8 t0 -175.48 -46.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.419 -0.801 . . . . 0.37 109.879 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.58 32.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.862 . . . . 0.39000000000000001 109.962 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.567 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 82.2 t90 -112.13 170.26 8.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.411 -0.806 . . . . 0.25 110.67 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.433 ' N ' ' CG ' ' A' ' 38' ' ' TRP . 25.0 p -169.66 -161.34 0.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.329 -0.857 . . . . 0.11 110.31 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.438 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -91.82 169.25 11.48 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 0.31 110.227 179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.28 -40.53 31.84 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.584 1.307 . . . . 0.58999999999999997 110.746 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.1 50.76 1.03 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.091 -1.005 . . . . 0.56999999999999995 110.689 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.438 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 61.7 m -136.58 -45.63 0.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.39000000000000001 110.086 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.34 32.45 51.69 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.354 -1.498 . . . . 0.22 109.354 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.23 166.72 10.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 0.12 110.443 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.4 p -91.59 -162.15 0.89 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.398 -0.814 . . . . 0.17000000000000001 110.161 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 50' ' ' TYR . 5.3 ttpp -61.67 -15.47 40.3 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.239 -0.913 . . . . 0.33000000000000002 110.377 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 49' ' ' ASP . 23.2 pt-20 -51.79 -40.68 60.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.052 -1.03 . . . . 0.42999999999999999 110.354 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 14.9 m-20 -80.58 -18.37 48.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.231 -0.918 . . . . 0.42999999999999999 110.368 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.419 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 4.8 m-85 -95.21 124.17 39.11 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.185 -0.947 . . . . 0.46999999999999997 110.455 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.604 HG21 HG21 ' A' ' 8' ' ' ILE . 97.9 t -117.21 148.02 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.279 -0.888 . . . . 0.48999999999999999 110.088 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.76 117.44 9.67 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.152 -0.968 . . . . 0.56999999999999995 110.096 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -67.72 141.92 56.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.56999999999999995 110.535 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -172.84 126.7 0.47 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.324 -0.86 . . . . 0.28000000000000003 110.406 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.56 52.66 0.83 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.28000000000000003 110.457 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.2 pttt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.96 -1.019 . . . . 0.46000000000000002 110.39 179.951 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.277 0.56 . . . . 0.38 110.356 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.422 ' HB3' ' HB2' ' A' ' 16' ' ' GLU . 37.2 m-85 -122.18 138.41 54.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -0.877 . . . . 0.68999999999999995 110.351 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.851 HD23 HD21 ' A' ' 52' ' ' LEU . 1.5 mp -91.03 164.16 14.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.409 -0.807 . . . . 0.65000000000000002 110.725 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -122.56 144.76 48.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -0.835 . . . . 0.28999999999999998 110.07 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.506 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 39.2 m95 -121.5 179.07 4.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 0.29999999999999999 110.537 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.851 HD13 HG13 ' A' ' 13' ' ' ILE . 2.1 tp -153.88 128.18 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.717 -0.614 . . . . 0.46000000000000002 110.068 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 45.3 t -76.97 98.03 4.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.37 110.291 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.0 OUTLIER -52.68 -23.3 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.097 -1.002 . . . . 0.41999999999999998 110.175 179.446 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.4 m -79.82 -30.61 40.52 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.388 -0.82 . . . . 0.48999999999999999 110.351 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -108.99 -54.44 2.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 0.28000000000000003 110.569 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.482 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 113.38 13.48 10.63 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.896 -1.281 . . . . 0.17000000000000001 109.896 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.428 ' O ' HD12 ' A' ' 6' ' ' ILE . 4.2 m80 -99.33 133.82 43.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.934 -1.333 . . . . 0.20999999999999999 110.047 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.851 HG13 HD13 ' A' ' 6' ' ' ILE . 3.9 mt -89.68 145.68 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.16 110.631 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.43 ' CE1' ' HA2' ' A' ' 19' ' ' GLY . 75.4 t80 -104.82 129.26 53.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.564 -0.71 . . . . 0.10000000000000001 110.352 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.414 ' HB3' ' HG ' ' A' ' 18' ' ' LEU . 2.4 t0 -102.8 104.39 14.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.301 -0.874 . . . . 0.11 110.006 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 2' ' ' TYR . 18.0 mt-10 -51.89 -23.0 4.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -0.865 . . . . 0.12 110.758 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.31 -2.74 26.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.235 -0.915 . . . . 0.19 110.943 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.433 ' O ' ' CG ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -173.42 68.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.987 -1.071 . . . . 0.27000000000000002 110.062 -179.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.43 ' HA2' ' CE1' ' A' ' 14' ' ' TYR . . . -62.97 -136.96 0.01 OUTLIER Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.328 -1.109 . . . . 0.20999999999999999 110.328 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -92.71 166.09 12.63 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.294 -1.121 . . . . 0.27000000000000002 110.512 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -109.21 -27.1 9.74 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.326 -0.858 . . . . 0.38 110.129 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.74 -54.16 17.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.39000000000000001 110.172 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -63.56 -24.76 67.94 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.228 -0.92 . . . . 0.39000000000000001 110.137 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.5 28.99 5.52 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.542 -1.423 . . . . 0.28000000000000003 109.542 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.688 ' CD1' HG21 ' A' ' 29' ' ' THR . 0.7 OUTLIER -81.49 79.88 7.99 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.153 -1.204 . . . . 0.31 110.442 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -53.26 152.82 7.63 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.254 -0.904 . . . . 0.40000000000000002 110.511 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -54.54 95.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.608 1.32 . . . . 0.25 110.307 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 144.81 -15.88 1.98 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.815 -1.314 . . . . 0.089999999999999997 109.815 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.688 HG21 ' CD1' ' A' ' 25' ' ' PHE . 1.6 m -50.45 121.94 6.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.017 -1.284 . . . . 0.14999999999999999 110.633 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -105.6 139.84 39.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.23999999999999999 110.266 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.87 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -47.32 -46.77 25.5 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.337 -0.852 . . . . 0.28000000000000003 110.835 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.67 -33.57 47.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.284 -0.885 . . . . 0.31 110.233 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.42 11.81 27.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.335 -0.853 . . . . 0.25 110.653 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.87 HD12 ' HA ' ' A' ' 31' ' ' PHE . 91.3 mt -109.44 108.17 59.83 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.011 -1.056 . . . . 0.26000000000000001 109.971 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 34' ' ' ILE . 15.0 Cg_endo -61.82 -164.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.482 1.254 . . . . 0.34000000000000002 110.785 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.16 -17.81 48.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.37 110.735 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.72 -43.58 62.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.13 -0.981 . . . . 0.39000000000000001 110.465 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 81.0 t90 -69.97 144.88 52.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.25 109.993 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 95.3 m -143.38 -175.12 4.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.11 110.401 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.9 OUTLIER -74.08 136.97 75.85 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.31 110.233 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -72.6 -13.05 27.25 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.463 1.244 . . . . 0.58999999999999997 110.846 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.51 -23.94 11.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.027 -1.046 . . . . 0.56999999999999995 110.756 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 95.8 m -111.86 -75.04 0.62 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.027 -1.046 . . . . 0.39000000000000001 110.418 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.38 36.83 0.67 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.402 -1.479 . . . . 0.22 109.402 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.66 -169.17 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -1.166 . . . . 0.12 110.499 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.7 p -88.8 -162.5 0.86 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.348 -0.845 . . . . 0.17000000000000001 110.4 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.25 -9.79 54.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.336 -0.853 . . . . 0.33000000000000002 110.639 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -52.14 -44.76 64.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.984 -1.072 . . . . 0.42999999999999999 110.463 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.577 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -71.31 -20.6 62.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.161 -0.962 . . . . 0.42999999999999999 110.033 179.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -96.06 134.08 39.54 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.248 -0.907 . . . . 0.46999999999999997 110.662 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.54 171.85 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.831 . . . . 0.48999999999999999 110.115 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.851 HD21 HD23 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -75.62 118.51 18.54 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.253 -0.904 . . . . 0.56999999999999995 110.311 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -63.12 105.42 0.7 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.56999999999999995 110.579 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.461 ' HG3' HD12 ' A' ' 52' ' ' LEU . 3.3 mt-10 -144.72 103.89 3.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.845 . . . . 0.28000000000000003 110.176 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.14 137.73 26.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.28000000000000003 110.484 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.018 -0.991 . . . . 0.46000000000000002 110.266 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.198 0.523 . . . . 0.38 110.414 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -122.35 139.64 53.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.68999999999999995 110.35 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.429 HD23 HD11 ' A' ' 52' ' ' LEU . 1.9 mp -104.1 179.79 4.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.65000000000000002 110.743 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -139.63 145.97 39.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.496 -0.752 . . . . 0.28999999999999998 110.009 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.524 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 34.1 m95 -127.82 134.72 49.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.082 -1.011 . . . . 0.29999999999999999 110.658 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.741 HD13 HG13 ' A' ' 13' ' ' ILE . 2.6 tp -111.62 132.62 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.023 -1.048 . . . . 0.46000000000000002 110.297 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.9 t -79.13 100.05 7.24 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.345 -0.847 . . . . 0.37 110.037 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.6 tt -56.17 -18.74 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.917 . . . . 0.41999999999999998 110.619 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.0 m -70.08 -39.56 75.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.885 . . . . 0.48999999999999999 110.824 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.9 p -126.8 -35.31 2.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.971 -1.081 . . . . 0.28000000000000003 111.116 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.614 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 108.97 44.7 1.08 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.852 -1.299 . . . . 0.17000000000000001 109.852 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 9.5 t60 -108.74 127.7 54.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -1.211 . . . . 0.20999999999999999 110.142 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.741 HG13 HD13 ' A' ' 6' ' ' ILE . 5.8 mt -93.09 133.52 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.16 110.8 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' OH ' HD11 ' A' ' 34' ' ' ILE . 71.3 t80 -102.84 121.39 42.39 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.506 -0.746 . . . . 0.10000000000000001 109.295 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -98.98 106.26 18.5 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.415 -0.803 . . . . 0.11 110.19 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.437 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -48.74 -24.16 1.3 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.385 -0.822 . . . . 0.12 111.015 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.65 14.45 8.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.067 -1.021 . . . . 0.19 110.803 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 tt -176.61 69.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.1 -1.0 . . . . 0.27000000000000002 109.999 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.06 -136.1 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.842 -1.303 . . . . 0.20999999999999999 109.842 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.403 ' OD2' ' N ' ' A' ' 23' ' ' GLU . 17.0 t70 -113.37 161.31 17.42 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.347 -1.09 . . . . 0.27000000000000002 110.179 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -97.27 -27.74 14.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.38 110.36 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.95 -29.03 58.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.92 . . . . 0.39000000000000001 110.345 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.403 ' N ' ' OD2' ' A' ' 20' ' ' ASP . 11.8 mm-40 -88.9 16.59 6.7 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.298 -0.876 . . . . 0.39000000000000001 110.805 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.1 28.38 63.87 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.456 -1.458 . . . . 0.28000000000000003 109.456 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -86.85 82.71 7.72 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.232 -1.158 . . . . 0.31 110.046 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.8 t -47.86 151.4 1.63 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.469 -0.769 . . . . 0.40000000000000002 110.961 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 36.8 Cg_exo -56.96 104.92 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.701 1.369 . . . . 0.25 110.467 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.1 35.51 0.76 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.622 -1.391 . . . . 0.089999999999999997 109.622 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.541 HG22 HD11 ' A' ' 34' ' ' ILE . 58.2 m -90.3 134.32 34.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.189 -1.183 . . . . 0.14999999999999999 110.32 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.437 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -105.72 135.51 47.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.306 -0.871 . . . . 0.23999999999999999 110.468 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.892 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -51.0 -47.21 61.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.28000000000000003 110.473 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -54.91 -41.43 70.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.322 -0.861 . . . . 0.31 110.442 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.98 -24.34 52.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.25 110.394 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.892 HD12 ' HA ' ' A' ' 31' ' ' PHE . 63.4 mt -68.88 118.36 60.39 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.342 -0.849 . . . . 0.26000000000000001 110.119 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -62.91 -150.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.182 0 O-C-N 123.446 1.235 . . . . 0.34000000000000002 110.512 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -100.12 -19.86 16.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.37 110.525 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.52 -40.04 58.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.187 -0.946 . . . . 0.39000000000000001 110.591 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 89.4 t90 -67.65 164.11 19.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.278 -0.889 . . . . 0.25 110.47 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.8 p -162.24 -160.89 0.7 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.11 110.343 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.4 t -88.56 120.85 70.37 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.401 -0.812 . . . . 0.31 110.173 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.35 -12.82 34.88 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.473 1.249 . . . . 0.58999999999999997 110.849 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.412 ' OD2' ' ND1' ' A' ' 12' ' ' HIS . 87.8 m-20 -102.55 -26.84 13.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.052 -1.03 . . . . 0.56999999999999995 110.674 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 96.6 m -114.32 -75.42 0.59 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.139 -0.976 . . . . 0.39000000000000001 110.327 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.3 40.83 0.35 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.396 -1.482 . . . . 0.22 109.396 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.442 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . . . -122.43 -175.09 3.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -1.173 . . . . 0.12 110.667 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 p -82.55 -166.71 1.36 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.385 -0.822 . . . . 0.17000000000000001 110.511 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -69.02 -8.76 48.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.32 -0.863 . . . . 0.33000000000000002 110.551 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -50.95 -42.88 60.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.987 -1.07 . . . . 0.42999999999999999 110.299 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.567 ' O ' HG22 ' A' ' 8' ' ' ILE . 2.8 p30 -76.02 -20.64 57.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.319 -0.863 . . . . 0.42999999999999999 110.377 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -92.86 131.41 37.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.46999999999999997 110.596 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 6' ' ' ILE . 35.9 m -124.27 163.19 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.279 -0.888 . . . . 0.48999999999999999 110.161 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.429 HD11 HD23 ' A' ' 3' ' ' LEU . 0.7 OUTLIER -81.86 120.35 25.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.56999999999999995 110.581 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -75.38 113.68 13.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -0.836 . . . . 0.56999999999999995 110.389 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.34 148.32 25.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 0.28000000000000003 110.446 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -98.99 57.87 1.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.28000000000000003 110.3 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.963 -1.018 . . . . 0.46000000000000002 110.35 -179.898 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.273 0.559 . . . . 0.38 110.366 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.589 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 42.6 m-85 -95.02 133.68 38.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.925 . . . . 0.68999999999999995 110.479 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.881 HD23 HD21 ' A' ' 52' ' ' LEU . 1.9 mp -75.04 164.44 26.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.65000000000000002 110.528 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -130.31 136.58 49.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.28999999999999998 110.093 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.517 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 29.6 m95 -115.84 170.61 8.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.966 . . . . 0.29999999999999999 110.283 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.864 HD13 HG13 ' A' ' 13' ' ' ILE . 2.1 tp -144.38 136.27 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.454 -0.779 . . . . 0.46000000000000002 109.775 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.433 ' H ' HD12 ' A' ' 6' ' ' ILE . 8.4 t -84.44 95.12 8.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.366 -0.834 . . . . 0.37 110.342 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.0 OUTLIER -52.81 -22.88 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.11 -0.993 . . . . 0.41999999999999998 110.043 179.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.2 m -72.72 -28.02 62.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.372 -0.83 . . . . 0.48999999999999999 110.302 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 78.9 m -124.6 -51.38 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.28000000000000003 110.64 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.539 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 117.3 19.34 5.11 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.833 -1.307 . . . . 0.17000000000000001 109.833 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.487 ' O ' HD12 ' A' ' 6' ' ' ILE . 5.8 m-70 -97.57 133.09 42.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.051 -1.264 . . . . 0.20999999999999999 110.102 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.864 HG13 HD13 ' A' ' 6' ' ' ILE . 3.9 mt -91.28 134.51 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.16 110.504 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.402 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 70.7 t80 -94.33 125.89 39.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.5 -0.75 . . . . 0.10000000000000001 109.892 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -95.83 102.55 14.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.459 -0.775 . . . . 0.11 110.289 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -49.35 -30.96 8.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.85 . . . . 0.12 110.702 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.589 ' HB2' ' CD2' ' A' ' 2' ' ' TYR . . . -91.74 17.47 8.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.269 -0.895 . . . . 0.19 110.457 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -177.0 70.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.17 -0.956 . . . . 0.27000000000000002 110.076 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.87 -135.4 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.89 -1.284 . . . . 0.20999999999999999 109.89 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD2' ' N ' ' A' ' 22' ' ' ALA . 16.3 t70 -113.12 168.97 9.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.345 -1.091 . . . . 0.27000000000000002 110.571 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -87.81 -46.62 9.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.27 -0.894 . . . . 0.38 110.073 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' N ' ' OD2' ' A' ' 20' ' ' ASP . . . -53.83 -43.76 69.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.337 -0.852 . . . . 0.39000000000000001 110.205 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -70.88 -30.22 66.54 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.32 -0.862 . . . . 0.39000000000000001 110.083 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.27 28.85 18.89 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.686 -1.366 . . . . 0.28000000000000003 109.686 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CE2' ' NE1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -69.19 82.86 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.275 . . . . 0.31 110.064 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.5 t -49.49 145.75 7.57 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.196 -0.94 . . . . 0.40000000000000002 110.723 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 38.4 Cg_exo -53.51 105.66 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.683 1.359 . . . . 0.25 110.712 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.48 41.98 0.26 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.879 -1.288 . . . . 0.089999999999999997 109.879 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.19 126.76 44.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -1.218 . . . . 0.14999999999999999 110.267 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.441 ' HG2' ' CB ' ' A' ' 33' ' ' ASP . 0.4 OUTLIER -118.38 148.68 42.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.23999999999999999 110.256 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.623 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -47.78 -40.74 21.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.254 -0.904 . . . . 0.28000000000000003 110.673 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -59.31 -32.38 70.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.191 -0.943 . . . . 0.31 109.983 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.441 ' CB ' ' HG2' ' A' ' 30' ' ' ARG . 21.3 t0 -95.39 12.67 28.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 0.25 110.551 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.662 ' O ' HG22 ' A' ' 34' ' ' ILE . 92.3 mt -113.83 64.21 1.17 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.092 -1.005 . . . . 0.26000000000000001 110.119 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -66.05 -21.24 56.53 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.538 1.283 . . . . 0.34000000000000002 110.508 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.92 -175.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.37 110.45 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.26 42.16 1.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.297 -0.877 . . . . 0.39000000000000001 110.175 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.424 ' NE1' ' CE2' ' A' ' 25' ' ' PHE . 85.6 t90 -51.92 143.54 13.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.25 110.553 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 8.4 m -135.07 172.31 13.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.342 -0.849 . . . . 0.11 110.173 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.439 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -55.92 151.6 23.76 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.31 110.334 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -74.22 -7.77 20.15 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.513 1.27 . . . . 0.58999999999999997 111.201 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -150.64 32.72 0.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.899 -1.126 . . . . 0.56999999999999995 111.053 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.439 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 59.0 m -142.11 -65.86 0.41 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.084 -1.01 . . . . 0.39000000000000001 110.045 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.54 29.4 3.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.496 -1.442 . . . . 0.22 109.496 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HB1' ' OD1' ' A' ' 49' ' ' ASP . . . -105.71 171.01 7.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -1.106 . . . . 0.12 110.462 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.5 p -90.13 -162.39 0.89 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.17000000000000001 110.205 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HG2' ' CE2' ' A' ' 31' ' ' PHE . 23.0 mttt -68.08 -14.33 62.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.341 -0.849 . . . . 0.33000000000000002 110.437 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -52.7 -45.87 67.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.098 -1.001 . . . . 0.42999999999999999 110.215 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.631 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.6 m-20 -70.49 -20.89 62.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.321 -0.862 . . . . 0.42999999999999999 109.992 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -97.76 134.75 40.51 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.378 -0.826 . . . . 0.46999999999999997 110.593 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.409 ' CG2' HG23 ' A' ' 6' ' ' ILE . 34.3 m -130.75 170.93 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.48999999999999999 110.274 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.881 HD21 HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -79.25 119.44 22.33 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.165 -0.959 . . . . 0.56999999999999995 110.344 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.433 ' N ' HD13 ' A' ' 52' ' ' LEU . 29.8 t80 -76.28 162.33 28.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.288 -0.883 . . . . 0.56999999999999995 110.529 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -126.03 106.92 9.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.28000000000000003 110.238 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -81.36 158.39 24.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.28000000000000003 110.48 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.933 -1.032 . . . . 0.46000000000000002 110.418 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.309 0.576 . . . . 0.38 110.441 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -65.76 137.11 57.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.68999999999999995 110.512 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.93 157.42 15.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 0.65000000000000002 110.481 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.431 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 0.9 OUTLIER -121.2 160.36 23.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.28999999999999998 110.097 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.447 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 55.9 m95 -135.09 127.1 29.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.151 -0.968 . . . . 0.29999999999999999 110.651 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.804 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -98.83 130.43 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.09 -1.006 . . . . 0.46000000000000002 110.028 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.804 ' N ' HD13 ' A' ' 6' ' ' ILE . 12.0 t -78.68 92.88 4.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.216 -0.928 . . . . 0.37 109.507 177.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 49' ' ' ASP . 48.0 pt -51.49 -23.99 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.884 -1.135 . . . . 0.41999999999999998 110.031 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.9 m -77.13 -27.4 53.91 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.546 -0.721 . . . . 0.48999999999999999 110.195 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 3.7 m -117.03 -47.35 2.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.246 -0.909 . . . . 0.28000000000000003 111.503 -178.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.574 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 114.28 -22.14 14.15 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.126 -1.59 . . . . 0.17000000000000001 109.126 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 13' ' ' ILE . 8.8 t60 -69.67 145.3 52.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -1.177 . . . . 0.20999999999999999 110.213 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.454 ' O ' ' CD2' ' A' ' 12' ' ' HIS . 7.2 mt -108.14 151.84 10.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.391 -0.818 . . . . 0.16 111.041 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -103.82 128.47 51.26 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.701 -0.624 . . . . 0.10000000000000001 109.992 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -102.89 103.85 14.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.532 -0.73 . . . . 0.11 110.344 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -51.37 -23.45 3.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.389 -0.819 . . . . 0.12 110.717 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.79 11.77 10.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.19 110.897 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -176.47 69.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.27000000000000002 109.906 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.72 -146.61 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.011 -1.236 . . . . 0.20999999999999999 110.011 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.06 172.96 9.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.399 -1.059 . . . . 0.27000000000000002 110.697 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -110.58 -21.57 12.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.38 110.301 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.11 -59.92 2.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.39000000000000001 110.399 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -57.68 -21.23 39.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.39000000000000001 110.3 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.36 31.96 6.92 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.198 -1.561 . . . . 0.28000000000000003 109.198 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -78.71 76.98 5.2 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.345 -1.091 . . . . 0.31 110.122 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 14.9 t -51.38 148.45 8.89 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.431 -0.793 . . . . 0.40000000000000002 110.865 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 38.4 Cg_exo -56.51 123.83 14.79 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.695 1.366 . . . . 0.25 110.493 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.6 22.87 5.28 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.572 -1.411 . . . . 0.089999999999999997 109.572 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.423 HG22 HD11 ' A' ' 34' ' ' ILE . 69.8 m -97.29 132.69 42.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -1.159 . . . . 0.14999999999999999 110.268 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.8 ttp85 -109.01 142.24 39.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.23999999999999999 110.394 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.861 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -48.01 -48.25 32.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.266 -0.897 . . . . 0.28000000000000003 110.821 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.54 -46.82 66.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.89 . . . . 0.31 110.179 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.59 -11.66 60.74 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.4 -0.813 . . . . 0.25 110.378 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.861 HD12 ' HA ' ' A' ' 31' ' ' PHE . 77.8 mt -87.46 121.53 71.11 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.026 -1.046 . . . . 0.26000000000000001 109.973 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.8 -174.9 0.51 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.402 1.212 . . . . 0.34000000000000002 110.505 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.37 -20.28 54.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 0.37 110.369 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -50.0 -37.32 32.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.39000000000000001 110.53 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 69.2 t90 -77.19 157.31 30.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.323 -0.861 . . . . 0.25 110.241 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 25.2 p -156.49 -160.38 0.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.376 -0.827 . . . . 0.11 110.192 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 1.2 t -81.22 145.77 56.82 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 0.31 110.123 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 5.5 Cg_exo -75.16 -12.98 21.22 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.397 1.209 . . . . 0.58999999999999997 111.194 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -121.23 -12.79 8.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.899 -1.126 . . . . 0.56999999999999995 111.387 -178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 99.1 m -116.17 -72.91 0.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.917 -1.114 . . . . 0.39000000000000001 110.597 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.29 29.65 1.9 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.675 -1.37 . . . . 0.22 109.675 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.552 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . . . -110.87 -174.88 2.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -1.154 . . . . 0.12 110.285 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.7 p -89.82 -158.86 0.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.17000000000000001 110.315 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 50' ' ' TYR . 11.9 tmtt? -64.22 -12.08 37.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.427 -0.796 . . . . 0.33000000000000002 110.568 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -48.33 -45.98 35.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.048 -1.032 . . . . 0.42999999999999999 110.846 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.552 ' OD2' ' HB3' ' A' ' 45' ' ' ALA . 2.7 p30 -79.53 -19.31 49.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.42999999999999999 110.334 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.416 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 2.7 m-85 -94.13 128.72 40.7 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.118 -0.989 . . . . 0.46999999999999997 110.573 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 52' ' ' LEU . 95.4 t -123.15 161.86 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.48999999999999999 110.148 179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.437 ' HA ' HD22 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -76.24 110.43 10.74 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.223 -0.923 . . . . 0.56999999999999995 110.371 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -51.33 144.21 10.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.56999999999999995 110.539 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -153.71 135.05 14.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.28000000000000003 110.385 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -77.81 100.76 6.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.28000000000000003 110.459 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 71.1 mttt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.943 -1.027 . . . . 0.46000000000000002 110.414 179.852 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.268 0.556 . . . . 0.38 110.344 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.444 ' CE1' ' HA2' ' A' ' 28' ' ' GLY . 34.1 m-85 -121.22 134.38 55.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.68999999999999995 110.383 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.772 HD23 HD21 ' A' ' 52' ' ' LEU . 1.7 mp -84.14 172.34 12.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.373 -0.829 . . . . 0.65000000000000002 110.689 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -138.08 130.21 28.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.322 -0.861 . . . . 0.28999999999999998 110.001 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.529 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 30.2 m95 -108.9 179.94 4.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.165 -0.959 . . . . 0.29999999999999999 110.374 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.905 HD13 HG13 ' A' ' 13' ' ' ILE . 2.7 tp -156.55 129.7 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.584 -0.697 . . . . 0.46000000000000002 110.209 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.1 t -79.29 98.35 6.63 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.375 -0.828 . . . . 0.37 110.301 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.9 tt -55.96 -20.32 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.961 . . . . 0.41999999999999998 110.18 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.1 m -75.73 -27.35 58.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.373 -0.83 . . . . 0.48999999999999999 110.125 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.2 m -120.45 -50.74 2.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.28000000000000003 110.743 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.516 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 113.06 19.95 6.56 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.17000000000000001 109.506 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -100.31 120.11 39.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -1.223 . . . . 0.20999999999999999 110.05 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.905 HG13 HD13 ' A' ' 6' ' ' ILE . 43.5 mt -81.95 134.88 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.93 . . . . 0.16 110.577 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.422 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 48.2 t80 -92.93 125.78 37.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.458 -0.776 . . . . 0.10000000000000001 110.067 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -99.35 103.55 15.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.499 -0.751 . . . . 0.11 109.975 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -49.57 -24.94 2.39 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.277 -0.89 . . . . 0.12 110.895 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.69 22.52 7.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.19 110.058 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.454 ' HA ' HD22 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -176.22 66.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.27000000000000002 110.041 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.89 -140.06 0.67 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.777 -1.329 . . . . 0.20999999999999999 109.777 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.42 173.24 6.39 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.357 -1.084 . . . . 0.27000000000000002 110.599 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.58 -23.38 12.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.365 -0.834 . . . . 0.38 110.159 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.18 -29.42 28.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.39000000000000001 110.329 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -87.39 14.03 8.81 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.303 -0.873 . . . . 0.39000000000000001 110.823 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.85 28.39 68.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.406 -1.478 . . . . 0.28000000000000003 109.406 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.562 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -86.85 79.1 8.91 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.24 -1.153 . . . . 0.31 110.316 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 15.3 t -60.77 154.51 57.46 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.403 -0.811 . . . . 0.40000000000000002 110.76 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 23.7 Cg_exo -60.7 119.29 6.38 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.751 1.395 . . . . 0.25 110.484 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.444 ' HA2' ' CE1' ' A' ' 2' ' ' TYR . . . 113.2 38.33 1.25 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.474 -1.45 . . . . 0.089999999999999997 109.474 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.4 m -114.58 130.84 56.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -1.158 . . . . 0.14999999999999999 110.391 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -108.5 142.15 39.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.23999999999999999 110.282 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.762 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -48.24 -43.88 32.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.124 -0.985 . . . . 0.28000000000000003 110.668 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -54.76 -22.7 14.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.941 . . . . 0.31 109.774 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.56 22.07 16.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.343 -0.848 . . . . 0.25 110.161 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.762 HD12 ' HA ' ' A' ' 31' ' ' PHE . 89.7 mt -120.11 70.64 15.49 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.26000000000000001 110.471 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -85.05 13.36 2.8 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.543 1.286 . . . . 0.34000000000000002 111.146 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.27 30.23 1.3 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.979 -1.076 . . . . 0.37 110.91 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 t70 51.49 44.72 28.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.11 -0.994 . . . . 0.39000000000000001 110.742 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.562 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 59.5 t90 -52.37 151.3 4.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.25 109.966 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 88.6 m -132.47 -169.26 2.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.137 -0.977 . . . . 0.11 110.768 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.468 ' HB3' ' CB ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -82.19 163.06 54.57 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.31 110.375 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -67.66 -33.91 26.63 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.609 1.32 . . . . 0.58999999999999997 110.222 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -150.25 57.63 0.95 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.56999999999999995 109.947 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' CB ' ' HB3' ' A' ' 40' ' ' CYS . 1.8 t -141.58 -56.0 0.47 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.347 -0.845 . . . . 0.39000000000000001 110.248 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.6 41.13 5.49 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.46 -1.456 . . . . 0.22 109.46 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.27 171.1 8.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.16 -1.2 . . . . 0.12 110.494 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.0 p -92.09 -172.51 3.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.17000000000000001 110.427 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -15.75 48.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.33000000000000002 110.261 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -54.41 -38.44 66.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.42999999999999999 110.223 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.528 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -76.45 -19.3 58.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.42999999999999999 110.449 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.41 ' CZ ' ' CH2' ' A' ' 38' ' ' TRP . 4.0 m-85 -95.3 129.86 42.27 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.162 -0.961 . . . . 0.46999999999999997 110.591 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 6' ' ' ILE . 33.2 m -125.6 172.8 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.48999999999999999 110.246 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.772 HD21 HD23 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -78.84 116.57 19.26 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.299 -0.876 . . . . 0.56999999999999995 110.252 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -69.83 139.69 53.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.282 -0.886 . . . . 0.56999999999999995 110.633 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 49.63 91.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.383 -0.823 . . . . 0.28000000000000003 110.737 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -57.07 114.3 2.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.28000000000000003 110.135 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.109 -0.948 . . . . 0.46000000000000002 110.435 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.288 0.566 . . . . 0.38 110.427 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -120.22 142.26 49.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 0.68999999999999995 110.505 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.411 ' O ' ' CG ' ' A' ' 16' ' ' GLU . 6.9 mp -108.96 159.55 16.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.44 -0.788 . . . . 0.65000000000000002 110.582 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.442 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 9.5 mttp -113.9 160.45 18.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.237 -0.915 . . . . 0.28999999999999998 109.832 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.527 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 29.1 m95 -128.2 133.07 48.82 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.093 -1.004 . . . . 0.29999999999999999 110.598 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.75 HD13 HG13 ' A' ' 13' ' ' ILE . 3.5 tp -104.02 141.62 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.093 -1.004 . . . . 0.46000000000000002 111.016 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.454 ' H ' HD12 ' A' ' 6' ' ' ILE . 16.1 t -92.35 102.35 14.84 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.385 -0.822 . . . . 0.37 109.978 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 49' ' ' ASP . 1.9 tt -55.79 -20.09 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.952 . . . . 0.41999999999999998 110.595 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.3 m -67.55 -36.73 81.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.48999999999999999 110.936 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.3 p -131.33 -34.4 1.41 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.984 -1.073 . . . . 0.28000000000000003 111.157 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.624 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 107.81 41.65 1.55 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.489 -1.444 . . . . 0.17000000000000001 109.489 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.458 ' CE1' ' HG2' ' A' ' 41' ' ' PRO . 13.7 t-80 -105.06 126.68 52.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -1.113 . . . . 0.20999999999999999 110.113 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.75 HG13 HD13 ' A' ' 6' ' ' ILE . 6.0 mt -93.69 133.18 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.16 110.685 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.469 ' HH ' ' HD2' ' A' ' 25' ' ' PHE . 72.5 t80 -97.33 132.23 43.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.571 -0.705 . . . . 0.10000000000000001 109.538 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.526 ' OD1' ' HB3' ' A' ' 17' ' ' ALA . 10.3 t70 -102.69 103.62 13.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.529 -0.732 . . . . 0.11 110.165 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 3' ' ' LEU . 26.0 mt-10 -52.2 -22.91 4.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.901 . . . . 0.12 110.596 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.526 ' HB3' ' OD1' ' A' ' 15' ' ' ASP . . . -88.25 12.68 13.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.19 110.699 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.8 tp -177.25 68.81 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.172 -0.955 . . . . 0.27000000000000002 109.655 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.99 -139.54 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.254 -1.139 . . . . 0.20999999999999999 110.254 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -89.37 164.35 14.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.44 -1.035 . . . . 0.27000000000000002 110.809 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -107.12 -31.98 8.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.444 -0.785 . . . . 0.38 109.93 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.29 -53.46 19.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.311 -0.868 . . . . 0.39000000000000001 110.264 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -60.86 -27.78 68.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.39000000000000001 110.072 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.12 28.41 6.87 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.601 -1.4 . . . . 0.28000000000000003 109.601 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.541 ' HE2' HD11 ' A' ' 34' ' ' ILE . 0.5 OUTLIER -66.67 83.53 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.066 -1.255 . . . . 0.31 110.128 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 14.0 t -50.79 145.83 10.95 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.456 -0.777 . . . . 0.40000000000000002 110.74 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 34.7 Cg_exo -55.56 116.84 3.44 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.631 1.332 . . . . 0.25 110.431 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 116.11 24.46 3.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.663 -1.375 . . . . 0.089999999999999997 109.663 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 56.8 m -98.13 116.2 29.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -1.198 . . . . 0.14999999999999999 110.149 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.406 ' HA ' ' HG2' ' A' ' 16' ' ' GLU . 15.2 ttp180 -94.99 142.66 27.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.244 -0.91 . . . . 0.23999999999999999 110.626 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.733 ' HA ' HD12 ' A' ' 34' ' ' ILE . 1.2 t80 -50.57 -27.19 6.29 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.282 -0.887 . . . . 0.28000000000000003 110.252 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.08 -33.8 58.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.146 -0.971 . . . . 0.31 109.804 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.412 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 5.2 t0 -89.51 7.58 35.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.521 -0.737 . . . . 0.25 110.45 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.733 HD12 ' HA ' ' A' ' 31' ' ' PHE . 33.8 mt -100.02 96.35 4.82 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.09 -1.006 . . . . 0.26000000000000001 109.67 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 34' ' ' ILE . 16.3 Cg_endo -62.16 -79.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.649 1.341 . . . . 0.34000000000000002 111.02 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -156.71 -35.87 0.08 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.944 . . . . 0.37 111.273 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -45.79 -30.0 1.51 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.172 -0.955 . . . . 0.39000000000000001 111.087 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.414 ' HB3' HG23 ' A' ' 34' ' ' ILE . 88.2 t90 -75.4 138.3 41.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.25 110.04 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.407 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 97.8 m -127.12 -175.1 3.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.11 110.266 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.41 ' SG ' ' CE2' ' A' ' 50' ' ' TYR . 0.5 OUTLIER -81.38 138.73 48.18 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.31 110.283 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.458 ' HG2' ' CE1' ' A' ' 12' ' ' HIS . 36.9 Cg_endo -71.66 -16.3 30.15 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.488 1.257 . . . . 0.58999999999999997 110.816 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.2 -0.36 15.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.988 . . . . 0.56999999999999995 111.236 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 64.2 m -138.45 -68.12 0.46 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.953 -1.092 . . . . 0.39000000000000001 110.404 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 39' ' ' CYS . . . 107.17 32.26 3.55 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.327 -1.509 . . . . 0.22 109.327 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.89 -168.74 1.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -1.106 . . . . 0.12 110.613 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 p -88.04 178.31 6.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.38 -0.825 . . . . 0.17000000000000001 110.526 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -65.05 -22.28 66.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 0.33000000000000002 110.172 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -58.04 -18.96 27.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.42999999999999999 110.406 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.464 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.1 m-20 -83.65 -15.47 48.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.42999999999999999 110.661 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.41 ' CE2' ' SG ' ' A' ' 40' ' ' CYS . 1.9 m-85 -99.81 145.24 27.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.046 -1.034 . . . . 0.46999999999999997 111.199 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.3 m -145.75 164.56 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.538 -0.727 . . . . 0.48999999999999999 109.905 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 53' ' ' TYR . 2.2 tp -69.77 127.76 34.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 0.56999999999999995 110.824 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.557 ' HD1' HG21 ' A' ' 6' ' ' ILE . 7.3 t80 -88.72 140.77 29.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.56999999999999995 110.202 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.411 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -167.08 87.68 0.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.28000000000000003 110.394 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.7 171.64 13.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.245 -0.909 . . . . 0.28000000000000003 110.186 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.972 -1.013 . . . . 0.46000000000000002 110.418 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.28 0.562 . . . . 0.38 110.322 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 24.7 m-85 -70.97 136.53 48.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.177 -0.952 . . . . 0.68999999999999995 110.345 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.699 HD23 HD21 ' A' ' 52' ' ' LEU . 4.8 mp -87.46 -178.27 6.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.358 -0.839 . . . . 0.65000000000000002 110.455 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.41 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 25.0 mttt -142.98 146.6 34.06 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.483 -0.761 . . . . 0.28999999999999998 110.165 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.562 ' CE3' ' CD2' ' A' ' 31' ' ' PHE . 22.7 m95 -130.09 123.6 30.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.29999999999999999 110.078 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.826 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -106.63 134.47 48.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.037 -1.04 . . . . 0.46000000000000002 110.278 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.826 ' N ' HD13 ' A' ' 6' ' ' ILE . 4.3 t -79.89 96.04 6.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.407 -0.808 . . . . 0.37 110.098 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.7 pt -53.23 -22.6 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.132 -0.98 . . . . 0.41999999999999998 110.146 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.6 m -75.57 -28.16 58.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.295 -0.878 . . . . 0.48999999999999999 110.203 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.4 m -115.24 -50.93 2.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.28000000000000003 110.869 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.56 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 113.12 19.02 6.95 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.47 -1.452 . . . . 0.17000000000000001 109.47 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 1.9 m170 -102.0 131.54 48.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.126 -1.22 . . . . 0.20999999999999999 110.002 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.418 HG13 HG12 ' A' ' 6' ' ' ILE . 73.0 mt -95.31 136.71 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.16 110.761 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.479 ' HH ' ' HE2' ' A' ' 25' ' ' PHE . 66.1 t80 -99.4 132.53 44.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.391 -0.818 . . . . 0.10000000000000001 109.959 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -109.7 111.56 23.1 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.511 -0.743 . . . . 0.11 109.703 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -51.15 -24.06 3.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 0.12 110.493 -179.233 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 2' ' ' TYR . . . -93.55 17.53 11.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.172 -0.955 . . . . 0.19 110.245 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -177.31 68.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.27000000000000002 109.71 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.28 -137.1 1.73 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.224 -1.151 . . . . 0.20999999999999999 110.224 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 22' ' ' ALA . 11.3 t70 -78.97 158.42 27.97 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.432 -1.04 . . . . 0.27000000000000002 110.776 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -104.13 -33.29 8.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.38 110.094 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . -80.01 -45.62 18.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.39000000000000001 110.205 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.12 -35.22 71.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.214 -0.928 . . . . 0.39000000000000001 109.976 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.2 20.37 7.53 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.568 -1.413 . . . . 0.28000000000000003 109.568 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.571 ' CE1' ' CD1' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -67.79 77.97 0.2 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.111 -1.229 . . . . 0.31 110.224 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.0 t -52.66 151.65 7.73 Favored Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.444 -0.785 . . . . 0.40000000000000002 110.702 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -58.89 116.77 3.49 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.703 1.37 . . . . 0.25 110.394 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.62 -23.95 5.59 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.346 -1.502 . . . . 0.089999999999999997 109.346 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.539 HG22 HD11 ' A' ' 34' ' ' ILE . 6.7 m -53.26 132.29 38.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -1.152 . . . . 0.14999999999999999 110.235 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.453 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 16.1 mtp180 -115.51 146.29 41.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.853 . . . . 0.23999999999999999 110.394 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.562 ' CD2' ' CE3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -50.93 -33.65 25.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 0.28000000000000003 110.273 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -53.21 -50.98 63.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.871 . . . . 0.31 110.02 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.416 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 4.5 t70 -70.06 -7.84 44.49 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.416 -0.803 . . . . 0.25 110.471 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.543 HG23 ' HB3' ' A' ' 38' ' ' TRP . 30.1 mt -103.4 94.8 6.23 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.156 -0.965 . . . . 0.26000000000000001 110.154 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 33' ' ' ASP . 30.0 Cg_endo -67.94 -88.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.663 1.349 . . . . 0.34000000000000002 110.834 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.29 -18.6 2.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.833 -1.167 . . . . 0.37 111.628 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.9 -55.02 12.98 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.796 -1.19 . . . . 0.39000000000000001 110.867 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.571 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 54.9 t90 -69.83 159.81 32.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.196 -0.94 . . . . 0.25 110.126 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -162.16 176.81 10.27 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.373 -0.83 . . . . 0.11 110.361 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -51.55 149.77 7.6 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.341 -0.85 . . . . 0.31 109.988 178.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.52 -27.85 70.19 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.527 1.278 . . . . 0.58999999999999997 110.74 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.2 57.36 0.89 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.935 . . . . 0.56999999999999995 110.217 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.469 ' CB ' ' HB3' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -152.46 -45.53 0.1 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.259 -0.901 . . . . 0.39000000000000001 110.045 -179.157 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.53 42.65 95.57 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.54 -1.424 . . . . 0.22 109.54 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.41 32.74 5.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -1.198 . . . . 0.12 110.823 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.1 p 44.02 -153.65 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.578 0.704 . . . . 0.17000000000000001 111.101 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -81.56 -13.08 58.49 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.515 -0.741 . . . . 0.33000000000000002 110.447 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.08 -48.84 43.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.085 -1.009 . . . . 0.42999999999999999 110.794 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 9.8 m-20 -76.64 -16.63 59.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.42999999999999999 110.43 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.41 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 1.8 m-85 -93.56 135.92 34.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.042 -1.036 . . . . 0.46999999999999997 110.51 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 71.4 t -131.59 150.12 33.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.282 -0.886 . . . . 0.48999999999999999 110.232 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.699 HD21 HD23 ' A' ' 3' ' ' LEU . 0.5 OUTLIER -63.63 125.12 23.24 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.352 -0.842 . . . . 0.56999999999999995 110.43 -179.546 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.644 ' N ' HD13 ' A' ' 52' ' ' LEU . 17.1 t80 -71.93 100.27 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 0.56999999999999995 110.38 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -143.19 103.81 4.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.28000000000000003 110.399 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.92 -173.37 4.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.242 -0.911 . . . . 0.28000000000000003 110.327 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.6 tttt . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.917 -1.039 . . . . 0.46000000000000002 110.371 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.215 0.531 . . . . 0.38 110.437 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.518 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 55.9 m-85 -77.78 139.72 39.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.32 -0.862 . . . . 0.68999999999999995 110.487 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 3' ' ' LEU . 8.7 mp -90.53 171.31 9.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.65000000000000002 110.397 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.438 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 19.6 mttp -136.12 158.37 44.58 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.28999999999999998 109.959 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.531 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 31.2 m95 -127.8 136.44 51.47 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -0.944 . . . . 0.29999999999999999 110.579 -178.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.729 HD13 HG13 ' A' ' 13' ' ' ILE . 3.4 tp -106.13 137.87 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.964 -1.085 . . . . 0.46000000000000002 110.568 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 11' ' ' GLY . 7.6 t -83.41 96.13 8.45 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.547 -0.721 . . . . 0.37 110.25 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 49' ' ' ASP . 2.4 tt -56.11 -19.95 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.981 -1.074 . . . . 0.41999999999999998 110.027 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.9 m -77.64 -27.15 50.97 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.325 -0.86 . . . . 0.48999999999999999 110.105 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 64.4 m -123.64 -54.99 1.74 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.338 -0.851 . . . . 0.28000000000000003 110.632 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.526 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 119.83 27.07 2.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.84 -1.304 . . . . 0.17000000000000001 109.84 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.664 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -109.36 144.06 38.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -1.185 . . . . 0.20999999999999999 110.278 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.729 HG13 HD13 ' A' ' 6' ' ' ILE . 7.2 mt -98.41 145.53 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.344 -0.847 . . . . 0.16 110.968 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 58.1 t80 -105.7 133.58 50.21 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.369 -0.604 . . . . 0.10000000000000001 109.369 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -101.6 106.76 17.87 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.552 -0.718 . . . . 0.11 110.198 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 30' ' ' ARG . 24.3 mt-10 -50.28 -25.98 4.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.308 -0.87 . . . . 0.12 110.722 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.518 ' HB2' ' CD2' ' A' ' 2' ' ' TYR . . . -100.07 19.97 15.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.19 110.352 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.489 ' HA ' HD22 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -177.55 70.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.27000000000000002 110.338 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' A' ' 25' ' ' PHE . . . -64.24 -135.69 0.01 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.572 -1.411 . . . . 0.20999999999999999 109.572 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -99.39 172.08 7.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -1.169 . . . . 0.27000000000000002 110.702 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.37 -24.18 20.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.38 110.003 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.25 -36.95 17.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.307 -0.87 . . . . 0.39000000000000001 110.106 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -66.91 -21.65 65.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.39000000000000001 110.074 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.16 31.06 53.8 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.258 -1.537 . . . . 0.28000000000000003 109.258 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.654 ' CE1' HG21 ' A' ' 29' ' ' THR . 0.1 OUTLIER -71.72 82.43 0.87 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.15 -1.206 . . . . 0.31 110.141 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.3 t -49.29 142.27 10.87 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.40000000000000002 110.767 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 39.0 Cg_exo -52.83 108.5 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.555 1.292 . . . . 0.25 110.69 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.01 44.04 0.26 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.602 -1.399 . . . . 0.089999999999999997 109.602 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.654 HG21 ' CE1' ' A' ' 25' ' ' PHE . 1.5 m -122.63 136.26 54.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -1.165 . . . . 0.14999999999999999 110.555 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.401 ' HA ' ' HG2' ' A' ' 16' ' ' GLU . 8.9 mtp180 -122.87 144.34 49.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.351 -0.843 . . . . 0.23999999999999999 110.224 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.593 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -48.18 -49.13 33.77 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.224 -0.922 . . . . 0.28000000000000003 110.494 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -53.37 -26.8 20.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.31 109.64 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.21 16.73 20.46 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.491 -0.755 . . . . 0.25 110.133 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.644 ' O ' HG22 ' A' ' 34' ' ' ILE . 92.2 mt -123.88 66.82 40.08 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.26000000000000001 110.327 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -84.68 14.46 2.45 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 123.61 1.321 . . . . 0.34000000000000002 111.412 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.28 41.89 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.879 -1.138 . . . . 0.37 110.886 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.1 t0 48.55 28.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.145 -0.972 . . . . 0.39000000000000001 110.872 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.424 ' NE1' ' CE2' ' A' ' 25' ' ' PHE . 63.7 t90 -53.7 151.64 5.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 0.25 110.28 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 83.4 m -148.65 -167.31 2.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.325 -0.859 . . . . 0.11 110.133 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.24 169.98 18.1 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.232 -0.918 . . . . 0.31 109.981 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -57.94 -47.7 19.53 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.563 1.296 . . . . 0.58999999999999997 110.206 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -178.82 57.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.45 -0.781 . . . . 0.56999999999999995 109.981 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 21.1 p -162.14 -36.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.152 -0.968 . . . . 0.39000000000000001 111.113 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . -95.67 -41.53 3.85 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.574 -1.411 . . . . 0.22 109.574 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' GLY . . . 56.82 163.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -1.047 . . . . 0.12 110.945 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 44.61 -161.23 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.468 -0.77 . . . . 0.17000000000000001 111.053 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -122.31 -21.53 5.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.338 -0.851 . . . . 0.33000000000000002 110.72 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.49 -28.96 48.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.136 -0.977 . . . . 0.42999999999999999 110.448 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.749 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.5 m-20 -74.07 -17.69 60.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.42999999999999999 110.34 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -97.15 136.41 37.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.095 -1.003 . . . . 0.46999999999999997 110.725 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.27 162.83 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.48999999999999999 109.914 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.88 118.84 19.87 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.121 -0.987 . . . . 0.56999999999999995 110.5 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -60.38 137.92 58.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.56999999999999995 110.518 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 51.49 91.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.28000000000000003 110.485 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -96.54 73.58 2.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.306 -0.871 . . . . 0.28000000000000003 110.432 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.7 mttt . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.934 -1.031 . . . . 0.46000000000000002 110.388 179.914 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.217 0.532 . . . . 0.38 110.322 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -131.63 133.84 45.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.68999999999999995 110.466 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.049 HD23 HD21 ' A' ' 52' ' ' LEU . 0.7 OUTLIER -90.67 167.21 12.7 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.248 -0.907 . . . . 0.65000000000000002 110.272 179.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -127.4 125.57 40.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.905 . . . . 0.28999999999999998 110.474 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.526 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 23.2 m95 -106.62 179.22 4.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.29999999999999999 110.032 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.731 HD11 ' HA2' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -157.69 126.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 119.844 -0.742 . . . . 0.46000000000000002 110.193 178.025 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.664 ' N ' HD13 ' A' ' 6' ' ' ILE . 12.5 t -73.47 91.1 1.76 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.353 -0.842 . . . . 0.37 109.488 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.5 pt -51.92 -22.95 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.195 -0.941 . . . . 0.41999999999999998 110.334 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 94.4 m -59.03 -27.86 65.87 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.379 -0.825 . . . . 0.48999999999999999 110.714 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -137.11 -36.7 0.66 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.145 -0.972 . . . . 0.28000000000000003 111.243 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.731 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 117.16 19.78 5.03 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.516 -1.326 . . . . 0.17000000000000001 110.077 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.37 115.1 26.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.047 -1.266 . . . . 0.20999999999999999 110.232 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 74.2 mt -84.2 128.62 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.925 . . . . 0.16 110.539 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.421 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 63.2 t80 -91.74 120.82 32.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.273 -0.892 . . . . 0.10000000000000001 109.814 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -99.18 103.98 15.91 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.217 -0.927 . . . . 0.11 109.879 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -47.58 -26.57 1.5 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.12 111.075 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.33 19.01 8.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.176 -0.953 . . . . 0.19 110.579 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -176.1 68.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.27000000000000002 110.165 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.16 -143.42 0.79 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.737 -1.345 . . . . 0.20999999999999999 109.737 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.56 165.25 12.43 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.34 -1.094 . . . . 0.27000000000000002 110.297 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.04 -41.79 6.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.237 -0.914 . . . . 0.38 110.346 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.72 -50.2 70.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.39000000000000001 110.26 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.09 -21.07 44.39 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.176 -0.953 . . . . 0.39000000000000001 110.397 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.38 23.25 17.1 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.221 -1.551 . . . . 0.28000000000000003 109.221 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.3 OUTLIER -83.83 78.91 9.64 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.242 -1.151 . . . . 0.31 110.05 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.4 t -49.24 151.67 2.42 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.357 -0.84 . . . . 0.40000000000000002 110.985 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 23.6 Cg_exo -60.68 80.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.713 1.375 . . . . 0.25 110.387 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 26' ' ' THR . . . 153.82 42.11 0.02 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.148 -1.581 . . . . 0.089999999999999997 109.148 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.6 m -112.56 134.44 54.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.35 -1.088 . . . . 0.14999999999999999 110.341 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mtm180 -111.43 145.96 38.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.829 . . . . 0.23999999999999999 110.163 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.685 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -52.39 -41.21 62.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.919 . . . . 0.28000000000000003 110.251 179.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -53.64 -43.63 68.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.873 . . . . 0.31 110.204 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.41 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 3.2 t0 -79.17 2.03 22.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.25 110.772 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 31' ' ' PHE . 88.7 mt -106.26 89.77 4.16 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.0 -1.063 . . . . 0.26000000000000001 110.075 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 33' ' ' ASP . 28.5 Cg_endo -68.77 -170.88 0.35 Allowed 'Trans proline' 0 C--N 1.314 -1.287 0 O-C-N 123.672 1.353 . . . . 0.34000000000000002 110.651 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.57 98.3 0.09 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.9 . . . . 0.37 110.329 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -175.68 -36.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.39000000000000001 110.285 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.573 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 87.9 t90 -90.29 142.35 27.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.837 . . . . 0.25 110.479 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.408 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 67.4 m -133.88 -174.51 3.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.11 110.191 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -83.55 156.13 65.47 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.077 -1.015 . . . . 0.31 110.286 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.67 -5.14 14.6 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.487 1.256 . . . . 0.58999999999999997 111.201 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 50.1 p30 -146.09 20.6 1.41 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.875 -1.14 . . . . 0.56999999999999995 110.968 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 76.8 m -143.0 -49.03 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.165 -0.959 . . . . 0.39000000000000001 110.424 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 39' ' ' CYS . . . 77.01 33.23 46.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.409 -1.476 . . . . 0.22 109.409 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.549 ' HB1' ' OD1' ' A' ' 49' ' ' ASP . . . -102.57 -172.05 2.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -1.169 . . . . 0.12 110.49 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.97 -171.91 2.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.855 . . . . 0.17000000000000001 110.332 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.454 ' HD3' ' CD2' ' A' ' 31' ' ' PHE . 20.3 mttt -60.56 -18.8 54.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.35 -0.844 . . . . 0.33000000000000002 110.227 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.24 -41.07 65.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.42999999999999999 110.361 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.549 ' OD1' ' HB1' ' A' ' 45' ' ' ALA . 2.1 m-20 -69.29 -24.23 63.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.42999999999999999 109.826 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -92.96 137.88 31.97 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.443 -0.786 . . . . 0.46999999999999997 110.512 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.427 HG22 ' N ' ' A' ' 52' ' ' LEU . 8.6 p -129.69 163.68 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.323 -0.861 . . . . 0.48999999999999999 110.032 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.049 HD21 HD23 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -69.84 108.75 4.1 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.114 -0.991 . . . . 0.56999999999999995 110.084 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -62.82 141.25 58.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.56999999999999995 110.749 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 52.43 89.87 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.85 . . . . 0.28000000000000003 110.557 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -95.42 55.43 1.72 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.161 -0.962 . . . . 0.28000000000000003 110.219 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.976 -1.012 . . . . 0.46000000000000002 110.314 -179.895 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.23 0.538 . . . . 0.38 110.356 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.513 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 23.0 m-85 -139.88 134.95 32.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.68999999999999995 110.358 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.45 HD23 HD21 ' A' ' 52' ' ' LEU . 2.6 mp -81.73 165.93 20.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.65000000000000002 110.759 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.44 ' C ' ' CD1' ' A' ' 5' ' ' TRP . 23.6 mttm -134.38 151.39 51.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.372 -0.83 . . . . 0.28999999999999998 110.12 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.554 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 20.1 m95 -133.03 127.15 33.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.3 -0.875 . . . . 0.29999999999999999 109.927 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.845 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -102.64 134.43 43.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.112 -0.992 . . . . 0.46000000000000002 110.898 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.845 ' N ' HD13 ' A' ' 6' ' ' ILE . 16.3 t -79.9 95.71 6.16 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.579 -0.7 . . . . 0.37 109.588 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.534 HG22 ' O ' ' A' ' 49' ' ' ASP . 2.1 tt -55.26 -20.12 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.41999999999999998 110.628 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.1 m -63.46 -27.98 69.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.28 -0.888 . . . . 0.48999999999999999 110.885 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.5 p -134.09 -35.89 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.967 -1.083 . . . . 0.28000000000000003 111.397 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.568 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 112.21 35.96 1.71 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.533 -1.318 . . . . 0.17000000000000001 109.854 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 4.2 t-80 -112.14 129.26 56.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.128 -1.219 . . . . 0.20999999999999999 110.397 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.424 HG13 HG12 ' A' ' 6' ' ' ILE . 13.5 mt -91.58 146.66 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.16 111.096 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -108.68 129.14 55.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.565 -0.709 . . . . 0.10000000000000001 109.809 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -105.32 106.75 17.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.549 -0.719 . . . . 0.11 110.234 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 2' ' ' TYR . 19.1 mt-10 -49.88 -24.54 2.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.12 110.664 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.513 ' HB2' ' CD2' ' A' ' 2' ' ' TYR . . . -88.0 14.25 9.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.19 110.71 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.6 tp -176.08 67.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.025 -1.047 . . . . 0.27000000000000002 109.955 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.43 -143.03 0.02 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.897 -1.281 . . . . 0.20999999999999999 109.897 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.88 165.38 11.59 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.37 -1.076 . . . . 0.27000000000000002 110.525 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -107.19 -20.02 13.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.38 110.545 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.59 -36.0 38.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.151 -0.968 . . . . 0.39000000000000001 110.392 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -81.42 -13.31 58.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.191 -0.943 . . . . 0.39000000000000001 110.729 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.81 27.7 16.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.073 -1.611 . . . . 0.28000000000000003 109.073 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -82.97 82.77 8.07 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.371 -1.076 . . . . 0.31 110.229 -179.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.3 t -49.69 142.34 12.36 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.173 -0.954 . . . . 0.40000000000000002 110.77 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 36.8 Cg_exo -53.05 109.66 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.559 1.294 . . . . 0.25 110.612 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.92 -14.03 5.23 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.142 -1.183 . . . . 0.089999999999999997 110.142 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.509 HG22 HD11 ' A' ' 34' ' ' ILE . 1.3 m -51.53 129.68 26.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.95 -1.324 . . . . 0.14999999999999999 110.804 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 -108.83 134.19 51.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.357 -0.84 . . . . 0.23999999999999999 110.003 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.684 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -47.06 -51.88 16.48 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.242 -0.911 . . . . 0.28000000000000003 110.947 -179.372 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -51.5 -37.15 47.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.18 -0.95 . . . . 0.31 109.96 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -85.5 8.8 17.82 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.438 -0.789 . . . . 0.25 110.274 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.684 HD12 ' HA ' ' A' ' 31' ' ' PHE . 78.5 mt -111.82 72.0 1.03 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.98 -1.075 . . . . 0.26000000000000001 110.226 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -71.46 -21.51 26.02 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.622 1.328 . . . . 0.34000000000000002 110.415 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -55.18 -172.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.37 110.447 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.72 43.97 1.04 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.892 . . . . 0.39000000000000001 110.349 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 83.2 t90 -52.6 144.88 12.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.336 -0.853 . . . . 0.25 110.251 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 91.6 m -130.96 -167.08 1.78 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.11 110.546 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -87.09 143.29 34.63 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.31 110.375 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -78.28 -17.07 13.42 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.567 1.298 . . . . 0.58999999999999997 111.009 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -28.55 9.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.05 -1.031 . . . . 0.56999999999999995 110.866 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 94.1 m -101.22 -71.99 0.69 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 0.39000000000000001 110.606 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.82 29.38 1.86 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.581 -1.408 . . . . 0.22 109.581 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.51 -173.84 2.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.103 -1.234 . . . . 0.12 110.337 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.1 p -97.12 -170.88 2.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.17000000000000001 110.393 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.501 ' HG3' ' CE2' ' A' ' 31' ' ' PHE . 5.8 tttt -61.44 -16.66 48.99 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.364 -0.835 . . . . 0.33000000000000002 110.388 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -58.29 -28.38 64.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -0.97 . . . . 0.42999999999999999 110.634 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.534 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.5 m-20 -86.23 -16.98 35.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.42999999999999999 110.51 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 7' ' ' CYS . 1.9 m-85 -94.34 138.28 32.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -0.932 . . . . 0.46999999999999997 110.86 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 52' ' ' LEU . 87.3 t -132.75 163.05 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.775 . . . . 0.48999999999999999 110.047 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.453 ' HA ' HD22 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -74.28 117.19 15.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.172 -0.955 . . . . 0.56999999999999995 110.334 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.422 ' N ' HD13 ' A' ' 52' ' ' LEU . 29.7 t80 -66.02 118.0 9.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.56999999999999995 110.531 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -112.18 149.03 32.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.28000000000000003 110.158 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -91.42 106.31 18.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.28000000000000003 110.403 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.9 tttt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.994 -1.003 . . . . 0.46000000000000002 110.299 179.87 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 2' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.996 0.427 . . . . 0.38 110.385 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.513 ' CD1' ' HB3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER 57.45 152.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.898 0.856 . . . . 0.68999999999999995 111.283 178.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.84 169.39 6.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.317 -0.865 . . . . 0.65000000000000002 110.517 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.71 128.13 15.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.39 -0.819 . . . . 0.28999999999999998 109.947 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.525 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 27.5 m95 -107.42 174.25 5.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.29999999999999999 110.019 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.922 HD13 HG13 ' A' ' 13' ' ' ILE . 2.4 tp -149.18 123.31 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.46000000000000002 110.438 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 9.1 t -69.33 95.12 0.76 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.376 -0.828 . . . . 0.37 109.933 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 9' ' ' THR . 11.0 pt -52.28 -22.76 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.16 -0.963 . . . . 0.41999999999999998 110.174 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.42 ' N ' HG13 ' A' ' 8' ' ' ILE . 34.2 m -61.37 -43.99 97.93 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.445 -0.784 . . . . 0.48999999999999999 110.915 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.9 p -123.59 -32.09 3.39 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.983 . . . . 0.28000000000000003 110.945 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.677 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 108.27 30.66 3.79 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.811 -1.316 . . . . 0.17000000000000001 109.811 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -95.17 112.97 24.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.244 -1.151 . . . . 0.20999999999999999 110.015 179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.922 HG13 HD13 ' A' ' 6' ' ' ILE . 63.2 mt -80.72 128.73 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.16 110.533 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.416 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 63.1 t80 -92.6 132.25 37.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.519 -0.738 . . . . 0.10000000000000001 110.052 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -101.69 104.57 15.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.541 -0.724 . . . . 0.11 110.102 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.513 ' HB3' ' CD1' ' A' ' 2' ' ' TYR . 10.2 mt-10 -53.4 -27.12 22.54 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.159 -0.963 . . . . 0.12 110.651 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.464 ' HB2' ' HB2' ' A' ' 2' ' ' TYR . . . -92.01 18.73 7.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.143 -0.973 . . . . 0.19 110.452 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -176.39 66.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.883 . . . . 0.27000000000000002 109.843 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.83 -142.64 0.06 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.952 -1.259 . . . . 0.20999999999999999 109.952 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.42 173.76 7.36 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.409 -1.054 . . . . 0.27000000000000002 110.727 -178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -109.62 -33.43 6.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.324 -0.86 . . . . 0.38 110.167 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.52 -60.44 3.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.39000000000000001 110.363 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -61.3 -17.88 55.82 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.39000000000000001 110.57 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.15 33.34 7.76 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.279 -1.529 . . . . 0.28000000000000003 109.279 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -81.06 76.44 8.01 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.394 -1.062 . . . . 0.31 110.174 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.7 t -50.97 151.22 4.67 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.341 -0.849 . . . . 0.40000000000000002 110.912 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -58.03 123.88 14.68 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.631 1.332 . . . . 0.25 110.466 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.7 23.87 4.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.538 -1.425 . . . . 0.089999999999999997 109.538 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.9 m -94.63 135.83 35.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.106 -1.232 . . . . 0.14999999999999999 110.325 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.66 138.4 47.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.349 -0.844 . . . . 0.23999999999999999 110.428 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.878 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -50.12 -30.97 12.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.219 -0.925 . . . . 0.28000000000000003 110.628 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -61.28 -55.04 36.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.153 -0.967 . . . . 0.31 110.204 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -28.76 69.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.25 110.243 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.878 HD12 ' HA ' ' A' ' 31' ' ' PHE . 82.4 mt -68.33 112.26 10.44 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.26000000000000001 110.288 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -66.29 -153.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.446 1.235 . . . . 0.34000000000000002 110.618 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -92.52 -12.42 31.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.37 110.699 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.27 -51.75 68.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.053 . . . . 0.39000000000000001 110.433 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.533 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 88.2 t90 -56.25 168.7 0.49 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.25 110.532 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.44 ' N ' ' CG ' ' A' ' 38' ' ' TRP . 25.4 p -167.2 -160.65 0.38 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.333 -0.854 . . . . 0.11 110.283 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 0.7 OUTLIER -87.53 144.13 35.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.397 -0.814 . . . . 0.31 110.307 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.16 9.72 3.97 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.667 1.351 . . . . 0.58999999999999997 111.281 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 37.4 p-10 -152.02 17.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.84 -1.163 . . . . 0.56999999999999995 110.934 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 58.0 m -144.92 -72.3 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.068 . . . . 0.39000000000000001 110.284 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.22 36.76 0.73 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.485 -1.446 . . . . 0.22 109.485 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.451 ' HB1' ' OE2' ' A' ' 48' ' ' GLU . . . -121.35 176.0 5.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -1.156 . . . . 0.12 110.592 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -100.8 -162.68 0.96 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.341 -0.85 . . . . 0.17000000000000001 109.964 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -55.15 -21.79 14.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.125 -0.984 . . . . 0.33000000000000002 109.722 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.451 ' OE2' ' HB1' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -53.56 -27.59 27.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.42999999999999999 109.91 179.293 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 4.4 m-20 -91.85 -21.69 20.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.431 -0.793 . . . . 0.42999999999999999 109.908 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -97.27 137.63 35.98 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.263 -0.898 . . . . 0.46999999999999997 110.655 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.464 ' CG1' HG23 ' A' ' 6' ' ' ILE . 7.2 p -127.23 148.1 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.48999999999999999 110.0 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.67 115.52 4.83 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.141 -0.974 . . . . 0.56999999999999995 110.348 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -70.29 118.02 12.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.37 -0.831 . . . . 0.56999999999999995 110.397 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.28 111.89 20.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.28000000000000003 110.313 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -110.8 135.46 51.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.28000000000000003 110.371 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.023 -0.989 . . . . 0.46000000000000002 110.319 179.828 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.17 0.509 . . . . 0.38 110.362 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -107.06 142.25 37.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.364 -0.835 . . . . 0.68999999999999995 110.39 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.62 170.66 7.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.395 -0.816 . . . . 0.65000000000000002 110.524 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -127.32 124.01 37.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.28999999999999998 110.372 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.479 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 35.5 m95 -100.94 172.43 7.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.197 -0.939 . . . . 0.29999999999999999 110.025 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.833 HD13 HG13 ' A' ' 13' ' ' ILE . 2.2 tp -147.37 126.47 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 0.46000000000000002 110.254 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 10.1 t -73.18 89.13 1.5 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.296 -0.877 . . . . 0.37 109.973 178.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.9 pt -49.77 -25.83 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.066 -1.021 . . . . 0.41999999999999998 109.982 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 m -75.61 -28.71 58.96 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.606 -0.684 . . . . 0.48999999999999999 110.147 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 1.5 m -112.57 -54.45 2.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.28000000000000003 110.497 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 7' ' ' CYS . . . 115.11 19.65 5.86 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.585 -1.406 . . . . 0.17000000000000001 109.585 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.55 ' O ' HD12 ' A' ' 6' ' ' ILE . 13.8 m80 -103.93 136.07 44.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -1.207 . . . . 0.20999999999999999 110.134 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.833 HG13 HD13 ' A' ' 6' ' ' ILE . 3.3 mt -93.93 130.05 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.321 -0.862 . . . . 0.16 110.477 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.526 ' CE1' ' HA2' ' A' ' 19' ' ' GLY . 81.0 t80 -97.68 133.14 42.61 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.10000000000000001 109.616 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -111.63 111.15 21.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.11 110.239 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 66.2 mt-10 -50.56 -23.35 2.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.383 -0.823 . . . . 0.12 110.989 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.65 8.05 15.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.976 -1.077 . . . . 0.19 110.968 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.486 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -176.6 68.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.022 -1.049 . . . . 0.27000000000000002 109.625 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.526 ' HA2' ' CE1' ' A' ' 14' ' ' TYR . . . -66.57 -138.39 0.04 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 110.011 -1.235 . . . . 0.20999999999999999 110.011 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -100.35 172.48 7.12 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.408 -1.054 . . . . 0.27000000000000002 110.812 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.88 -31.68 9.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.384 -0.823 . . . . 0.38 110.318 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.93 -50.37 35.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.278 -0.889 . . . . 0.39000000000000001 110.187 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -60.3 -18.35 48.83 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.304 -0.872 . . . . 0.39000000000000001 110.574 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.14 23.03 23.52 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.389 -1.484 . . . . 0.28000000000000003 109.389 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.584 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 1.8 m-30 -83.07 78.14 9.63 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.269 -1.136 . . . . 0.31 110.411 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.401 ' OG1' ' HD2' ' A' ' 27' ' ' PRO . 14.6 t -58.35 155.8 25.27 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.443 -0.785 . . . . 0.40000000000000002 110.678 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD2' ' OG1' ' A' ' 26' ' ' THR . 33.4 Cg_exo -53.75 113.35 1.28 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.619 1.326 . . . . 0.25 110.463 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.7 34.61 1.05 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.276 -1.53 . . . . 0.089999999999999997 109.276 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.469 HG22 ' CG1' ' A' ' 34' ' ' ILE . 30.4 m -117.2 121.55 41.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -1.163 . . . . 0.14999999999999999 110.351 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.453 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 0.5 OUTLIER -108.61 150.86 26.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.279 -0.888 . . . . 0.23999999999999999 110.353 179.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.852 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -47.58 -42.79 24.61 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.285 -0.885 . . . . 0.28000000000000003 111.015 -179.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -60.34 -42.73 96.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.31 110.808 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -78.28 -24.89 46.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.212 -0.93 . . . . 0.25 110.463 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.852 HD12 ' HA ' ' A' ' 31' ' ' PHE . 65.2 mt -63.62 111.12 4.57 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.26000000000000001 110.231 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 34' ' ' ILE . 28.8 Cg_endo -66.78 -174.37 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.41 1.216 . . . . 0.34000000000000002 109.81 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -68.4 -157.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.073 -1.017 . . . . 0.37 110.309 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.9 t0 65.19 9.84 5.91 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.324 -0.86 . . . . 0.39000000000000001 111.423 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.584 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 74.3 t90 -109.82 164.98 12.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.751 -1.218 . . . . 0.25 110.482 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.5 p -167.28 -161.7 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.887 . . . . 0.11 110.335 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 1.4 t -89.99 140.98 27.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.31 110.285 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 40' ' ' CYS . 7.0 Cg_exo -70.91 -7.2 20.87 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 O-C-N 123.482 1.254 . . . . 0.58999999999999997 111.378 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -127.73 -9.11 5.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.911 -1.118 . . . . 0.56999999999999995 111.499 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 84.3 m -121.76 -75.62 0.59 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.897 -1.127 . . . . 0.39000000000000001 110.536 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.19 33.46 0.96 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.536 -1.426 . . . . 0.22 109.536 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.22 177.02 4.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -1.205 . . . . 0.12 110.447 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.4 p -72.28 -162.79 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.17000000000000001 110.365 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -75.19 -4.58 39.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.33000000000000002 110.734 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.05 -41.25 62.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.993 -1.067 . . . . 0.42999999999999999 110.453 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 1.6 m-20 -71.35 -25.66 62.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.42999999999999999 110.008 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -89.06 132.29 34.84 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.296 -0.877 . . . . 0.46999999999999997 110.487 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 5' ' ' TRP . 87.1 t -130.28 159.66 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.48999999999999999 110.129 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.7 tp -64.45 117.41 7.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.154 -0.966 . . . . 0.56999999999999995 110.529 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.414 ' CB ' ' O ' ' A' ' 4' ' ' LYS . 28.0 t80 -76.8 125.54 29.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.56999999999999995 110.35 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -142.2 160.58 39.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.299 -0.876 . . . . 0.28000000000000003 110.285 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -119.94 89.22 3.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.28000000000000003 110.376 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.4 mttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.015 -0.993 . . . . 0.46000000000000002 110.447 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.205 0.526 . . . . 0.38 110.429 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.503 ' CE1' ' NH2' ' A' ' 30' ' ' ARG . 40.6 m-85 -76.29 137.43 39.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.68999999999999995 110.334 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.507 HD23 HD21 ' A' ' 52' ' ' LEU . 6.7 mp -81.32 167.68 19.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.389 -0.819 . . . . 0.65000000000000002 110.465 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.41 ' HG3' ' HA ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER -138.51 124.86 20.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.28999999999999998 110.08 179.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.501 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 34.4 m95 -100.89 142.14 32.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.29999999999999999 110.266 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.789 HD13 ' N ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -107.52 129.04 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.958 -1.089 . . . . 0.46000000000000002 109.806 178.127 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.789 ' N ' HD13 ' A' ' 6' ' ' ILE . 9.6 t -77.19 87.08 3.64 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.374 -0.829 . . . . 0.37 109.172 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 49' ' ' ASP . 2.0 tt -50.47 -22.63 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.15 -0.969 . . . . 0.41999999999999998 110.531 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 m -66.51 -30.23 70.5 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.284 -0.885 . . . . 0.48999999999999999 110.685 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 p -140.15 -15.86 0.98 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.907 -1.121 . . . . 0.28000000000000003 112.662 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.656 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 104.8 -28.3 15.39 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.29 -1.434 . . . . 0.17000000000000001 110.049 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -51.86 135.35 30.18 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.06 -1.259 . . . . 0.20999999999999999 110.415 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.44 ' CG1' HG12 ' A' ' 6' ' ' ILE . 6.7 mt -109.81 142.48 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.82 . . . . 0.16 110.768 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -98.22 123.14 42.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.596 -0.69 . . . . 0.10000000000000001 109.433 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.41 ' HA ' ' HG3' ' A' ' 4' ' ' LYS . 5.1 m-20 -103.26 108.51 19.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.11 110.137 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -48.23 -25.64 1.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.12 110.764 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.431 ' HB2' ' CD2' ' A' ' 2' ' ' TYR . . . -92.32 21.07 5.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.19 110.234 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 tp -176.24 60.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.27000000000000002 109.988 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.51 -139.55 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.852 -1.299 . . . . 0.20999999999999999 109.852 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.69 172.15 7.01 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.392 -1.064 . . . . 0.27000000000000002 110.561 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.47 -45.07 4.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.353 -0.842 . . . . 0.38 110.356 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.51 -54.64 41.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.39000000000000001 110.354 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -60.57 -16.94 42.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.249 -0.907 . . . . 0.39000000000000001 110.595 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.33 29.99 23.39 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.935 -1.666 . . . . 0.28000000000000003 108.935 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.415 ' CZ ' ' CD1' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -80.94 78.42 7.75 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.441 -1.035 . . . . 0.31 110.291 -179.56 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.4 t -52.06 149.17 9.81 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.327 -0.858 . . . . 0.40000000000000002 110.592 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.86 116.7 3.44 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.675 1.355 . . . . 0.25 110.514 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.483 ' HA2' ' CE1' ' A' ' 2' ' ' TYR . . . 131.97 -23.34 4.17 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.468 -1.453 . . . . 0.089999999999999997 109.468 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.56 HG22 HD11 ' A' ' 34' ' ' ILE . 97.3 m -55.95 129.77 41.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -1.092 . . . . 0.14999999999999999 110.458 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.503 ' NH2' ' CE1' ' A' ' 2' ' ' TYR . 47.5 mtt85 -107.94 148.51 29.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.23999999999999999 110.244 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.83 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -49.84 -39.38 38.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 0.28000000000000003 110.627 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.5 -44.9 62.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.31 110.435 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -82.29 5.13 21.08 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.309 -0.869 . . . . 0.25 110.384 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.83 HD12 ' HA ' ' A' ' 31' ' ' PHE . 96.1 mt -106.62 99.38 24.69 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.002 -1.061 . . . . 0.26000000000000001 110.231 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -64.17 -163.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.592 1.312 . . . . 0.34000000000000002 110.54 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -77.95 -4.0 44.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.361 -0.837 . . . . 0.37 110.984 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -65.44 -31.46 72.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.95 -1.093 . . . . 0.39000000000000001 110.342 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.444 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 86.2 t90 -82.91 167.35 18.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.25 110.173 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.421 ' O ' ' CE2' ' A' ' 38' ' ' TRP . 25.9 p -159.07 -160.4 0.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.11 110.607 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . 2.4 t -95.66 140.98 22.57 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.497 -0.752 . . . . 0.31 110.376 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.36 -2.06 12.16 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.538 1.283 . . . . 0.58999999999999997 111.336 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -132.0 13.9 4.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.891 -1.131 . . . . 0.56999999999999995 111.075 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 64.6 m -147.61 -71.65 0.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.011 -1.055 . . . . 0.39000000000000001 110.377 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.63 33.5 1.0 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.744 -1.342 . . . . 0.22 109.744 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.55 -170.71 1.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -1.201 . . . . 0.12 110.466 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.7 p -107.27 -162.59 0.85 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.344 -0.848 . . . . 0.17000000000000001 110.059 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -57.99 -19.48 31.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.155 -0.966 . . . . 0.33000000000000002 109.847 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -51.92 -40.37 60.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.42999999999999999 110.299 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.655 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.6 m-20 -78.02 -23.19 48.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.315 -0.866 . . . . 0.42999999999999999 109.974 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -94.84 138.04 33.14 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.321 -0.862 . . . . 0.46999999999999997 110.406 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.3 t -122.78 160.89 24.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.299 -0.876 . . . . 0.48999999999999999 110.167 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.507 HD21 HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -72.04 101.58 2.76 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.262 -0.899 . . . . 0.56999999999999995 110.129 179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.428 ' CD1' ' HB ' ' A' ' 6' ' ' ILE . 2.7 t80 -68.39 160.6 29.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.413 -0.805 . . . . 0.56999999999999995 110.35 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.74 158.77 18.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -0.88 . . . . 0.28000000000000003 110.312 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.21 -177.65 0.14 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.28000000000000003 110.326 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.022 -0.989 . . . . 0.46000000000000002 110.289 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.265 0.555 . . . . 0.38 110.358 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -67.89 135.55 52.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.305 -0.872 . . . . 0.68999999999999995 110.462 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mp -91.85 170.99 9.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.65000000000000002 110.054 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.57 ' O ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -130.98 133.61 45.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.106 -0.996 . . . . 0.28999999999999998 110.919 -179.423 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.515 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 24.7 m95 -118.54 178.8 4.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.327 -0.858 . . . . 0.29999999999999999 109.445 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.716 HD11 ' HA2' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -163.32 124.58 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.297 -0.877 . . . . 0.46000000000000002 110.488 178.207 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.629 ' N ' HD13 ' A' ' 6' ' ' ILE . 15.5 t -69.17 93.43 0.61 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.459 -0.775 . . . . 0.37 109.591 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 49' ' ' ASP . 2.6 tt -54.44 -19.67 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 0.41999999999999998 110.576 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.405 ' OG1' ' HB2' ' A' ' 49' ' ' ASP . 76.3 m -65.14 -27.89 69.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.205 -0.935 . . . . 0.48999999999999999 110.95 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.1 p -134.35 -35.35 0.92 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.053 -1.029 . . . . 0.28000000000000003 111.375 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.716 ' HA2' HD11 ' A' ' 6' ' ' ILE . . . 112.95 36.43 1.52 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.445 -1.359 . . . . 0.17000000000000001 109.794 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.439 ' O ' ' HA ' ' A' ' 6' ' ' ILE . 10.1 m170 -106.46 108.96 20.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.104 -1.233 . . . . 0.20999999999999999 110.269 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.497 ' CD1' ' CE1' ' A' ' 53' ' ' TYR . 89.9 mt -81.29 131.58 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.366 -0.834 . . . . 0.16 110.762 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.48 ' HH ' ' HD2' ' A' ' 25' ' ' PHE . 81.2 t80 -97.88 128.25 44.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.338 -0.851 . . . . 0.10000000000000001 109.555 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -109.75 110.92 22.08 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.353 -0.842 . . . . 0.11 109.673 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.451 ' CG ' ' HA ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -49.37 -24.33 1.88 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 0.12 110.824 -178.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.5 9.94 14.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.183 -0.948 . . . . 0.19 110.683 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.87 67.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.029 -1.045 . . . . 0.27000000000000002 109.806 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.08 -140.56 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.008 -1.237 . . . . 0.20999999999999999 110.008 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.05 164.38 23.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.416 -1.049 . . . . 0.27000000000000002 110.728 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -114.4 -25.73 8.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.378 -0.826 . . . . 0.38 110.158 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.38 -46.88 25.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -0.881 . . . . 0.39000000000000001 110.185 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -69.56 -34.64 74.48 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.269 -0.894 . . . . 0.39000000000000001 110.358 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.73 32.62 2.63 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.766 -1.334 . . . . 0.28000000000000003 109.766 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.563 ' HE2' HD11 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -72.33 82.48 1.04 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.053 -1.263 . . . . 0.31 109.782 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 13.2 t -48.26 142.64 7.76 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.40000000000000002 111.083 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 26' ' ' THR . 27.8 Cg_exo -58.28 111.4 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.681 1.358 . . . . 0.25 110.484 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 137.24 -25.22 3.03 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.422 -1.471 . . . . 0.089999999999999997 109.422 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.6 m -56.68 130.73 46.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -1.108 . . . . 0.14999999999999999 110.349 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.451 ' HA ' ' CG ' ' A' ' 16' ' ' GLU . 1.0 OUTLIER -107.13 142.04 37.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.23999999999999999 110.349 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.574 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -53.08 -36.46 60.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.28000000000000003 110.168 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -54.74 -26.0 31.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.31 109.797 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -96.17 -21.11 18.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.374 -0.829 . . . . 0.25 110.058 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 31' ' ' PHE . 20.3 mt -60.04 114.53 10.04 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.26000000000000001 109.7 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.66 -162.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.478 1.252 . . . . 0.34000000000000002 110.592 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -95.97 20.48 9.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.905 . . . . 0.37 110.487 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -102.92 -31.44 10.25 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.938 . . . . 0.39000000000000001 110.281 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.441 ' HB3' ' CG2' ' A' ' 34' ' ' ILE . 85.1 t90 -67.29 147.76 52.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.25 110.3 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 92.1 m -148.05 -174.53 4.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -0.871 . . . . 0.11 110.399 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.21 140.62 53.1 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.185 -0.947 . . . . 0.31 110.335 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -72.16 -19.74 25.73 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.52 1.274 . . . . 0.58999999999999997 110.822 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.31 -22.63 15.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.56999999999999995 110.507 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 75.1 m -116.46 -61.46 1.72 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.21 -0.931 . . . . 0.39000000000000001 110.381 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.45 36.1 3.65 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.37 -1.492 . . . . 0.22 109.37 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.41 ' HB3' ' OD2' ' A' ' 49' ' ' ASP . . . -114.05 159.29 20.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -1.109 . . . . 0.12 110.474 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.8 p -65.35 -160.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.17000000000000001 110.34 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 50' ' ' TYR . 32.6 ttpt -67.96 -9.62 46.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.33000000000000002 110.775 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -50.76 -40.68 55.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.025 -1.047 . . . . 0.42999999999999999 110.752 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.526 ' O ' HG22 ' A' ' 8' ' ' ILE . 49.0 p-10 -86.76 -15.76 38.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.42999999999999999 110.809 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.419 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 2.2 m-85 -91.95 140.72 29.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.46999999999999997 110.916 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 6' ' ' ILE . 34.7 m -140.36 164.93 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.41 -0.806 . . . . 0.48999999999999999 110.203 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.57 HD12 ' O ' ' A' ' 4' ' ' LYS . 0.9 OUTLIER -64.67 122.22 16.33 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.245 -0.909 . . . . 0.56999999999999995 110.649 -179.646 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.548 ' N ' HD12 ' A' ' 52' ' ' LEU . 77.5 t80 -74.31 116.42 14.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.56999999999999995 110.395 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -133.13 173.13 11.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.285 -0.885 . . . . 0.28000000000000003 110.493 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -65.27 -164.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.341 -0.849 . . . . 0.28000000000000003 110.394 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 tttp . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.05 -0.976 . . . . 0.46000000000000002 110.351 179.788 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.309 0.576 . . . . 0.38 110.301 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.445 ' CE1' ' HA2' ' A' ' 28' ' ' GLY . 18.1 m-85 -115.87 136.7 52.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.68999999999999995 110.365 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mp -81.9 165.31 20.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -0.852 . . . . 0.65000000000000002 110.527 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -135.61 129.74 33.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 0.28999999999999998 109.885 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.536 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 28.9 m95 -107.24 173.81 6.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.29999999999999999 110.22 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.745 HD13 HG13 ' A' ' 13' ' ' ILE . 1.7 tp -138.99 127.17 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.447 -0.783 . . . . 0.46000000000000002 109.969 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 11.5 t -76.93 87.56 3.48 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.367 -0.833 . . . . 0.37 109.807 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.483 HG21 HG21 ' A' ' 51' ' ' VAL . 38.1 pt -49.14 -25.36 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.147 -0.971 . . . . 0.41999999999999998 110.087 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 m -69.27 -28.7 66.54 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.537 -0.727 . . . . 0.48999999999999999 110.131 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 83.6 m -123.36 -50.31 1.89 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.284 -0.885 . . . . 0.28000000000000003 110.803 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.475 ' C ' HD11 ' A' ' 6' ' ' ILE . . . 120.75 -5.99 11.41 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.253 -1.139 . . . . 0.17000000000000001 110.253 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -76.12 137.82 40.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.851 -1.382 . . . . 0.20999999999999999 110.391 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.745 HG13 HD13 ' A' ' 6' ' ' ILE . 3.7 mt -95.07 127.4 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.16 110.239 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.426 ' HB3' ' HB2' ' A' ' 5' ' ' TRP . 82.4 t80 -79.9 121.61 25.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.407 -0.808 . . . . 0.10000000000000001 109.91 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -99.03 104.93 17.0 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.351 -0.843 . . . . 0.11 109.989 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 2' ' ' TYR . 20.4 mt-10 -49.2 -24.28 1.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.466 -0.771 . . . . 0.12 110.771 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.12 17.97 6.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.126 -0.984 . . . . 0.19 110.474 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.78 53.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.27000000000000002 109.797 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.65 -136.74 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.052 -1.219 . . . . 0.20999999999999999 110.052 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 11.2 t0 -89.33 165.68 14.23 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.365 -1.08 . . . . 0.27000000000000002 110.412 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.67 -25.47 11.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.38 110.22 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.71 -56.69 5.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.39000000000000001 110.11 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -60.42 -22.09 62.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.172 -0.955 . . . . 0.39000000000000001 110.156 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.16 28.66 8.01 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.378 -1.489 . . . . 0.28000000000000003 109.378 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.524 ' CZ ' HD13 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -74.09 75.74 1.74 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.215 -1.168 . . . . 0.31 110.448 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -60.31 151.35 68.64 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.432 -0.793 . . . . 0.40000000000000002 110.581 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -52.02 95.29 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.585 1.308 . . . . 0.25 110.569 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.445 ' HA2' ' CE1' ' A' ' 2' ' ' TYR . . . 152.68 -21.48 0.81 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.67 -1.372 . . . . 0.089999999999999997 109.67 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.633 HG22 HD11 ' A' ' 34' ' ' ILE . 24.4 m -64.92 128.99 38.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -1.202 . . . . 0.14999999999999999 110.553 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.412 ' HG2' ' CB ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -116.31 145.22 43.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.23999999999999999 110.19 179.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.701 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -47.96 -47.31 32.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.241 -0.912 . . . . 0.28000000000000003 110.831 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -50.35 -33.72 21.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.298 -0.876 . . . . 0.31 110.095 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.412 ' CB ' ' HG2' ' A' ' 30' ' ' ARG . 10.3 t0 -93.45 12.97 23.12 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.432 -0.792 . . . . 0.25 110.27 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 31' ' ' PHE . 92.8 mt -117.04 62.88 3.06 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.072 -1.017 . . . . 0.26000000000000001 110.358 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.89 -14.74 36.08 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.558 1.294 . . . . 0.34000000000000002 110.638 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -59.56 -159.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.37 110.55 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -107.34 39.68 1.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.341 -0.849 . . . . 0.39000000000000001 110.605 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.473 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 78.6 t90 -57.65 146.33 31.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.128 -0.983 . . . . 0.25 110.066 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.3 m -136.7 -178.59 5.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.229 -0.919 . . . . 0.11 110.436 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.425 ' CB ' ' HB2' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -67.32 149.9 98.17 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.288 -0.883 . . . . 0.31 109.999 179.555 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -70.62 -5.14 16.07 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.668 1.351 . . . . 0.58999999999999997 111.513 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -156.18 32.11 0.34 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.817 -1.177 . . . . 0.56999999999999995 111.216 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.425 ' HB2' ' CB ' ' A' ' 40' ' ' CYS . 57.7 m -141.19 -57.86 0.49 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.015 -1.053 . . . . 0.39000000000000001 110.234 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.56 26.15 7.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.39 -1.484 . . . . 0.22 109.39 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.561 ' HB1' ' CG ' ' A' ' 49' ' ' ASP . . . -99.13 177.19 5.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.171 -1.193 . . . . 0.12 110.359 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.4 p -113.7 -165.15 0.98 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.326 -0.858 . . . . 0.17000000000000001 110.129 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -32.45 44.1 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.296 -0.877 . . . . 0.33000000000000002 110.436 177.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.94 -33.84 11.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.456 -0.778 . . . . 0.42999999999999999 110.294 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.561 ' CG ' ' HB1' ' A' ' 45' ' ' ALA . 2.4 m-20 -84.49 -26.19 28.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.42999999999999999 109.785 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -92.59 128.11 38.32 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.374 -0.828 . . . . 0.46999999999999997 110.296 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.483 HG21 HG21 ' A' ' 8' ' ' ILE . 94.2 t -119.47 160.6 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.174 -0.954 . . . . 0.48999999999999999 110.252 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -76.68 103.33 6.6 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.167 -0.958 . . . . 0.56999999999999995 110.208 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -59.56 99.0 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.37 -0.831 . . . . 0.56999999999999995 110.701 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 50.44 81.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.894 . . . . 0.28000000000000003 110.769 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.0 167.53 17.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.28000000000000003 110.128 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.015 -0.993 . . . . 0.46000000000000002 110.384 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ' CD' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_